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Treatment of wounds with therapeutic ultrasound has been shown to induce
physiological changes which result in the stimulation of tissue repair. Such stimulation
has been demonstrated under both clinical and experimental conditions. Although
ultrasound is employed to help resolve a multitude of clinical conditions, which
suggests efficacy and clinical acceptance, the specific physiological mechanisms by
which ultrasound produces these effects remain elusive. This thesis describes in vivo
and in vitro studies examining the effect of therapeutic levels of ultrasound on certain
aspects of mammalian cutaneous repair.
The effect of 3 MHz therapeutic ultrasound, pulsed 2ms on, 8ms off, at
spatially and temporally averaged intensities (I(sATA)) of 0.1 and 0.5 W/cm2 on the rate
of contraction of full thickness excised rat flank skin wounds was examined. It was
found that ultrasound increased the rate of wound contraction leading to a
significantly smaller scar.
In vitro studies were carried out to determine the ability of ultrasound to
interact with various components of the repair process thought to be central to the
wound contraction process. The fibroblast is thought to generate the forces necessary
to facilitate wound contraction. In vitro studies reported here appear to suggest that
therapeutic ultrasound does not directly promote fibroblast proliferation or
fibroblast-mediated matrix contraction. The recruitment of fibroblasts into the wound
site is thought to depend on a variety of substances, including several growth factors,
which promote fibroblast proliferation and migration. It is known that platelet a-
granules are stores for some of these substances and it is thought that platelet
degranulation at the wound site is the initial source of fibroblast mobilisation factors.
In vitro studies reported here appear to suggest that therapeutic ultrasound may
interact with platelets thereby encouraging their degranulation and the concomitant
release of factors that may encourage fibroblast activity within the wound site. Later
in the repair process macrophage-derived substances are thought to take over this
fibroblast activating role. In vitro studies carried out here suggest that therapeutic
ultrasound can interact with macrophage-like cells (U937s) and in doing so modulate
the elaboration of fibro-proliferative and fibro-contractile substances.
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Preface
This thesis is divided into 14 chapters. Chapters 1 and 2 are introductory
chapters which describe the basic principles of cutaneous wound repair and
ultrasound physics, respectively. Chapter 3 deals with the mechanisms by which
therapeutic levels of ultrasound are thought to interact with biological materials.
Chapter 4 describes the clinical and laboratory-based literature regarding the effect
of therapeutic levels of ultrasound on wound repair. This thesis contains both in vivo
and in vitro studies into the effect of ultrasound on wound repair; chapter 5 describes
the materials, methods and models employed in vitro studies, together with
experiments designed to examine, and optimise, the sensitivity of the in vitro models
employed. Chapter 6 describes the techniques employed and the results obtained
during the characterisation of the ultrasound dose to which biological materials were
exposed in this thesis. Ultrasonic dosimetry is essential if the findings made in this
study are to be related to the findings of other workers.
Chapters 7 through 11 are experimental chapters. Chapter 7 describes a study
carried out to investigate the effect of treatment with therapeutic ultrasound on the
contraction of full thickness flank skin wounds in the rat. Having observed that
therapeutic ultrasound could promote wound contraction in vivo, further studies were
performed in an attempt to elucidate the responsive biological target(s) involved in
this response. Chapters 8 and 9 consider the ability of ultrasound to interact directly
with human fibroblasts in vitro to promote their proliferation and their ability to
contract collagen lattices. Chapter 10 describes a study into the ability of therapeutic
ultrasound to indirectly modify human fibroblast proliferation and/or fibroblast-
mediated lattice contraction by first interacting with platelets. Chapter 11 describes
a similar study in which the ability of ultrasound to modulate pro-proliferative and/or
pro-contractile substance release from macrophages was examined.
Chapter 12 summarises the experimental findings of this thesis and chapter
13 describes conclusions that may be drawn from those findings. The final chapter
in this thesis, chapter 14, describes certain avenues of important future work that may
be followed. Towards the end of this thesis are the appendices which include: reagent
and culture media recipes, detailed experimental protocols, small supplementary
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Chapter 1. Cutaneous wound repair
Introduction
Many attempts have been made to define the process of wound healing. It has been
described consisely by Walter and Israel (1987) as "the body's replacement of
destroyed tissue by living tissue". This replacement includes both regeneration, the
complete re-establishment of the original tissue, and repair, the replacement of the
original tissue with functionally inferior scar tissue. This definition encompasses the
field of adult cutaneous repair, as the epidermis heals by regeneration, whereas, the
dermis heals by repair.
Acute tissue injury initiates a dynamic and orderly but complex series of
cellular and biochemical interactions that leads to the formation of new tissue and
the eventual repair of the wound. The cellular components of the repair process
include blood cells such as platelets, polymorphonuclear leucocytes, mast cells,
monocytes and T lymphocytes as well as connective tissue cells such as fibroblasts
and endothelial cells. The cells migrate to the site of tissue damage in a precise
sequence thought to be determined primarily by a wide variety of soluble factors that
are released at the site of injury from a wide variety of sources such as tissue
breakdown, blood coagulation and cells. Once they arrive, each cell type has specific
functions to perform in order to facilitate the process of repair.
As an aid to comprehension, the process of repair is classically and arbitrarily
described as a scheme of temporally overlapping events, termed phases of repair. The
three phases of wound repair, as described by Clark (1990), are:
1. inflammation
2. new tissue formation
3. matrix formation and remodelling.
Following injury, and in the absence of any retarding phenomena, cutaneous wounds
are visualised as proceeding through the above phases of repair, with the ultimate
generation of scar tissue.
This chapter will describe the cellular and extracellular activities associated
with each of the three phases, as mentioned above. Cutaneous repair phenomena
directly associated with the work undertaken in completion of this thesis will be
described in a more extensive fashion. Subsequent sections will describe wound
contraction and the theories put forward to explain this phenomenon.
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1.1 Inflammation
Inflammation is a vascular and cellular response which defends the body against alien
substances, disposes of dead and dying tissue, and which generates an environment
conducive to the generation and propagation of granulation tissue. The process of
inflammation can be temporally divided into early and late phases (Clark, 1988b).
1.1.1 Early inflammation
The early phase of inflammation is characterised by clot formation within damaged
vessels which effects haemostasis, and within the wound void which provides a
provisional matrix for cell migration into the wound space. Blood vessel disruption
leads to the extravasation of blood constituents and results in platelet aggregation
and blood coagulation. Platelet adhesion and aggregation, stimulated by locally
generated thrombin and exposed fibrillar collagens, initially leads to the generation
of a haemostatic plug. The initial adhesion of platelets leads to the release of various
substances, including ADP and thrombin, that are responsible for stimulating the
recruitment of additional platelets. Several adhesive proteins including fibrinogen,
fibronectin, thrombospondin and von Willebrand factor are also released from
platelet a-granules; these proteins promote further platelet aggregation and adhesion
to sub-endothelial fibrillar collagen matrix (Terkeltaub and Ginsberg, 1988).
Coagulation of extravasated blood at the wound site is thought to be the result
of both the intrinsic and extrinsic blood clotting pathways, and the action of activated
platelets (figure 1.1). The inciting event in each route of clotting is the expression of
a surface, a consequence of injury, that promotes adsorption and activation of
specific coagulation coenzymes (Dvorak et a!. 1988). Factor XII (Hageman factor)
is activated (to XIIa) by adsorption onto fibrillar collagen, exposed during injury,
which activates the intrinsic coagulation cascade. Tissue factor, released during tissue
damage, activates factor VII; active factor VII (Vila) induces activation of the
extrinsic coagulation cascade. Platelets and endothelial cells activated by low levels
of thrombin (Stern et a!. 1988), and platelets activated by contact with fibrillar
collagen, express surface membrane coagulation factors shared by the intrinsic and
common coagulation pathways, and thereby assist in the coagulation process. The
overall effect of these different coagulation mechanisms is to convert the plasma
protein fibrinogen into an insoluble network of fibrin, which stabilises the initial
haemostatic platelet plugs within the damaged vessels and provides a provisional
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Figure 1.1 Injury exposes blood constituents to fibrillar collagen and tissue
factor. Factor XII (Hageman factor) is activated to Xlla on the surface of fibrillar
collagen, initiating the intrinsic clotting cascade by activating Xl (to Xla). Tissue
factor released during tissue damage activates factor VII; active factor VII (VIIa)
induces activation of the extrinsic clotting cascade. Platelets activated by low
levels of thrombin, or by contact with fibrillar collagen, express surface membrane
coagulation factors shared by both the intrinsic and extrinsic coagulation
pathways, and thereby assist the coagulation process.
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matrix within the wound void. Clotting via the intrinsic coagulation pathway leads
to the generation of bradykinin (Proud and Kaplan, 1988) and to the initiation of the
classical complement cascade (Ghebrehiwetetal. 1981) which leads to the generation
of the complement derived anaphylatoxins C5a and C3a. Both bradykinin and the
anaphylatoxins increase the permeability of undamaged vessels adjacent to the
injured area, resulting in the release of plasma proteins (including fibrinogen) and
the generation of an extravascular clot. The mechanism by which bradykinin increases
vessel permeability is thought to involve an induction of prostaglandin production
(Terragno et a!. 1972).
The anaphylatoxins increase blood vessel permeability both directly, by
inducing a rapid interaction between neutrophils and microvascular endothelium
(Wedmore and Williams, 1981; Issekutz, 1981) which results in vascular damage by
hydrogen peroxide production; and indirectly, by stimulating the release of the
vasoactive mediators histamine and leukotriene C4 and D4 from mast cells (Williams,
1988). The anaphylatoxins are also thought to attract neutrophils (Snyderman et a!.
1970) and monocytes (Marder et a!. 1985) to the site of injury; the latter develop into
macrophages, which characterise the late inflammatory phase.
In addition to their activities associated with clotting, activated platelets also
release a plethora of biologically active substances. Such substances released from
activated platelets may contribute to the inflammatory process by:
(a) modulating vascular tone and permeability e.g. serotonin (dePrada et a!. 1981),
thromboxanes and prostaglandins (Goetzl, 1981).
(b) attracting inflammatory cells, such as neutrophils and monocytes, to the site of
injury, e.g. platelet-derived growth factor PDGF (Deuel and Huang, 1984); platelet
factor-4 PF4 (Deuel et a!. 1981).
(c) initiating subsequent phases of repair by stimulating the migration, proliferation
and the synthesis of extracellular matrix components by connective tissue cells e.g.
PF4, (Senior et a!. 1983), PDGF (Huang et a!. 1988), transforming growth factor-beta
TGF-J3 (Assoian, 1988), epidermal growth factor EGF (Banks, 1988), basic fibroblast
growth factor bFGF (Fox, 1988), and platelet-derived endothelial cell growth factor
(Pierce et a!. 1991; Miyazono and Heldin, 1989).
Neutrophils are classically considered to be the first leucocytes to populate an
area of inflammation and injury; however, it has been suggested that monocytes, the
precursors of macrophages, begin to invade the wound at much the same time (Turk
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et a!. 1976). Both cell types are attracted to the site of injury by an array of
chemotactic factors generated during the physical process of wounding and as a
consequence of the initial response to injury (table 1.1).
Table 1.1 Identified leucocyte attractants
Attractant	 Source	 Reference
CS?	 Complement cascade	 Hugli and Morgan, 1984
Kallikrein'	 Intrinsic clotting pathway 	 Gallin and Kaplan, 1974
Fibrinopeptide?	 Fibrin clot formation 	 Senior et a!. 1986
Fibrin degradation product? 	 Plasinin degradation of fibrin	 McKenzie et a!. 1975
Formylmethionyl peptidesl	 Contaminating bacteria	 Freer et a!. 1980
Leukotriene B4	Activated neutrophils	 Ford-Hutchinson, 1981
Platelet activating factor	 Platelets, neutrophils, monocytes 	 Hanahan, 1986
(py)#	 and endothelial cells
TNFad	 Activated monocytes	 Ming et a!. 1987
PDGF#
	Platelets and activated	 Deuel and Huang, 1984
macrophages	 Deuel et a!. 1982
PF4'	 Platelets	 Deuel et a!. 1981
PD-ECGF	 Platelets	 Pierce et a!. 1991
TGF-fl'	 Platelets and activated	 Wahi et a!. 1987
macrophages,T lymphocytes
Thrombin'	 Clotting cascade	 Bar-Shavit et a!. 1983
Elastin fragments	 Wound site debridement	 Senior et a!. 1980
Fibronectin fragments' 	 Wound site debndement 	 Clark et a!. 1988
Collagen fragments'	 Wound site debridement	 Postlethwaite and Kang,
1976
Key:	 = Chemoattractive to both neutrophils and monocytes
= Chemoattractive to monocytes alone
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In addition to providing the stimulus for directed migration of neutrophils,
chemotactic factors have been shown to induce an upregulation in the expression of
the f32 integrin family of receptors on the surface of neutrophils (Tonnenson et a!.
1988). These dimeric complexes mediate the adherence of neutrophils to blood vessel
endothelium and thereby facilitate diapedesis of leucocytes between adjacent
endothelial cells. Activation of the neutrophil by chemoattractants stimulates the
release of elastase and collagenase enzymes (Janoff, 1985; Hibbs et a!. 1985), which
are thought to facilitate cellular penetration of blood vessel basement membranes.
As neutrophils traverse the endothelium, they respond to a concentration gradient
of chemotactic signals (table 1.1) by cellular polarization and migration toward the
source of that gradient. As the neutrophils reach the source of the chemoattractant,
the gradient is no longer apparent and their directed motion ceases (Wahi, 1989).
The main function of neutrophils within the wound site is thought to be to rid
the site of foreign particles, especially contaminating bacteria, as experimentally
induced neutropenia has been shown to have no effect on wound healing in guinea
pigs in the absence of gross infection (Simpson and Ross, 1972). The environment
of the inflammatory site stimulates neutrophil degranulation, a consequence of which
is the secretion of toxic reactive oxygen intermediates (ROl). The release of 02,
H202 and other toxic oxygen species complements their phagocytic capacity to destroy
contaminating bacteria (Wahi, 1989); however, the release of these ROl can also
cause significant damage to surrounding tissues (Halliwell, 1987). Neutrophil
infiltration is observed to cease, and neutrophil numbers to fall, within a few days
after injury in the absence of significant ongoing bacterial infection. Effete
neutrophils are phagocytosed by tissue macrophages (Haslett and Henson, 1988).
This fall in neutrophil number is regarded as the end of the early inflammatory phase
of repair (Clark, 1988b).
1.1.2 Late inflammation
Irrespective of whether the neutrophil infiltrate resolves or persists, monocyte
infiltration continues, a process presumably dependent on selective monocyte
chemoattractants (table 1.1) which include fragments of extracellular matrix
components (Schiffmann and Gallin, 1979) including collagen (Postlethwaite and
Kang, 1976), elastin (Senior et a!. 1980) and fibronectin (Clark et a!. 1988); thrombin
(Bar-Shavit et a!. 1983) and transforming growth factor-13 (TGF-j3) (Wahi et a!. 1987)
23
also act as chemoattractants. After injury, the number of blood monocytes in general
circulation has been observed to increase two to threefold (van Furth et a!. 1973; van
Waarde et a!. 1976). This is thought to be caused by a macrophage product called
"factor inducing monopoiesis" (FIM), which is produced at the site of inflammation
(Sluiter et a!. 1983). Thus infiltrating macrophages may augment the number of
monocytes entering the wound site in a positive feedback manner. During the waning
stages of inflammation, this feedback ioop is thought to be terminated by another
soluble factor called monocyte production inhibitor (MPI) (van Waarde et a!. 1978).
After migrating from the vasculature into the wound site, monocytes rapidly
differentiate into activated inflammatory macrophages (Riches, 1988). The
mechanisms responsible for driving the differentiation of monocytes into activated
inflammatory macrophages are unclear, however, certain environmental stimuli
including: the presence of insolubilized fibronectin (Hosein et a!. 1985), low oxygen
tension (Hunt, 1987), the presence of certain chemotactic stimuli (Ho et a!. 1987), the
presence of interferons and of bacteria] Iipopolysaccharides, have all been implicated
in this process (Riches, 1988).
Wound macrophages, like neutrophils, take part in bacterial clearance and
also scavenge dead and damaged tissue from within the wound site (Newman et a!.
1982). Macrophages not only phagocytose bacteria and scavenge tissue debris, but
also generate chemotactic factors which recruit additional inflammatory cells and
release enzymes which augment tissue degradation (Tsukamoto et a!. 1981). In
addition to their role in tissue debridement, wound macrophages are thought to
elaborate growth and regulatory factors critical to the coordination of granulation
tissue formation. Evidence for this latter role comes from the pioneering work of
Leibovich and Ross in 1975, who demonstrated that the induction of monocytopenia,
through a combination of hydrocortisone to eliminate circulating macrophage
precursors and anti-macrophage serum to eliminate resident macrophages, severely
inhibited the repair of guinea pig wounds. Under these conditions, fibroblast and
endothelial cell recruitment and proliferation, capillary generation and matrix
biosynthesis were all adversely affected. Furthermore, the removal of damaged tissue
was markedly reduced with the accumulation of large amounts of fibrin.
Subsequent studies by Leibovich and Ross (1976) reported that peritoneal
macrophages cultured in vitro secreted growth factor activity, called macrophage-
derived growth factor (MDGF), which stimulated the proliferation of guinea pig
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wound fibroblasts. MDGF, secreted by activated macrophages, has also been shown
to stimulate the proliferation of smooth muscle cells (Greenburg and Hunt 1978;
Glenn and Ross, 1981; Martin et a!. 1981), arterial endothelial cells (Greenburg and
Hunt, 1978; Martin et a!. 1981) and mouse keratinocytes (Ristow, 1986). It has since
been realised that MDGF activity is a combination of several well characterised
growth factors (Raines and Ross, 1989). The factors macrophages are known to
secrete include platelet-derived growth factor (PDGF) (Shimokado et a!. 1985;
Martinet et a!. 1986), basic fibroblast growth factor (bFGF) (Baird et a!. 1985),
transforming growth factor-/3 (TGF-/3) (Assoian et a!. 1987), insulin-like growth
factor-i (IGF-1) (Rom et a!. 1989), tumour necrosis factor-a (TNF-a) (Kreigler eta!.
1988), the epidermal growth factor-related transforming growth factor-a (TGF-a)
(Madtes et a!. 1988), interleukin-1 (IL-i) (Postlethwaite et a!. 1983) and fibroblast-
activating factor (FAF) (Dohiman et a!. 1984). The production of many of these
factors, including TGF-a, TGF-f3, PDGF A-chain and insulin-like growth factor 1
(IGF-1), have been demonstrated in wound macrophages by mRNA phenotyping
(Rappolee et a!. 1988). The functions of these and other substances in the initiation
and propagation of granulation tissue will be discussed in subsequent sections of this
chapter.
1.2 New tissue formation
The inflammatory response provoked by tissue injury is rapidly followed by the phase
of new tissue formation often referred to as the proliferative or fibroplastic phase.
During cutaneous wound repair, new tissue formation is manifest by
1. Re-epithelialization
2. Granulation tissue formation.
1.2.1 Re-epithellalization
Re-epithelialization is the reconstitution of the cells of the epidermis into an
organised, keratinised stratified squamous epithelium that covers the wound defect
and provides the barrier properties of the skin. The process of re-epitheialization
begins some time before the initiation of granulation tissue formation, usually
commencing within a few hours after injury (Stenn and Depalma, 1988). Re-
epithelialization is brought about by the migration of epidermal cells from the free
edge of the wound towards the centre of the surface separating viable from non-
viable tissue.
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In response to wounding, epidermal cells at the wound margin have been
observed to undergo a cellular metamorphosis that involves the retraction of
intracellular tonofilaments, dissolution of intercellular attachments (specifically
desmosomes) and basement membrane attachments (hemidesmosomes) (Krawczyk
and Wilgram, 1973), cellular flattening, the formation of peripheral actin filaments
(Gabbiani et a!. 1978) and the projection of pseudopodia (Odland and Ross, 1968).
The free edge generated during wounding, in tandem with these cellular changes,
give the epidermal cells of the wound margin somewhere to migrate and the cellular
machinery to expedite that migration. Because of the proliferative capacity of cells
of the stratum basale, it was initially assumed that wounds were re-epithelialized by
cells originating from this layer of the epidermis. However, it has been demonstrated
that epidermal cells at the wound margin have a unique phenotype, termed the
phenotype of regenerative maturation (Mansbridge and Knapp, 1987), in which they
display certain phenotypical characteristics common to cells of both the stratum basale
and the stratum granulosum.
The signals for epidermal cell phenotype switching are effectively unknown.
However the observations that low extracellular calcium concentrations impart
keratinocytes with the phenotype of regenerative maturation, whereas normal calcium
concentrations drive terminal differentiation in vitro (Hennings et a!. 1980), and that
a calcium chelating protein called SPARC (Holland et al. 1987) is absent from
normal epithelium but present during re-epithelialization, suggests that calcium may
be involved in this switching (Clark, 1990).
These modified epidermal cells form a multilayered tongue-like structure at
the wound margin that migrates beneath the eschar, and in doing so dissects viable
tissue from desiccated non-viable tissue (Clark, 1990) a process thought to involve
the elaboration of hydrolases including collagenase by the migrating cells (Harris and
Krane, 1974). As the epidermis migrates over the wound surface the basement
membrane is regenerated (Woodley and Briggaman, 1988). The stimuli for epidermal
migration are not well understood; however, it has been suggested that the driving
force for epidermal cell movement may involve contact guidance by matrix
components of the clot, chemotactic factors generated during clotting and platelet
degranulation, the loss of nearest neighbour cells (Heinmark and Schwartz, 1988),
or a combination of all of these stimuli (Clark, 1990). While re-epithelialization is a
well documented phenomenon, mechanistically much has yet to be determined.
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In vitro studies have demonstrated that when epithelial explants are cultured
on a basement membrane-like substratum (i.e composed of laminin, heparan
sulphate, proteoglycans and collagen types IV and V) few of the explants spread out,
but explants in contact with non-basement membrane proteins, collagens type I and
III or fibronectin, exhibit significant migration (Woodley et a!. 1985). This suggests
that loss of the basement membrane during wounding, and its replacement by a
provisional matrix of fibrin and fibronectin, generated during clotting, may be a major
stimulus for epidermal cell migration over the wound (Clark et a!. 1983; Fujikawa,
1981). The observation that migrating epithelial cells generate fibronectin (Clark et
a!. 1983), has led to the suggestion that the initial stimulus for migration is probably
plasma-derived fibronectin, and further migration is promoted by the synthesis of
fibronectin by the migrating cells themselves (Clark et a!. 1983). Transforming growth
factor-f3 (TGF-13), which has been observed to encourage epithelial cell migration in
vivo (Yang and Moses, 1990), has been proposed as a critical signal in epithelial cell
migration (Clark, 1990). This proposal stems from the observations that TGF-/3 has
been shown to stimulate a 6-fold increase in fibronectin synthesis in cultured
keratinocytes (Wilkner et a!. 1988), to stimulate keratinocytes motility apparently
through stimulation of fibronectin deposition (Nickoloff et a!. 1988), and is thought
to induce fibronectin receptor expression in keratinocytes (Toda et at. 1987). Thus
TGF-13 may facilitate epidermal migration through the induction of matrix fibronectin
production and cell surface fibronectin receptor expression.
Epidermal migration over the wound surface is known not to depend on cell
proliferation (Winter, 1972), in fact, it has been suggested that TGF-f3, which is a
potent inhibitor of keratinocyte proliferation in vitro (Shipley et a!. 1986), may be
actively engaged in inhibiting cellular proliferation of the epidermal tongue (Clark,
1990). The migrating epidermal tongue is thought to be supplied with additional cells
by epidermal cell proliferation at or near the wound margin (Winter, 1972). The
stimuli for epithelial cell proliferation have not been delineated, but several growth
factors, such as epidermal growth factor, transforming growth factor-a and fibroblast
growth factor, have been suggested as possible candidates (Clark, 1990). Such growth
factors may arise as a consequence of platelet degranulation or macrophage
activation and act to promote proliferation in a paracrine manner, or, may be
synthesized by epidermal cells themselves and promote proliferation in a autocrine
fashion (Coffey et a!. 1987). Once the migrating edges have united, migration ceases
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and epidermal cells rapidly reassume their normal phenotype and attach to each
other by desmosomes, to the basement membrane via hemidesmosomes, and thereby
reconstitute the epidermis. A more comprehensive review of re-epithelialization has
been written by Stenn and DePalma (1988).
1.2.2 Granulation tissue formation
The process of granulation tissue formation, which is partially dependent on cellular
interactions initiated during the inflammatory phase, is an early step towards
replacing the dennal component, lost during injury, with scar tissue. It is
characterised by the accumulation of macrophages, the colonisation of the wound
space by fibroblasts (which involves both fibroblast proliferation and migration), the
deposition of a loose connective tissue matrix (composed of fibronectin, hyaluronic
acid and collagen types I and III), and neovascularisation. Fibroblast proliferation,
migration and the synthesis and elaboration of collagenous and non-collagenous
matrix are collectively referred to as fibroplasia (Clark, 1990).
It is thought that the processes of fibroplasia and angiogenesis are stimulated
in part by a number of growth and chemotactic factors released by platelets and
macrophages during inflammation (Huang et a!. 1988), and by the fibroblasts and
endothelial cells themselves, to which they respond in an autocrine fashion (Sporn
and Roberts, 1986). Fibroblasts respond to these stimuli by proliferation, migration,
matrix deposition, and wound contraction. The matrix generated by fibroblasts
provides a substrate on which macrophages (Ciano et a!. 1986), new blood vessels
(Madri and Pratt, 1988) and fibroblasts (McCarthy et a!. 1988) can migrate into the
wound. Endothelial cells of vessels within the undamaged wound periphery respond
to these growth and chemotactic signals by degradation of their basement
membranes, directed migration, proliferation and capillary formation.
Neovascularization is necessary to satisfy the metabolic demands of fibroplasia and
re-epithelialization.
1.221 Neovascutarization
Neovascularization of wounds occurs simultaneously with fibroplasia by the sprouting
of capillary buds from blood vessels adjacent to the wound; these buds subsequently
extend into the wound site. Granulation tissue, while only transient, is metabolically
very active and consequently requires a profuse blood supply. New capillary
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formation (angiogenesis) is an extremely complex process that depends on
endothelial phenotype alteration, migration, proliferation, and synthesis of an
appropriate extracellular matrix (Madri and Pratt, 1988). This section will briefly
review the process of wound neovascularisation; more comprehensive reviews of the
process include those of Madri and Pratt (1988) and Zetter (1988).
Angiogenesis in the adult occurs as a sprouting process in which new
capillaries bud from pre-existing small venules (Findlay, 1986; Furcht, 1986; Zetter,
1988), and can be summarised as follows. One of the first events that can be
observed in angiogenesis involves the disruption of the basement membrane on the
side of the venule facing the angiogenic stimulus. It is thought that the basement
membrane is degraded by enzymes from the endothelial cells themselves, as high
concentrations of collagenases and plasminogen activator are secreted by capillary
endothelial cells stimulated in vitro by angiogenic substances (Gross et a!. 1983). After
the basement membrane has been opened the second essential event in the
angiogenic process is the directed migration of the endothelial cells from pre-existing
vessels toward the site of the angiogenic stimulus (Ausprunk and Folkman, 1977).
The migrating cells align with each other in a bipolar configuration to form a sprout.
The vessel sprouts elongate and undergo a process of canalization (tube formation)
formed by a curvature that develops in the capillary endothelial cell. Once a sprout
has formed, endothelial cells in its mid section undergo mitosis. The leading cells at
the tip of the sprout continue to migrate but usually do not divide (Ausprunk and
Folkman, 1977; Burger and Klintworth, 1981). Individual sprouts then join, or
anastomose, with each other to form a loop. These loops elongate and may become
the origin of additional sprouts. The loops and sprouts continue to converge on the
source of angiogenic activity. Blood flow begins slowly shortly after loops have
formed. Since the junctions between endothelial cells are initially loose and there are
gaps in the endothelial lining these immature capillaries are fragile and very
permeable (Hashimoto and Prewitt 1987). The final stage of capillary development
is the development of a mature capillary bed in which the capillaries are surrounded
by basement membrane components (Ausprunk et a!. 1981), and in some cases by a
layer of perivascular cells called pericytes (Hashimoto and Prewitt 1987)
The angiogenic stimuli responsible forwound neovascularization are unknown,
however, numerous stimuli (reviewed by Folkman and Klagsbrun, 1987; Madri and
Pratt, 1988; Zetter, 1988) have been reported that promote endothelial cell growth
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in vitro and/or angiogenesis in situ (using the chick chorioallantoic membrane and the
corneal angiogenesis assays), several of which are known to be found in healing
wounds. The process of wound neovascularization is thought to result from the
actions of various angiogenic stimuli, generated during injury or as a consequence of
the initiation of the repair process (Zetter, 1988; Clark, 1990). Vascular and cellular
damage during tissue injury leads to the release of proteolytic enzymes into the
interstitium, enzymatic degradation of components of the extracellular matrix is
thought to release matrix fragments which have both direct and indirect angiogenic
effects. Fragments of fibronectin have been shown to be directly chemotactic for
endothelial cells in vitro (Bowersox and Sorgente, 1982), and fragments of fibronectin,
elastin and collagen have been shown to be chemotactic for monocyte-macrophages
(Postlethwaite and Kang, 1976; Senior et a!. 1980; Clark et a!. 1988). Activated
macrophages are known to release potent angiogenic stimuli (Polverini et a!. 1977)
including: fibroblast growth factor (FGF) (Baird et a!. 1985), E-series prostaglandins
(Ziche et a!. 1982; Form and Auerbach, 1983), tumour necrosis factor-a (Frater-
Schroder et a!. 1987; Leibovitch et a!. 1987) and angiotropin (Hockel et a!. 1987).
Macrophage activation and the elaboration of angiogenic agents is thought to be
modulated in part by the relatively hypoxic environment of the wound (Knighton et
a!. 1983). Various platelet-derived substances, generated during platelet
degranulation, are also thought to promote the angiogenic response. Platelet-derived
endothelial cell growth factor (PD-ECGF) has been shown to directly promote both
endothelial cell migration (Ishikawa et a!. 1989) and proliferation (Miyazono and
Heldin, 1989) in vitro, and has been shown to promote angiogenesis in vivo (Ishikawa
et a!. 1989). PD-ECGF is also thought to be indirectly angiogenic due to its
chemotactic attraction for monocytes (Pierce et a!. 1991), which may augment its
direct angiogenic effects. Transforming growth factor-/3 (TGF-/3) has also been shown
to both directly influence endothelial cell migration in vivo (Yang and Moses, 1990)
and, like PD-ECGF, promote monocyte-macrophage chemotaxis (Wahi et a!. 1987)
and can thus be considered to be directly and indirectly angiogenic.
Other platelet-derived substances are thought to be indirectly angiogenic as
a result of their chemotactic attraction for monocyte-macrophages. Such substances
include: platelet activating factor (PAF) (Hanahan, 1986), platelet-derived growth
factor (Deuel and Huang, 1984), and platelet factor 4 (Deuel et a!. 1981). Platelets
also produce an enzyme (Oosta et a!. 1982), that may function to release heparin
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from the basement membrane of endothelial cells, a substance also released by mast
cells during degranulation that is known stimulate endothelial cell migration in vitro
(Azizkhan et a!. 1980). Also, as basement membrane heparin is thought to be a
storage site for FGF (Vlodavsky et al. 1987; Baird and Ling, 1987), degradation of
this storage depot may result in solubilisation of this potent angiogenic agent.
Although neutrophils are recruited into the wound site in the early phase of
inflammation (p 21) there is currently no evidence for the role of specific neutrophil
products in the direct stimulation of angiogenesis. However, neutrophils are known
to elaborate substances chemotactic for monocyte-macrophages, including leuktriene
B4 (Ford-Hutchinson, 1981) and PAF (Hanahan, 1986), and may consequently be
involved indirectly in the process of angiogenesis.
The mechanisms that limit the process of wound angiogenesis are not clear.
Orlidge and D'Amore (1987) showed that pericytes act to inhibit the growth of
adjacent endothelial cells and thus may be responsible for a down regulation in the
angiogenic response. Other events associated with later stages of repair may also act
as a brake to the angiogenic process. Such events include: (1) the cessation of
chemotactic/mitogenic factor generation, as the inflammatory response wanes, (2) the
production of heparin-like molecules by endothelial cells, which may serve to capture,
store and inactivate FGF molecules (Zetter, 1988), and, (3) a return to a normal,
non-macrophage-activating, oxygen tension; thus reducing angiogenic factor
production by these cells (Knighton et al. 1983).
Granulation tissue has a lavish blood supply, however, as the wound matures
and the granulation tissue is remodelled into a relatively acellular scar, a regression
in the capillary network occurs. The mechanism underlying capillary regression is
effectively unknown, but is thought to be a continuation of the angiogenesis "braking"
system described above, i.e. a result of the loss of angiogenic stimuli. Capillary
regression is characterized by a swelling of mitochondria within the endothelial cells
of regressing vessels, platelet adherence to the degenerating endothelial cells,
vascular Stasis and endothelial cell necrosis, and finally, ingestion of effete endothelial
cells by macrophages (Ausprunk et a!. 1978; Folkman, 1982).
1.2.2.2 Fibroplasia
The recruitment of fibroblasts to the wound site and the ensuing synthesis and
elaboration of collagenous and non-collagenous matrix is often referred to as
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fibroplasia. The colonisation of the wound site by fibroblasts, essential for granulation
tissue formation, is thought to involve both fibroblast migration and proliferation.
The origin of wound fibroblasts has been the centre of debate for a long time (Skalli
and Gabbiani, 1988). Initially it was thought that leucocytes became transfonned into
fibroblasts during the process of repair (Cohnheim, 1867), however, it has since been
proven that leucocytes do not have the capacity to transform in such a manner, and
that granulation tissue fibroblasts arise from local connective tissue. The question still
remains as to whether granulation tissue fibroblasts can arise from any
mesenchymally-derived cell present in dermis and subcutaneous tissue such as
fibrocytes, pericytes and smooth muscle cells (Crocker et a!. 1970). The work of
Bouissou et a!. (1988) suggests that granulation tissue fibroblasts originate from
resting fibrocytes, rather than smooth muscle cells, in the wound margins, a view
generally supported by actin isoform and intermediate filament cytoskeletal analysis
(Schurch et a!. 1984; Skalli and Gabbiani, 1988). However, a-actin which is apparently
specific to smooth muscle cells, has been found to be transiently expressed by
granulation tissue fibroblasts (Darby et a!. 1990).
1.2.2.2.1 Fibroblast migration
It is thought that the migration of fibroblasts into the wound site is achieved by
various mechanisms under the control of a complex array of stimuli. The stimulus for
directional movement can be a soluble attractant gradient (diemotaxis), an adhesion
gradient (haptotaxis) or associated with the three dimensional arrangement of
extracellular matrix fibrils within the tissue (contact guidance).
A variety of substances found in healing wounds have been shown to promote
the migration of fibroblasts in vitro, and thus may contribute to the colonisation of
wounds by fibroblasts in vivo.
A. Chemotaxis
Chemotaxis has been defined as the directed migration of cells in response to a
concentration gradient of soluble attractant (McCarthy et at. 1988). A multitude of
agents known to be present during cutaneous repair have been shown to be
chemotactic for fibroblasts. Such substances include complement metabolites, growth
factors generated during platelet degranulation and synthesized by activated
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macrophages and lymphocytes, and matrix fragments generated during wound
debridement (table 1.2).
B. Cell adhesion and haptotaxis of fibroblasts migrating into wounds
Haptotaxis has been defined as the directed migration of cells along an adhesion
gradient (McCarthy et a!. 1988). It is now appreciated that certain components of the
extracellular matrix can promote the migration of cells directly, while other
components may impede it (McCarthy et a!. 1988). When the dermis is wounded, the
composition of the extracellular matrix changes drastically (Repesh et al. 1982). As
a result of the vascular response to injury, a transudate of plasma escapes into the
extravascular space and coagulates within the lesion forming a clot. The fibrin within
the clot is decorated with fibronectin originating from plasma (Kurkinen et a!. 1980).
As the wound matures and granulation tissue is formed, the composition of the
extracellular matrix changes. Fibroblast infiltration into the wound coincides with an
increase in fibroblast-derived fibronectin, collagen type III fibres and hyaluronic acid
(Repesh et a!. 1982). As granulation tissue resolves, collagen type I fibrils begin to
predominate, and the wound undergoes remodelling. The adhesive non-collagenous
proteins, primarily fibronectin, of the extracellular matrix are of primary importance
when considering the migration of connective tissue cells into the wound.
Fibronectin has multiple ligand-binding activities which can be simplified as
matrix-binding activities and cell-binding activities. Different binding activities are
localised in different domains of the fibronectin molecule.
Matrix-binding activities:
Cell-binding activities:
binding to collagen types I-IV, fibrin, thrombospondin,
chondroitin sulphate, dermatan sulphate, heparin, heparan
sulphate, hyaluronic acid
binding to fibroblasts, macrophages and vascular
endothelial cells
The adhesion of cells to the extracellular matrix is essential to cell motility.
Cells must adhere sufficiently to the substrate to generate the traction force required
for cell motility yet not be so adherent that they are incapable of breaking adhesions
and translocating (McCarthy et a!. 1988). Cell adhesion to fibronectin is primarily
thought to involve integrin recognition of the tetrapeptide arginyl-glycyl-aspartyl-
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serine (RGDS using the single-letter amino acid code) sequences within fibronectin
(Yainada and Kennedy, 1984). However, the binding of cells to fibronectin has also
been shown to involve the interaction of cell membrane-associated proteoglycans with
heparin binding domains within fibronectin (Lark et a!. 1985; McCarthy et a!. 1986).
There is also some evidence that glycosaminoglycans (Schwartz and Juliano, 1985)
and glycolipids (gangliosides) (Speigel et a!. 1984) are involved in cellular adhesion
to fibronectin.
Two types of adhesion structures, close contacts and focal contacts, have been
observed on attached cells in vitro (Izzard and Lochner, 1980). Close contacts, which
are thought to represent relatively weak cellular adhesion, are characterized by a
distance of 20-30 nm between cell membrane and substrate, whereas focal contacts
represent stronger adhesion and are characterised by a distance of 10-15 nm between
cell membrane and substrate. Since the number of focal adhesions increases the
motility rate decreases, it is probable that the close contacts may be involved in
facilitating cell movement (Kolega et a!. 1982). When cell binding to fibronectin is
restricted to either the RGDS domain, or the heparin binding (proteoglycan) domain,
only the weak close contacts form. However, when cell binding to both adhesive
domains is permitted, using whole fibronectin, both close and the stronger focal
contacts form (Lark et a!. 1985), thus indicating that strong adhesion to fibronectin
is facilitated by the collective influence of several distinct, weaker, interactions. Close
contacts are thought to supply the cell with sufficient adhesion to facilitate traction
(i.e to allow grip) without being too adhesive and thus preventing translocation. By
regulating the level of adhesion to fibronectin the cell may be able to regulate its
capacity to migrate.
The binding of cell membrane-associated heparan sulphate proteoglycan to
fibronectin, via the heparin binding domain, is thought to partially facilitate cell-
fibronectin adhesion. It has been demonstrated that hyaluronic acid and chondroitin
sulphate weaken this binding (Culp et al. 1979; Brennan et a!. 1983). Thus an
interplay between different proteoglycans and hyaluronic acid at cell-matrix
attachment sites may be involved in determining the state of cell adhesion. It has
been suggested that chondroitin sulphate directly competes with heparan sulphate for
heparin binding sites on the fibronectin molecule, thus the differential synthesis and
elaboration of proteoglycans by fibroblasts could dictate the level of their adhesion,
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1988). This may explain the high levels of hyaluronic acid found during granulation
tissue formation, a time when fibroblasts are actively migrating into the wound.
McCarthy et a!. (1985) demonstrated that fibronectin gradients, set up in a Boyden
chamber, haptotactically influence cell motility. Further work by McCarthy et a!.
suggests that the fibronectin cell motility domain (which is also thought to facilitate
cell adhesion) is distinct from the RODS cell adhesion domain (McCarthy et a!.
1986).
C. Contact guidance during fibroblast migration into wounds
Contact guidance refers to the tendancy of cells to align along and thereafter migrate
along discontinuities in substrata to which they are attached. The orientation of the
filamentous components of the wound extracellular matrix changes as the wound
progresses through repair. The clot (primarily fibrin and fibronectin) and newly
deposited collagen at the wound periphery has a random fibrillar pattern. As
fibroblasts migrate into the wound there is a progressive change from this random
fibrillar pattern to a more orderly array of fibrils running parallel to the wound
surface (Repesh et a!. 1982). This ordered array is thought to be a consequence of
centripetal fibroblast migration, towards the centre of the wound, within the early
matrix. It is suggested that during this centripetal migration, fibroblasts advance,
remove the random fibronectin fibrils, and leave ordered fibronectin fibrils in their
wake (Sas et a!. 1985). This modification of the early fibrous matrix is thought to
influence the entry of further cells into the wound site. As fibroblasts migrate into
such orientated matrices they are observed to align parallel to the orientation of the
matrix fibres (Bryant, 1977; Repesh et a!. 1982). In this way contact guidance forces
exerted by the fibres contribute directly to sustaining the influx of fibroblasts into the
wound site.
D. Penetration of the matrix
In addition to the stimuli for directional movement, fibroblasts and other migratory
cells must have free space into which they can migrate. Fibroblast and macrophage
migration into the wound site involves the penetration of the extracellular matrix
(ECM). Such cellular penetration is thought to be facilitated by various mechanisms.
Fibroblasts and macrophages are known to elaborate a variety of enzymes (plasmin,
plasminogen activator, and collagenase) capable of digesting the matrix (Reich et a!.
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1976). Fibroblasts also clear a route by phagocytosis of the ECM, a process
potentiated by fibronectin (Saba and Jaffe, 1980). The hydration of hyaluronic acid,
produced by fibroblasts, may also be involved in opening up spaces within the matrix
of the healing wound (Toole, 1981). In addition to the mechanical expansion of
hyaluronic acid, it may also function to stabilise cheniotactic gradients by holding free
water in place (McCarthy et al. 1988)
1.2.2.2.2 Fibroblast proliferation
As previously mentioned the recruitment of fibroblasts into the wound site involves
both migration and proliferation. A variety of substances found in healing wounds
have been shown to promote the proliferation of fibroblasts in vitro, and thus may
contribute to the colonisation of wounds by fibroblasts in vivo.
Proliferation is thought to be influenced by many agents, the most critical of
which are thought to be peptide growth factors (Wong and Wahl, 1989). Table 1.3
lists the growth factors thought to be responsible for fibroblast proliferation during
wound repair. Growth factors can be divided into two distinct classes which are
complementary, as neither class of factor alone will cause proliferation. Prior to the
initiation of growth, fibroblasts apparently require two signals, a competence signal
and a progression signal (Pledger et a!. 1977). Competence factors do not stimulate
DNA synthesis but activate quiescent cells in the G0 phase of the mitotic cycle,
enabling them to become responsive to the action of progression factors. Progression
factors cause cells to progress from G 1 to the S phase and causes initiation of DNA
synthesis (Scher et a!. 1979). Factors such as PDGF and bFGF impart competence
signals (Scher et a!. 1979), whereas factors such as EGF act as progression factors
(Wong and Wahl, 1989). Some of the factors that stimulate fibroblast proliferation
have not yet been classified as either competence or progression signals. Among
these are IL-i and TGF-13. It is uncertain whether IL-i acts to increase cell surface
receptors for other growth factors such as EGF and PDGF (Wong and Wahi, 1989).
TGF-f3 may stimulate fibroblast proliferation through the stimulation of PDGF or IL-
1 production by fibroblasts to which they respond in an autocrine manner (Loef et
a!. 1986). From table 1.3 it would appear that there is a great deal of overlap, and
consequently redundancy, in the mitogenic capabilities of growth factors released
during wound repair. This apparent redundancy may be explained by the fact that
many of the observations of growth factor mitogenicity reported in table 1.3 were
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made in vitro under two dimensional (planar) culture conditions, environmental
conditions rarely encountered in vivo. It is possible that the three dimensional
environment experienced by cells within wound tissue regulates their ability to
respond to mitogenic stimuli. Alternatively, this array of mitogenic factors may be
necessaiy to induce proliferation under the assortment of environmental conditions
experienced by the fibroblast during the repair process. Supporting evidence for the
role of one growth factor, PDGF, in wound fibroblast proliferation comes from in
vivo observations of peak levels of this growth factor at times of peak fibroblast
proliferation (Grotendorst et al. 1988).
With the exception of the relatively recently discovered PD-ECGF (Ishikawa
et a!. 1989), activated macrophages have been shown to be able to produce all of the
currently accepted fibroblast growth factors; thus further supporting the view that the
macrophage and its activities are central to the process of wound repair.
1.3 Matrix formation and remodelling
While matrix formation and remodelling is generally described as the third phase in
the repair process, it begins at about the same time as the new tissue formation
phase. However, matrix remodelling continues for many months if not years after
granulation tissue has resolved, which explains its position in the temporal sequence
of wound repair (Clark, 1990). During matrix remodelling, granulation tissue is
gradually replaced by scar tissue, a less cellular and less vascular connective tissue.
Even under optimal conditions the scar is an imperfect substitute for the dermis,
since it has lower breaking strength, serves as a diffusional barrier to nutrients and
oxygen and often results in deformation and reduction of function of the original
tissue (Shosan, 1981; Chvapil and Koopman, 1984).
The deposition of the extracellular matrix (ECM) within the wound site
follows a fixed temporal and spatial scheme, with the composition and structure of
the ECM progressively changing from the time at which it is first deposited. Spatially,
ECM is first deposited at the wound margins as part of the initial granulation tissue
and later more centrally as the granulation tissne fills the wound space.
Consequently, the composition and structure of granulation tissue ECM at a given
site within the wound depends on the time elapsed since injury and the location of
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The temporal scheme by which the different ECM components are deposited
is thought to be associated with their function within the wound. The clot formed as
a consequence of vascular injury is primarily fibrin decorated with plasma fibronectin.
As the wound matures and granulation tissue is formed, the composition of the
extracellular matrix changes. Initially the extracellular matrix is primarily composed
of hyaluronic acid and fibronectin supplemented with limited levels of collagens types
I, III and V, all primarily synthesized by fibroblasts. The high levels of the non-
suiphated glycosaminoglycan hyaluronic acid endow this early matrix with a low
impedance for cellular ingrowth. Fibronectin is thought to provide both chemotactic
and haptotactic stimuli for cellular migration, and also to act as a substrate for that
migration. Fibronectin appears to act as a nidus for collagen fibrillogenesis and
subsequently to transmit the forces of contraction from fibroblasts to the collagenous
matrix. The early deposition of collagen types I, III and V is thought to provide the
wound with nascent tensile strength. As the matrix matures: (1) hyaluronic acid and
fibronectin effectively disappear, (2) type I collagen becomes the predominant ECM
component - thus increasing the tensile strength of the wound, and, (3) proteoglycans
are deposited - increasing the wounds resilience to deformation. The individual
extracellular matrix components will now be discussed in more detail.
1.3.1 Hyaluronic acid (HA)
HA is a glycosaminoglycan (GAG). HA is primarily found during the first few days
after injury, after which time HA levels fall (Balaz and Holmgren 1950; Bently, 1967;
Dorner, 1967; Anseth 1961). It was initially suggested by Baiaz and Holmgren (1950)
that HA plays a critical role in fibroblast proliferation, a suggestion supported by the
observation that HA appears at times of mitosis and cell movement during organ
generation (Toole, 1972).
Two, not necessarily exclusive, theoretical explanations have been proposed
to explain the role of HA in cell motility. (1) HA may control the adhesion and
detachment of the cell membrane from the extracellular matrix (Lark et a!. 1985;
Rollins and CuIp, 1979), and, (2) I-LA, which can become highly hydrated, could cause
tissue swelling, thus creating additional space between the matrix and/or cells and
thereby allow the recruitment of additional cells into these areas (Toole, 1981). HA
may also be important for fibroblast proliferation. Several workers have reported that
HA synthesis is elevated in subconfluent fibroblasts (Tomida et a!. 1974) and
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following growth factor induced proliferation (Lembach, 1976). As granulation tissue
matures, HA is progressively lost by the action of fibroblast-denved hyaluronidase
(Ruggiero et a!. 1987). The suiphated GAGs that replace HA are associated with a
protein core (Hascall and Hascall, 1981) and are termed proteoglycans. Little work
has been directed at defining the stimuli responsible for HA and proteoglycan
synthesis by fibroblasts; IL-i and TGF-j3 have, however, been implicated (Whiteside
et a!. 1985; Postlethwaite and Kang, 1988).
1.3.2 Fibronectin
The adhesive glycoprotein fibronectin is thought to fulfil many roles in the repair of
cutaneous wounds. Fibronectin has been shown to act as a chemotactic factor for
monocytes (Clark et a!. 1988a) and as a non-specific opsonin of tissue debris (Brown,
1986), as a haptotactic substrate and chemotactic factor for cell movement
(fibroblasts McCarthy et a!. 1988, epithelial cells (Nickoloff et a!. 1988) during new
tissue formation, and as a scaffold for new matrix deposition (Clark, 1988a). In all
these situations cell binding is crucial (p 33). Fibronectin is a component of the fibrin
clot (Kurkinen et a!. 1980), its association with fibrin within the clot is thought to
regulate monocyte-macrophage invasion of the wound space (Ciano et a!. 1986).
Fibronectin also augments the attachment of fibroblasts to fibrin thereby facilitating
their early ingrowth into the fibrin clot at the wound site (Grinnell et a!. 1980).
Fibronectin is often found in areas of the wound bed where active migration and
proliferation are occurring for example around ingrowing fibroblasts, underneath the
migrating epidermis, and within the walls of new blood vessels; thus suggesting that
it provides a provisional matrix for cell translocation (Clark, 1990). It has also been
speculated that a template of fibrillar, extracellular fibronectin is essential for
collagen deposition (McDonald et al. 1982; Clark, 1988a). Such speculation derives
from the spatial and temporal distribution of fibrillar fibronectin and collagen during
granulation tissue formation (Kurkinen et a!. 1980; Holund et a!. 1982; Viljanto et a!.
1981), and the observation that the pattern of collagen deposition follows that
previously portrayed by fibronectin (Clarke, 1988a). Fibronectin is also a component
of the fibronexus (Singer, 1979), the linkage structure between myofibroblasts and
collagen, which is thought to transmit cellular contraction forces to the wound
margin, via collagen, and thereby affect wound contraction (p 49). The factors within
wounds that regulate production of fibronectin by fibroblasts are effectively unknown.
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However, the peptide growth factors EGF and TGF-J3 (known to be released from
platelet a-granules during degranulation and by activated macrophages) and IL-i
(released primarily by activated macrophages) have been shown to increase
fibronectin synthesis in vitro (Chen et a!. 1977; Krane et a!. 1985; Ignotz and
Massague, 1986; Ignotz et a!. 1987) and consequently may involved in fibronectin
synthesis during cutaneous repair in vivo.
1.3.3 Proteoglycans (Chondroitin-4-sulphate, Dermatan sulphate, Heparan sulphate)
Chondroitin-4-sulphate and dermatan sulphate levels increase during granulation
tissue formation as hyaluronic acid levels decrease (Bently, 1967). Little is known
about proteoglycan function in vivo except that these substances contribute
significantly to tissue resilience (Hascall and Hascall, 1981).
Other proteoglycan functions have been suggested:
1. Regulation of cell motility.
2. Regulation of cell growth
3. Regulation of collagen synthesis
1. Regulation of cell motility
The state of cell adhesion-deadhesion to surfaces is critical to the process of cell
motility. It has been proposed that an interaction of cell surface heparan sulphate
proteoglycan with fibronectin mediates the bonding of cells to substrate, while
accumulation of hyaluronic acid is known to weaken this bond (Cuip et a!. 1979). By
regulating cell surface heparan sulphate and hyaluronic acid levels the cell is able to
regulate adhesion and thus motility.
2 Regulation of cell growth
Cell shape and substratum anchorage are critical to the process of cell division. As
proteoglycans are involved with the regulation of cellular adhesion, modulations of
that adhesion would also be expected to influence proliferation (Letourneau et a!.
1980). Evidence for this regulatory role have come from observations of reduced
sulphated proteoglycan synthesis, in tandem with elevated hyaluronic acid synthesis,
during active proliferation (Underhil and Keller, 1976), and, the observation that
cells actively shed heparan sulphate prior to division (Kraemer and Tobey, 1972).
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Further, it has been suggested that heparan sulphate may regulate cell proliferation
within the wound by binding growth factors (Klagsbrun and Shing, 1985; Raines and
Ross, 1985).
3. Regulation of collagen synthesis
It has been suggested, from various lines of evidence, that proteoglycans may regulate
collagen synthesis (Wood, 1960; Armitage and Chapman, 1971; Kischer and Shetlar,
1974; McPherson and Piez, 1988). As chondroitin-4-sulphate is present in significant
amounts in granulation tissue (Kischer and Shetlar, 1974), but not in mature scar
(Shetler et al. 1972) it is suggested that it may be involved in the initial generation
of the collagenous matrix and subsequent matrix remodelling.
1.3.4 Collagen
Collagen is a generic term encompassing a family of at least 12 triple chain
glycoproteins found in the extracellular matrix (McPherson and Piez, 1988). At least
three classes of collagen occur in connective tissue: (1) fibrillar collagens (types I, III
and V), which have uninterrupted triple helices; (2) basement membrane collagen
(type IV), which has an interrupted triple helix and forms a mesh work in the lamina
densa; and, (3) other interstitial collagens with interrupted helices (types VI, VII and
VIII). The chief characteristic of the fibnilar collagens (I, III and V) is the ability of
their monomers to polymerise both side by side and end to end into long fibrillar
aggregates or bundles (Treistad and Silver, 1981). These fibrillar bundles are the
major structural collagens in all connective tissues (Clark, 1990).
Studies of collagen deposition during wound repair have primarily focused on
the two most characterised and abundant collagen types, i.e. fibrillar collagens type
I and type III. Normal skin contains approximately 80-90% type I and 10-20% type
III (Epstein, 1974; Miller, 1976). Various laboratories have observed a transient
increase in the relative levels of type III collagen relative to type I collagen, during
the first few days after wounding; levels subsequently rapidly return to that of normal
skin (Bailey et a!. 1975; Clore et a!. 1979; Gay et a!. 1978). As fetal skin has a higher
ratio of type III to I collagen (Epstein, 1974), these observations have led to the
suggestion that skin fibroblasts may transiently assume fetal fibroblast characteristics
in response to tissue injury (McPherson and Piez, 1988). It is thought that the same
fibroblast population produces both types I and III collagen; the mechanism of
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switching is unclear, but is thought to involve the actions of prostaglandin E 2 and IL-
1 (Agelli et a!. 1987; Steinman et a!. 1982).
More recent studies have reported that fibrillar type V collagen increases
during granulation tissue development in parallel with tissue vascularity, an
observation that led to the suggestion of an association between capillary endothelial
cells and type V collagen (Hering et a!. 1983). The observation that collagen type V
is abundant in hypertrophic scars (Ehrlich and White, 1981), which are known to
have a lavish capillary network, may further support this association.
The factors that regulate collagen deposition within the wound are not fully
understood; however certain peptide growth factors, which have been shown to
stimulate collagen synthesis by fibroblasts in vitro, are thought to encourage collagen
production during wound healing. Both TNF-a and IL-i, which are secreted by
activated macrophages, have been shown to promote collagen synthesis by fibroblasts
(Beutler and Cerami, 1986; Krane eta!. 1985). This upregulation of collagen synthesis
is apparently controlled at the level of mRNA (Krane et a!. 1985; Agelli et a!. 1987).
Whether this is due to an increased transcription of the collagen gene or increased
stability of the mRNA molecule itself is not clear. TGF-/3, elaborated by platelets and
macrophages, is also thought to mediate collagen synthesis directly. When injected
subcutaneously into newborn mice, rapid fibrosis consistent with rapid increases in
the production of collagen are observed (Roberts et a!. 1986). In vitro studies have
shown that, like IL-i, TGF-j3 stimulates the amount of collagen protein and mRNA
produced per fibroblast (Ignotz and Massague, 1986; Ignotz et a!. 1987). In addition
to stimulating collagen synthesis, TGF-j3 also causes an increase in the incorporation
of newly synthesized collagen into the extracellular matrix (Ignotz and Massague,
1986; Roberts et a!. 1986). While the above discussion relates to the stimulation of
synthesis of fibrillar types I and III collagen, Narayan and Page (1983) reported that
PDGF, which is released by platelets and secreted by activated macrophages,
stimulates the synthesis and matrix incorporation of fibrillar type V collagen. Certain
other factors may play an indirect role in stimulating collagen synthesis by stimulating
the recruitment of fibroblasts into the wound site. Tables 1.2 and 1.3 (p35 and p39)
list many of the factors thought to be responsible for stimulating the colonisation of
wound sites by fibroblasts.
Mechanisms are thought to exist that downregulate the production of matrix
proteins, and thereby prevent uncontrolled deposition of matrix components within
44
the wound site. Though such mechanisms have yet to be fully elucidated, the
following may bring about this regulation. While iL-i has been shown to stimulate
collagen mRNA transcription by fibroblasts (see above), it has also been shown to
induce fibroblasts to synthesize prostaglandin E2 (PGE2), and PGE2 is known to cause
a down regulation in the synthesis of collagen types I and III (Wong and Wahi,
1991). Also interferon-y, released by activated T-lymphocytes, has been shown to
specifically suppress collagen synthesis in human fibroblasts with little or no
suppression in overall protein synthesis (Duncan and Berman, 1985; Jiminez et a!.
1983).
The early formation of collagen types I, III and V fibrils are thought to furnish
the wound with nascent tensile strength. As the matrix matures during the ensuing
few weeks after injury, these fibrils progressively aggregate into larger fibrillar
bundles and gradually provide the wound with increasing rigidity and tensile strength
(Heughan and Hunt, 1975; Trelstad and Silver, 1981). The rate at which wounds gain
tensile strength is slow. Levenson et a!. (1965) studied the gain in tensile strength of
incisional rat skin wounds, and reported that such wounds had only gained between
20 and 25% of their final strength three weeks after injury. Scar tissue is
mechanically weaker than normal unwounded skin. Levenson et a!. 1965 reported
that by 9 weeks post wounding, after which time little improvement in tensile strength
is observed, wound tissue was 20 to 30% weaker than unwounded rat skin.
The way in which wounds progressively gain tensile strength is thought to be
dependent not only on the rate of collagen deposition, but also on collagen
remodelling with the gradual formation of larger collagen bundles (Kirscher and
Shetlar, 1974) and an alteration of inter-molecular cross-links (Bailey et a!. 1975).
Collagen remodelling during the formation of a scar is thought to be dependent on
both continued synthesis and collagen degradation (Clark, 1990). The rate of collagen
degradation changes as wound healing proceeds, starting relatively slowly during the
early stages and becoming progressively more rapid as wound maturation occurs
(Zeitz et a!. 1978). The degradation of fibrillar collagen types I and III during
remodelling is thought to be undertaken by specific collagenases synthesised by
fibroblasts (Mignatti et a!. 1988), whereas, fibrillar type V collagen degradation may
involve the release of a specific collagenase from macrophages (Hibbs et a!. 1985).
The secretion of collagenase is not a constitutive property of fibroblasts, but is
thought to be induced by various growth factors secreted primarily by macrophages
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(Riches, 1988) and possibly epithelial cells (Johnson-Wint, 1980). A variety of growth
factors have been shown to stimulate collagenase production by fibroblasts in vitro,
including: IL-i (Postlethwaite et a!. 1983; Huybrechts-Godin et a!. 1985), TNF-a
(Dayer et a!. 1985), EGF (Chua et a!. 1985), PDGF (Deuel and Huang, 1984; Bauer
et a!. 1985), and IGF-1 (Conover et a!. 1985/1986). However, the physiological role
of these mediators in collagen turnover during the wound repair process remains to
be defined (Mignatti et a!. 1988).
Growth factors may also regulate the level of new matrix degradation. TGF-13
not only directly stimulates collagen synthesis (see above), but also has the ability to
inhibit proteolytic degradation of newly synthesized matrix proteins including collagen
(Sporn et a!. 1987). In this regard TGF-j3 has been shown to both induce fibroblasts
to produce protease inhibitors (Laiho et a!. 1986; Docherty et a!. 1985) and secrete
reduced levels of the proteases themselves (Laiho et a!. 1986; Chiang and Nilsen-
Hamilton, 1986; Matrisian et a!. 1986).
1.4 Wound contraction
Wound contraction is the process by which the surface area of excisional wounds is
decreased by the inward movement of the wound margins (Snowden et al. 1984). It
may also be defined as the process by which the size of a full thickness open wound
is diminished, and is characterised by the centripetal movement of the whole
thickness of surrounding skin (Peacock, 1984).
In many loose-skinned mammals contraction is the major process by which
surface wounds are healed; it seldom leads to deformity or loss of function unless it
occurs over a joint and scar tissue is fixed to the underlying tissue. In humans
however, contraction rarely goes to completion except in veiy small wounds, and may
result in significant deformity and loss of function, the extent of which depends on
the size and location of the wound. Humans have lost local dermal mobility in many
areas. In man, skin is more or less firmly attached to relatively inelastic and immobile
fascia, which in turn is attached to major musculature, bone or other underlying
structures. Many mammals such as rats possess a well developed layer of cutaneous
striated muscle, the panniculus carnosus, of which only vestigial remnants remain in
human beings. This muscle and the lack of substantial attachment of integument to
underlying structures permit contraction to occur to its fullest extent without
interfering with the mechanical function of underlying structures. The same process
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occurs in human beings, but in contrast to many other mammals it can lead to
constriction, distortion or immobiisation in some locations owing to tension
developed through attachment of the integument to underlying structures. Thus
excessive contraction is often seen as a serious complication to healing.
Although initially wound contraction was thought to be caused by forces
generated by newly deposited collagen fibres (Billingham and Russell, 1956) in 1956
Abercrombie and colleagues showed that this movement was the result of forces
generated by cells residing in the central granulation tissue. It appears that wound
contraction is a dynamic process where cells organise their surrounding connective
tissue matrix. Historically, many theories have been proposed but few have survived
the test of time.
1.4.1 Theories of wound contraction
Five major theories regarding the mechanism of wound contraction have been put
forward:
1. The Push Theoiy: the wound margins may be pushed in by extension of the
surrounding skin.
2. The Growth and Push Theory: the wound margins may grow and push themselves
inwards by pushing on the surrounding skin.
3. The Sphincter Theory: contractile material at the wound edge may act as a
sphincter.
4. The Picture Frame Theory: active cells within the margin of the wound may
migrate inwards, pulling on the material within the margins of the defect.
5. The Pull Theoty: material within the defect may exert tension and pull the margins
of the defect inwards.
Reviewed by van Winkle 1967
Theories 1 and 2 were abandoned after the demonstration that excision of the
wound bed led to re-expansion of the wound (Cuthbertson, 1959), suggesting that
tension had been created within the wound bed and that no growth of the wound
margins had occurred. Theory 3 was abandoned when it was observed that
rectangular wounds do not contract into a circular shape, a prerequisite for the purse
string effect of sphincter action (Peacock, 1984).
Theory 4, the picture frame theory was first advanced by Grillo et a!. (1958);
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supporting evidence for this theoiy came from the observation that when the wound
margin is removed wounds retract (Watts et a!. 1958). Critics of this theory have
argued that contraction was inhibited due to a physical separation of granulation
from the surrounding skin thus removing the mechanism of force transduction from
granulation tissue to wound margins (van Winkle, 1967).
The remaining theory, the Pull Theory, which proposes that "material" within
the wound defect exerts a tension and pulls the margin of the defect inwards.
Supporting evidence for this theory comes from the observation of wound expansion
following the complete excision of granulation tissue within the wound (Abercrombie
et a!. 1954; Watts et a!. 1958; Cuthbertson, 1959) and the centripetal movement of
marks tattooed onto the surface of granulation tissue within splinted wounds
(Chariton et a!. 1961). Snowden and Cliff (1985) demonstrated that explanted
granulation tissue contracts in vitro, and that the tension generated by such explants
is associated with total cellularity, thus supporting both the pull theory and the role
of cellular components of the granulation tissue in contraction. The cell-derived force
of wound contraction has been ascribed to the fibroblasts, which unlike macrophages
and the endothelial cells of capillaries, are mainly orientated along the radial lines
of contraction within wounds (Welch et a!. 1990).
Two main theories have been proposed to explain how fibroblasts may generate, and
transmit, the force necessary to facilitate wound contraction.
1. The cell contraction - myofibroblast theory (Gabbiani et a!. 1971).
2. The cell traction - fibroblast theory (Ehrlich and Rajaratnam, 1990).
Both theories agree that wound contraction is an active cellular phenomenon
that depends on the activity of viable fibroblasts; however, the two theories propose
different mechanisms by which such cells generate the contractile force necessary to
facilitate this process. The myofibroblast theory suggests that the contraction force
is derived from a muscle-like cellular contraction; whereas, the fibroblast theory
suggests a tank tread-like traction activity by the cell on the matrix.
The two theories of wound contraction are described below. The in vivo and
in vitro evidence in support of a given theory follows its description. Fibroblast-
mediated contraction of fibroblast-populated collagen lattices [FPCLs] (p160), a
widely accepted in vitro model of the process of wound contraction, has been
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differentially employed to provide support for both theories; its application will be
discussed.
1.4.1.1 The cell contraction - myofibroblast theory
While examining wound granulation tissue, Gabbiani eta!. (1971) observed significant
numbers of cells, termed myofibroblasts, that displayed morphological characteristics
of both fibroblasts and smooth muscle cells (SMCs). The presence of significant
numbers of these cells, morphologically similar to smooth muscle cells (i.e. contractile
cells), within actively contracting granulation tissue encouraged Gabbiani et a!. to
suggest a role for these apparently contractile cells in the process of wound
contraction.
The morphological characteristics of myofibroblasts include:
1. Large bundles of actin microfilaments (40-80 A) running parallel to the long
axis of the cell, which display electron dense areas where filaments attach to
the cell membrane, both similarly observed in SMCs.
2. Deformed/indented nuclei. SMC nuclei become folded and twisted during
active contraction.
3. Numerous intercellular junctions including desmosomes and gap junctions, and
structures resembling the basal lamina of SMC.
(Gabbiani et a!. 1971; 1972; 1978)
4. A co-linear assembly of intracellular microfilaments and extracellular
fibronectin (and types I and III collagen) termed "the fibronexus".
(Singer, 1979; Singer et a!. 1984; Tomasek et a!. 1987; Tomasek and Haaksma,
1991).
The cell contraction - myofibroblast theory suggests that movement of microfilament
(actin) bundles (also termed stress fibres), contracts the myofibroblast in a muscle-
like fashion. As the myofibroblast displays many cell:cell and cell:matrix (fibronexus)
contacts, this cellular contraction pulls collagen fibrils towards the body of the
myofibroblast, and holds them until they are stabilized into position (Rudolph, 1980).
This gathering of collagen fibres towards the myofibroblast cell "body" leads to the
shrinkage of granulation tissue. As the extracellular matrix of the wound is
continuouswith the undamaged wound margin, this granulation tissue shrinkage pulls
on the wound margin and leads to wound contraction. This theory proposes that the
coordinated contraction (cellular shortening) of many myofibroblasts, synchronised
with the help of gap junctions, generates the force necessary for wound contraction
(Skalli and Gabbiani, 1988).
Evidence which appears to support the cell contraction - myofibroblast theory
1. Cells with myofibroblastic characteristics, primarily actin microfilament bundles,
are present within actively contracting granulation tissue (Gabbiani eta!. 1971). It has
been reported that after active contraction has ceased the myofibroblast population
declines (Rudolph et a!. 1977; McGrath and Hundahl, 1982).
2. Wound contraction is known to be inhibited by the application of skin grafts, full-
thickness grafts being more inhibitory than split-thickness grafts. It has been
demonstrated that myofibroblasts make only a fleeting appearance in contraction-
inhibited grafted wounds, whereas in ungrafted contracting wounds they remain for
much longer (Rudolph, 1979); their presence suggests an active role.
3. Strips of granuloma tissue, rich in myofibroblasts, can be induced to contract by
stimuli known to induce smooth muscle cell contraction. This suggests that
myofibroblasts are not only morphologically but functionally similar to smooth muscle
cells, thus supporting the role of the smooth muscle-like cell, the myofibroblast, in
wound contraction (Majno et a!. 1971, Garcia-Valdecasas et a!. 1981).
4. Microfilament bundles (stress fibres) dissected out of living cells or studied within
permeabilized cells can contract upon the addition of ATP (Isenberg et a!. 1976;
Kreis and Birchmeier, 1980), thus suggesting that a cell containing such bundles
contains the machinery for cellular contraction and consequently wound contraction.
Evidence from FPCL contraction in vitro.
1. Attached FPCL, i.e. those adherent to the surface on which the collagen
polymerised, do not undergo a reduction in surface area; they do, however, reduce
in volume due to dorso-ventral contraction (Guidry and Grinnell, 1985). Various
workers have reported that fibroblasts within such contracting attached FPCL
develop characteristics morphologically similar to myofibroblasts in tissues
undergoing contraction (Skalli and Gabbiani, 1988; Schultz and Tomasek, 1990).
Tomasek et a!. (1992) demonstrated that normal human palmar aponeurosis
fibroblasts cultured for 5 days in attached collagen lattices developed abundant actin
microfilaments orientated parallel to the long axis of the cell. They also demonstrated
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that bundles of microfilaments formed close associations with extracellular filaments,
which showed intense anti-fibronectin labelling, resembling the fibronexuses described
by Singer (1979). Fibroblasts from other sources have also been reported to acquire
certain of these myofibroblastic characteristics when cultured in attached collagen
lattices, including fibronexus-like fibronectin fibrils on, and microfilament bundles
within, human foreskin fibroblasts (Mochitate et a!. 1991), and microfilament bundles
within rabbit synovial fibroblasts (Unemori and Werb, 1986) and porcine periodontal
ligament fibroblasts (Farsi and Aubin, 1984). The presence of myofibroblastic cells
within these contracting attached lattices suggests a role for the myofibroblast in
collagen lattice contraction and presumably in wound contraction. It should, however,
be noted that other workers studying similar attached lattices have been unable to
observe microfilament bundles, the principal characteristic of myofibroblasts
(Grinnell and Lamke, 1984).
2. Release of attached lattices, by "rimming", some time after polyinerisation, results
in a rapid, symmetric contraction of the collagen lattice (Dodd et a!. 1982; Unemori
and Werb, 1986; Mochitate et a!. 1991; Tomasek et a!. 1992). Rapid contraction
occurs within the first 10 minutes after release of the lattice from the substratum,
with greater than 70% of this contraction occurring within the first 2 minutes
(Tomasek et a!. 1992). Rapid contraction results in a shortening of the elongated
fibroblasts and a compaction of stress fibres with their subsequent disappearance
from the cell (Dodd et a!. 1982; Unemori and Werb, 1986; Mochitate et a!. 1991;
Tomasek et a!. 1992). This rapid collagen lattice contraction is thought to be
primarily dependent upon active fibroblast contraction, as disruption of the actin
cytoskeleton of the cell with cytocholasin D, just prior to release, inhibits it (Dodd
et a!. 1982; Tomasek et a!. 1992). Such results suggest that the fibroblast-derived
force, necessaiy for both lattice contraction and wound contraction, can be generated
by cellular contraction of the actin component of the cytoskeleton i.e. stress fibre
contraction. Such rapid contraction has been observed in rabbit skin wounds
following the removal of a wound splint (Abercrombie et a!. 1960), an observation
that tends to support the myofibroblast theory of wound contraction.
3. Studies using free floating FPCL, which are released from their attachment to the
petri dish soon after polymerisation, have reported the transient expression of certain
myofibroblastic characteristics, specifically gap junctions, during active lattice
contraction (Bellows et a!. 1982).
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1.4.1.2 The cell traction - fibroblast theory
The traction theory proposes that fibroblasts bring about a closer approximation of
matrix fibrils by exerting "traction forces" (analogous to the traction of wheels on
tarmac) on extracellular matrix fibres to which they are attached. This theory
proposes that fibroblasts neither shorten in length, nor do they act in a co-ordinated
multicellular manner (as proposed by the myofibroblast theory); but, rather that a
composite force, made up of traction forces of many individual fibroblasts, is
responsible for matrix contraction. Such traction forces are shearing forces tangential
to the cell surface generated during cell elongation and spreading (Stopak and
Harris, 1982).
The traction theory is based on observations and proposals made by Harris
et al. (1981) and Stopak and Harris (1982). From observing fibroblasts and the forces
they generate while cultured on distortable sheets of silicone rubber and in collagen
lattices, they proposed that the phenomenon seen as fibroblast migration in two
dimensional culture conditions, actually serves quite a different and previously
unsuspected function in the body, namely the remodelling of extracellular matrix
fibres, an activity critical to wound repair. As individual fibroblasts elongate and
spread on distortable silicone sheets they cause that surface to wrinkle (Harris et a!.
1981). This wrinkling is thought to represent a "gathering effect" of the fibroblast on
the elastic surface. According to this theory, the composite effect of many fibroblasts
gathering collagen fibrils within the wound, is thought bring about wound contraction.
The traction theory of connective tissue remodelling has since been championed in
the field of wound repair by Ehrlich (Ehrlich, 1988a/b; Ehrlich and Rajaratnam
1990).
Evidence which appears to support the cell traction - fibroblast theory
There are several lines of evidence to suggest that wound contraction is brought
about by means other than coordinated cellular contraction.
1. Significant contraction (25%) has been shown to occur in full-thickness pig skin
wounds prior to the appearance of cells with myofibroblastic characteristics (McGrath
and Hundahl, 1982), thus suggesting that wound contraction can proceed without
such cells being present.
2. Rat wounds have been observed to contract to 60% of their original size by 7 days
post wounding, although during this time less than 15% of fibroblasts had
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myofibroblastic characteristics. At 21 days when active contraction has all but ceased
peak levels of myofibroblastic cells were observed (Rudolph, 1979). These
observations suggesting that the rnyofibroblastic phenotype may be a consequence of
contraction rather than the cause.
3. Darby et a!. (1990) reported that full thickness rat skin wounds contract by
approximately 40% prior to the appearance of myofibroblastic cells.
4. Very few fibroblasts displaying myofibroblastic characteristics are present in burn
wounds at 7 days post-wounding, by which time such wounds had contracted by 40%
(Ehrlich and Hembry, 1984).
5. Myofibroblasts are not readily identifiable in healing rat wounds before 7 days
when closure is 50% complete (Majno et a!. 1971).
5. Skin wounds in the mutant Tight Skinned Mouse (TSM) are slow to contract,
taking approximately 6 weeks to full closure rather than the normal 3 weeks. Wound
closure in the TSM is characterised by a three week delay, prior to the onset of
contraction, then a 3 week period of contraction. During the pre-contractile phase
large numbers of myofibroblasts were found; however, after the onset of, and during,
active contraction fewer myofibroblasts were found (Hembry et a!. 1986), thus
suggesting that myofibroblasts may not be actively involved in wound contraction.
6. Myofibroblasts are apparent in frostbite injury, where there is little if any
contraction (Li et a!, 1980).
7. Whereas it has been reported that strips of granuloma tissue contract in response
to agent known to stimulate SMC contraction, wound granulation tissue does not
respond in a similar fashion (Majno et a!. 1971), thus questioning the role of these
smooth muscle-like cells, myofibroblasts, in wound contraction.
Evidence from FPCL contraction in vitro.
1. Fibroblasts within actively contracting collagen lattices have also been observed to
gather together collagen fibrils as they elongate and spread (Bell et a!. 1979; Harris
eta!. 1981).
2. It has been reported that fibroblasts contracting collagen lattices actually elongate
in the direction of the contractile force they exert rather than shorten as would be
expected of a contractile cell (Bell et a!. 1979; Stopak and Harris, 1982).
3. It has been reported that during active contraction of FPCL, few cells displaying
actin bundles (stress fibres) are present, however, upon cessation of lattice
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contraction many cells displaying prominent stress fibres are apparent (Bellows et a!.
1982; Ehrlich, 1988a; Tomasek et a!. 1992). This implies that fibroblasts rather than
myofibroblasts bring about matrix compaction of this wound contraction model.
4. Cells with myofibroblastic characteristics are more apparent at the lattice periphery
than in more central areas of contracting FPCL (Bellows et a!. 1982; Stopak and
Harris, 1982; Ehrlich, 1988a). When the contraction of myofibroblast-enriched
lattices, prepared by removing the central (myofibroblast deficient) area of the lattice,
was compared with that of whole lattices, the rate of lattice contraction was
unaffected by myofibroblast enrichment (Ehrlich 1988a). Additionally, contraction of
the central area, removed during this attempt at myofibroblast enrichment, was
unaffected by removal of the myofibroblast-rich perimeter (Ehrlich, 1988a). These
observations suggest that there is no requirement for myofibroblastic cells in lattice
contraction.
5. When contraction was studied in similar-sized wedges cut from FPCLS that either
included or excluded the myofibroblast-rich lattice perimeter, contraction was seen
to be slowest in those areas rich in myofibroblasts (Ehrlich and Rajaratnam, 1990).
6. It has also been observed that cells in more central areas of FPCL have fewer, if
any, intercellular connections than those in the lattice perimeter (Ehrlich, 1988a).
This observation taken together with the observation that central areas of FPCL
contract equally as well as, if not more rapidly than, more peripheral areas, suggests
that fibroblasts compact the collagen matrix by working as individual units, rather
than, as the myofibroblast theory suggests, as a mass of interconnecting/inter-
communicating cells (Ehrlich, 1988a).
7. When the rate of FPCL contraction in lattices seeded with fibroblasts cultured
from normal skin (no myofibroblasts) was compared with that of lattices seeded with
fibroblasts cultured from hypertrophic scar (rich in myofibroblasts), the source of
cells was found to have no influence on the rate of lattice contraction (Ehrlich, 1984).
This appears to question the idea that a contraction-specialised cell (i.e. the
myofibroblast) resides in actively contracting tissue.
8. Rungger-Brandle & Gabbiani (1983) suggested that the morphological attributes
of myofibroblasts, specifically their prominent stress fibres, made these cells the most
logical choice for the production of contractile forces, especially as stress fibres in
permeabilised cells can be made to contract by adding ATP. However, Ehrlich and
Rajaratnam (1990) demonstrated that both myofibroblasts (with actin filament
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bundles or stress fibres) and fibroblasts (with fine filamentous actin) permeabilised
with glycerol could contract equally well in response to ATP. Cellular contraction
appears to have no requirement for stress fibre bundles. Additionally, when ATP is
applied to fibroblasts in collagen lattices at levels known to stimulate cellular
contraction in monolayer, neither a stimulation in cellular contraction nor in lattice
contraction is observed (Ehrlich and Rajaratnam, 1990). Microscopical examination
of ATP treated lattice fibroblasts revealed ruptured intracellular actin filaments thus
questioning the ability of stress fibre-based cellular contraction to bring about wound
contraction.
These in vitro observations suggest that the presence of microfilament bundles
(or stress fibres), and by inference myofibroblasts, is not necessary for cell-mediated
wound contraction. Wound contraction would appear to proceed in the presence of
fibroblasts alone. It has recently been proposed that the myofibroblastic phenotype,
which displays many stress fibres, rather than being responsible for contraction, is in
fact a highly motile form of the fibroblast thought to facilitate migration from the
wound site after conclusion of active contraction (Ehrlich, 1992 personal
communication). This however contradicts the widely held belief that the presence
of stress fibres is normally associated with tight adhesion to the underlying substrate
(Willingham et a!. 1977; Herman et a!. 1981). Fibroblasts migrating out of a primary
tissue explant generally lack stress fibres in the first few days of culture when they
are migrating rapidly; with time migration slows down and the stress fibres become
more prominent (Couchman and Rees, 1979).
In vitro evidence from FPCL studies
Evidence given in support of the cell contraction - myofibroblast theory invariably
comes from FPCL studies carried out on fibroblast seeded collagen lattices that
remain attached to the plastic culture dish in which the lattice was polymerised; such
lattices are termed "attached lattices" and unless released do not decrease in surface
area, though their volume (i.e. depth) has been shown to slowly reduce as a
consequence of fibroblast activity (Guidry and Grinnell,, 1985). In contrast, evidence
given in support of the cell traction - fthroblast theory invariably comes from studies
using "rimmed" lattices that float beneath the surface of exuded culture medium,
termed free floating collagen lattices". The surface area of such floating lattices is
seen to diminish with time. Which of these methods of use of the FPCL assay is
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more like the in vivo situation, and consequently more closely parallels wound
contraction, is a matter of opinion. It has, however, been suggested that during
contraction attached FPCLs develop into an active "tissue" resembling granulation
tissue, whereas floating FPCLs develop into a resting tissue that resembles the dermis
(Mochitate et a!. 1991). The granulation tissue of a full thickness excisional skin
wound is attached at its peripheiy to "normal" dermis, the major component of which
is type I collagen. This "normal" tissue at the wound margin is neither rigidly fixed,
nor is it completely free to move; it exerts a reactive force in response to the inward
pull of the granulation tissue. Thus an isometric tension would be expected to be
generated within the wound, associated with the contractile force of the granulation
tissue and the reaction by the wound margin. It thus would appear that neither free
floating lattices, which experience no opposing or reactive force, nor, attached
lattices, which experience an insuperable opposing force, accurately parallel the in
vivo situation. Such observations may question the relevance of this model, as it is
currently employed, to study the mechanisms underlying the process of wound
contraction.
The rapid recoil following the release of attached FPCL, described by several
authors including Tomasek et a!. (1992) and Dodd et a!. (1982) in support of the cell
contraction - myofibroblast theory, may also be explained in terms of cell traction.
It is possible that cyto-tractile activities of fibroblasts put the collagen matrix and
consequently matrix-attached cells under tension leading to the formation of stress
fibres, and that these traction induced stress fibres act as a tension store. The rapid
contraction, observed after rimming attached lattices, may thus be an indirect effect
of cellular traction, due to the generation of stress fibres as a consequence of
frustrated cell locomotion (Ehrlich and Rajaratnam, 1990).
1.4.1.3 Summary
There are currently two theories of cell-mediated wound contraction, the cell
contraction - myofibroblast theory and the cell traction - fibroblast theory. The
former suggests that myofibroblasts, cells with characteristics of both fibroblasts and
smooth muscle cells, undergo contraction in a muscle-like fashion, while attached to
each other and the extracellular matrix, and thereby bring about contraction. The
latter suggests that fibroblasts compact the extracellular matrix by a traction-like
matrix gathering process and thereby facilitate contraction. The two theories of
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contraction are not necessarily mutually exclusive. It is possible that wound
contraction is brought about by fibroblasts actively engaging in both tractile and
contractile activities either simultaneously or sequentially. From the observations of
Majno et a!. (1971); Rudolph, (1979); McGrath and Hundahl, (1982); Ehrlich and
Hembry, (1984) and Darby et a!. (1990) contraction is known to proceed initially
without myofibroblastic cells. However, these cells become more prevalent as the
wound contraction process continues. It is possible that the wound matrix is initially
remodelled by the process of fibroblast traction which is subsequently superseded by
the contractile activity of myofibroblastic cells. Regardless of the mechanism by which
the forces necessary for wound contraction are generated, current evidence suggests




2.1 Basic physics of mechanical vibrations
Ultrasonic energy travels through a medium in the form of a wave. Mechanical or
acoustic waves arise when particles, composing a medium, are supplied with energy
and are driven to vibrate. These particles then transfer some of this energy to
adjacent particles causing them to vibrate and so pass on the energy in the form of
a wave. Mechanical waves thus require a conducting medium. The human ear can
detect a wide range of airborne sounds, but is unable to detect extremely low notes
(infrasound), or extremely high notes (ultrasound). Ultrasound is usually defined as
having a frequency above 20 kHz. All mechanical vibrations whether they are
ultrasound, audible sound or infrasound, and irrespective of whether they are
propagating through solids, liquids or gases, have certain common physical properties.
In this chapter these properties are described.
2.1.1 The surface wave analogy
The pattern of circular ripples produced on the surface of a still pond by throwing
in a small stone is a useful analogy for the wave properties of sound (figure 2.1).
These expanding ripples consist of a series of alternating peaks and troughs which
at any one point in time resemble the pattern seen in figure 2.2. If wave propagation
is frozen any given point in time, the diagonal RS of figure 2.1 would have an
appearance resembling figure 2.2. The regular repeating unit that describes the wave
is termed the wavelength (2) and is defined as the distance from any measurable
point to the next similar point after it has completed one full cycle of positive and
negative displacement (e.g. from crest to crest). The amplitude of a wave is the
maximum excursion of the wave above (or below) its original undisturbed value. A
large wave from a large stone has a greater amplitude than a small wave from a small
stone. Amplitude is thus a measure of the power of a wave.
It is not necessary to freeze time to get the same pattern as that illustrated in
figure 2.2. If one imagines a float, located at point P (figure 2.1), close to the site of
impact of a stone, when waves pass the float it will be lifted during the peak and
dropped during the trough relative to its original position, but remain in essentially
the same position relative to the source of the wave. The displacement of the float










Figure 2.1. Graphical representation of the expanding series of waves propagating
away from a point source (S). The solid circles represent the wave peaks while the































--	 P = location of float
R = remote point
Figure 2.2. Sectional view, along the line RS, of the wave pattern in figure 2.1.
Showing the wavelength (i), the wave amplitude (A) and the distance from the wave
source.
One wavelength (A)









Figure 2.3. Diagrammatic representation of the displacement of a particle in the





movement of a body, as described for this float, about a mean point is an example
of simple harmonic motion (SHM), which is described by a sine curve. Thus, particles
(in this case molecules of the water surface) oscillate with SHM, remaining in
essentially the same position relative to the source (S) while the wave may cover
large distances. Wave progression occurs through energy transfer; no net movement
of the medium occurs. The advancing wave is effectively the energy put in by the
disturbance causing particles to oscillate with SHM. Particles transfer their energy,
by colliding with, or rubbing against, neighbouring particles. This energy transfer
drives neighbouring particles to oscillate. This repeating process of particle oscillation
followed by energy transfer is commonly termed wave propagation.
2.1.2 Physical properties of mechanical waves
Waves flow away from their source. The whole curve in figure 2.3 is effectively
moving forward with a velocity (v), which is measured by the distance which any
particular part of the curve travels in unit time. The velocity of wave propagation is
highly dependent upon the efficiency of energy transfer from a given vibrating
particle to its neighbour. Energy transfer, and thus velocity of propagation, is
fundamentally dependent upon the physical properties of the conducting media. Such
physical properties include both the size and number of particles present per unit
volume (i.e. density, p) and the magnitude of the complex inter-molecular
interactions of the conducting medium (Table 2.1). The relationship between wave




K is the Young's modulus of a solid rod or the bulk modulus
of elasticity of a liquid
When liquids are heated significant expansion occurs; the same mass occupies
a greater volume, which leads to a decrease in density. This decrease in density
facilitates more rapid propagation of sound waves. Thus the velocity of mechanical
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waves in a liquid usually increases with increasing temperature. For example, the
velocity of sound in water rises from about 1400 ms' at 0°C to about 1550 ms' at
60°C. As can be seen in Table 2.1 the velocity of ultrasound in soft tissues is
approximately 1500 ms'.
Table 2.1. Velocity and characteristic impedance of sound in biological and other
materials.
Material	 Velocity	 Density	 Acoustic
impedance
(m sec')	 (g m1')	 (kg m•2 sec')
	
Air	 333.5	 1.29 x i0	 429
Water (20°C)	 1480	 1.00	 1.52 x 106
Water (37°C)	 1520	 1.00	 1.52 x 10'
	
Blood	 1555	 1.06	 1.62 x 10'
	
Fat	 1460-1470	 0.92	 1.35 x 106
Muscle	 1545-1630	 1.07	 1.65-1.74 x 106
Kidney	 1560	 1.04	 1.62 x 106
	
Liver	 1540-1585	 1.06	 1.63-1.68 x 106
	
Bone	 2710-4000	 1.38-1.81	 3.75-7.38 x 106
see p'7l)	 (Adapted from Wells, 1977)
The number of wavelengths which pass any given point per unit time is termed
the frequency (f) of that source. Once generated, this frequency remains constant
inespective of the propagating medium. The particles which propagate this wave also
vibrate with this frequency.
The velocity (v), frequency (f) and the wavelength (2) are interrelated as
described by this equation:
Since the frequency remains constant, but the velocity changes as the wave travels
from one medium to another, it follows from the above equation that the wavelength
must also change.
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When observing the pattern of expanding ripples on a pond it can be seen that
as the wave moves further away from the source its amplitude progressively
decreases. The perimeter of each circular wave gradually increases and so the initial
input of energy has to be spread over an ever increasing area. Absorption is another
contributing factor to the loss of energy content from the wave. The transfer of
energy between particles is never 100% efficient and so some energy is lost at each
transfer; this energy appears as heat which elevates the temperature of the
conducting medium.
The wave produced by a small source (termed a point source) is initially a
circle having a small radius. As the wave travels away from the source its radius of
curvature increases until any small portion of the wave front appears flat. This flat
wave front, which continues to move away from the source, is called a plane
progressive wave.
Interference is a fundamental property of all waves. If any two or more waves
arrive together at the same point in space, they will merge together to form a new
wave which is the algebraic sum of the amplitudes of each individual wave. If two
waves of the same frequency, amplitude and phase, interfere, a wave of twice the
original amplitude but of the same frequency results. If two similar waves which are
180° out of phase interfere their amplitudes cancel each other out.
2.13 Transverse and Longitudinal (compressional) waves
The basic physics of mechanical waves have so far been described in terms of surface
waves. Though useful, this analogy has several limitations. In surface waves the
particles oscillate in the vertical plane as the wave propagates in the horizontal plane.
Such waves are termed transverse waves (figure 2.4 (B)) and are usually restricted
to solids; materials having strong three-dimensional intermolecular coupling forces.
Liquid-borne surface waves, though useful as an analogy, are a special case. Energy
is propagated and transferred by a cyclical flow of water just beneath the surface of
the liquid. Anything which interferes with this cyclical flow of water beneath the
surface will effect energy propagation and hence velocity of this wave. Thus, liquid-
borne surface waves are unusual in that propagation velocity is dependent upon the
depth of the liquid. This is clearly demonstrated as oceanic waves approach a beach.
As the sea becomes shallower the wave's propagation velocity decreases and
consequently its wavelength decreases.
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Figure 2.4. A graphical illustration of the direction of the particles of a medium
relative to the direction of wave propagation for compressional (or longitudinal) and
transverse (or shear) waves.







Direction of wave propagation
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The other class of mechanical wave, which includes both audible sound and
ultrasound, differ from transverse waves in that the direction of particle vibration is
the same as the direction of wave propagation. Such waves are termed longitudinal
or compressional waves (figure 2.4 (A)).
When a compressional wave propagates as a plane progressive wave, all the
particles of the medium which lie in a plane parallel to the advancing wave front are
displaced together. It is convenient to think of the propagating medium as being
composed of multiple layers (i.e. planes of particles) arranged parallel to the wave
front. At any given point in time some of these layers will be displaced in the
direction of the propagating medium while others will have returned to their original
position or overshot it and be displaced in the opposite direction (figure 2.5 (A)). As
explained in the surface wave analogy each layer of the conducting medium should
be oscillating with simple harmonic motion. So the displacement at any given point
in time can be found from a sine curve. Figure 2.5 (B) shows the displacement of
each layer from its original position at time t. Certain layers are passing through their
undisturbed position and are thus demonstrating zero displacement. Taking positive
displacement to be a movement to the left of zero and negative displacement to be
to the right. It can be seen that layers on either side of the layers of zero
displacement are either moving towards them or away from them. If moving towards
them the medium at that point is compressed and therefore the pressure at that point
must be increased. Conversely, if adjacent layers are moving away from zero
displacement layers then the pressure at that point must be decreased. Points of zero
particle displacement are points of maximum or minimum pressure.
As the displacement follows a sine wave (figure 2.5 (C)), and displacement
generates pressure, it follows that pressure follows the same sine wave (figure 2.5
(D)). The mid points between maximum and minimum pressure (i.e. zero pressure)
are also points of maximal displacement which correspond to the point in SHM
where the particle has stopped moving. Thus, the displacement of the layers and
instantaneous pressure produced within a medium by a mechanical wave are both
described by a sine wave having the same frequency, but the maximum of one curve
corresponds to zero in the other. That is to say the two curves are a quarter of a
cycle out of phase with each other. For a mechanical wave propagating through a
liquid medium it is more convenient to measure pressure than particle displacement.
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Figure 2.5. Graphical representation of the displacement of layers of a medium by
a compressional wave and the effect of this displacement on the distribution of
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66
In any given solid medium transverse or shear waves travel much more slowly
than compressional waves. For a solid the velocity of transverse waves (Vt) is given
by:
Where:	 0 is the shear modulus of elasticity
p is the density of the material 	 (Williams, 1983)
In general, the velocity of transverse waves in a given medium is half the velocity of
compressional waves in that same medium.
Under certain circumstances some of the energy of a compressional wave can
be transformed into transverse waves, this phenomenon is termed mode conversion.
For example, it is thought to occur When ultrasound is obliquely incident upon a
strong reflector such as at soft tissue - hard tissue (bone) interfaces. As transverse
waves do not propagate well in aqueous media they are readily absorbed by the soft
tissue and their energy appears as heat. It has been suggested that the sensation of
pain experienced when the hand is placed in the path of moderately high intensity
therapeutic ultrasound is due to temperature rises within the periosteum (nutritive
and sensory outer coating of bone) due to the absorption of transverse waves.
2.1.4 Reflection and refraction
Whenever a mechanical wave encounters a boundary between two dissimilar media
both reflection and refraction of that wave occurs. A simple way of explaining these
phenomena is to apply Huygen's principle, which states that every point along a wave
is itself a point source and emits either a circular wave (in two dimensions) or a
spherical wave (in three dimensions). The line obtained by joining up all the wave
fronts from each of these numerous point sources indicates the next shape and
position of that wave front (figure 2.6). The reflection and refraction of a plane wave
front is shown in figure 2.7. The same information is displayed as a ray diagram
(figure 2.8), where a ray represents a line drawn at right angles to each wave front.
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Figure 2.6 An illustration of Huygen's principle - any wave front is regarded as a
large number of point sources each generating a spherical wave. Interference between


















Figure 2.7 A schematic illustration of reflection and refraction occurring at the
interface between two media. The refracted wave is deflected because the velocity of














Figure 2.8. Showing the same information presented in figure 2.7 except that the
individual wave fronts have been replaced by rays (i, r and r' represent the angles of
incidence, reflection and refraction).
Normal
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The angle of incidence (i) can be seen to equal the angle of reflection (r), whereas
the angle of incidence and the angle of refraction (r') are related by Snell's Law:
sini - vi
Sifl r'	 v2
Where:	 vi is the velocity of the incident wave in medium 1.
v2 is the velocity of the refracted wave in medium 2.
2.1.5 Acoustic impedance
The parameter that determines how much of the incident wave is reflected or
refracted at any given interface between two media is acoustic impedance. Acoustic
impedance (Z) is defined as the product of the density of a material (p) and the
velocity (v) of sound within it:
Z=pv
Referring to figures 2.7 and 2.8, let Zi be the acoustic impedance of medium i and
Z2 be the acoustic impedance of medium 2. If Zi equals Z2 there will be no
reflection at the interface (if the velocities are also the same there will be no
refraction at the interface). However, if Zi does not equal Z2 then some of the wave
will be reflected and some will be refracted. The larger the difference between Zi
and Z2 then the greater the proportion of the incident energy will be reflected. The
relationship of partitioning between reflection and refraction is complicated by the
angle of incidence. The simplest situation is where the incident wave approaches the
interface at right angles to it. The reflected wave would then retrace its own path and
the transmitted portion of the wave would carry on in a straight line without
refraction, though its velocity, and thus its wavelength, may be different. For normal
incidence the equations which relate to this partitioning of incident energy (Ii) into







Where I is the intensity of the wave (transmitted power per unit area).
(Table 2.1 (p62) gives acoustic impedance values for some common biological and
other materials).
2.1.6 Standing waves
A plane wave of normal incidence which is reflected back along its own path
interferes with that portion of itself which has not yet reached the reflector to form
a standing wave. On reflection waves undergo a half wavelength phase change. Figure
2.9 demonstrates what happens when a plane travelling wave strikes a flat perfect
reflector.
Figure 2.9(1) shows that when an incident wave meets the reflector at the instant of
zero displacement it is reflected (with a half wavelength phase shift) so that both
waves are exactly in phase. The amplitudes of both waves add together to give a
resultant wave whose amplitude, at any given point, is twice that of the incident wave
- constructive interference.
Figure 2.9(2) shows the same wave incident one quarter of a wavelength later. That
same wave is now striking the reflector at a displacement maximum. The reflected
wave at the point of reflection (due to phase change) will be at a displacement
minimum and will therefore cancel out the incident wave giving a resultant zero
displacement at every point - destructive interference.
Figure 2.9(3) shows the wave incident a further quarter of a wavelength later, at a
point of zero displacement so that the incident and reflected waves interfere
constructively giving a wave whose amplitude is twice that of the incident wave.
However, since this wave is half a wavelength out of phase with the first reflected
wave (figure 2.9(1)), the displacement at any point is in the opposite direction to that
shown in figure 2.9(1). A quarter wavelength later, the wave meets the reflector at
a displacement maximum (as in figure 2.9(2)) and destructive interference again
occurs.
Standing wave fields, demonstrating constructive interference, can be described
as a regularly repeating pattern of points where the displacement of particles is













varies from positive to negative at the same frequency as the incident wave, but at
twice its amplitude - termed displacement antinodes (A), figure 2.9(3). Nodes and
antinodes are separated by a distance equal to one quarter of a wavelength. Under
the conditions described above, all the energy contained in the incident wave (except
for that lost by absorption) is returned in the reflected wave. That is to say there is
no net flow of energy through the medium supporting the standing wave. This does
not mean, however, that the standing wave field has no energy. The standing wave
phenomenon concentrates and effectively amplifies the ultrasonic energy applied to
a system, which may lead to potentially hazardous ultrasonic exposure of biological
tissues (Williams, 1983).
If any other sinusoidally varying parameter of the wave is examined, under
standing wave conditions, it can be seen that we get the same result. The pressure
generated by a compressional wave is a quarter of a wavelength out of phase with
particle displacement (figure 2.5 (D)). Therefore the pressure measured in a standing
wave field would have the same alternating pattern but would be displaced by a
quarter of a wavelength from the displacement pattern, so that the displacement
node would be located at a pressure antinode and the displacement antinode at a
pressure node.
Partial standing waves occur when the reflector is less than 100% efficient. In
such a situation the standing wave would be superimposed on the plane progressive
wave field, and the maximum displacements or pressures would be less than twice
that of the incident wave. In practice, standing waves seldom occur in the absence of
travelling waves, and thus the minimum displacement and hence minimum pressure
amplitudes have some finite value.
2.1.7 Resonance
Resonance occurs when the input of energy to a system is in phase with the natural
frequency of oscillation of that system. If energy is supplied in phase then the
amplitude of the oscillating system is maintained or increased. If the same energy is
supplied in a random manner then destructive interference occurs and the amplitude
decreases. To improve the efficiency of any device which is required to transmit,
generate or receive a single frequency of mechanical vibration it is usual to
manufacture such a device so that it is in resonance at that frequency.
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2.1.8 Power density - intensity
The amount of energy contained in a wave as it passes a given point is normally
expressed in terms of the intensity at that point. Intensity is defined as the rate of
flow of energy through an imaginaiy plane, one centimetre or one metre squared,
orientated at right angles to the direction of wave motion. The units of intensity are
thus watts/rn 2 (Wm 2), more commonly expressed as Wcm 2
 or even as mWcm 2. The
intensity (I) of a plane progressive wave is related to the maximum pressure
amplitude (Po) produced within the conducting medium by the equation:
p2
2Pc
Where p is the density of that medium and c is the velocity of the wave in it. C IS
the acoustic impedance.






Where Uo is the maximum velocity of the oscillating particles of the medium as the
wave passes. If there is no absorption or scattering, the intensity of a plane
progressive wave remains constant.
2.1.9 Mechanical waves of different frequencies
Figure 2.10 shows a frequency spectrum for mechanical waves where a logarithmic
scale has been chosen. The spectrum consists of three overlapping regions. The
central region encompasses the audible spectrum from about 20-30 Hz up to about
16000 Hz, these frequencies approximating to the upper and lower frequency limits
of the human ear. The region below about 20 Hz is termed infrasound whilst
frequencies above 16 kHz are termed ultrasound.
Air becomes a progressively less efficient propagating medium for mechanical
vibration as its frequency increases above 20 kHz. The main reason for this is that
for a given power input, the maximum displacement amplitude of the gas molecules





























Figure 2.10. The acoustic spectrum, showing the source or application throughout







































the average distance (mean path) between molecules. Thus most of the gas molecules
close to the source of vibration will be unable to collide with neighbouring molecules
and thus pass on energy and facilitate wave propagation.
As propagation of mechanical waves within a given medium is dependent upon
the transmission of energy from one particle to another, the upper frequency at
which waves will propagate is also determined by the inertia of particles which make
up that medium. The inertia of a body is a measure of its tendency to resist motion
when subjected to a small transient force. For a given power input the displacement
amplitude decreases with increasing frequency. Eventually the particle is unable to
respond as the applied force is not sufficient to overcome its inertia and thus remains
stationary. The wave therefore does not propagate.
2.2 Generation of thera peutic ultrasound
In the previous section the basic physics and properties of mechanical waves were
described. This section deals more specifically the generation of ultrasonic wave
forms associated with the therapeutic application of ultrasound. Ultrasonic waves are
defined as mechanical waves having frequencies above the limit of detection of the
human ear, i.e. greater than 16 - 20 kHz. Therapeutic applications of ultrasound are
normally restricted to the use frequencies between 0.5 - 3 MHz (Dyson, 1990)
generated by piezoelectric transducers.
2.2.1 Plezoelectric transducers
A transducer is a device for converting energy from one form into another, in this
case a conversion of electrical energy into ultrasonic energy. Piezoelectric transducers
rely on the capacity of certain crystals to generate an electric charge when they are
subjected to pressure or distortion. This effect, known as the piezoelectric effect, was
first described by Pierre and Jacques Curie in 1880 (Williams, 1983). The converse
effect is true, i.e. when a voltage is applied to a piezoelectric material it undergoes
mechanical deformation. The phenomenon is due to electric charges bound within
the crystal lattice of the material. It is the interaction between this bound electric
field and the applied electric field that leads to the mechanical deformational changes
(Cady, 1964).
If a disc is cut from a piezoelectric material and electrodes appropriately
applied by coating with a film of a metallic conductor (e.g. gold, silver or aluminium),
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when a voltage is applied across the two electrode surfaces the crystal undergoes a
mechanical deformation. This change in shape can be reversed if the field is reversed,
i.e. a change in the polarisation of the voltage applied across the electrodes results
in a corresponding change in the direction of distortion of the crystal. Thus, the
application of an a.c. voltage across the crystal results in an oscillating change in
shape. The application of an a.c. voltage having an ultrasonic frequency would
therefore result in the crystal oscillating at the same frequency.
As the amplitudes of oscillation of the piezoelectric crystals are very small the
phenomenon of resonance is employed to maximise output. The thickness of the
piezoelectric disc determines the resonant frequency of the sinusoidal voltage to be
applied across the disc in order to produce ultrasound. This can be explained as
follows:
A state of resonance arises when the surfaces of a piezoelectric disc are
separated by a distance equal to an odd number of half wavelengths; here all waves
constructively interfere leading to summation of displacement and hence ultrasonic
output. To manufacture a transducer which is resonant at a particular frequency, the
wavelength is first calculated from the velocity of sound in that material and the
desired frequency. The crystal is then cut to be half (or a multiple of half) of the
calculated wavelength in thickness. The frequency of the electrical signal is then
swept around the expected resonant frequency until the crystal oscillates with
maximum displacement amplitude for any given input power.
This resonant frequency is called the fundamental resonant frequency of the
transducer. This is dependent on transducer thickness. If the driving frequency is
progressively raised above this value, the ultrasonic output decreases as you move
away from resonance and approaches zero when the driving frequency corresponds
to 1 wavelength within the transducer. As the driving frequency is further increased
the ultrasonic output also increases until another resonant state is attained at a
frequency 3 times that of the fundamental frequency. This frequency corresponds to
1.5 wavelengths within the transducer, and is termed the third harmonic frequency.
Yet another resonant condition occurs at the fifth harmonic when the driving
frequency is 5 times the fundamental frequency and corresponds to 2.5 wavelengths
within the transducer.
The piezoelectric effect is restricted to crystals which lack electrical symmetry
e.g. quartz, tourmaline, lithium sulphate, cadmium sulphide. Piezoelectric materials
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can be fabricated from barium titanate and lead zirconate titanate (PZT) (Jaffe et a!.
1955). These materials are mixed with various chemicals, cast to the desired shape
and dimensions and then heated above the materials Curie temperature (typically 300
- 600°C) while exposed to a polansing 2000 V/mm d.c. voltage. The Curie
temperature is that temperature above which the molecules of the material are free
to move in response to an applied force. If a piezoelectric material is heated above
its Curie temperature and allowed to cool in the absence of a d.c. field it will lose its
piezoelectric properties.
Initially, quartz crystals were used for the generation of therapeutic ultrasound
by the reverse piezo-electric effect. Quartz has now generally been replaced by
barium titanate and PZT. The last two materials have the advantage that, because
of their ferro-electric properties, only a small voltage is required to drive the crystal
to oscillate. This obviates the requirement for a bulky sound head transformer
common to quartz transducers, which require a high (several kV) driving voltage.
PZT is preferable to barium titanate because it retains its marked piezo-electric
properties up to much higher temperatures and is less sensitive to mechanical shock.
Polyvinylidene difluoride (PVDF), a plastic with piezoelectric properties, has been
introduced more recently. The piezoelectric property is conferred on this plastic by
applying a large voltage (about 108 V/rn) across the polymer (de Reggi et a!. 1981).
PVDF has an acoustic impedance which is much closer to that of water than other
piezoelectric transducer materials and as such is more efficient at delivering the
ultrasound to the biological target.
2.2.2 Transducer construction
Piezoelectric transducers designed to supply therapeutic levels of ultrasound consist
of a single circular piezoelectric disc, the dimensions of which favour resonance at
the particular frequency of interest. The piezoelectric element has electrodes on the
inner and outer (relative to the treatment face) surfaces. The inner face of this disc
is air backed leading to an impedance mismatch which encourages the reflection of
the generated ultrasonic energy. This reflected energy leaves the applicator head by
the outer face of the transducer, which is bonded to the applicator casing with an
adhesive of similar impedance to the piezoelectric disc. This adhesive also functions
as an electrical insulator. As the piezoelectric element also vibrates in its lateral
plane it is necessary to isolate it from the casing material, by a layer of acoustic
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insulation, to reduce possible operator exposure hazards by side wall irradiation on
protracted use. The front face of therapeutic transducers is usually metallic; this
protects the more delicate piezoelectric element within and encourages a more even
acoustic field distribution.
2.3 The structure of ultrasonic fields
If the wavelength of sound is larger than the dimensions of the source which
produced it, then the sound will spread in all directions (i.e. as a spherical wave)
away from the source, like the ripples in a pond caused by a small stone. This is true
for audible sound which has a typical frequency of 1 kHz and a velocity in air of
about 340 m/s, and consequently a wavelength of about 34 cm. In the resulting
acoustic field the intensity (I) at any point (x) is given by the following equation:
d2
where:	 Lo is the emitted intensity by the source
d is the distance of point x from the source
If the wavelength of sound is smaller than the dimensions of the source a
different set of conditions apply. The wavelength of 1 MHz ultrasound, which travels
through water or body tissues at a velocity of 1540 m/s, is approximately 1.5 mm.
Ultrasonic sources, in therapy equipment, range from 10 to 25 mm in diameter, and
as such are of the order of 10 times larger than the wavelength of sound they are
emitting. Under such conditions the sonic energy does not spread as a spherical
wave; rather, it is contained within a cylindrical beam of approximately the same
diameter as the transducer and travels in the form of a plane progressive wave.
However, the intensity of that wave is not the same at all points within the
beam. This is because individual wave fronts from different parts of the source have
to travel different distances to reach a given point. Waves fronts, originating from
different points, that arrive in phase with one another interfere constructively to
produce sites of high ultrasonic intensity. However, wave fronts that arrive a half
wavelength out of phase with each other destructively interfere and produce sites of
zero intensity. The resulting interference pattern, called a diffraction pattern, can be
divided into two regions (figure 2.11). The region close to the source (transducer) is
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called the near field (or Fresnel zone) whilst the other region is known as the far
field (or Fraunhofer zone). The boundary between these regions occurs at a distance
d from the source; this can be found by employing the following equation:
2d=a_
A
where:	 a is the radius of a circular source
I is the wavelength in that medium.
At the point d the cylindrical beam begins to diverge. If the rays which depict the
diverging waves are extrapolated back to their source they meet at the centre of a
circular generator. The angle of divergence, 0, of the beam in the far field is given
by:
0.611
sin 0 = ____
a
where:	 2 is the wavelength of sound in that medium
a is the radius of a circular source.
This pattern is generated within biological tissues whenever high frequency
ultrasound is used; it is thus of great importance that it be examined in full.
If a pressure sensitive detector, whose dimensions are smaller than a wavelength, is
placed at the centre of a large circular transducer and slowly moved away from it at
right angles to its transmitting surface (i.e. along its central axis), the detector output
will show a repeating sequence of peaks and troughs similar to that in figure 2.12 (1).
The peaks are those points where individual waves have arrived approximately in
phase and have constructively interfered to give pressure maxima. The troughs are
those points where almost half of the waves have arrived half a wavelength out of
phase with the remainder and have thus destructively interfered. Complete
constructive or destructive interference is virtually impossible to achieve so the
pressure maxima and minima never reach zero.
Close to the transducer, in the near field, the peaks are sharp and close
together. They become broader and wider apart with increasing distance from the
transducer until the last peak, normally higher and broader than the rest and called
the last axial maximum. This peak (at C in figure 2.12) is at the point, d, which marks
the boundary between the Fresnel and Frau nhofer zones. The area around point d
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Figure 2.11. A diagrammatic representation of the cylindrical (Fresnel) and diverging
(Fraunhofer) portions of the ultrasonic beam produced by ultrasound transducers.
Transducer
Fresnel zone	 :	 Fraunhofer zone
d = distance from source after which beam diverges










Figure 2.12. Diagrammatic representation of the distribution of acoustic pressure
within an ultrasonic beam: (1) along the central axis of the transducer, (2) across the
beam axis, at various axial locations, and, (3) in the form of 'ring patterns', which










is usually the most uniform high intensity region within the ultrasonic beam.
The variation in pressure is more complicated transversely, as is revealed if
the detector is swept across the face of the transducer, at right angles to the beam
axis. As can be seen from figure (2.12 (2)) the trace that cuts the axis at point A, an
axial maximum, has a central peak and two or more side lobes separated by troughs.
However, the trace that cuts the axis at point B, an axial minimum, has a central
trough and two or more peaks which occupy the positions of the troughs in scan A.
This situation is repeated at each axial minimum and maximum in the near field. The
amount of energy in the side lobes decreases with distance from the transducer until
only a single axial peak is found in the scan of the last axial maximum (scan through
point C of figure 2.12 (2)). Beyond this point the far field is entered and the height
of the peak decreases as its base broadens with divergence of the beam (scan through
point D in figure 2.12 (2)).
The acoustic field generated by a circular source, as in therapeutic ultrasound
transducers, has circular symmetry. The three dimensional distribution of intensity
can be visualised if the two dimensional map in figure 2.12 (2) is spun about its long
axis. Sections through this three dimensional map show so called "ring patterns";
which can be obtained if some material sensitive to some parameter of the acoustic
field is placed in a plane parallel to the transducer face. Figure 2.12 (3) shows the
ring patterns expected at the four points A - D previously described.
2.4 Ultrasonic dosimetry
The previous section demonstrated that because of interference phenomena the
ultrasonic intensity, measured as pressure, varied from point to point within the
beam, especially within the near field. Such inhomogeneity emphasises the
requirement for full quantitative and qualitative description of these fields so that we
can relate biological effects to specific ultrasonic characteristics. If, as in ultrasound
therapy, the beam is continually moved evenly and repeatedly through the treatment
area, then that area receives a time-averaged dose which is a function of the amount
of ultrasonic energy emitted by the transducer and the duration of the treatment. It
is therefore essential that we are able to measure the quantity of ultrasound emitted
and have some idea of its distribution in both time (if pulsed) and space. In order
to attempt to reproduce experimental bioeffects, in both the experimental and the
clinical arena, it is essential that experimentalists and clinicians are supplied with
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clear, and unequivocal, information regarding exposure conditions necessary to
observe a given bioeffect.
The numerous techniques in common use for ultrasonic dosimetry may be
divided into two groups, those which measure total ultrasonic power emitted by the
transducer and those which describe the distribution and variation of this power
within the field. The most common approach to ultrasonic dosimetry is to measure
the total amount of radiated energy by one technique and divide this by the effective
radiating area (ERA) of the beam, obtained by some other technique. Such an
approach would give us the spatially averaged intensity (P), normally quoted in terms
of watts per square centimetre (W/cm 2), over the whole beam. The dosimetry
methods employed in this thesis, to measure the total amount of radiated energy and
its distribution in time and space, are described in chapter 6. Rather than
simply supplying information regarding the average intensity applied to a given
biological target, some authors prefer to quote the most extreme "hot spot" intensity,
here defined as the spatial peak intensity (F), experienced by a biological target within
the ultrasonic field. When one is examining the effect of ultrasound on biological
targets exposed within the near field (as in this thesis) the spatial peak intensity is
usually located in the centre of the beam, co-axial with the centre of the transducer
face. Due to the highly variable pressure distribution within the near field the spatial
peak intensity (F), within a lateral cross section of an ultrasonic beam, may be
several times the spatial average intensity (I s) at the same site.
When applied in pulsed mode, ultrasonic intensity can be described in four
ways. The most commonly employed method of quantifying the output of pulsed
ultrasound is by averaging the intensity over time (including off time when the
transducer is not emitting) and effective radiating area, this is known as the spatial
averaged temporal averaged intensity (I(sATA)). The second method is to quote the
temporally averaged intensity at the most intense hot spot of the ultrasonic field,
which is equivalent to the spatial peak intensity of continuous ultrasound. This is
known as the spatial peak temporal average intensity (I )). The remaining two ways
of quantifying intensity in the pulsed mode are calculated from the 1(SATA) and P'
values while taking into account transducer on time only. These give values of the
average and peak intensities within each pulse and are known as spatial average
temporal peak intensity (I) and spatial peak temporal peak intensity (P'nI')). The
term temporal peak is often replace with pulsed averaged (PA) when ultrasound is
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delivered as long (ms) pulses and thus become P" and J) respectively.
For example:
Suppose that a therapeutic transducer is driven in continuous mode so that its
spatially averaged intensity is 1 W/cm 2 . Its spatial peak intensity could be somewhere
between 2 & 6 W/cm 2 (say 4 W/cm 2). If the generator is now switched to pulsed
mode so that the pulse off time is four times longer than the pulse on time (i.e., a
duty cycle of 1:4), then the 1(SATA) and 1(SFrA) would drop to 0.2 W/cm 2 and 0.8 W/cm2
respectively, whereas the 1J'A) and 1(SPPA) values would remain at 1 and 4 W/cm2
respectively.
In addition to these peak and averaged intensity measurements, complete
characterisation of an ultrasonic field should include measurement of the intensity
distribution across the beam, perpendicular to the beam axis (lateral beam plots) at
a site which corresponds to the location of the biological target under study. There
are other dosimetric parameters which need to be known and quoted when any
biological effect of ultrasound is being examined. Certain ultrasound bioeffects
appear to be dependant upon frequency. Young and Dyson (1990) demonstrated that
ultrasound at a frequency of 0.75 MHz encouraged wound angiogenesis to a greater
extent than 3 MHz, all other parameters being fixed. In addition to frequency, the
following should also be stated: mode of exposure (continuous or pulsed), description
of the modulation envelope (pulsed), pulse and pause time - termed the mark:space
ratio, exposure duration, the number of exposures given and the time between
exposures. The amount of heat generated as a consequence of exposure should also
be stated.
2.5 DetectIon and measurement of ultrasound
Ultrasound output can be measured in a number of ways. The most common
methods used are:
1. Radiation force methods
2. Piezoelectric hydrophone methods
3. Calorimetric (absorption) methods
4. Optical methods
2.5.1 Radiation force methods
Any medium or object placed in the path of an ultrasonic beam is subject to a steady
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force called the radiation pressure force which tends to push that material in the
direction of wave propagation. This pressure is distinct from the oscillating particle
pressure (described earlier in section 2.4) and is not fully understood. If an ultrasonic
beam strikes a totally absorbing target, at room temperature, the force generated by
the beam is approximately 68 mg for each watt of ultrasound. The measurement of
radiation force is the most commonly used technique for measuring total power
produced by a transducer. The total ultrasonic power of the therapy device employed
in this study was measured using a custom engineered radiation force balance
(chapter 6, p190).
2.5.2 Piezoelectric hydrophone methods
A hydrophone is a small piezoelectric ultrasound transducer which is used as a
receiving element. The piezoelectric element in hydrophones produces a voltage
response to ambient pressure. The element dimensions are small compared with the
dimensions of a wavelength, which allows the hydrophone to measure point pressures
produced irrespective of pressures at neighbouring points. They have resonant
frequencies much greater than the source being investigated to reduce the likelihood
of a state of resonance occurring (e.g. it is appropriate to use a hydrophone of
resonant frequency 20 MHz to study the output of transducers producing a 1 or 3
MHz field). Hydrophones are usually used to investigate relative intensity distribution
within ultrasonic fields, (i.e. for beam plots, see chapter 6). They can also be used
to measure absolute intensity, foc example at hot spots such at the last axial
maximum; for this the hydrophones have to be calibrated in terms of acoustic
intensity. A polyvinylidene difluoride (PVDF) piezoelectric hydrophone was used to
obtain beam plots of the therapy transducers used in this study. The method used to
generate beam plots is describe in chapter 6.
2.5.3 CalorImetric (absorption) methods
When a beam of ultrasound travels through a medium, part of the energy of the
beam is absorbed and converted to heat which is manifested as a temperature rise
in that medium. From the temperature rise of a given volume of liquid of known
absorption coefficient at the frequency and temperature of interest (e.g. castor oil),
the power dissipated from the transducer can be calculated. The temperature rise
within the absorbing volume is normally measured using highly sensitive
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thermocouples.
As well as this measurement of total power, thermocouples or thermistors can
be used as point intensity detectors in both absorbent and non-absorbent media. In
absorbent materials, e.g. biological tissue, local absorption of ultrasonic energy gives
rise to a temperature rise. From this temperature rise, knowing the absorption
coefficient of that tissue, at the frequency and experimental temperature under study,
the ultrasonic intensity at that site can be calculated. In non-absorbent materials
thermocouples or thermistors contained within a small volume of absorbing material
are used. As the absorbent material absorbs energy it heats up. This increase in
temperature is monitored by the encapsulated calorimeter and again can be related
to ultrasonic intensity at a given point. Field plots of the distribution of intensity
within a sound field can be obtained by using many of these calorimeters distributed
throughout the ultrasonic beam or by moving the calorimeter across the beam.
2.5.4 Optical methods
The molecules of the medium through which a sound beam is propagating are
alternately compressed and then pulled apart. This results in small local variations
in the medium density which in turn leads to variation in refractive index. A beam
of light which is passing through a sound beam is deflected by an amount which is
proportional to the intensity of the acoustic field. Schlieren systems utilise this
property to produce a visual display of the shape of the ultrasonic beam passing
through an optically transparent medium such as water. Optical techniques are
generally used for qualitative assessment of the extent and uniformity of ultrasonic
fields.
This section covered briefly the most common detection and measuring
methods used by investigators in the field of ultrasonic bioeffects. These, and other
less common methods, have been more extensively described by Wells (1977).
2.6 AttenuatIon of ultrasound
The intensity of a wave of ultrasound travelling through a medium is found to
decrease as a function of distance. This attenuation is thought to be due to a number
of mechanisms including beam divergence, scattering, absorption, diffraction and




As explained earlier (p&I), beam divergence refers to the deviation from a parallel
beam so that the energy per unit area is reduced. The role played by this
phenomenon is greater at lower frequencies.
2.6.2 Scattering
Scattering refers to the random reflection of incident ultrasound by small (relative
to wavelength) obstacles placed in its path. As previously explained (section 2.1.5),
when an ultrasound beam encounters an interface between two substances of
differing acoustic impedances part of the energy is reflected. If the size of the
reflector is large relative to the wavelength of sound and the dimensions of the beam
then it is called a specular reflector and a plane wave is reflected as a plane wave.
If, however, the dimensions of the reflector are smaller than a wavelength then the
reflector acts as a point source and radiates a spherical wave. Biological material is
far from homogenous; different tissues vary widely in the composition and
architecture of their cellular and acellular components and as such exhibit differing
acoustic impedances. They thus contain a range of surfaces whose dimensions vary
from that of a specular reflector through to cell nuclei, which are approximately one
thousandth of the wavelength of 1 MHz ultrasound. Provided that they are of
different acoustic impedance to their surroundings, these small reflectors scatter or
re-radiate the ultrasonic energy in all directions; the energy no longer moves in the
original direction of propagation and so attenuation of the beam occurs (figure 2.13).
2.63 Absorption
Ultrasound attenuation by absorption occurs when the ordered vibrational energy of
the wave is converted into other forms of energy such as heat. The mechanisms by
which absorption occurs include those due to viscous loss (termed classical
mechanisms) and those due to the relaxation process.
2.63.1 VIscous Loss
Ultrasound travels through a medium by driving the particles of that medium to
vibrate. Energy transfer between neighbouring particles then facilitates its
propagation. The mechanism of absorption by viscous loss is based on the fact that
the viscosity of the medium tends to oppose the vibrational motion of the particles,
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Figure 2.13 A diagrammatic representation of the scattering patterns produced by










and some of this energy is converted into heat. Absorption is thus dependent upon
the viscosity of the propagating medium. Absorption due to viscous loss increases
non-linearly with increasing frequency. At frequencies used in biomedical research,
viscous loss does not account for much ultrasonic absorption (Wells, 1977).
2.6.3.2 Relaxation
Another mechanism by which absorption can occur arises because energy can exist
in a system in various forms, such as molecular vibrational energy, lattice vibrational
energy, translational energy, and so on. When an ultrasonic wave propagates through
this system there is an increase in energy in one or more of these forms during the
compressive part of the cycle. If none of this energy flows to another form, then it
would be immediately returned to vibrational energy of the wave during the
decompressive part of the cycle and there would be no net absorption. However,
some energy always flows into another form during the compressional half cycle
(Wells, 1969). During the decompressional half cycle the majority of the energy will
be immediately returned in the form of vibrational energy. However, the energy
which had flowed to one or more of the other energy forms takes a characteristic
period of time to return as vibrational energy. Thus some energy is returned out of
phase with the original propagating wave which results in absorption.
Furthermore, some energy does not return to the vibrational form but remains
in one of the other forms and is thus effectively absorbed. The magnitude of
relaxational absorption is determined by the time constant of the relaxation process.
At low frequencies, the phase delay in energy transfer is negligible, and the
absorption is small. The absorption increases with frequency, up to a maximum value
when the shared energy is anti-phase; above this frequency the absorption falls
because there is less time available for the energy to flow from one form to another.
Typically, maximum absorption due to relaxation occurs at frequencies around 2 to
5 MHz (Wells, 1969). Relaxation processes are generally the most important
contributors to ultrasonic absorption in biological tissues at these frequencies.
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Chapter 3. Interaction of ultrasound with biological materials
Introduction
The mechanisms of interaction of ultrasound with biological materials can be divided
into two groups, thermal and non-thermal.




A given bioeffect may result from the action of one, or the interaction of several, of
the mechanisms listed above.
3.1 Thermal
Biological materials do not transmit ultrasonic energy with 100% efficiency. As an
ultrasonic beam travels through tissue the energy contained within it decreases with
distance traversed. This energy loss from the beam, termed attenuation, results from
the absorption or scattering of energy by the material. The energy absorbed by the
material primarily appears as heat and causes an increase in temperature of that
material. The amount of absorption, and thus the amount of heat generated, within
a material is dependent upon: 1. absorption characteristics of that material, 2. the
characteristics of ultrasound (such as frequency) and, 3. the amount of ultrasonic
energy passing through it.
1. Characteristics
The absorption of ultrasonic energy, and thus the amount of heat generated, is
greater in tissues having high absorption coefficients. Tissues with high protein (or
mineral) content such as muscle (or bone) have higher absorption coeffictents than
tissues with high fat or water content. For example the intensity of a beam of 3 MHz
ultrasound is 50% attenuated by about 16mm of fat but only about 3mm of muscle
(table 3.1). Structures having high absorption coefficients such as superficial cortical
bone, joint menisci, fibrotic muscle, tendon sheaths and major nerve roots are
therefore preferentially heated (Lehman and Guy, 1972). Ultrasound will largely pass




The half value depth for 1 and 3 MHz ultrasound in various media
Medium	 Penetration depth (mm)
1MI-Iz	 3MHz
Water	 11500.0	 3833.0
Adipose tissue	 50.0	 16.5
Skeletal muscle (fibres coaxial with beam) 	 24.6	 8.0
Skin	 11.1	 4.0




Compact bone	 2.1	 -
(after Hoogland, 1986)
Hopewell, 1982). For bone, which has an even higher absorption coefficient than
muscle, the rate of heating is even higher, possibly explaining the benefit of ultrasonic
therapy in selectively heating joints such as in the treatment of epicondylitis (Binder
et a!. 1985). When an ultrasonic wave travelling through muscle is incident upon bony
structures, because of impedance mismatch, nearly 30% of the incident energy is
reflected. This reflected wave returns through the muscle traversed on its incident
journey. Energy is again removed during this return journey and deposited as
additional heat. In addition to reflection, mode conversion is also thought to occur
at such muscle/bone interfaces. Briefly, part the of the incident compressional wave
is converted into a transverse wave; as soft tissues have a limited ability to conduct
transverse waves they are rapidly absorbed and converted into heat. The majority of
the transverse wave energy is deposited within a few millimetres of the muscle/bone
interface. This area close to the bone, which is richly endowed with blood vessels and
nerve endings, includes the periosteum. The heat deposited within the periosteum
raises its temperature and, if it exceeds a certain value, is interpreted as pain.
Consequently, the application of therapeutic ultrasound at anatomical sites where
bone is close to the surface of the skin will lead to the sensation of pain at lower
intensities than sites that have a thick layer of absorbent muscle (Williams, 1983).
The temperature rise within a tissue depends upon the transport of heat away
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by blood flow. Tissues differ widely in their degree of vascularity, and the rate of
blood flow through any given tissue can vary in response to physiological need at any
given time. It should be noted that as soon as a temperature rise is produced within
most tissues, in vivo, it initiates physiological responses that result in the dilation of
blood vessels and an increase in blood flow, which increases the rate that heat is lost
(Williams, 1983). Overheating, and consequently thermal damage, can occur in tissues
of impaired vascularity at ultrasonic intensities unable to produce significant
temperature rises in similar healthy, well vascularised, tissue (Dyson, 1990).
2 Ultrasonic frequency
For a given tissue the absorption of ultrasonic energy, and thus the amount of heat
generated in that tissue, will increase with increasing frequency. For example 1 MHz
ultrasound has lost half of its initial intensity after passing through 48mm of fat and
about 9mm of muscle, while 3 MHz ultrasound can pass through only about 16mm
of fat or about 3mm of muscle before it has lost half its energy (table 3.1). The loss
of ultrasonic intensity from the beam is paralleled by a gain in temperature by the
tissue. Thus by controlling the frequency of ultrasound applied, with a knowledge of
the composition of the tissue under treatment, the therapist has some control over
the depth at which heating occurs.
3. Ultrasonic intensity applied
For a given tissue, exposed to a given frequency of ultrasound for a fixed amount of
time, the amount of heat generated in that tissue will increase with increasing
ultrasonic intensity.
It is possible to estimate the order of temperature rise (T) that may be
expected after irradiation with an intensity I after a time t, in the absence of any





a3 is the absorption coefficient of the tissue (typically 0.03 Np cm at 1 MHz)
p is the tissue density (approximately 1 g/cc)
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Cm is the specific heat per unit mass of the tissue (4.2 Joules/g)
From the equation it can be seen that temperature change is directly related
to ultrasonic intensity. According to the typical values indicated, temperature
increases of the order of 0.014°C/second (0.8°C/minute) would be expected for an
ultrasonic intensity of 1.0 W/cm 2 (1(a)). These estimates may be more applicable to
poorly vascularised tissues such as cutaneous scars or tendons, but will probably over-
estimate the actual heating observed in highly vascularised tissue such as muscle or
granulation tissue. It has been stated that the temperature rise caused by a given
time-averaged intensity, applied for a given amount of time, will be the same
regardless of whether ultrasound is applied in pulsed or continuous mode (Williams,
1990) i.e. continuous 1 MHz ultrasound applied at an intensity of 0.5 W/cm2 (1(a)) for
5 minutes will cause the same temperature rise as 5 minutes of 1 MHz pulsed (2ms
on, 8 ms off) ultrasound at an intensity of 2.5 W/cm2 j(1'A) However, the process of
pulsing ultrasound may reduce the likelihood of cavitation (p96) (Williams, 1990).
Regulated exposure to heat, regardless of the means of its generation, can
have various beneficial effects. Increase in the extensibility of collagenous tissue,
blood flow, pain relief and the resolution of inflammation, and decrease in muscle
spasm and joint stiffness have all been observed in tissues maintained for between
5 - 30 minutes at temperatures between 40 - 45°C (Lehman and Delateur, 1982). It
has been suggested that the main advantage of using ultrasound rather than a non-
acoustic method to raise tissue temperature is that ultrasound allows protein-rich
tissues to be heated preferentially. Highly collagenous (i.e. proteinaceous) scar tissue,
joint capsules, and tendons lying deep within the body can therefore be heated to
within the therapeutically effective range without producing damaging temperature
elevations within the less collagenous skin and subcutaneous adipose tissue lying
superficial to them.
The thermal mechanism is thought to be the major mechanism by which
ultrasound exerts its therapeutic effects in the treatment of musculo-skeletal disorders
(Summer and Patrick, 1964), where intensities of the order of 0.5 - 3.0 W/cm2
(I(a)/i(SATA)) are employed. However, this mechanism is thought to be implicated to
a lesser degree in the stimulation of tissue repair (Dyson et a!. 1968), where
beneficial therapeutic effects can be achieved without a significant elevation in
temperature. Such studies have employed intensities of the order of 0.1 - 0.2 W/cm2
(I(SATA))
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More comprehensive reviews of the biological effects of ultrasound attributed
to heat have been compiled by Wells (1977), Fry (1979) and Williams (1983).
3.2 Non thermal
If an ultrasonic bioeffect is observed in the absence of physiologically significant
heating or cannot be mimicked by heating to the temperature attained during
ultrasonic exposure then the observed bioeffect was probably not caused by a thermal
mechanism i.e. a non thermal mechanism was involved. Such bioeffects can be
demonstrated when the average ultrasonic intensity is low, or the system is cooled,
so that little or no temperature rise occurs.
Bioeffects of therapeutic ultrasound that appear to result from non-thermal
mechanisms include: the stimulation of tissue repair (Dyson et a!. 1968) and more
specifically soft tissue repair (Paul eta!. 1960; Dyson et a!. 1976) stimulation of blood
flow in chronically ischaemic tissues (Hogan et a!. 1982), stimulation of protein
synthesis by fibroblasts (Webster et a!. 1978) and of bone repair (Dyson and Brookes,
1983).
3.2.1 Acoustic Cavitation
The theories and physics of acoustic cavitation are extremely complex. This section
should be viewed as a gross simplification of the physics with a bias towards possible
biological interactions. Acoustic cavitation is the term applied to describe the
oscillatory activity of gas or vapour-filled bubbles which are powered by and thus
extract energy from the incident acoustic field (Williams, 1983). Some of the energy
(about 10%) is re-radiated as an acoustic wave but the remainder is transformed into
other forms and may appear as heat (resulting in the production of free radicals) or
as shock waves or hydrodynamic shear fields which can disrupt biological tissue.
These bubbles grow by a process termed rectified diffusion, from tiny in-
homogeneities within conducting media, called micronuclei, under the influence of
ultrasonic fields. The occurrence of any form of cavitational activity is highly
dependent on the number and availability of these micronuclei.
Rectified diffission may be explained as follows:
When bubbles contract, in response to ambient pressure increase, the partial pressure
of the gas within the bubble increases. This encourages gas to diffuse out of the
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bubble. Conversely when the bubble expands, gas is encouraged to diffuse into the
bubble. Since the rate of diffusion is dependent upon the surface area for diffusion
less gas will leave the bubble when it is contracting (smaller surface area) than will
enter it when it is expanding (larger surface area) this mechanism of rectified
diffusion is termed the "area effect". In addition to this mechanism, another
mechanism termed the "shell effect" is also thought to facilitate rectified diffusion.
This second mechanism is due to the fact that as the bubble expands it compresses
vapour around the outside of the bubble, thus increasing the concentration gradient
across the skin of the bubble. As the rate of diffusion into the bubble depends on this
gradient, inward diffusion is greater when the vapour is compressed i.e. when the
bubble is in its expanded state. The process of rectified diffusions thus results in a
net diffusion of gas into the bubble which results in bubble growth. This process of
rectified diffusion competes with the normal diffusion of gas out of the bubble which
is due to the normal tendency of small bubbles to shrink in response to surface
tension.
A more complete physics-based description of the theoiy of rectified diffusion
is given by Crum (1984).
The cavitational behaviour of these bubbles once formed depends upon the
ultrasonic field they experience. Two extremes of cavitation activity have been
identified, the gentle oscillation of gas filled bubbles in low intensity sound fields
termed stable cavitation, and the violent and destructive behaviour of short-lived
vapour-filled bubbles in high intensity sound fields termed transient cavitation (Flynn,
1964). Stable and transient cavitation should not be thought of as separate entities
but rather extremes of a continuum. This is illustrated by the fact that a bubble
exhibiting the characteristics of stable cavitation changes its behaviour as intensity
increases until it exhibits characteristics associated with transient cavitation at high
acoustic intensities (Williams, 1983).
3.2.1.1 Stable cavitation
Stable cavitation is thought of as being non-violent. It refers to the motion of a
bubble gently oscillating in phase with the pressure variations induced by the acoustic
wave (Nyborg, 1977). Thus, the bubble contracts by a given amount as the acoustic
pressure at that site reaches a maximum and expands by almost the same amount
when acoustic pressure reaches its minimum value. With stable cavitation, bubbles
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grow in response to the pressure fluctuations of the sound field, over a period of
several wave cycles, from micronuclei present in the sonicated medium, by rectified
diffusion. Throughout the period of bubble growth, the sound field leads to a
pulsating motion of the bubble.
The biological activity associated with stable cavitation is based upon the
generation of microscopic streaming fields around oscillating bubbles called acoustic
micro-streaming. Large hydrodynamic shear stresses occur within the acoustic
streaming flow generated near solid or gaseous bodies oscillating at an ultrasonic
frequency while immersed in a liquid (Nyborg, 1965). This microstreaming flow
includes a small closed inner circulation and an outer circulation which may extend
over distances many times larger than the dimensions of the oscillating source. The
greatest shear stresses occur within the inner (boundary layer) flow, and objects in
suspension, such as cells, are only subject to large shear stresses for a short time
(milliseconds) as they are carried past the oscillating surface by the outer eddy of the
micro-streaming flow (Williams and Miller, 1980). However, in tissues cells which are
not free to move can be exposed to these stresses throughout the period of
irradiation, unless the ultrasound applicator is kept in motion.
The amplitude of bubble oscillation, and thus cavitational activity, is
dependent upon bubble size. Cavitational activity associated with a growing
microbubble increases with increasing size of the oscillating bubble until it reaches
resonant size, at which point further increase in size of the bubble will result in a
decrease in the magnitude of cavitational activity. The resonant size for a bubble at
an ultrasonic frequency of 1 MHz is approximately 7i.i.m in diameter (Williams, 1983).
3.2.1.2 Transient Cavitation
Transient cavitation is the phenomenon whereby a bubble grows very rapidly during
that portion of the wave cycle when the pressure falls to a low value, then collapses
during the next part of the wave cycle when the pressure increases. The whole
process from formation of the bubble to its collapse is thought to occupy less than
one wave period. It occurs most readily at low ultrasonic frequencies (15 - 40 kHz)
and high ultrasonic intensities (Williams, 1983).
Transient cavitation is a violent but microscopic phenomenon generating shock
waves and very high temperatures within bubbles. Noltingk and Neppiras (1950)
deduced that the temperature rise within a collapsing bubble could exceed several
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thousand °C. Such high temperatures lead to the pyrolytic breakdown of water
vapour leading to the production of highly reactive H and OH free radicals (Coakley
and Nyborg, 1978). Such free radicals are short lived, but, after interaction with
undissociated water or gas molecules, may generate longer lived secondary species
such as H202 (Del Duca et al. 1958). It is well documented that the presence of free
radicals, particularly hydroxyl radicals, can result in adverse biological effects (Ward,
1981), such as cell death and DNA strand breaks resulting in chromosomal
aberrations (Sasaki and Matsubara, 1972).
There is, however, despite many studies, no evidence of chromosomal defects
produced by clinical ultrasound (Duck and Whish, 1986; Miller, 1985a; Miller et a!.
1991). Further, there is , as yet, no evidence that ultrasound causes free radical
production within the cell itself. It is generally thought that the cells in such close
proximity to a collapsing bubble would be destroyed by shock waves before their
DNA could be altered. Not allowing for this, the free radicals would have a cell
membrane and various cytoplasmic constituents to traverse en route to the nucleus,
and would thus have ample opportunity to regain their less reactive status.
However, it has been demonstrated that free radicals can develop in the
extracellular fluid around cells (Crum et a!. 1987). As the reaction length of a free
radical under such conditions is of the order of between 15 and 90 A (Ward et a!.
1985) any free radical-cell interaction would occur at or near the cell membrane.
Studies have shown that therapeutic ultrasound can cause damage to endothelial cells
when standing waves are generated (Dyson et a!. 1974), and increase the ion
transport through biological membranes (Mortimer, 1981). However, it is not clear
what role, if any, free radicals play in these particular phenomena. It is generally
accepted that transient cavitation is an unlikely event using ultrasound at therapeutic
levels, especially if standing wave formation is avoided.
3.2.1.3 The study of acoustic cavitation
The phenomenon of cavitation is highly unpredictable which makes its physical and
biological effects difficult to study. The unpredictability in its occurrence stems from
the fact that far more energy is required to generate bubbles than is required to drive
pre-existing bubbles to oscillate. As explained earlier cavitation is dependent upon
the presence of micronuclei; it is also dependent upon many other variables including
ultrasonic intensity (its temporal and spatial distribution), frequency and the
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availability of dissolved gases.
This has led many investigators to examine in vitro model systems in which the
cavitational activity of stabiised bubbles, of resonant size, are driven to oscillate.
Miller et a!. (1978) developed such a system, based on a Nucleopore membrane, to
examine the cavitation derived micro-streaming effects of megaHertz frequency
ultrasound. Miller et a!. (1978) demonstrated that stable gas bubbles can produce
significant biological changes at extremely low acoustic intensities in the megahertz
range. Fresh human platelets were shown to aggregate in vitro, in the presence of
such stable gas bubbles, at continuous wave (c.w.) intensities as low as 32 - 64
mW/cm2 (1(a)) using 1 MHz ultrasound (Miller et a!. 1978) and, subsequently, at c.w.
intensities as low as 16 - 32 mW/cm 2 (1(a)) using 2.1 MHz ultrasound (Miller, 1979a).
Rupture has also been demonstrated in platelets following exposure to similar
acoustic parameters in the presence of stabiised gas bubbles (Miller et a!. 1979b).
More recently Williams and Miller (1980) demonstrated that human erythrocytes
could be ruptured when exposed to 1.6 MHz ultrasound at intensities as low as 20 -
30 mW/cm2 in the presence of resonant sized gas bubbles.
Thus stable gas bubbles of the correct size may be driven to oscillate by
extremely low intensities of therapeutic ultrasound at megaHertz (therapy)
frequencies. The hydrodynamic shear forces within the acoustic micro-streaming
fields generated by these oscillating bubbles are more than large enough to disrupt
cells in vitro (Williams, 1983). Whether such cavitational activity is responsible for the
many in vivo bioeffects associated with low level, apparently non-thermal, ultrasonic
exposure depends upon the presence of nucleation sites and the subsequent growth
and development of cavities is currently unknown.
3.2.1.4 Cavitational activity in vitro
Much of the wealth of information on cavitationally-induced bioeffects comes from
in vitro experiments. This is because the energy absorbed by cells in suspension in
vitro can easily flow away into the suspending medium, and as such, cells in
suspension are less likely to be influenced by temperature rise (Williams, 1985). It
has been suggested that some form of cavitation mechanism is involved in most if not
all of the reported in vitro ultrasonic bioeffects (Miller, 1985b) as many of the
bioeffects demonstrated to date in vitro can be suppressed by elevating ambient
pressure (Ciaravino et a!. 1981; Webster et a!. 1978; Mortimer and Dyson, 1988).
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Many workers have attempted to quantitate the "threshold" conditions
required for cavitation to occur in vitro. Unfortunately there are many cavitation
detection techniques, of varying sensitivities, each with its own following of
experimentalists. This has lead to the publication of markedly different values for the
"threshold" conditions for its occurrence. It was pointed out by lernetti (1971) that
the reported threshold acoustic pressure amplitudes for bubble formation using 1
MHz ultrasound ranged from 1.75 to 240 atmospheres (0.175 - 24 MPa). There is
thus no "safe" threshold pressure amplitude below which cavitation is always absent.
Many of the factors which influence this "threshold" have been mentioned
earlier in this section; they include the number and size of micronuclei, the presence
of foreign surfaces for the attachment and stabiisation of bubbles, the content of
dissolved gas, the treatment of the sample (eg mixing/stirring) and the frequency,
intensity and pulsing regime of the ultrasonic beam. In general, the intensity
"threshold" for the occurrence of cavitation increases with frequency in the megahertz
range. One explanation for this is that as the frequency increases there is
progressively less time for gas molecules to diffuse into the micronucleus during the
negative pressure portion of the cycle, so bubbles are less likely to develop. Many
therapeutic ultrasound generators can deliver pulsed as well as continuous wave
ultrasound. The effect of pulsing ultrasound on cavitation varies with the pulsing
scheme. Hill (1972) stated that if the same amount of acoustic energy is delivered in
the form of extremely short but intense pulses, separated by relatively long intervals
(as in diagnostic ultrasound), the long off-time would facilitate dissolution of bubbles
developed during the pulse. This dissolution can be encouraged by increasing the
ambient pressure of the system. In contrast, it has been stated that multiple
millisecond pulses (similar to the pulsing regimes of therapy devices) encourages the
likelihood of transient cavitation within a medium (Ciaravino, 1981).
The rate at which a given bubble will develop is dependent upon the
instantaneous value of the acoustic pressure amplitude of a pulsed beam and its
duration rather than the time averaged intensity at that site. It has been
demonstrated that the level of lysis of a stirred erythrocyte suspension was greater
when the same spatially and temporally averaged intensity was delivered in the form
of 2 millisecond pulses (from a commercially available therapeutic device) than when
delivered in continuous mode. The level of erythrocyte lysis increased as the length
of the pulses became shorter i.e with increasing pulse peak intensity (Williams, 1983).
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In vitro studies of cells in suspension invariably employ some form of vessel
to hold the sample under test. The walls of such vessels may contain microscopic gas-
filled cracks or hydrophobic sites which will encourage the growth of small gas
bubbles under the appropriate acoustic conditions. Micronuclei may also be
introduced into an experimental system by pippetting, stirring, shaking or rotating cell
suspensions in an attempt to ensure they are homogenous. Williams (1982)
demonstrated increasing cavitationally-induced red blood cell lysis as the speed of a
magnetic stirrer was increased when the system was exposed to 0.75 MHz continuous
ultrasound at an intensity of 1 W/cm2 (within the therapeutic range). Williams also
investigated other methods of agitation on the level of red blood cell lysis including
shaking and percussive impact on the exposure vessel and found elevated
cavitationally induced red blood cell lysis with increasing mechanical disturbance
(Williams, 1982). These effects were so dramatic that the author pointed out that it
was pointless carrying out in vitro studies without considering pre-treatment of the
sample and the effects of any agitation technique on the nucleation properties of that
suspension.
The geometry of the in vitro exposure system also has a profound effect on the
subsequent growth and development of bubbles during exposure. Any interface at
right angles to the path of a plane acoustic beam will reflect part of the incident
beam forming a partial standing wave field. The increased pressures produced by
standing wave fields can lead to highly active cavitational phenomenon, possibly
transient cavitation with concomitant heat generation and free radical release as
demonstrated in biological fluids such as plasma and amniotic fluid (Crum et a!.
1987). lernetti (1971) studying cavitation in gassy distilled water, demonstrated that
the threshold ultrasonic intensity at which cavitation occurred decreased as the
volume of the sample increased. This probably reflects the greater probability of
finding nuclei in a greater volume of liquid.
In view of the above considerations it is not surprising that there is no single
"threshold" value for the occurrence of cavitation. The cavitation-based lysis of
erythrocytes in vitro is a fine example. Using 1 MHz continuous wave ultrasound the
threshold intensity required to lyse a suspension of unstirred erythrocytes is about 1.5
W/cm 2, but, when gently stirred this drops to about 0.6 W/cm 2. The threshold
intensity drops even lower to 0.2 W/cm2 when resonant sized gas bubbles are
introduced into the exposure system (Williams and Miller, 1980).
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3.2.1.5 Cavitational activity in vivo
Many workers have previously suggested that nucleation sites for bubbles do not exist
in vivo, for example in freshly drawn cat blood (Harvey, 1951). However, it has been
suggested that micronuclei must occur in vivo in mammalian tissues as these are the
nucleation sites from which bubbles grow during decompression (Fulton, 1951). It has
been proposed that micronuclei are continuously formed as a result of local
mechanical tensions. It has been observed that animals at complete rest, experiencing
mild decompressional conditions, form visible bubbles; whereas, if muscular
contraction occurs bubbles occur in profusion (Fulton, 1951). There is more recent
evidence to support this proposal; Chater and Williams (1982) could not get
mammalian blood to cavitate in vivo at MHz frequencies and yet Gramiak and Shah
(1971) could readily detect microscopic gas bubbles in the chambers of a beating
human heart; where it is suggested that a combination of rapid flow and sudden
pressure changes favour nucleation.
Martin et a!. (1981), working on mice, demonstrated transient cavitation
associated damage in vivo following application of therapeutic levels of ultrasound
to surgically exposed liver tissue coupled with saline. The ultrasound was applied at
frequencies between 0.88 and 3.0 MHz in continuous mode and the intensities used
were between 1 and 7 W/cm 2. However, it was suggested that the initiating
cavitational events occurred within the saline or at the liver/fluid interface, rather
than within the liver itself. Also skin blisters, with an appearance that suggested they
were formed as a result of a transient cavitation event, have been produced following
a 25 minute exposure to 0.8 MHz ultrasound at an intensity of 1.33 W/cm2
(Wittenzeller, 1976); however, it has been suggested that the impedance mismatch
between the coupling medium and the skin may have given rise to cavitational events
at this interface rather than within the skin (Williams, 1983).
Until recently, there appeared to be conclusive in vivo evidence for the
existence of gaseous nuclei, and the occurrence of cavitation within tissues insonated
with therapeutic levels of ultrasound (ter Haar and Daniels, 1981; ter Haar et a!.
1982). These authors exposed the legs of anaesthetized guinea pigs to 0.75 MHz
continuous wave ultrasound at intensities of 0.08 to 0.68 W/cm 2 (1(a)) and observed
the production of gas bubbles associated with tissue interfaces. At 0.68 W/cm 2 many
bubbles were present within muscles throughout the leg; whereas, 0.08 W/cm2
appeared to be the threshold intensity for stable bubble generation in vivo. However
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the accuracy of this work, specifically the cavitation detection method used, has
recently been challenged (Watmough et a!. 1991).
Other workers have reported much higher threshold intensities, well beyond
the therapeutic range, for the occurrence of cavitation in vivo. Sommer and Pounds
(1982) reported that the threshold for cavitation in porcine tissue was 75 +1- 8 W/cm2
(1w) at a frequency of 0.37 MHz. They defined the onset of cavitation using the
presence of bubble subharmonics as a detection mechanism. Lee and Frizzel (1988)
found the threshold of cavitation in mouse neonates to be between 53 and 74 W/cm2
(1(a)) at a frequency of 1 MHz. They used a biological endpoint, namely cavitationally-
induced hind limb paralysis of neonates, as their assessment mechanism. Frizzel et
a!. (1983) used the same biological endpoint method to show the cavitation threshold
intensity requirement to be approximately 60 W/cm 2 (I) for 3 MHz ultrasound.
Williams (1981a) showed that the diverse changes in platelet function and the
blood coagulation system he observed in vitro (see section 3.2.1.4, p100) appeared to
be initiated by some fonn of cavitational activity within the blood or plasma. When
he attempted to reproduce these effects in vivo, in a volunteer, by insonating (with
0.75 MHz ultrasound at an intensity of between 0.25 and 0.34 W/cm 2, 1(a), for between
30 and 45 seconds) an antecubital vein upstream of a sampling cannula no effect was
observed. A similar result was observed in rabbits by Chater and Williams (1982) who
were again unable to detect platelet damage or erythrocyte lysis using 30 - 40 second
exposures of 0.75 MHz ultrasound at intensities up to 17 W/cm2 (1w). Contradictoiy
results were presented by Wong and Watmough (1981) who found that 1 - 2 W/cm2
(1(a)) of 0.75 MHz ultrasound directed into the beating hearts of anaesthetized rats
(applied through the diaphragm) resulted in cavitation-based erythrocyte lysis. It was
initially suggested that the turbulence and large pressure changes experienced within
the beating heart enhanced the nucleation characteristics of the blood and in doing
so lowered the threshold intensity for generating ultrasonic cavitation in vivo
(Williams, 1983). However, it was subsequently shown by Williams eta!. (1986) that
this erythrocyte lysis resulted from a thermal ultrasonic effect. Damage to endothelial
cells in the chick embryo and to the uterus of the mouse have been reported (Dyson
et a!. 1974; ter Haar et a!. 1979) in standing wave fields, the mechanism of this damage
is unknown but appear not to be typical of heating (Sacks et a!. 1981), and it has been
suggested that hydrodynamic shear stress-induced changes induced in cells located
adjacent to vibrating bubbles trapped in the standing wave field could be involved
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(Dyson 1993, personal communication).
In general mammalian tissues in vivo contain fewer micronuclei than solutions
in vitro; it has been stated (Williams, 1983) that this is probably because all fluids
entering or leaving living tissues must be filtered through cell membranes. Thus
quiescent biological fluids and tissues appear to be remarkably resistant to bubble
formation during decompression (Harvey, 1951) or to ultrasonically-induced cavitation
at intensities similar to and greater than those commonly employed in physiotherapy
(Williams et a!. 1981; Chater and Williams, 1982).
In summary, there is no conclusive evidence available to date that demonstrates
beyond doubt that therapeutic intensities, and frequencies, of ultrasound are able to
induce bubble growth and oscillation (stable cavitation) in vivo in the absence of
standing wave fields. That is not to say such events do not occur in vivo; rather,
attempts and techniques employed so far have been unable to detect them. Less
complex biological systems in vitro suggest that if such events did occur in vivo they
could modify cell function and possibly even lead to localised tissue damage. As yet
undetectable cavitational events in vivo may explain many of the observed ultrasound
bioeffects shown to occur in the absence of any physiologically significant temperature
rise (Dyson et a!. 1970, Dyson et a!. 1976; Dyson, 1981; Dyson and Smalley, 1983;
Young and Dyson, 1990a,c).
3.2.2 Acoustic Microstreaming
Large hydrodynamic shear stresses occur within the acoustic streaming flow generated
near solid, or gaseous, bodies (see stable cavitation above) oscillating at an ultrasonic
frequency while immersed in a liquid (Nyborg, 1965). Several workers have suggested
that these shear forces are responsible for cell rupture and damage (Williams, 1972;
ter Haar et a!. 1979). Others have suggested that microstreaming and its associated
stresses are responsible for altering the surface charge of cells (Repacholi, 1970;
Repacholi et a!. 1971; Taylor and Newman, 1972). It has also been suggested that this
microstreaming around cellular and/or extracellular biological entities may modulate
cell function, possibly by affecting the integrity of the cell membrane (Dyson, 1985).
Microstreaming may also influence cell function by modifying the local environment
around cells such as by altering metabolite gradients surrounding cells (Young, 1988).
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3.2.3 Radiation Force
Any structure, large or small, suspended in a liquid and exposed to ultrasound is
acted on by a net radiation force. In a plane progressive wave (section 2.1.2., p6l) the
force is in the direction of wave propagation and is proportional to the intensity of the
beam. This forms the basis of dosiinetric total power measurements made using sound
balances (sections 2.5.1., p87 and 6.1.1., p189). In a standing wave field (described in
section 2.1.6, p72) the direction of the force on an object depends upon the properties
of that object. Most free cells in suspension move to pressure minima (nodes)
whereas, gas bubbles in suspension move towards pressure maxima (antinodes). Cells
in suspension are thus encouraged to form bands. This is thought to explain the
banding phenomenon described by Dyson eta!. (1974) who demonstrated the banding
of blood in small blood vessels of chick embryos exposed to standing wave fields. This
banding proved to be reversible but was sometimes accompanied by endothelial
damage. Standing wave occurrence should be avoided as it is also associated with
elevated likelihood of transient cavitation and concomitant free radical/thermal
damage to biological tissues.
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Chapter 4. Physiological effects of therapeutic ultrasound
4.1 Introduction
The previous chapter described the major physical mechanisms thought to be
responsible for the bioeffects observed when therapeutic levels of ultrasound are
employed experimentally and clinically. Therapeutic ultrasound is used to treat both
acute and chronic injuries; there is experimental and clinical evidence that it can, in
certain circumstances, produce physiological changes which result in reduced swelling,
facilitated healing, improved musculoskeletal mobility and the relief of pain (Kitchen
and Partridge, 1990). This chapter will review the literature relevant to modulation
of soft tissue repair by therapeutic ultrasound. As this thesis relates to studies carried
out to examine the interaction of therapeutic ultrasound with wound healing
processes of the skin, emphasis has been placed upon literature relating to cutaneous
repair.
The nature of many wound healing studies including clinical trials, case reports
and some experimental studies carried out in vivo, is such that observations of
ultrasonic bioeffects are often made some time after initial injury and treatment. As
such they are often reported in terms of eventual outcome, rather than in terms of
the immediate response or responding biological target. Treatment often occurs
during the inflammatory phase (soon after injury), whereas the effect of treatment
is often not assessed until much later, perhaps during the subsequent granulation
tissue production or matrix synthesis and remodelling phases of repair. Such studies
are essential, often supplying the impetus for further experimental and clinical work,
though their value is limited in that they do little to advance understanding of the
effect of ultrasound at the cellular or molecular level. These studies will be discussed
in terms of the observed biological effects, rather than in terms of the possible
biological target.
Other studies set out to explain the mechanisms of interaction in terms of
responding biological targets. These studies often involve studying the ability of
ultrasound to modulate specific cellular activities in vitro, and some may appear to
require unacceptable extrapolation with regard to their clinical relevance. These
studies will be described in terms of the wound healing phase to which the cellular
activity under study is normally associated.
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4.2. Cutaneous repair.
Although little is known about the direct effect of ultrasound on the repair of the
epidermis, progress has been made in describing and understanding its effects on the
repair of the underlying soft connective tissue that constitutes the dermis. Though a
time-scale compartmentalisation of wound repair phenomena risks over simplification
and inaccuracy, such a dissection of information is useful as an aid to understanding
the complexities of the repair process. For this reason, tissue response to injury and
its modulation by therapeutic ultrasound is divided up into three overlapping phases:
1. Inflammation
2. New tissue formation
3. Matrix formation and remodelling
The process of cutaneous repair has previously been described in chapter 1. In the
following sections, each phase of repair will be briefly described, together with the
appropriate ultrasound bioeffects literature.
4.2.1. Inflammation
Blood vessel disruption during tissue injury leads to the extravasation of blood
constituents. The resulting processes of platelet aggregation and blood coagulation
at the site of injury initiate the early inflammatory phase of wound repair. Clot
formation within damaged vessels affects haemostasis, and within the surrounding
connective tissue provides a provisional matrix for cell migration into the wound
space. Mediators released as a consequence of blood coagulation, complement
pathways, matrix damage, cell activation or death, induce the recruitment of
inflammatory leucocytes and increase the permeability of undamaged vessels at the
wound periphery resulting in additional leakage of plasma proteins. Neutrophils,
which arrive in the early inflammatory phase, attempt to clear the area of foreign
particles, especially bacteria. If effective, no further influx of neutrophils occurs and
the effete neutrophils are phagocytosed by macrophages. As the neutrophil infiltrate
resolves and macrophage accumulation continues, an arbitrary division can be drawn
between the early and late inflammatory phases. Peripheral blood monocytes
continue to infiltrate the wound site in response to specific monocyte
chemoattractants. Monocytes once within the wound site are progressively activated
and display the phenotype of macrophages. Macrophages are thought to elaborate
a wealth of biologically active substances many of which are involved with the
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recruitment of further inflammatory cells. Growth factors and other substances are
also released by macrophages and are thought to be essential for the initiation and
propagation of granulation tissue.
4.2.1.1 The effect of ultrasound on inflammation
The effect of ultrasound on activities associated with the process of inflammation will
be described under the following sub-headings:
A. The effect of ultrasound on early inflammation - platelets
B. The anti-inflammatory action of ultrasound
C. The effect of ultrasound on the resolution of inflammation - oedema
D. The effect of ultrasound on late inflammation
A. The effect of ultrasound on early inflammation - platelets
Studies examining the effects of ultrasound on platelet activity have been conducted
less in anticipation of beneficial therapeutic interaction than from concern over the
possible hazards of bringing about a haemostatic reaction inadvertently during the
clinical use of this modality. It has been reported that in vitro insonation (c.w., 1
MHz) of anti-coagulated whole blood for 5 minutes at an intensity as low as 65
mW/cm2 (1(a)) caused a time-dependent decrease in recalcification tune (ie., the time
taken for macroscopic fibrin strand formation when enough calcium ions are added
to overcome the effects of the anticoagulant) (Williams et a!. 1976a). Williams et a!.
(1976b) later demonstrated that this effect was due to limited ultrasound-derived
platelet damage of a sub-population of platelets leading to the release of platelet
factor 3. They found that thrombi, produced by the recalcification of insonated and
sham-insonated human platelet rich plasma (PRP), where morphologically dissimilar.
Platelet thrombi from insonated samples contained some debris of disrupted platelets
and the remaining intact platelets were abnormal in that (a) they were more
vacuolated, (b) they formed a larger number of smaller aggregates and (c).their clot
retraction mechanism was impaired. It was found that these morphological changes
could be duplicated by incubating similar PRP samples with small amounts of platelet
debris from homogenised platelets.
Williams eta!. (1978) examined the release of f3-thromboglobulin (/3-Tg) from
platelets in anti-coagulated whole blood insonated with 0.75 MHz continuous
ultrasound. They demonstrated an intensity-dependent increase in/3-Tg release above
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an intensity of 0.8 W/cm 2 (1( a)) .
 When the platelets were insonated in a mixture of
EDTA and theophylline (which inhibits the normal release mechanism of platelets
and leaves them functionally inert) the level of /3-Tg released was reduced by 70%.
The remaining 30% indicates that ultrasound causes some f3-Tg release by other than
physiological means. It was suggested that ultrasound in some way mechanically
disrupts a certain percentage of possibly more susceptible platelets, which in turn
facilitates the degranulation of further platelets by normal physiological mechanisms.
This mechanical disruption argument was supported by the observation of
corresponding increases of free haemoglobin from insonated erythrocytes (Williams
etal. 1978).
In addition to platelet degranulation Chater and Williams (1977) found that
under certain in vitro ultrasonic irradiation conditions it was possible to initiate
aggregation of platelets and that the magnitude of this effect decreased with
increasing frequency at a constant intensity of 2.0 WIcm2 (1(a)). Such an observation
suggests that the phenomenon of cavitation, which is less probable with increasing
frequency, may be involved in platelet disruption in vitro.
Such studies have lead to concern being expressed over the ability of
therapeutic ultrasound to cause intravascular blockage by inducing platelet
aggregation and degranulation in vivo. Contradictory observations have been made.
In vivo studies by Zarod and Williams (1977) demonstrated the presence of
occasional small aggregates of platelets trapped within capillaries of the guinea pig
pinna, following ultrasound treatment (1:1 pulsed 0.75 and 3 MHz ultrasound at an
intensity of 1.0 W/cm2, i(sATA)) of the central ear artery. However, subsequent studies
demonstrated excessive (i.e. damaging) temperature elevations under the
experimental conditions employed and it was suggested that the platelet aggregates
observed resulted from thermal damage to the endothelium rather than a direct
interaction with platelets (Williams, 1985). Furthermore in vivo studies on adult
human volunteers using continuous wave 0.75 MHz ultrasound at an intensity of 0.34
W/cm2 (1(a)) for 30 seconds (Williams et a!. 1981) and in rabbits again using
continuous wave 0.75 MHz ultrasound at intensities of up to 17 W/cm 2
 (I) (Chater
and Williams, 1982) were unable to demonstrate any platelet activation or vascular
damage following insonation of blood vessels with therapeutic ultrasound.
Thus, while there is a significant body of experimental evidence that suggests
that therapeutic ultrasound can modulate platelet activity in vitro, apparently by
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limited cavitational damage, it would appear that therapeutic ultrasound cannot
similarly modulate or damage platelets in vivo, provided that excessive temperature
elevations are avoided.
It is difficult to relate the above in vivo studies where uninjured vasculature
is insonated, to the application of ultrasound to sites of traumatised vascular
endothelium as found in wounds, as in the latter situation platelet aggregation would
be initiated by the exposure to subendothelial matrix components prior to ultrasound
treatment. It is possible that ultrasound, when applied to acutely traumatised tissue,
may modulate additional platelet activity at the wound site, possibly encouraging
wound repair by stimulating the release of growth factors and other stimulatory
agents, rather than acting as the inciting event.
B. The anti-inflammatory action of ultrasound
For many years clinicians have claimed that ultrasound may be a potent anti-
inflammatory agent (Reid, 1981 cited by Snow and Johnson, 1988). Support for these
opinions are based more on clinical impressions rather than on scientific evidence
(Snow and Johnson, 1988). Earlier placebo-controlled clinical trials were unable to
demonstrate any clear cut difference in inflammation between insonated and sham-
insonated individuals (Mueller et a!. 1954; Roman, 1960; Flax, 1964). In a more
recent experimental study on Wistar rats, which compared the effect of pulsed
ultrasound (1.5 MHz, pulsed 1:1, intensities 0.5 - 2.0 W/cm2 I") with a
nonsteroidal anti-inflammatory drug (flurbiprofen) on the acute inflammatory
response to subcutaneously implanted (bacteria-laden) irritant sponges, no anti-
inflammatory action was observed (Goddard et a!. 1983).
El Hag et a!. (1985), in a clinical trial of 33 patients, found that pulsed
therapeutic ultrasound (3 MHz, pulsed 1:4, intensity 0.5 I") could reduce swelling
almost as effectively as 10 mg of steroidal anti-inflammatory dexamethazone.
However, in more recent placebo controlled work, they demonstrated anti-
inflammatory activity following sham-insonation, and it was therefore suggested that
the anti-inflammatory action of ultrasound may be placebo-based (Hashish et a!.
1986). In a later placebo-controlled double blind clinical trial Hashish et a!. (1988)
examined the contribution of placebo and massaging effects of pulsed ultrasound
therapy (3 MHz, pulsed 1:4, intensity 0.5 W/cm2 I( ") following bilateral surgical
extraction of lower third molars. The results of this study demonstrated that the anti-
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inflammatory effects of ultrasound therapy were placebo-mediated via sham
treatment rather than massage action. Other studies have been unable to
demonstrate an anti-inflammatory effect of therapeutic ultrasound. Snow and
Johnson (1988), reported no difference when they compared the anti-inflammatory
action of insonation (0.75 MHz, pulsed 1:4, intensity 1 W/cm 2 I' )) with sham-
insonation on inflammation of the abdomen induced by ultraviolet radiation, in 20
adult volunteers. On examination of their results, it would appear that they
demonstrated a trend towards more rapid resolution of inflammation following
insonation though this was apparently ignored by the authors. To date there is no
conclusive evidence that supports the concept that therapeutic ultrasound can act in
an anti-inflammatory manner.
C. The effect of ultrasound on the resolution of inflammation - oedema
In 1985, 79% of NHS physiotherapy departments and 68% of private practitioners
reported that they used therapeutic ultrasound to reduce "local oedema" (ter Haar
et at. 1987). As physiotherapists are generally unlikely to see patients during the early
part of the inflammatory phase of repair, i.e. during the onset of oedema, it can be
assumed that clinicians employ the modality in an attempt to diminish swelling rather
than to prevent its occurrence. Several more specific clinical reports have indicated
that therapeutic ultrasound can encourage oedema resolution; such reports include
some uncontrolled clinical observations made by Ferguson (1981) using pulsed 1
MHz ultrasound at an intensity of 0.5 W/cm2 (presumably 1(SAPA), as not stated) and
Oakley (1982) using continuous 3 MHz ultrasound at an intensity of 0.125 W/cm2
(1(a)) who both reported greatly reduced swelling as a result of treatment in cases of
acute physical trauma. The lack of appropriate controls and dosimetry does, however,
limit the value of such observations.
There is a significant body of laboratory-based work that supports the idea
that therapeutic ultrasound is capable of encouraging oedema resolution. Fyfe and
Chahl (1985) demonstrated that a single application of pulsed therapeutic ultrasound
(0.75/1.5/3.0 MHz, pulsed 1:1/1:4, intensity 0.5 W/cm 2 I' )) had a significant effect
on sites of silver nitrate-induced oedema in the rat. They observed that over the first
24 hours, oedema was elevated above control levels; after this time insonated sites
demonstrated significantly less oedema. A similar observation was made by Hustler
et a!. (1978) studying the effect of continuous ultrasound (0.75 MHz, intensity 0.61
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W/cm2 1(a)) on the resolution of bruising and oedema in guinea pig pinnae. After
making standard injuries, they observed that in some experimental animals more
extensive oedema resulted in ears treated with ultrasound than in ears that were
sham-treated, but the subsequent oedema and bruise regression rates were greater
in insonated ears than in control ears. Such work appears to indicate that ultrasound
both (1) encourages the development of oedema and (2) supports the above clinical
findings in that it appears to favour its subsequent resolution. This has led to the
suggestion that ultrasound acts in a "pro-inflammatory" manner, accelerating the
process of inflammation and its resolution, rather than suppressing inflammation by
acting in an anti-inflammatory manner (Dyson, 1990).
As the earliest changes in vascular permeability following injury are thought
to be brought about by histamine and the major source of histamine in man is the
mast cell, it is possible that the enhanced oedema results from ultrasound mediated
mast cell degranulation at the wound site. There are several reports in support of this
hypothesis. Straburzynski (1964) was able to demonstrate a significant elevation in
the blood histamine level, and a corresponding depletion of mast cells in the skin and
the lungs, following application of 0.8 MHz ultrasound (no other dosimetry given)
to the thorax of 107 guinea pigs. More recently, Fyfe and Chahl (1984) demonstrated
that a single treatment of therapeutic ultrasound (0.75/1.5/3.0 MHz, pulsed 1:4,
intensity 0.5 W/cm2 I( "), to unwounded rat ankles in vivo led to a small but
significant increase in vascular permeability, as demonstrated by dye leakage, which
could be abolished by prior treatment with a combination of a histamine H1-receptor
antagonist and a serotonin antagonist. Further, on histological examination
significantly more degranulated mast cells were observed in ultrasound-exposed
tissues than in similar sham-exposed tissues. Additional in vitro evidence came from
Hashish (1986) who similarly demonstrated that pulsed ultrasound at therapeutic
levels (3 MHz, pulsed 1:4; intensities of 0.1, 0.5 and 1.5 W/cm 2 1) could stimulate
degranulation in rat peritoneal mast cell preparations.
The mechanism by which non-cytolytic mast cell degranulation occurs is
thought to be triggered by raised intracellular calcium ions within the cell (Yurt,
1981). As it has been demonstrated that therapeutic levels of pulsed ultrasound (1
MHz, pulsed 1:4, 0.5 - 1.0 W/cm 2 I") can increase the uptake of calcium ions by
fibroblasts in vitro, apparently as a result of reversible cell membrane perturbation
(Mummery 1978; Mortimer and Dyson, 1988), it has been suggested that this
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modulation of calcium flux may be the mechanism by which ultrasound alters mast
cell activity (Dyson, 1985) and consequently early inflammation.
D. The effect of ultrasound on late inflammation
Few studies have specifically examined the effect of ultrasound on the cellular
activities associated with late inflammation, fewer still have specifically employed
therapeutic parameters of ultrasound.
Saad and Williams (1982), working on the rat, reported that the application
of therapeutic ultrasound (1.65 MHz continuous, approximate intensity 1.0 - 1.5
W/cm2 1( a)) to the umbilical area of the abdomen, led to a decrease in the clearance
of colloidal particles by the reticuloendothelial system. This suggests an effect on the
mononuclear phagocyte system, which, if it occurred in wounds, could effect the
course of inflammation and hence subsequent repair processes. However, Saad and
Williams (1986) demonstrated that injection of in vitro insonated (1.65 MHz
continuous, intensity 1.6 W/cm2 I) lymphocytes similarly reduced colloid clearance.
They also showed that these in vitro insonated lymphocytes demonstrated reduced
electrophoretic mobility, thought to be associated with changes in surface
glycoprotein. As it is known that such altered lymphocytes are sequestered by
macrophages prior to "glycoprotein repair" (Ford et a!. 1976), it was proposed that
the reduced ability to clear blood-borne colloids was a consequence of over-loading
the reticuloendothelial system with damaged lymphocytes.
As previously stated, macrophages not only phagocytose damaged tissue, but
also elaborate various bioactive substances, including growth factors, that appear
crucial to the later granulation tissue production phase of repair. These substances
stimulate fibroblasts and endothelial cells to form a collagen-rich, well vascularised
tissue, called granulation tissue, at the wound site. The effect of ultrasound on the
interaction between inflammatory phase cells and proliferative phase cells has been
examined in vitro. Work on the interaction of therapeutic ultrasound, with the
promonocyte "macrophage-like" cell line U937, suggested that pulsed therapeutic
ultrasound (0.75 & 3.0 MHz, pulsed 1:4, intensity 2.5 W/cm2 I'') could both
encourage the synthesis, and release, of "factors" mitogenic to 31'3 fibroblasts (Young
and Dyson, 1990b). If the synthesis, and elaboration, of such factors is similarly up-
regulated in macrophages in vivo this may, in part, explain the improvement in
wound repair noted in the clinical and experimental use of this modality.
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There is evidence that T lymphocytes play a significant role in the process of
wound repair (Barbul, 1988). While there is at present no evidence to suggest a
similar role for the B lymphocyte population, the close functional associations and
interrelationships between T and B lymphocytes encourages further investigation of
this possibility. Desai et a!. (1989) were unable to observe any effect of a 15 minute
in uzero insonation, with therapeutic intensities (1.0 and 3.0 W/cm 2 I) of 1 MHz
continuous ultrasound, on the proliferation and differentiation of both T lymphocytes
and B lymphocytes during murine fetal development. Further, they were unable to
detect changes in the proportion of polymorphonuclear leucocytes, lymphocytes, or
monocytes 5-10 days after birth as a result of fetal exposure to ultrasound. This work
suggests that therapeutic levels of ultrasound appear not to interact, in any significant
manner, with the process of leucopoiesis; this, however, does not preclude significant
interactions with peripheral leucocytes actively engaged with the process of wound
repair. Further work is necessary to investigate the effect of therapeutic ultrasound
on the activity of T lymphocytes during the wound repair process.
Experimental evidence in vivo has further supported the idea that ultrasound
can accelerate the resolution of the inflammatory phase. Young and Dyson (1990a)
demonstrated that by five days post wounding ultrasound-treated (0.75 & 3.0 MHz,
pulsed 1:4, intensity 0.5 W/cm2 I(sAPA)) excisional wounds in the rat contained fewer
'inflammatory' cells (neutrophils and macrophages) and more mature granulation
tissue than sham-insonated control wounds. This suggests that insonated wounds were
more "advanced" than similar sham-insonated control wounds. Such an observation
could be explained in terms of the ultrasonic exposure encouraging the rate of one,
or more, of the leucocytic activities associated with the late inflammatory phase, thus
shortening the duration of this phase. Alternatively, it may be explained in terms of
a more rapid resolution of the former early inflammatory phase in response to
ultrasound, thus facilitating a more rapid progression to the late inflammatory phase.
4.2.2. The new tissue formation phase of wound repair
The formation of new tissue occurs next in this simplified scheme of wound repair.
New tissue formation during cutaneous repair involves re-epithelialisation and
granulation tissue formation. Re-epithelialisation is the reconstruction of the
epidermis into an organised stratified squamous keratinised epithelium that covers
the wound defect and provides the barrier properties of the skin. The process of
115
granulation tissue formation includes the further accumulation of macrophages,
colonisation of the wound space by fibroblasts (which involves both proliferation and
migration), deposition of loose extracellular matrix (containing fibronectin, hyaluronic
acid and collagen), and angiogenesis. As fibroblasts proliferate and migrate into the
wound space, they have been reported to undergo an alteration in phenotype, which
permits cell motility and concomitant deposition of the aforementioned loose
extracellular matrix (fibroplasia). In addition these cells align themselves and their
newly deposited matrix along the radial axes of The wound, form cell-cell and cell-
matrix associations, and are thereby able to generate a force within the tissue that
results in wound contraction. The generation of a rich vasculature (angiogenesis)
occurs simultaneously with the process of fibroplasia and is essential to meet the high
metabolic demands encountered during the formation of new tissue within a wound
site.
4.2.2.1 The effect of ultrasound on new tissue formation.
This section will initially describe the clinical Literature regarding the effect of
ultrasound on the repair of soft tissue lesions, specifically work examining its effect
on impaired or chronic wound healing states such as venous ulcers and pressure
sores. Later in this section non-clinical studies which may help to explain clinical
observations will be described. Such studies included those relating to the effect of
ultrasound on cell proliferation, cell migration, wound contraction and angiogenesis.
As the direct effect of ultrasound on the process of re-epithelialisation has not been
investigated, these non-clinical studies will centre around the process granulation
tissue formation. The literature regarding the effect of ultrasound on the synthesis
and deposition of extracellular matrix components found in granulation tissue and
scar tissue will be dealt with later in this chapter (section 4.2.3.1).
Clinical literature
Adequately controlled clinical trials, reporting the change of an objectively
measurable parameter, in response to therapeutic ultrasound are rare. Dyson et a!.
(1976) examined the effect of treatment with 3 MHz pulsed (2:8) ultrasound, at an
intensity of 0.2 W/cm 2 (1"), on the healing of varicose ulcers. In a single-blind
study involving 25 patients, they found that ultrasonic therapy significantly
encouraged healing, as assessed by measuring the reduction in ulcer area, when
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compared with similar sham-exposed ulcers. Roche and West (1984), in a similar
venous ulcer trial that employed the same ultrasonic treatment and assessment
parameters, this time with a sample of 26 patients, also observed a more rapid
reduction in ulcer size in ultrasound treated than in sham-treated control ulcers.
In a more recent clinical trial Callam et a!. (1987) carried out a twelve week, 108
patient, study of the effect of weekly ultrasound therapy on the healing of chronic leg
ulcers of mixed aetiology (including: venous only, venous and arterial, venous and
diabetic). They employed 1 MHz pulsed ultrasound at an intensity of 0.5 W/cm2
(presumably though not stated) and found that the proportion of ulcers healed
after 12 weeks was 20% greater in the standard treatment plus ultrasound group,
than in the group that received standard treatment alone. Unfortunately, as with
many clinical studies in the field of ultrasound bioeffects, this study was not placebo-
controlled and as such should be viewed with caution. The most recent trial studying
the effect of therapeutic ultrasound (pulsed 1:9, 1 MHz ultrasound at an intensity of
0.5 W/cm 2, presumably I, as not stated) on venous ulcer healing did not
demonstrate any statistically significant difference between ultrasound-treated and
similar sham-treated wounds (Lundeberg et a!. 1990). They did, however, report a
trend that suggested that ultrasound was more effective than placebo treatment.
Interestingly, they stated that their experimental design, particularly their sample size
(n = 44), was such that an improvement of less than 30% could not be detected.
As with the literature on the effect of ultrasound on venous ulcer healing, the
literature relating to its effect on pressure sore resolution is limited, both in quantity
and quality. Paul et a!. (1960) made the clinical observation that therapeutic
ultrasound was "markedly effective in relieving congestion, cleansing necrotic areas and
promoting healing with healthy, non-adherent skin approaching normal thickness",
following treatment of 23 sores on spinal cord injury patients, which were previously
refractive to standard therapies. They employed 1 MI-k ultrasound (presumably
Continuous) at intensities of 1.0 and 0.5 W/cm2 (presumably I(a)) for various exposure
times depending upon area to be treated. A better designed study of pressure sore
healing, in response to ultrasound, has been carried out more recently by McDiarmid
et a!. (1985). In a preliminary randomised double blind trial, employing 3 MHz
pulsed (2:8) ultrasound at an intensity of 0.8 W/cm2 (IJ') for various exposure
periods depending on area of treatment, it was found that there was a non-
statistically significant trend towards improved healing in insonated sores when
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compared with sham-insonated sores. McDiarmid et a!. (1985) indicated that their
study was carried out in an attempt to validate the clinical observations made by Paul
et a!. (1960). However, the ultrasonic parameters employed by the two groups were
completely different. Interestingly, McDiarmid eta!. (1985) reported that microbially-
infected sores appeared significantly more responsive to ultrasound therapy than
similar uninfected sores. This observation finds parallels in the work of Popisilova et
a!. (1984) who demonstrated that 4 week old experimental murine granulomata,
generated by the subcutaneous implantation of E. co/i inoculated viscose sponges,
contained more than twice as much collagen following exposure to continuous wave
therapeutic ultrasound (0.8 MHz, 1.5 W/cm2, 1(a)) than similar non-insonated control
granulomata.
Non-clinical literature
Research reports relating to the effect of therapeutic ultrasound on specific cellular
activities of the granulation tissue formation will be described under the following
headings:
A. The effect of ultrasound on cell proliferation in vitro.
B. The effect of ultrasound on cell proliferation in vivo.
C. The effect of ultrasound on other aspects of granulation tissue
formation.
A. The effect of ultrasound on cell proliferation in vitro
During wound repair, fibroblast recruitment is essential for the subsequent
elaboration, remodelling and contraction of the extracellular matrix; endothelial cell
proliferation is crucial to meeting the metabolic demands of reparative tissue.
Unfortunately, there are only two published reports relating to the direct
effect of therapeutic ultrasound on the proliferative capacity of untransformed
fibroblasts (Loch et a!. 1971; Webster, 1980), and none which relate to the in vitro
proliferation of endothelial cells, transformed or otherwise. Ultrasound studies to
date have invariably employed spontaneously transformed or transformation-induced
cell lines, for example chinese hamster ovary fibroblasts (Armour and Corry, 1982),
L5178Y lymphocytic cells (Clarke and Hill, 1969), C1300 neuroblastoma cells (Ross
et a!. 1983), Hela epithelial cells (Kaufmann et a!. 1977) and Chinese hamster V79
cells (Ciaravino et a!. 1981). As the proliferative capacity of such cells has already
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been compromised, and consequently cannot be termed "normal", the use of such
cells to attempt to reproduce the modulatoiy effects of ultrasound on cell
proliferation, in normal tissues, in vivo should be contested.
Most studies which report the effect of ultrasound on proliferative capacity of
mammalian cells in vitro have been conducted either in view of safety concerns of
ultrasonic exposure (mostly diagnostic), or to examme the capacity of therapeutic
ultrasound to selectively kill cells under hyperthermic conditions (cancer therapy). As
such their experimental endpoints were usually cell death or loss of proliferative
capacity and the ultrasonic doses applied are excessive when compared with normal
therapeutic doses. Few studies have been conducted with the specific aim of
examining the beneficial interaction of clinically relevant therapeutic regimes of
ultrasound, with the process of wound repair, at the cellular level. The limited
number of cell growth and survival studies which have included therapeutic levels of
ultrasound have reported conflicting results.
The majority of studies have indicated that ultrasound at therapeutic levels in
some way impairs the proliferative capacity of mammalian cells in vitro, and that this
damage is related to ultrasonic intensity, the mode of ultrasound application
(continuous or pulsed), and to the availability of gaseous nuclei at which cavitational
activity may occur.
Loch et a!. (1971) carried out an ultrasonic safety study which included
therapeutic ultrasound parameters. They examined the effect of a 10 minute exposure
of 1 MHz continuous wave ultrasound, at intensities of between 0.05 - 3.0 W/cm2
(i(a)), on the growth and proliferation of three mammalian cell lines exposed in
monolayer (embryonic brain fibroblasts, HeLa epithelial cells and transformed
amnion cells). They observed that intensities above 0.1 W/cm 2 led to damage and a
reduced proliferative ability in all cell types studied. Kaufman et a!. (1977) examined
the effect of increasing intensities (from 0.3 - 30 W/cm2 I) of a 5 minute 1 MHz
continuous wave insonation on the viability and colony forming ability of HeLa and
Chinese Hamster Ovary (CHO) cells in vitro. They found that viability and
proliferative capacity was unaffected below approximately 1 W/cm2 (I), but was then
reduced progressively to an intensity of 10 W/cm2 (I). The threshold for impairment
was significantly higher than that found by Loch et a!. (1971), though their exposure
times and experimental design differed. In agreement with the work of Kaufmann et
a!. (1977), Ross et a!. (1983) was unable to demonstrate any significant deleterious
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effect on C1300 neuroblastoma cell division following insonation with 1 MHz
continuous wave ultrasound when they employed intensities up to a maximum of 1
W/cm2 (I(s)). Similarly, Decat and Leonard (1984) were unable to demonstrate any
effect, beneficial or deleterious, on the proliferation of phytohaemagglutmin-
stimulated rabbit peripheral blood lymphocytes following exposure to 1 MHz
continuous wave ultrasound at intensities of 0.5 or 1 W/cm 2 (I).
Other workers have demonstrated deleterious effects on cells and impairment
of proliferation post-insonation using fixed intensities which represent the upper limit
of the therapeutic range. Ciaravino and Miller (1978) reported a 15 - 20% reduction
in V-79 chinese hamster cell proliferation exposed for more than 0.1 mm to 1 MHz
continuous wave ultrasound at an intensity of 3 WIcm2 (1(a)). Kaufman and Miller
(1978) demonstrated impaired growth of V-79 cells post-sonication with 1.07 MHz
continuous wave ultrasound at an intensity of 2.5 W/cm2 (I). Fu et a!. (1980),
expanding on the work of Kaufman and Miller (1978), examined V-79 proliferation
following insonation with continuous wave 1 MHz ultrasound at intensities of 0.25
to 30 W/cm 2 (I) during different phases of the cell cycle. They found that
mitotically synchronised cells insonated during the M and S phases were more
resistant to loss in reproductive integrity than cells in G1 or G2.
Evidence to implicate cavitation as a key agent in this ultrasound-derived in
vitro cell damage includes the alleviation of such cell damage by: increasing ultrasonic
frequency (Armour and Cony, 1982), increasing atmospheric pressure (Ciaravino et
at. 1981b) and reducing culture medium gas content (Coakley et at. 1971); all the
above are recognised methods of reducing the incidence of cavitation. Thus, Bleaney
et a!. (1972), under non-cavitating conditions, were unable to demonstrate any effect
on the reproductive integrity of Chinese hamster lung cells following 1.5 MHz
insonation at physiological temperatures. They employed intensities within, and well
above, the therapeutic range using both pulsed (intensity max - 15.0 W/cm 2 1('))
and continuous wave ultrasound (intensity max - 8.8 W/cm 2 Similarly, Webster
(1980) insonating human foetal fibroblasts with 0.75 or 3 MHz pulsed ultrasound at
intensities of 0.5 and 2 W/cm2 (IJ) was unable to demonstrate any effect on cell
survival or proliferation.
Interestingly when cells are cultured in three dimensional arrangements (e.g.
in spheroids) and exposed to therapeutic ultrasound, at parameters known to result
in damage or impaired proliferation in cell suspensions, such damage and impairment
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is significantly reduced (Sacks et a!. 1981). The basis for this reduced response
appears to be due to the physical protection of cells in spheroids. It is suggested that
cells residing in comparable three dimensional structures in vivo would be similarly
protected if cavitation was to occur (Sacks et a!. 1981). As cavitation has yet to be
conclusively observed during "therapeutic" insonation in vivo (Watmough et a!. 1991),
the relevance of in vitro test systems designed in such a way that they allow, or even
encourage, cavitation must be questioned. Systems which actively discourage the
onset, and perpetuation, of cavitation may be more relevant to the study of ultrasonic
bioeffects associated with the therapeutic use of this modality in vivo.
DNA synthesis is a prerequisite to the division of cells. Several workers have
examined the rate of DNA synthesis, measured by 3H-thymidine incorporation,
following exposure of mammalian cells to therapeutic ultrasound in vitro. Again
conflicting results have been reported. Those reports that have demonstrated
increased DNA synthesis in response to therapeutic levels of ultrasound are as
follows. Elmer and Fleisher (1974), examining neonatal mouse tibial epiphyses in
culture, reported an enhancement in DNA synthesis following exposure to 1 MHz
continuous wave ultrasound at an intensity of 1.8 W/cm 2 (I( ). Repacholi eta!. (1979),
examining 3H-thymidine incorporation in concanavalin A stimulated lymphocytes in
response to 0.87 MHz continuous wave ultrasound, demonstrated an enhancement
in DNA synthesis which was amplified as the intensity was increased from 0.5 to 1.1
W/cm2 (I )). Interestingly when the ultrasonic intensity was raised to 3 W/cm 2 (the
maximum of the therapeutic range) or above, 3H-thymidine uptake was suppressed.
The authors associated this observation with lymphocytes being blocked in G 1. The
low intensity work of Repacholi eta!. (1979) has been validated by Kondo and Yoshii
(1985) who reported enhanced DNA synthesis in mouse L cells following exposure
to 1.2 MHz continuous wave ultrasound at intensities between 0.5 and 1.5 W/cm 2 1(a).
However, Webster (1980) studying the effect of pulsed 0.75 and 3 Mhz ultrasound
at pulse average intensities of 0.5 and 2.0 W/cm2 (I(sAPA)) was unable to demonstrate
any effect on DNA synthesis in cultures of human foetal fibroblasts, which may
suggest that the response to ultrasound may vary according to the cell type or the
culture conditions employed.
The cell proliferation and DNA synthesis studies appear to contradict each
other. Most proliferation studies indicate a reduction in proliferative capacity post
insonation; whereas, most DNA synthesis studies suggest a stimulation in mitotic
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activity. This may be explained as follows: many in vitro exposure systems encourage
the likelihood of cavitation associated cell damage. If this cellular damage includes
chromosomal damage it is possible that the observation of increased uptake of 3H-
thymidine may be associated with DNA repair rather than replication in preparation
for cell division.
Therapeutic ultrasound is commonly used in clinical practice in both pulsed
and continuous mode, at frequencies of between 1 and 3 MHz, and at spatially and
temporally averaged intensities of up to 3 W/cm 2. There is, however, a dearth of
experimental work examining the effect of ultrasound on mammalian cell
proliferation/DNA synthesis at frequencies other than 1 MHz used in continuous
mode and at relatively high ultrasonic intensities. As pulsed 3 MHz ultrasound, at
low spatial and temporal averages, has been shown to encourage certain aspects of
cutaneous repair both in vivo (e.g. Dyson et a!. 1970; Webster et a!. 1979; Dyson and
Smalley, 1983; Young and Dyson, 1990a1c) and in vitro (e.g. Webster et a!. 1978,
Harvey et a!. 1975; Young and Dyson, 1990b) further work, employing such
apparently efficacious ultrasonic parameters, should be actively encouraged to redress
this imbalance.
B. The effect of ultrasound on cell proliferation in viva
Contradictory results have been reported by the few studies that have attempted to
study cellular proliferation in response to therapeutic levels of ultrasound in vivo.
Dyson et a!. (1970), in a study of the effect of pulsed and continuous 3.5 MHz
ultrasound on the repair of experimental rabbit ear wounds, demonstrated that
ultrasound applied at certain intensities/pulsing regimes significantly enhanced the
rate of cell proliferation, as measured by 3H-thymidine uptake. They found that
treatment with pulsed ultrasound (2:8) at intensities of 0.25, 0.5 and 1.0 W/cm2
(1(SAPA)) and continuous ultrasound at an intensity of 0.1 W/cm 2
 (I), all stimulated
cell proliferation; with the greatest increase observed after treatment with pulsed
ultrasound at an intensity of 0.5 W/cm2 (L(1'A)). This work finds support in the more
recent work of Young and Dyson (1990a) who studied the effect of pulsed 0.75 and
3 MHz therapeutic ultrasound, at an intensity of 0.5 W/cm2 J, on the repair of
full thickness excised wounds in the flank skin of adult Wistar rats. They
demonstrated that by five days post wounding, there were significantly more
fibroblasts in granulation tissue of ultrasound-treated wounds, than in granulation
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tissue of similar sham-insonated control wounds. However, by seven days post-
wounding there was no difference in cellularity between ultrasound-treated and
similar-sham insonated wounds; this suggests that ultrasound-treated wounds attained
maximal proliferative and/or migratory capacity more rapidly than sham-insonated
wounds. In contrast, Miller et a!. (1988) were unable to detect any change in the
mitotic index of chinese hamster cheek pouch epithelia following insonation with 1.07
MHz continuous wave ultrasound at intensities of between 0.5 - 10.0 W/cm2 (1(a)).
This contradiction may be explained by examining the disposition of the
cellular activities studied. It has been suggested that cells actively involved in
reparative processes may be predisposed by the wound environment towards
responding to therapeutic intervention with ultrasound. However, Kremkau and
Witcofski (1974) studying the effect of ultrasound on hepatocyte proliferation during
liver regeneration after partial hepatectomy, in which hepatocytes should be similarly
predisposed, demonstrated a mitotic index reduction of between 20 and 60%
following a 5 minute exposure to 1.9 MHz continuous ultrasound at an intensity of
60 mW/cm2 (I( ). Similarly, Pospisiova and Rottova (1977) measuring the DNA
content of experimental granulomas, a model for tissue repair that involves
connective tissue proliferation, demonstrated that insonation with 0.8 MHz
continuous ultrasound at an intensity of 1.0 W/cm 2 (1(a)), led to a reduction in total
DNA content.
As a consequence of this lack of agreement, the capacity of therapeutic
ultrasound to modulate cell proliferation in vivo is still open to question. The
different ultrasonic exposure conditions and cellular targets employed by different
authors may explain the differing results obtained. Dyson eta!. (1970) and Young and
Dyson (1990a) employed 0.75 and/or 3 MHz pulsed ultrasound and enhanced
proliferation, whereas the remaining authors were either unable to demonstrate any
effect, or reported diminished proliferation, and used 1 MHz continuous ultrasound.
C. The effect of ultrasound on other aspects of the new tissue formation phase of
repair
Cellular recruitment into the wound site involves both stimulated proliferation and
migration. Mummery (1978) demonstrated that the motility of fibroblasts, on a two
dimensional substrate, was increased following exposure to 3 MHz pulsed ultrasound
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at intensities of between 0.5 and 2.0 WIcm2 (I"). Ultrasound was found to reduce
the number of changes in direction rather than increasing the velocity of individual
cells. As migration of various cell types is central to the process of wound repair,
stimulated cellular migration may in part explain many of the effects observed after
clinical and non-clinical ultrasound application.
Fibroblast migration within the extracellular matrix has recently been proposed
as a possible mechanism by which granulation tissue generates the force necessary
for wound contraction (Ehrlich, 1988). This in vitro modulation in fibroblast
movement may be, in part, responsible for the stimulatory effects of therapeutic
ultrasound on wound repair observed in vivo. More specifically, this may explain the
observations made by Dyson and Smalley (1983) who demonstrated that cryosurgical
lesions made in the flank skin of adult Wistar rats and exposed to 3 MHz pulsed
ultrasound, at an intensity of 0.5 W/cm 2 (1'), contracted more rapidly than similar
sham-insonated control wounds. No temperature elevation consequent to ultrasonic
exposure was observed and as such a thermal mechanism of interaction was deemed
unlikely.
Granulation tissue contraction is thought by some to be effected by a
population of phenotypically altered fibroblasts, often referred to as myofibroblasts,
which demonstrate many morphological, pharmacological and immunological
characteristics common to smooth muscle cells (SMC) (Gabbiani et a!. 1971). It has
been demonstrated that ultrasound can cause both the contraction of excised guinea
pig uterine SMC preparations in vitro (Talbert et a!. 1975) and increase the frequency
of mouse uterine SMC contraction in vivo (ter Haar et a!. 1978); in addition
treatment with therapeutic ultrasound has also been shown to increase the
contractility of cardiac muscle (Mortimer et a!. 1984; Mortimer et a!. 1986). The
structural and functional similarities between myofibroblasts and SMCs, may provide
an alternative explanation for the stimulation in wound contraction observed by
Dyson and Smalley (1983). The excitation of smooth muscle cells . involves
depolarisation of the plasma membrane followed by a transient flux of calcium ions
activating an actin-myosin filament sliding system. Mummery (1978) and Mortimer
& Dyson (1988) demonstrated that therapeutic levels of ultrasound could increase
the uptake of calcium by fibroblasts in vitro, apparently as a result of a reversible
perturbation of the cell membrane. This membrane perturbation, and the ensuing
calcium flux, appear to result from cavitational activity within the exposure system,
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as after pressurising the exposure system to 2.3 atmospheres, a method known to
prevent cavitation, no change in fibroblast calcium uptake could be observed
(Mortimer and Dyson, 1988). As it has yet to be conclusively proven that ultrasonic
cavitation can occur in vivo, it is possible that some other non-cavitational and non-
thennal mechanism of interaction may be capable of modulating intracellular calcium
in fibroblasts within wounds, thus facilitating the more rapid wound contraction noted
in cryosurgical lesions by Dyson and Smalley (1983).
As previously mentioned, the generation of a rich vasculature (angiogenesis)
is essential to meet the high metabolic demands encountered during the formation
of new tissue within a wound site. Young and Dyson (1990c) empioyed microfocal
X-ray techniques to demonstrate that pulsed therapeutic ultrasound (both 0.75 and
3 MHz), applied soon after injury and employed at an intensity of 0.5 W/cm2 (i(S)),
could promote the process of angiogenesis in rat flank skin wounds. It was reported
that by 5 days after injury there were approximately 30% more blood vessels in
wounds treated with 0.75 MHz ultrasound, and 20% more blood vessels in those
treated with 3 MHz ultrasound, compared with sham-insonated control wounds.
4.2.3 Matrix formation and remodelling
The third and final phase of wound repair is matrix formation and remodelling. This
time scale compartmentalisation of wound repair, though useful, is artificial and over
simplified. Matrix formation is not temporally exclusive of new tissue formation. In
fact new tissue formation and matrix formation begin simultaneously. Matrix
remodelling does, however, continue for months, if not years, after the dissolution
of granulation tissue which explains its position in this scheme of repair.
The clot formed as a consequence of vascular injury is primarily fibrin
supplemented with plasma fibronectin. With time and the recruitment of fibroblasts
into the wound site this clot is replaced with a provisional matrix rich in fibronectin
and hyaluronic acid and supplemented with collagen types I and III. Remodelling
involves the relatively rapid elimination of most of the fibronectin and hyaluronic
acid from the matrix and the slow accumulation of large fibrous bundles of type I
collagen supplemented with proteoglycans that respectively provide the residual scar
with increasing tensile strength and resilience to deformation.
4.2.3.1 The effect of ultrasound on matrix formation and remodelling
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The effect of ultrasound on activities associated with the matrix formation and
remodelling phase of repair will be described under the following sub-headings:
A. The effect of ultrasound on matrix synthesis in vitro
B. The effect of ultrasound on matrix synthesis in vivo
C. The effect of ultrasound on matrix remodelling.
A. The effect of ultrasound on matrix synthesis in vitro
The generation of a protein-rich extracellular matrix by fibroblasts during granulation
tissue formation and its revision during the subsequent remodelling phase of repair
are vital processes in the overall scheme of wound healing. There are few published
reports relating to the effect of therapeutic ultrasound on the protein synthesis in
vitro. Both increase and decreases in the rates of protein synthesis have been
documented, sometimes in the same report, following exposure to ultrasound.
Repacholi (1981), studying protein synthesis in human lymphocytes,
demonstrated a biphasic response to ultrasonic intensity. He demonstrated an
increase in protein synthesis by activated lymphocytes which had been exposed to
0.87 MHz continuous ultrasound for 30 minutes at an intensity of 1.1 W/cm 2 (1(a));
whereas, a similar exposure at the higher intensity of 4.0 W/cm 2 lead to an inhibition
of protein synthesis. Elmer and Fleischer (1974) examined the effect of 1 MHz
continuous ultrasound, at an intensity of 1.8 W/cm 2 (1w), on the growth of cultured
tibiae removed from new born mice. They found that insonated tibiae incorporated
more radioactive proline than similar control tibiae, but this result did not prove to
be statistically significant. Harvey et a!. (1975) reported that treatment of human
fibroblasts with 3 MHz pulsed ultrasound consistently led to greater stimulation of
protein synthesis than continuous wave ultrasound. Continuous ultrasound at an
intensity of 0.5 W/cm 2 (1w) led to a 20% increase in protein synthesis, whereas,
pulsed ultrasound, at an intensity of 0.5 W/cm2 (I(A)), resulted in a 30% increase
in protein synthesis above sham-insonated control fibroblasts. Interestingly, when
fibroblasts were pretreated with cortisol, which acts as a membrane stabiiser, no
increase in protein synthesis could be observed. This suggested that the cell
membrane is involved with the modulation of protein synthesis by ultrasound.
Webster et a!. (1978), again exposing human fibroblasts to 3 MHz ultrasound,
this time only in pulse mode, at an intensity of 0.5 W/cm2 (I'), also demonstrated
an increase in protein synthesis. If their test system was pressurised to 2 atmospheres
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the effect was no longer observed, suggesting that the effect may be attributable to
cavitation. This taken together with the observed effect of cortisol by Harvey et al.
(1975), suggests that cell membrane perturbation as a result of cavitational activity
may be the mechanism by which ultrasound stimulates protein synthesis in this
system. Later, Webster et a!. (1980) demonstrated that collagen synthesis by human
fibroblasts was up-regulated as a function of this enhanced general protein synthesis
following exposure to pulsed, 3 MHz, ultrasound at an intensity of 0.5 W/cm2 (I(sAPA)).
Edmonds and Ross (1988), in agreement with the work of Webster et a!. (1978) and
Harvey et a!. (1975), demonstrated enhanced protein synthesis in murine C1300
neuroblastoma 2A cells following exposure to pulsed 1 MHz ultrasound (60 ms on,
60 ms off) at an intensity of 3.4 W/cm2 (L(sAPA)). Their results also suggested that
enhancement in protein synthesis correlated closely with transient cavitational activity
within their exposure system. As previously stated, cavitation has yet to be
conclusively demonstrated during "therapeutic" insonation in vivo (Watmough et a!.
1991); consequently the clinical relevance of these observations, that appear to
implicate a major role for cavitation in the up-regulation of protein synthesis in vitro,
must be viewed with caution.
B. The effect of ultrasound on matrix synthesis in vivo
Therapeutic ultrasound was first reported to stimulate protein synthesis in vivo by
Belewa-Staikowa and Kraschkowa (1967). Protein synthesis in the liver, kidney and
heart was studied after 1 MHz continuous wave ultrasound was applied to the
abdomen of adult rats. They reported an ultrasonic intensity dependent biphasic
response in all organs studied. An increase in protein synthesis was observed
following exposure to intensities of 0.2 and 0.6 W/cm 2 (1). However, a decrease in
protein synthesis was reported when they increased the intensity to 1 W/cm 2 (I).
Other studies have been carried out that are more relevant to wound repair.
Pospisilova eta!. (1971), examined the effect of ultrasound (0.8 MHz, 1.5 W/cm 2 1(a))
on the initial generation (first two weeks) of extracellular matrix components in
experimental murine granulomata, induced by subcutaneous implantation of viscose-
cellulose sponges. This is a widely accepted, though questionable, model of
granulation tissue generation during cutaneous repair. They demonstrated that
insonation led to a delay in granulation tissue maturation, as assessed by the
replacement of glycosaminoglycans (measured by hexosamine levels) by collagen
127
(assessed by hydroxyproline levels) 8 and 12 days post implantation. They suggested
that ultrasound interacts in such a manner as to lengthen the inflammatory process;
and thus by implication, delays the normal process of "repair". This observation is in
clear conflict with the work of Young and Dyson (1990) who reported a more rapid
progression of wound repair in response to therapeutic ultrasound.
Later, Popisilova carried out a more comprehensive study into the effect of
ultrasound on experimental granulation tissue generation and remodelling
(Pospisilova, 1976). This study examined the effect of continuous ultrasound (0.8
MHz, 1 W/cm 2 P) on granulomata collagen, glycosaminoglycan (GAG) and glyco-
protein levels, during both inflammation and granulation tissue formation.
Granulomata were excised 7, 11, 15, 21, 25, 30 and 35 days post implantation. In
inflammatory phase granulomata treated with ultrasound there was significantly more
collagen, GAG and glycoprotein present. In "proliferative phase" granulomata there
was significantly more collagen and glycoprotein, but significantly less GAGs present.
This would suggest that ultrasound is facilitating more rapid, and perhaps more
extensive, "repair"; by encouraging both earlier and more extensive collagen synthesis.
This conflicts, somewhat, with their earlier data (Pospisilova et a!. 1971) that
suggested that ultrasound delayed granulation tissue maturation.
It has been reported that experimental granulomata generated by
subcutaneous implantantion of viscose sponges inoculated with non-pathogenic
bacteria (E. coil) produce significantly (three times) more collagen, as assessed by
hydroxyproline three to four weeks after implantation, than similar uninocculated
sponges. When such E. coil impregnated sponges are treated with continuous
ultrasound (0.8 MHz, 1.5 W/cm 2, 5 minutes per day) for five days prior to sponge
excision; protein synthesis is further enhanced such that insonated sponges contain
eight times as much collagen as uninoculated sponges (Pospisilova et a!. 1974). It was
suggested by the authors that ultrasound prolongs cell proliferation at the "wound
site", ensuring the presence of productive cells in the granulation tissue for a longer
time. However, in view of the work Harvey et a!. (1975) and Webster et a!.
(1978/1980) these observations may alternatively be explained in terms of more
collagen being produced per cell rather than more collagen producing cells being
present. In 1977, Pospisilova and Rottova substantiated earlier observations relating
to the effect of ultrasound on granulomata protein synthesis. They again
demonstrated that significantly more collagen was deposited in 21 day old
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granulomata that received multiple applications of 0.8 MHz continuous ultrasound
(intensity 1 W/cm2 (1(a)), treatment duration 5 minutes) than was synthesized and
deposited in similar untreated controls.
Additional experimental evidence supporting that of Pospisilova et a!. (1976)
and Pospisilova and Rottova (1977) indicating that protein synthesis is/can be
encouraged in response to ultrasonic therapy has been published. Webster (1979)
studied protein synthesis during the repair of cryosurgical lesions made in the flank
skin of rats, in response to the application of 3 MHz pulsed ultrasound at an intensity
of 0.4 W/cm2
 (1'). Hydroxyproline assays clearly demonstrated that therapeutic
ultrasound-treated wounds contained significantly more collagen than similar sham-
insonated wounds by seven days after injury. Jackson et a!. (1991) studied the effect
of ultrasound therapy on the rates of repair of Achilles tendons in the rat. Following
hypodermic needle puncture, tendons were either given a 4 minute exposure to
continuous 1 MHz ultrasound at an intensity of 1.5 W/cm 2 (1(a)) or given a similar
sham-insonation, which was repeated each day for up to 5 days, after initial injury.
Collagen synthesis was measured by incorporation of 3H hydroxyproline at 3 and 5
days after injury. No difference in collagen synthesis was observed between insonated
and sham-insonated tendons 3 days after injury. However, by 5 days after injury the
ultrasound-treated tendons were synthesizing significantly more collagen than similar
sham-insonated controls.
Other workers have been unable to demonstrate any effect of therapeutic
levels of ultrasound on protein synthesis in vivo. Stevenson et a!. (1986), studied the
effect of therapeutic ultrasound (20 daily 5 minute applications of continuous 3 MHz
ultrasound at an intensity of 0.75 W/cm 2
 I) on tendon healing in the chicken. While
they demonstrated that surgically damaged tendons treated with ultrasound made a
more rapid functional recovery, they were unable to demonstrate any effect on
collagen content, measured by hydroxyproline assay, within the repairing tissue.
C. The effect of ultrasound on the matrix remodelling
In the clinical and experimental application of ultrasound to sites of acute injury,
wounds are normally treated within a few days, rather after a period of weeks or
months following injury. As such, it is unlikely that the cellular activities
predominantly associated with matrix remodelling will be direct targets of treatment.
Rather, some cellular process(es) associated with the earlier, inflammatory or
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granulation tissue formation, phases of repair may be modified by the applied
ultrasound. It is assumed, therefore, that any change in the physical characteristics
of the scar are as a result of ultrasonic modulation of one, or more, of the cellular
processes associated with the preceding phases of repair.
Drastichova et a!. (1973) reported that therapeutic levels of ultrasound (the
only parameter reported was an "average" intensity of 1.5 WIcm2) applied soon after
wounding, significantly increased the ensuing gain in tensile strength of guinea pig
scar tissue. More recently Dyson (1981) further added weight to this poorly reported
observation by demonstrating that both the tensile strength and extensibility of rat
scar tissue (Dyson, 1981) could be improved by the application of ultrasound. Dyson,
(1981) studied bilateral cryosurgical lesions made in the flank skin of adult Wistar
rats. Lesions that received 3 MHz pulsed ultrasound (2:8) at an intensity of 0.5
W/cm 2 (I 1') had a greater breaking strength and were more extensible than similar
sham insonated lesions when measured 1, 2 and 4 months after injury. It is likely that
this improvement in tissue breaking strength is linked to the elevation in collagen
synthesis observed in various ultrasound exposed wounds and wound models
(Popisilova, 1976; Popisiova and Rottova, 1977; Harvey et a!. 1975; Webster et a!.
1979; Jackson et a!. 1991). Scanning electron microscope studies have shown that
ultrasound-treated cryosurgical lesions produce scars that have a finer and more
regular lattice arrangement of collagen fibres than similar sham-insonated lesions
(Dyson, 1981). Such an arrangement is more like that of uninjured skin, which may
explain the greater extensibility of ultrasound treated scar tissue.
In contrast to the majority of publications suggesting that therapeutic
ultrasound can encourage the rate, or "final" outcome, of the process of dermal
repair, Shamberger et a!. (1981) reported no improvement in the tensile strength of
incisional rat skin wounds following treatment with 5 MHz ultrasound at therapeutic
dosages. On examination of Shamberger's experimental protocol two significant
points should be noted. Firstly, ultrasound was applied to the wound via a transducer
arrangement that was rigidly fixed to the animal's skin. Such an arrangement prevents
the movement of the applicator head, a practice advocated by Forster and
Palanstanga (1981) which is known to be necessary (i), to prevent standing wave
ultrasonic fields occurring within tissues (which can lead to potentially damaging
ultrasonic exposures due to amplification); and (ii), to ensure that the applied
ultrasound is not concentrated within small areas of the tissue receiving treatment.
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The latter point relates to the non-uniform distribution of ultrasonic energy within
ultrasonic fields that result from interference phenomena (see section 2.3). Secondly,
both clinicians and basic scientists involved in the study of therapeutic ultrasound are
gradually becoming aware of the benefits of treatment with ultrasound as soon after
acute injury as is practicably possible. The literature appears to indicate that some
component(s) of the inflammatory phase may be the responsive biological target(s)
in the therapeutic application of ultrasound (Dyson, 1990). As Shamberger et a!.
(1981) was unable to apply ultrasound until the fourth post-operative day, due to
experimental design, it is possible that many of the inflammatory components, with
which ultrasound may react, were no longer present.
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Chapter 5. In vitro techniques and methods
Introduction
This section details the cell lines and experimental models (bioassays) employed in
the study of ultrasonic modulation of cellular activity in vitro. Model verification
studies, carried out in an attempt to optimise the use of both the fibroblast
proliferation assay and the fibroblast populated collagen lattice contraction assay, are
also included.
This chapter includes the following:
(1). Human dennal fibroblast culture and characterisation.
(2). The U937 promonocyte cell line.
(3). The methylene blue fibroblast proliferation assay
(4). The fibroblast-populated collagen lattice contraction assay
5.1 Human dermal fibroblasts
5.1.1. Primary culture and sub-culture of human dermal fibroblasts
Human dermal fibroblasts were derived from a small elliptical skin biopsy taken from
the flexor aspect of the distal third of the forearm of a 35 year old healthy male
volunteer. Fibroblasts were cultured by the primary explant technique (Appendix 3,
p337), originally developed by Harrison 1907, in which cells migrate out of fragments
of tissue along the base of the tissue culture flask (figure 5.1). Cells were observed
at the periphery of explanted skin by 5 days in culture. Confluency between the
islands of explanted tissue was apparent by 10 days. Once confluence was achieved
short trypsinization (Appendix 4, p338) was performed to select for fibroblasts and
against the more adherent cell types such as epithelial cells. The cells recovered from
the primary culture following short trypsinization were centrifuged at 80 x g,
resuspended in fibroblast growth medium (Appendix 2B, p335), and seeded into a
fresh culture flask. Once this secondary culture became confluent short trypsinization
was again employed to select for fibroblasts. This secondary culture (termed passage
1, or p1) and subsequent cultures were passaged at near confluency with a sub-
cultivation ratio of 1:3. At passage 2, fibroblasts in cultures derived from explanted
skin were morphologically homogenous being multipolar in disperse culture and
forming whorls of bipolar cells at near-confluency. No change in culture morphology




Figure 5.1. Primary growth from explanted human forearm skin (x 360)
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contraction assays.
Fibroblasts were routinely cultured in 80 cm2
 tissue culture flasks (Nunclon,
Nunc, Denmark) in Ham's FlO medium buffered with 20 mM Hepes buffer (04 1-
02390, Gibco, Scotland) and supplemented with 10% fetal calf serum and the
antibiotics penicillin and streptomycin at 100 units/mi and 100 g/ml respectively.
Passage 4 (p4) fibroblasts were stored by freezing-down in liquid nitrogen ((Appendix
5A, p339). Two weeks prior to requiring fibrobiasts for experimentation these p4
fibroblasts were recovered from the liquid nitrogen (Appendix 5B, p 339) and
cultured as prior to freezing-down. Fibroblasts underwent a further two passages (to
p6) prior to bioassay use.
5.1.2. Characterisation of human dermal fibroblasts
This section is concerned with demonstrating that the cells cultured from explanted
human skin (as described above) were of a fibroblastic lineage rather than some
other skin-derived cell lineage. Fortunately, for those interested in studying fibroblast
activity in vitro, fibroblast growth from tissue explants is relatively prolific compared
with the majority of the possible contaminating cell types. When tissue explants are
cultured in serum-supplemented medium, certain factors contained in serum (many
of them platelet-derived) have a strong mitogenic effect on fibroblasts, but tend to
inhibit the growth of other cell types, such as epithelial cells, by inducing terminal
differentiation (Freshney, 1987). While the cellular outgrowth from connective tissue
explants may initially contain several cell lineages, continued culture in serum-
supplemented medium preferentially encourages the growth of fibroblasts. Thus
Murphy and Daniel (1987) reported that while primary cultures of explanted
periodontal ligament initially contained 98% fibroblasts and 2% epithelial cells, 100%
of the population were fibroblasts by the second passage.
In this thesis human dermal fibroblasts were cultured to, and used at, passage
6, thus reducing the possibility of cellular contamination, and allowing the generation
of sufficient cell numbers for study. At passage 6, fibroblasts derived from explanted
human forearm skin were morphologically homogenous under phase microscopy.
Prior to confluency (figure 5.2a) they were multipolar with numerous lamellipodia
(flattened cytoplasmic protrusions); when confluent (figure 5.2b), they assumed a
spindle shaped morphology and were arranged in parallel arrays and whorls
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Figure 5.2b. Inverted phase micrograph (x 360) of confluent dermal fibroblasts.
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human fibroblasts used in this thesis is consistent with that of the accepted human
fibroblast morphology. The expression of characteristics specific to other cell lineages,
known to contaminate primary fibroblast cultures, was investigated in order to
confirm the identity of these presumptive p6 human dermal fibroblasts. This
investigation took the form of immunocytochemical staining using indirect
immunofluorescence techniques.
5.1.2.1. Contaminating cell types
The major cell types that may contaminate fibroblast cell lines are epithelial cells,
endothelial cells and smooth muscle cells. Although macrophages and lymphocytes
are present in biopsy material, in culture these cells are either weakly adherent or
non-adherent to plastic tissue culture surfaces. As such they tend to be lost from the
culture during medium replacement.
Epithelial cells tend to attach more firmly to tissue culture plastic, and are
released less easily from this attachment by trypsin, than fibroblasts (Owens et a!.
1974). Limited trypsinization (Appendix 4, p338) was initially performed to detach
cells from the primary culture (around the explant) and subsequently during routine
passage, in an attempt to reduce epithelial cell contamination. p6 human dermal
fibroblasts were exposed to anti-cytokeratin antibodies in order to confirm the lack
of epithelial cell contamination (p138). Cytokeratins are intermediate filaments
expressed only in epithelial cells.
Endothelial cells appear to respond to trypsin in a similar manner to that
observed in fibroblasts, and limited trypsinization does not preferentially select
against them. Fortunately, endothelial cells have more stringent growth requirements
than fibroblasts (Kumar et a!. 1987) and tend to be easily overgrown by them. It has
been widely reported that confluent cultures of endothelial cells have a cobblestone
appearance (Kumar et a!. 1987), clearly dissimilar to the whorl-like arrangement of
bipolar fibroblasts at confluency noted above (figure 5.2b). p6 human dermal
fibroblast cultures were stained with antibodies to Factor-Vill-related antigen, a
universal marker for endothelial cells (Kumar et a!. 1987), in order to confirm the
lack of endothelial cell contamination (p139).
Smooth muscle cell (SMC) contamination represents more of a problem, as
there is as yet no satisfactory method by which SMCs can be distinguished from
fibroblasts. While the intermediate filament, desmin, is generally thought to be
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restricted to muscle cells, several reports have demonstrated desmin within
fibroblastic cells (Hansson eta!. 1989; SkaIJi eta!. 1986). Also, when SMCs are placed
in culture, desmin disappears around the fifth passage (Skalli et a!. 1986). It has,
however, been reported that SMC may be differentiated from fibroblasts on the basis
of cellular morphology (Freshney, 1987). Sub-confluent SMCs in culture are reported
to be round cells, a shape they retain at confluency, giving cultures the cobblestone-
like appearance of confluent endothelial cells. Such a morphology clearly differs from
the initially multipolar sub-confluent and subsequently bipolar whorl-arranged
fibroblasts. A distinction based purely on culture morphology cannot be totally
conclusive, as cells in culture show an enormous capacity for morphological plasticity.
That SMCs were present as cellular contaminants in p6 human dermal fibroblast
cultures cannot be ruled out.
5.1.2.2. Immunohistochemical cell Identification - background
A. Intermediate filaments
Intermediate filaments are rope-like polymers of fibrous polypeptides that are
thought to play a structural or tension-bearing role in the cell. A variety of tissue
specific/cell specific forms of intermediate filament are known; they differ in the type
of polypeptide they contain. The different intermediate filaments and the cell type
to which they are normally ascribed are: keratin filaments in epithelial cells,
neurofilaments in nerve cells, glial filaments in astrocytes and Schwann cells, desmin
filaments in muscle cells and vinientin filaments in mesenchymally derived-cells
including fibroblasts (Alberts et a!. 1989). A given cell type can contain more than
one form of intermediate filament, for example glial cells contain both vimentin and
glial filaments (Rungger-Brandle and Gabbiani, 1983). The intermediate filament
profile of a cell tends to be retained at times when all other identifying criteria have
been lost, such as during neoplastic growth (Gabbiani et a!. 1981), and, as such is
useful in the identification of cells of unknown origin.
p6 human dermal fibroblast cultures were stained with antibodies to vimentin
(an intermediate filament marker of mesenchymal tissue-derived cells) and
cytokeratins (intermediate filament markers of epithelial cells).
Vimentin: Vimentin is widely distributed in cells of mesenchymal origin including
fibroblasts (Ngai et a!. 1990), endothelial cells (Semich and Robenek, 1990), white
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blood cells (Alberts et a!. 1989), pigment cells (Rappersberger et a!. 1990) and some
muscle cells (Takase et a!. 1988). Vimentin has also been shown to be present in
some keratinocytes in culture (Rungger-Brandle and Gabbiani, 1983) but absent in
sections of human skin (Rappersberger et a!. 1990). The vimentin antibody employed
in this characterisation was a mouse anti-swine monoclonal raised against purified
vunentin from porcine eye lens (DAKO-vimentin, M725, DAKO Ltd, UK). The
monoclonal is reported (1) not to cross react with any other intermediate filament,
and, (2) to have a broad species reactivity.
Cytokeratins: Cytokeratins are found in epithelial and glial cells, both in vivo and in
vitro (Rungger-Brandle and Gabbiani, 1983). It has also been reported that SMCs can
contain cytokeratins (Turley et a! 1988). Despite this latter report keratin expression
has come to be regarded as the single most invariable characteristic of epithelial cells.
There are at least 19 distinct forms of cytokeratin in human epithelia (Moll et a!.
1982). These can be divided up into two subfamilies, acidic keratins and neutral or
basic keratins, each subfamily coded for by a different set of genes. Keratin filaments
are always heteropolymers formed from an equal number of subunits from each of
these two subfamilies. Epithelial cells therefore express at least two keratins, the
specific expression of keratins by epithelia depending on cellular location and the
state of differentiation. While studying the labelling of a panel of 20 mouse-derived
cytokeratin antibodies on human skin, Lane et al. (1985), observed that one antibody,
namely LP34, labelled all epidermal cells with the exception of those comprising the
inner hair root sheath; while another antibody, namely LE1, labelled the inner hair
root sheath. LP34 and LE1, kind gifts to the laboratoiy from Dr P. Purkis (The
London Hospital, London, UK), were employed to investigate epidermal cell
contamination of p6 human dermal fibroblast cultures. A cloned cell line of simian
virus 40 transformed human foreskin keratinocytes (SVK14), cultured in RPMI-1640
with 10% FCS, was used at passage 31 as a positive control for anti-cytokeratin
labelling. Positive staining, with a polyclonal antibody to human cytokeratin, has
previously been reported for this cell line (Taylor and Papadimitrou, 1982).
Secondary antibodies: The secondary antibody used to detect both anti-vimentin and
anti-cytokeratin labelling was a sheep antibody to mouse IgG conjugated to
fluorescein isothiocyanate (FITC) (Product number F-6257, Sigma, UK). Non-specific
138
labelling (independent of primary antibody) of this secondary antibody to both p6
human dermal fibroblasts and SVK14 keratinocytes was examined.
B. Factor-Vill-related antigen (von Willebrand factor)
Confluent monolayers of endothelial cells have a characteristic cobblestone
appearance, clearly dissimilar to the whorl-like arrays of confluent fibroblasts. This
cobblestone morphology cannot be totally relied upon to differentiate between
fibroblasts and endothelial cells, as confluent endothelial monolayers undergo a
phenomenon termed sprouting, in which confluent endothelial cells assume a
fibroblast-like morphology (Kumar et a!. 1987). Factor-VIlI-related antigen is thought
to be a universal marker for all endothelial cells with the exception of those of lymph
node post-capillary venules (Kumar eta!. 1987). Factor-VIlI-related antigen has been
shown to be localised within Wiebel-Palade bodies of endothelial cells (Warhol and
Sweet, 1984). A rabbit polyclonal antibody to human Factor-Vill-related antigen
(product number A082, DAKO Ltd, UK) was employed to assess endothelial
contamination of p6 human dermal fibroblast cultures. Bovine aortic endothelial cells
(p7), maintained in Modified Eagles Medium supplemented with 10% FCS, were
used as a positive control for Factor-Vill-related antigen staining. The secondary
antibody employed to detect anti-Factor-Vill-related antigen binding was a goat
antibody to rabbit IgG, conjugated to tetramethyirhodamine isothiocyanate (TRITC)
(product number T-5268, Sigma, UK). Non-specific labelling (independent of primary
antibody) of this secondary antibody to both p6 human dermal fibroblasts and p7
bovine aortic endothelia was examined.
5.1.2.3. Immunohistochemical characterisation - methodology
The indirect immunofluorescence methods employed to characterise p6 human
dermal fibroblasts are described in full in (Appendix 16, p352). Briefly, p6 human
derinal fibroblasts, p31 SVKI4 transformed keratinocytes, and p7 bovine aortic
endothelial cells were cultured to confluence on glass coverslips. p6 human dermal
fibroblasts underwent anti-vimentin, anti-cytokeratin (LP34 & LE1) and anti-Factor-
Vill-related antigen inmmunofluorescent staining. p3! SVK14 transformed
keratinocytes and p7 bovine aortic endothelial cells were stained for cytokeratin
(LP34 & LE1) and Factor-Vill-related antigen respectively, and were used as
positive staining controls. The sheep-anti-mouse FITC and goat-anti-rabbit TRITC
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secondary antibodies were applied without prior addition of primary antibodies to
demonstrate the level of non-specific binding of secondary antibodies. After staining
the confluent cell monolayers were viewed under a fluorescence microscope
(Olympus BH2, fitted 450-490 and 546 nm excitation filters). Monolayers
demonstrating both positive and negative staining were photographed using Kodak
Ektachrome P 1600 film.
5.1.2.4. Results
From figures 5.3 - 5.5 (p142 to 144) the following points are apparent:
Vimentin labelling: As can be seen from figure 5.3a, p6 human dermal fibroblasts
label positively for vimentin; the lack of labelling following the application of the
secondary antibody alone (figure 5.3b) indicates that this labelling is due to the
specific binding of anti-vimentin antibodies to cellular vimentin.
Cytokeratin labelling: As can be seen from figures 5.4a and 5.4b, p6 human dermal
fibroblasts do not display positive staining for either LP34 or LE1. p31 SVK14
transformed keratinocytes are positive for both anti-cytokeratin antibodies (figures
5.4c & 5.4d). Non-specific labelling was not demonstrated in response to the
application of the fluorescein-conjugated sheep anti-mouse secondary antibody to
either p6 fibroblasts (figure 5.3b) or p31 SVK14 keratinocytes (figure 5.4e).
Factor-Vill-related antigen: As can be seen from figures 5.5a, p6 human dermal
fibroblasts do not display positive staining for Factor-Vill-related antigen. p7 bovine
aortic endothelial cells are positive for Factor-Vill-related antigen (figure 5.5c).
Non-specific labelling was not demonstrated in response to the application of the
rhodamine-conjugated goat anti-rabbit secondary antibody to either p6 fibroblasts
(figure 5.5b) or p7 bovine aortic endothelial cells (figure 5.5d).
5.1.2.5. Discussion
The observation that p6 human dermal fibroblasts are vimentin positive confirms the
mesenchymal origin of these cells. The lack of cytokeratin positive cells indicates that
p6 human dermal fibroblast cultures were not contaminated with epithelial cells. On
the basis of factor-Vill-related antigen staining there would appear to be no
endothelial cell contamination.
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5.1.2.6. Summary of p6 human dermal fibroblast characterisation
In summary, the p6 human dermal fibroblasts generated from human forearm skin
were confirmed to be cells of the fibroblastIc lineage. Evidence to confirm this
includes: 1. The multipolarity of subconfluent cells and the whorl-like array of bipolar
cells at confluency, 2. The labelling with vimentin, 3. The lack of labelling for
cytokeratins, and, 4. The lack Factor-Vill-related antigen labelling.
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Figure 5.3	 Immunohistochemical localisation of vimentin intermediate filaments.
Figure 5.3a Positive staining of p6 fibroblasts incubated with mouse anti-swine
vimentin, detected using FITC-conjugated sheep anti-mouse IgG (x 125).
Figure 5.3b Lack of positive staining of p6 fibroblasts incubated with the secondary
(primary detection) antibody, FITC-conjugated sheep anti-mouse IgG, alone (x125).
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Figure 5.4 Immunohistochemical localisation of keratin intermediate filaments.
Figure 5.4a.	 p6 human dermal fibrohiasts stained with the anti-cvtokeratin antihodv [P34 (x 125).
Figure 5.4h.	 p6 human dermal fibrohiasts stained with the anti-cytokeratin antibody LEl (x 125).
Figure 4c.
_'j
p31 SVKI4 keratinocvtes stained with the anti-cvtokeratin antibody LP34 (x 125).
K . .	 tntihodv IL! (x 12).
Figure 5.4e.	 p3 1 SVKI4 keratinocvtes stainedwith secondary
 (prima detection) antibody, F! IC-
conjugated sheep anti-mouse IgG, alone (x 125).
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Figure 5.5	 Immunohistochemical localisation of Factor-Vill-related antigen.
Figure 5.Sa	 The lack of positive staining of p6 human dermal fibroblasts incubated with the
Factor-VILI-related antigen, detected using TRITC-conjugated goat anti-rabbit IgG (x 125).
ligure 5 .h	 Ihe lack ol positive staining 0! p( human Jermal libroblasts incubated with the
secondary (primary detection) antibody, TRITC-conjugated goat anti-rabbit IgG, alone (x 125).
Figure 5.5c
	 The positive staining of p7 bovine aurtic endothelial cells incubated with the factor-
VHf-related antigen, detected using TRITC-conjugated goat anti-rabbit IgG (x 125).
ligure s.sd	 I he laLk ot	 )1l\ e LiIflIflg ot p bovine aortie endotheliiI cells incubated with the
secondary (primary detection) antibody, TRITC-conjugated goat anti-rabbit IgG, alone (x 125).
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5.2. The U937 promonocvte cell line
5.2.1. Constitutive characteristics.
The U937 cell line originated from the pleural fluid of a 37 year old male patient
with diffuse histiocytic Iyinphoma (Sundstrom and Nilsson, 1976). The U937 cell line
has been shown to be a neopiastic cell of the monocyte lineage, sharing many
morphological, histochemical and functional characteristics ofmonocyte-macrophages
(Sundstrom and Nilsson, 1976; Harris and Ralph 1985; Lyons and Ashinan, 1989).
Some of the most notable monocyte-macrophage characteristics displayed by U937s
include: (1) the surface expression of the leucocyte integrin CR3 (the receptor for
complement component C3bi and the antigen recognised by the "macrophage
specific" antibodies Mac-i, OKM1 and Moi) which is thought to be an important
receptor for particle phagocytosis and subsequent respiratory burst in mononuclear
phagocytes (Belier et a!. 1982), (2) the surface expression of the FCR1
immunoglobulin G receptor which is expressed specifically by monocytes and tissue
macrophages (Anderson, 1982), (3) the release of lysozyme into culture medium, a
monocyte specific characteristic (Ralph et a!. 1976), (4) U937s, like monocytes,
elaborate tumour necrosis factor in response to granulocyte macrophage-colony
stimulating factor (Sabatini et a!. 1990), (5) the cytochemical profile of monocytic
lineage cells, including the presence of fluoride inhibitable esterase, alkaline and acid
phosphatase, and f3-glucuronidase activities (Sundstrom and Nilsson, 1976; Harris and
Ralph, 1985).
The U937 is a morphologically monoblastic cell which shares many
morphological, histochemical and functional characteristics of monocyte-
macrophages. The U937 can be induced to differentiate further along the monocyte-
macrophage lineage by exposure to both physiological agents (cytokines, retinoic acid,
vitamin D derivatives) and non-physiological inducing agents (phorbol esters) (Lyons
and Ashman, 1989). This induced differentiation involves phenotypic changes that
resemble those observed during terminal differentiation of normal monocytic cells
(Pedrinaci et a!. 1990). Induction with such substances both increases the expression
of certain constituitive macrophage characteristics (see above), and encourages the
expression of further macrophage characteristics such as substratum adherence and
cessation of proliferation (Hass et a!. 1990), thus giving the cell the morphological
and functional characteristics of more differentiated monocyte-macrophages (Harris
and Ralph, 1985).
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5.2.2. Phorbol ester-induced U937 characteristics
When actively proliferating suspension cultures of U937 cells are treated with
phorbol esters, including 413-phorbol 12-myristate 13-acetate (PMA), cellular growth
is inhibited and cells adhere to plastic surfaces (Nilsson et a!. 1980; Ways et a!. 1987;
Hass et a!. 1990), both characteristics of peripheral blood mononuclear cells. These
adherent, phorbol ester-exposed, U937s express characteristics indicative of more
differentiated cells than uninduced U937s (Elsas et a!. 1990; William et a!. 1990;
Kemp et a!. 1990). Such induced characteristics include (1) elevated expression of
CR3 and FcR1 (Harris and Ralph 1985), (2) increased expression of: fluoride
inhibitable esterase, alkaline and acid phosphatase, and /3-glucuronidase activities
(Harris et a!. 1985), (3) monocyte-macrophage differentiation antigen expression,
including CD14 (Pedrinaci et a!. 1990) and 7C3 (Zuckerman et a!. 1987), (4) a
monocyte-like network of vimentin intermediate filaments (Taimi et a!. 1990), (5) the
elaboration of granulocyte-macrophage colony stimulating activity (GM-CSA), a
glycoprotein capable of stimulating the growth of granulocyte and macrophage
colonies from bone marrow cells - a macrophage characteristic (Ascensao and
Mickman, 1984; Liu and Wu, 1992), (6) the capacity to generate superoxide anion
(Ox) free radicals in response to appropriate stimuli (Balsinde and Mollinedo. 1988)
a characteristic of activated macrophages (Johnston et a!. 1978), (7) both peripheral
blood monocytes (PBMs) and U937s secrete plasminogen activator (u-PA) and low
levels of plasminogen activator inhibitor, secretion of the latter can be substantially
increased, in both PBMs and U937s, by exposure to PMA (Gross and Sitrin, 1990).
Interestingly, U937s have been observed to retrodifferentiate after removal of
phorbol ester (Hass et a!. 1990; Hass, 1992).
5.23. Growth factor synthesis by the U937
In addition to their role in tissue debridement wound macrophages are thought to
elaborate various growth and regulatoiy factors, often grouped together as
macrophage-derived growth factor (MDGF), which are thought to be critical for
granulation tissue formation. MDGF is known incorporate the activities of: platelet-
derived growth factor (PDGF), basic fibroblast growth factor (bFGF), transforming
growth factor-$ (TGF-/3), insulin like growth factor-i (IGF-1), tumour necrosis
factor-a (TNF-a), the epidermal growth factor-related transforming growth factor-a
(TGF-a) and interleukin-1 (IL-i) (Raines and Ross, 1989). Actively phagocytosing
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peripheral blood monocyte-derived macrophages have also been shown to produce
fibroblast activating factor (FAF) (Dohiman et a!. 1984; Dohlman et al. 1985).
The U937 cell has been shown to elaborate the majority of these MDGF
components. U937s express PDGF A chain mRNA, which increases with phorbol
ester treatment (Alitalo et a!. 1987; Makela et a!. 1987). While immunoprecipitable
levels of PDGF are clearly apparent in conditioned medium from phorbol ester
induced U937s, little is apparent prior to induction (Makela et a!, 1987). U937s also
express mRNA for TGF-/3 which, like PDGF A chain mRNA, is upregulated by
phorbol ester induction (Assoian et a!, 1987; Wager and Assoian, 1990). Whether this
upregulation in TGF-/3 mRNA is paralleled by secretion of active TGF-/3 into culture
medium is as yet unknown. U937s exposed to the phorbol ester, PMA, release TNF-a
into their culture medium; prior to induction they appear not to elaborate TNF-a.
Peripheral blood monocytes have also been shown to synthesise TNF-a in response
to PMA (Sabatini et a!. 1990). Some reports suggest that U937s constitutively
elaborate IL-i (Palacios et al. 1982; Barak et a!. 1986) while others question this,
reporting that the elaboration of IL-i requires the induction of differentiation by
agents such as PMA (Wakasugi et a!. 1984; Merluzzi et a!. 1987). This confusion may
partially be explained by the observation that U937s constitutively produce an IL-i
suppressor factor thought to mask IL-i activity (Fujiwara and Ellner, 1986). The
stimulation of U937s with PMA results in the appearance of both intracellular FAF
and the secretion of FAF into the medium (Turck et a!. 1988; Turck et el. 1989:
Demeter eta!. 1991). U937s at rest, prior to induction with PMA, transcribe the IGF-
1 gene, express IGF-1 mRNA and release IGF-1 at a low level. Upon PMA exposure
the rate of transcription increases, but there is a reduction in cytoplasmic IGF-1
mRNA. Despite this, exposure to PMA leads to a rapid release of IGF-1 from the
cell, a process that occurs in the presence of protein synthesis blockers suggesting
that it is a release of preformed IGF-1 (Nagoaka et a!. 1990). The fact that U937
cells can rapidly release presynthesized IGF-1 is consistent with the role of
mononuclear phagocytes in wound healing and tissue fibrosis. Thus, like the platelet
that carries preformed growth factors such as PDGF, the macrophage may be primed
to augment mesenchymal growth at the wound site.
5.2.4. Induction of differentiation/maturation by phorbol esters
Phorbol esters, a group of plant-derived compounds with diverse effects on cellular
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function, are potent differentiation-inducing agents in several leukaemic cell lines
(Nilsson et a!. 1980). One mechanism through which they exert, at least, a portion of
their effects, is by activating the Ca2
 phospholipid-dependent kinase, protein kinase
C (Castagna et a!. 1982). Phorbol esters activate protein kinase C by substituting for
diacyiglycerol (Castagna et a!. 1982). Diacylglycerol, a product of the phosphatidyl
inositol pathway, is an important cellular regulator of protein kinase C. Once
activated, protein kinase C is able to phosphoiylate serine or threonine residues on
target proteins. Phorbol esters are thought, in part, to induce differentiation in U937s
by activating protein kinase C to phosphorylate a 47 kD cytosolic protein termed
pleckstrin (or P47) (Gailani et a!. 1990).
5.2.5. Uses of the U937 cell line
The U937 cell is widely used as a model for monocyte-macrophages in many areas
of biomedical investigation including research into the pathogenesis of HIV, cancer
and pathogenic bacteria. Monocyte-macrophages are an important target for human
immunodeficiency virus (HIV) infection; the U937 is widely used, and presumably
widely accepted, as a model for studying HIV infection and therapy (Folks et a!.
1988; Perno et a!. 1990; Dubreuil et a!. 1990; Kim et a!. 1990; Vitkovic et al. 1990;
Mann et a!. 1990; Pauza and Singh, 1990; Gollapudi and Gupta, 1990; Mace and
Gazzolo, 1991; Locardi et a!. 1990). The U937 has also been employed as a
macrophage model in other areas of virology including the study of herpes simplex
type-i pathogenesis (Tenney and Morahan, 1987). The U937 has been used in
bacteriology research: as a model of bacteria-macrophage interaction in the
cytopathology of Legionellapneumophila, which are thought multiply within alveolar
macrophages (Peariman et a!. 1988; Cianciotto et a!. 1990); as a model for the effect
of bacterial leucotoxins on human monocytes (Simpson et a!. 1988); and in the
development of live oral vaccines of Salmonella typhi (Dragunsky et al. 1990). In its
capacity as a leukaemia-derived cell line the U937 has been used in cancer research:
as a target cell for attempts at leukaemia differentiation therapy (Nakaya et al. 1990;
Peck and Bollag, 1991), to examine deficiencies in haemopoeitic organ homing of
leukaemic cells (Hardy et al. 1990), and as an in vitro target cell to monitor the
antitumour host defences of pulmonary macrophages from lung cancer patients
(McDonald and Atkins, 1990).
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5.2.6. DissImilarity to cells of the monocyte-macrophage lineage
Some differences between the U937s induced to differentiate along the macrophage
lineage and normal cells of the monocyte-macrophage lineage have been reported.
These include: differences in the regulation and intracellular processing of cytokines
e.g tumour necrosis factor-a (Hass et a!. 1991); the expression of high levels of the
CD4 surface antigen, a characteristic of T lymphocytes rather than monocyte/-
macrophages (Teppler et a!. 1990); and U937s, unlike peripheral blood monocytes,
appear to be incapable of producing leukotrienes (Nolfo and Rankin, 1990).
5.2.7. The culture of U937s
U937s obtained from the European Collection of Animal Cell Cultures (Porton
Down, UK.) were cultured in suspension in 80 cm 3 flasks in RPMI-1640 medium
containing 10% v/v heat-inactivated fetal calf serum, 100 .&g/ml of streptomycin, 100
units/mi penicillin and 25 mM Hepes buffer (pH 7.4). Flasks were seeded with U937s
at a cell density of between 0.5 and 1 x iO cells/ml. Population doubling time was
observed to be approximately 40 hours. Cultures were split at a 1:5 ratio twice a
week.
5.3. The methylene blue fibroblast proliferation bioassay
5.3.1. Introduction
The methylene blue bioassay was first described by Lagneau et a!. (1977) as a
technique for measuring cytotoxicity. It has since been modified and used as a
proliferation assay for tumour cells (Martin et a!. 1978), human and rat fibroblast cell
lines and for epithelial cell lines (Oliver eta!. 1989). The methylene blue bioassay was
used in this work as the main method for quantitating fibroblast proliferation in vitro.
5.3.2. Overview of the methylene blue bioassay
This assay relies on (1) the ability of methylene blue to stain cells in monolayer, and
(2) the ability to relate the amount of stain eluted from a monolayer to the number
of cells within that monolayer. Methylene blue is a basic dye that is positively charged
at pH 8.5. When added to cells in culture it forms salts with negatively charged tissue
components. The main basophilic components of fibroblasts are the anionic
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phosphate groups of DNA. During cell division, as the nucleic acid content of the
monolayer increases, there is a proportional increase in the available binding sites for
the dye. After methylene blue staining, the excess dye is removed leaving only the
bound dye. The addition of acid-alcohol leads to the protonation of acidic groups
which releases the previously bound dye into the eluent. The absorbance of the
eluent is then determined using a spectrophotometer. This absorbance is related to
the amount of bound dye, and therefore also to the amount of DNA present in the
monolayer. By generating a standard curve of cell number versus absorbance,
absorbance values obtained during experimentation, on the same cell line, can be
converted into cell number (refer to page 152).
5.3.3. The binding of methylene blue.
The methylene blue dye used in this thesis (MB-i, Sigma Diagnostics, St. Louis,
USA) not only binds to the basophilic anionic phosphate groups of DNA, but may
also bind other basophilic cell components, including RNA and cytoplasmic proteins.
Accordingly, if there is an increase in the synthetic activity of cells, in response to a
given treatment, more methylene blue will bind per cell, thus over estimating cell
number. Routine cell counts using a haemocytometer are necessaiy to control for
such an outcome, and were carried out routinely in parallel with each methylene blue
proliferation assay performed.
Methylene blue also appears to bind to components of the tissue culture
medium, fetal calf serum supplement and biomaterials under test (e.g. components
of platelet releasates and macrophage supernatants studied in this thesis). To control
for this error a minimum of 12 wells on each 96-well plate were set aside as "medium
blanks", cell-free wells which were plated with medium alone. Where various
macrophage supernatants or platelet releasates were being compared on a single 96-
well plate, medium blank wells were initially plated with fibroblast growth medium
(Ham's FlO + 10% FCS), to control for fibroblast plating medium, then plated with
the macrophage supernatant or platelet releasate, to control for the "substance under
test". Average A values obtained from these "medium blank wells" were subtracted
from the A values of cell-containing experimental wells prior to further analysis of
fibroblast proliferation.
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5.3.4. The relationship between absorbance (A 650nm) and methylene blue dye
concentration.
The relationship between absorbance (A 650nm) and concentration of methylene blue
has been investigated by Oliver eta!. (1989). They demonstrated that when methylene
blue was eluted from stained cells using acid-alcohol (ethanol : 0.1 M HCI) a positive
linear relationship exists between methylene blue concentration (range 0 - 40 mgi-')
absorbance at 650 nm. However, when eluted with an aqueous solution of lower pH
this linear relationship was lost, due to dimer fonnation.
Oliver et a!. (1989) also demonstrated that absorption spectra of methylene
blue eluted from stained cells using acid-alcohol differed from that obtained by
elution with an aqueous based solution of similar pH. Elution of methylene blue with
acid alcohol resulted in a single, large, clearly defined, absorbance peak at 650 nm;
compared with two, small, poorly defined peaks at 600 and 650 nm when aqueous
elution was employed.
As a consequence of the observations made by Oliver et a!. (1989), regarding
both the linear relationship between methylene blue dye concentration and
absorbance at 650 urn, and the absorption spectra generated by elution using acid
alcohol, this was chosen as the method of dye elution throughout this thesis.
5.3.5. The relationship between absorbance and cell number.
The relationship between measured absorbance (A 650 nm) and cell number is
dependent upon a fixed mean nuclear:cytoplasmic ratio. It is theoretically possible
that the nuclear:cytoplasmic ratio could vaiy with cell type, passage number, source
species or in response to a given experimental condition. To overcome differences
between cell type, passage number or source species a calibration curve (or standard
plot) of absorbance at a wavelength (A) of 650nm (i.e. A) versus cell number, was
generated for each cell type. Thus facilitating the conversion of measured A into
a cell number for each cell type under experimental investigation (see prcparation
of standard curve, p152).
A potential source of error in this assay is that under certain experimental
conditions the mean nuclear:cytoplasmic ratio may change, thus altering A650, which
could be interpreted as a change in cell number, though without an actual change
necessarily having taken place. The calibration curve, having been prepared prior to
this hypothetical experimentally-induced change in nuclear:cytoplasmic ratio, can no
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longer be used to accurately convert experimental absorbances into cell numbers.
Oliver et a!. (1989) examined a variety of cell lines, including Rat 1 (fetal rat lung
fibroblasts); IMR9O (cloned human fetal lung fibroblasts); HFL (fetal lung fibroblast
line) Chang cells (cloned liver epithelial cell line), and SIRC (rabbit corneal
fibroblasts) under various culture conditions, which included studying the effects of
platelet-derived growth factor (PDGF), prostaglandin E2, and macrophage
conditioned media, and found no change in nuclear:cytoplasmic ratio. However, this
clearly does not preclude such a change taking place.
5.3.6. Preparation of a standard curve for the methylene blue bioassay
Introduction. Calibration curves of absorbance (A 650 nm) versus fibroblast number
were constructed (1) in order to confirm that there was a linear relationship between
absorbance (A 650 nm) and cell number, and (2) to facilitate the conversion of
experimentally-obtained absorbances, generated using the methylene blue bioassay,
into fibroblast number.
Method. The method employed here is based on the standard protocol for the
"Methylene Blue Fibroblast Proliferation Assay" (Appendix 8, p342).
Briefly, adult forearm fibroblasts (p6) were resuspended in Ham's FlO medium
supplemented with 10% fetal calf serum and 2% penicillin/streptomycin at a
concentration of 1 x i0 cells/mi. This cell suspension was then serially diluted with
culture medium to give cell suspensions containing 5 x iO, 2.5 x iO, 1.25 x iO and
6.25 x iO cells/mi. These cell suspensions were plated out, in 100 p.1 volumes, into the
wells of a 96-well flat bottomed tissue culture microtitre plate; such that for each cell
concentration 16 duplicate wells were filled. The remaining wells were filled with
culture medium only, to allow for later correction of absorbance due to culture
medium. The 96 well plate was then sealed to guard against evaporation and placed
in a 37°C incubator for a period of 12 hours to allow cells to attach to the tissue
culture plastic. After 12 hours the culture medium was aspirated off, the fibroblasts
(now in monolayer) were washed, fixed, stained, the stain eluted, and the absorbance
(A 650 nm) for each well measured.
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Results. Average absorbance (A 650 nm) values were calculated for each cell
concentration, and the average absorbance (A 650 nm) of medium-only wells
subtracted from these values. These corrected average absorbance figures (table 5.1,
p154) were plotted against cell concentration (figure 5.6A), and a linear regression
analysis performed (figure 5.6B). Standard deviation and standard error of corrected
absorbance was calculated, and plotted to display the distribution of absorbances
from the average. It is apparent from figure 5.6B that there is a positive linear
relationship between fibroblast number and absorbance (A 650 nm). The regression
analysis data can then be used to covert experimental absorbance figures into cell
number as follows:
Linear regression data:	 R2	=	 0.9996
a	 =	 -0.00 1875
b	 =	 0.040845
For a given experimental absorbance value X
X -aCell Number = _____
b
Thus for this standard curve:
X + 0.001875CellNumber = ____________
0.040845
Discussion. The observation that a linear relationship exists between cell number
and absorbance (650 nm) up to a concentration of 1 x iO cells per well (1 x iO cells
per ml) is consistent with the findings of Oliver et a!. (1989). This observation
indicates that as long as measured absorbances, obtained during experimentation, do
not exceed the absorbance displayed by the 1 x iO cells/mi suspension, they may be
converted into cell number using this calibration curve. Several fibroblast calibration
curves were carried out during the course of this work; for a given proliferation assay
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5.3.7. Examination of the sensitivity of the methylene blue fibroblast proliferation
assay to exogenous stimulatory factors (fetal calf serum).
Introduction. Serum is known to contain varying quantities of several polypeptide
growth factors capable of stimulating fibroblast proliferation in vitro. Serum growth
factors mitogenic for fibroblasts in vitro include those released from platelet -
granules during clotting: platelet-derived growth factor, PDGF, (Ross et a!. 1986);
transforming growth factor-beta, TGF-/3, (Moses et a!. 1985); basic fibroblast growth
factor, bFGF, (Gospodarowicz, 1974); and epidermal growth factor, EGF, (Davidson
et a!. 1988). The methylene blue proliferation assay was used to study the effect of
fetal calf serum (FCS) concentration on the proliferation of p6 human dermal
fibrobiasts as a preliminary to investigating the effect of ultrasound.
This study was performed (1) to examine the ability of the p6 human dermal
fibroblasts (used in this thesis) to respond to known mitogenic substances, and (2)
to assess the ability of the methylene blue fibroblast proliferation assay to detect that
proliferative response.
Method. A modified version of the standard methylene blue fibroblast proliferation
assay protocol (Appendix 8, p342) was employed. Briefly, sub-confluent p6 human
dermal fibrobiasts were trypsinised (Appendix 4, p338) and resuspended in fibroblast
growth medium (Appendix 2B, p335) to 3 x i0 cells/mI. 100 p.1 volumes of this
suspension, containing 3000 cells, were dispensed into each well of rows B through
G of a 96-well microtitre plate. Each well in rows A and H, of the same plate,
received 100 p.1 of fibroblast growth medium (medium blank wells). The plate was
then sealed to reduce desiccation and placed in a 37°C incubator for 12 hours to
permit cell attachment. Four 96-well microtitre plates were set up in this way.
After 12 hours all four plates were removed from the incubator. One plate
was "stopped" according to steps 6 through 8 of Appendix 8 (p342) and stored in a
dust free environment. The three remaining plates were treated as follows:
Under sterile conditions, the sealing tape was removed and the medium in each well
was carefully aspirated off without disturbing the fibroblast monolayer. 100 p.l of
fibroblast growth medium (Appendix 2B, p335), containing 0.5, 1.0, 2.5, 5.0, 10.0, or
20% FCS, was then added to each well such that 2 columns of wells on each plate,
including medium blank wells, received a given FCS concentration. The three plates
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set up in this manner were then sealed and returned to the 37°C incubator.
Individual plates were removed from the incubator and "stopped" after 60, 108, or
156 hours. After the 156 hour plate had been "stopped", all 4 plates were stained with
methylene blue, the stain eluted, and absorbance (A) values obtained for each well
using a spectrophotometer. Average medium blank A650 readings were calculated and
subtracted from the cell-containing wells. The resulting A650 values were converted
into cell number using a standard curve (figure 5.6B, p155) for p6 human dermal
fibroblast cell number versus A650 . Median fibroblast number was calculated for each
of the FCS levels at each time point (Table 5.2) and displayed graphically along with
their respective 95% confidence intervals (figure 5.7, p159). Non-parametric analysis
(Mann Whitney U-test) was performed between each FCS concentration, at each
time point, to ascertain the sensitivity of the methylene blue fibroblast proliferation
assay to FCS (see Appendix 17, tables 1 through 4 (p353).
Results. From figure 5.7, showing cell number against FCS concentration at 12, 60,
108 and 156 hours post plating, it can be seen that as FCS concentration is increased
there is a parallel increase in fibroblast number. The peak median fibroblast number
is observed at the 108 hour time point in all FCS concentrations, with the exception
of 20% FCS, where the cells continue to proliferate up until 156 hours. Fibroblast
proliferation in response to 1.0% FCS is significantly faster than in response to 0.5%
FCS at the 60, 108 and 156 hour time points (p = 0.001815, p = 0.000036 and p =
0000137 respectively). Similarly, when 2.5% FCS is compared with 1.0% FCS, or,
5.0% is compared with 2.5%, or, 10.0% is compared with 5.0%, or, 20% is compared
with 10% at each of the 60, 108 or 156 hour time points, the higher FCS
concentration always results in significantly more fibroblast proliferation (Appendix
17, tables 1 through 4, p353). No significant differences were observed between any
of the columns in the 12 hour, pre-FCS, plate. A summary of the results of statistical
analyses can be found in Appendix 17 (p353).
Discussion. The above data suggest that the p6 human dermal fibroblasts used in this
thesis are capable of responding, in a dose dependent fashion, to known mitogenic
substances. The data also indicates that the methylene blue assay used is capable of
measuring that response. The observation that the assay reports a statistically
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FCS suggests that this technique is a highly sensitive one; it also suggests that the
assay may be able to detect even smaller differences in FCS concentration. The
observation that peak median proliferation occurs at 108 hours post plating, in all but
those wells receiving 20% FCS, is probably explained in terms of nutrient depletion.
Conclusions. In conclusion, p6 human dermal fibroblasts proliferate, in a dose
dependent manner, to known mitogenic substances. The methylene blue assay, as
employed above, is capable of detecting the response of fibroblasts to mitogenic
agents.
5.4. The fibroblast-populated colla gen lattice (FPCL) contraction assay
5.4.1. Introduction
In this section the use of the FPCL contraction assay as an in vitro model for wound
contraction is considered. This model was used in experimental work to study the
ability of therapeutic ultrasound to:
(1) interact directly with, and modulate the contractile capacity of, human dermal
fibroblasts within collagen lattices.
(2) facilitate the release of substances from platelets capable of modulating the
contractile ability of human dermal fibroblasts within collagen lattices.
(3) encourage the synthesis, and elaboration, of substances from macrophages (pro-
monocyte U937) capable of modulating the contractile ability of human dermal
fibroblasts within collagen lattices.
A brief overview of FPCL contraction, including the methodology involved in their
manufacture, is given below. This is followed by a review of the evidence that
supports the use of such three dimensional matrix-based in vitro techniques over
planar culture techniques as a model for the role of the fibroblast in vivo. The
literature regarding the suggested mechanisms by which fibroblasts mediate collagen
lattice contraction will then be discussed. This section includes a literature-based
review of fibroblast-collagen attachment and details the theories proposed to explain
fibroblast-mediated lattice contraction. A description of some preliminary studies
carried out prior to the examination of both the direct effect and indirect effects
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(modulated via platelets or macrophages) of therapeutic ultrasound on FPCL
contraction, then follows. These preliminary studies were carried out to detennine
the optimal concentrations of the various lattice components (collagen, cells and
serum) and to determine the ability of fibroblast populated collagen lattices to
respond to exogenous stimuli.
5.4.2. OvervIew of FPCL contraction
The contraction of hydrated collagen lattices seeded with human fibroblasts was
initially observed by Elsdale and Bard (1972). They suggested that the diminution in
lattice size, termed gradual lattice collapse, resulted from mechanical disturbance of
the lattice as a consequence of cellular motility. Later Bell et al. (1979) described the
possible use of fibroblast mediated collagen lattice contraction, both to produce an
immunologically tolerated tissue-like wound dressing, and as a model for studying the
role of the fibroblast in wound repair. Because fibroblast reorganisation of hydrated
collagen lattices is an in vitro process that leads to the development of an in vivo-like
tissue, there has also been considerable interest in this system as a model for fibrosis
and connective tissue organisation (Guidry and Grinnell, 1987).
FPCLs are composed of a mixture of fibroblasts (in single cell suspensions
after release from monolayer), culture medium and solubilised (monomeric) collagen.
Once mixed, the fibroblast/medium/collagen combination is aliquoted into bacterial
petri dishes, which are then placed in a 37°C environment. The collagen rapidly
polymerises and traps the cells in a three dimensional matrix. After polymerisation
the petri dish can be thought of as containing two phases, the solid phase being
composed of polymerised collagen and cells, the liquid phase being composed of
culture medium. Initially, and for some time after plating, fibroblasts have a spherical
shape which, with time, becomes elongate. As the fibroblasts progressively elongate
and spread within the matrix, a dynamic change occurs, termed lattice contraction,
whereby the lattice undergoes a clearly visible reduction in size. Depending on
whether lattices are freed from their attachment to the petri dish, termed rimming
(Dodd et a!. 1982), or left attached, this reduction in size is visualised as a decrease
in lattice area (retaining the circular shape of the petri dish) or depth (Guidry and
Grinnell, 1985), respectively. During lattice contraction the liquid phase is expressed
from the FPCL as the collagen fibres are brought closer together. Initially, soon after
plating, lattices are almost transparent, but as contraction proceeds they gradually
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become opaque (Bell et a!. 1979). Lattice contraction results in increased fibrillar
density and a greater organisation of the collagen fibres (Bell et a!. 1979; Ehrlich et
a!. 1983; Buttle and Ehrlich, 1983) The rate, and ultimate degree, of fibroblast
mediated collagen lattice contraction, is dependent upon many variables, the most
influential of which are serum concentration, cell number and collagen concentration.
Lattice contraction does not occur in the absence of serum and is directly
proportional to cell number and inversely proportional to collagen concentration
(Buttle and Ehrlich, 1983; Ehrlich, 1988b).
5.4.3. Evidence to support the use of FPCL
The collagen lattice system allows a three dimensional (3d) interaction between
fibroblasts and also between fibroblasts and the extracellular matrix. Several lines of
evidence suggest that the study of cells within 3d tissue culture arrangements is
physiologically more relevant to the in vivo situation than the more common planar
arrangements. Monolayer culture imposes an abnormal dual environment and elicits
responses not characteristic of cells in vivo (Nusgens et a!. 1984). In monolayer, cells
are subjected to two distinct environments: one, a solid substrate with which the
ventral surfaces interact, and the other, a large volume of fluid that bathes the dorsal
surfaces. In contrast fibroblasts of the dermis are embedded in a three dimensional
matrix that provides similar conditions for all parts of the cell surface. Fibroblasts in
monolayer grow to confluency, a condition not normally observed in vivo, but only
when this abnormal state is attained are cells regulated in vitro. In vivo, on the other
hand, in the dermis, for example, fibroblasts normally enter the G 0, i.e. leave the cell
cycle even though separated by extracellular matrix. The FPCL is an in vitro system
that can be used to examine the activities of effectively mitotically inactive cells (Bell
et a!. 1979; Sarber et a!. 1981; Bell et a!. 1983; Buttle and Ehrlich, 1983) similarly
separated by matrix in a single relatively uniform environment (Nusgens et a!. 1984).
As the loss of mitotic activity within FPCLs has been shown not to be due to
exhaustion of the medium, cell-cell contact inhibition nor impermeability of the
matrix to materials in the medium, and has been shown to be reversed by allowing
cells to grow in monolayer (Sarber et a!. 1981; Nusgens et a!. 1984; Nishyama et a!.
1989; Coustry et a!. 1990); this lack of mitotic activity has been interpreted as being
caused by a high level of cell-collagen fibril interactions or cell-matrix contact
inhibition (Nishyama et a!, 1989). Such proliferation control mechanisms are thought
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to regulate connective tissue cells in vivo, and thus the effectively non-cycling cells
in FPCLs are thus more representative of fibroblasts in vivo than monolayer cultures.
Kono et a!. (1990a) also observed the lack of mitotically active cells, demonstrating
that only 4.3% of cells within a FPCL were in S phase the remainder being arrested
in Gc,/Gt . On the basis of such observations they considered the FPCL model to be
analogous to the dermis with respect to cell growth and cell cycle phase composition.
Fibroblasts and other mesenchymal cells incorporated into three dimensional
(3d) polymerised collagen lattices adopt stellate or elongate morphologies, depending
on whether lattices are rimmed or are restricted by culture vessel attachment
(Nakagawa et a!. 1989). Such morphologies displayed in 3d lattices are more like
those of cells in vivo than the flattened multi-pseudopodial or spindle shaped
appearance of cells grown on two dimensional glass or plastic surfaces (Elsdale and
Bard, 1972; Grinnell and Bennett, 1981; Tomasek et a!. 1982; Tomasek and Hay,
1984). It has been suggested that this modulation in cell shape which occurs when
cells are cultured within lattices may influence various cellular activities, including the
selective regulation of gene transcription (Hatamochi eta!. 1989; DiPersio eta!. 1991)
and the responsiveness to exogenous mitogenic stimuli including various peptide
growth factors (Nakagawa et a!. 1989). When attached FPCLs are freed from their
restriction, a rapid contraction is observed over a period of a few minutes (Tomasek
et a!. 1992) indicating that while attached, a tension had developed within the lattice.
This phenomenon termed "stress relaxation" of FPCLs (Mochitate et a!. 1991), is
associated with a change from the normal bipolar fibroblast morphology to a more
rounded shape. Consequent with this change in shape after stress relaxation, an
immediate reduction of 35% in DNA synthesis and 30% protein synthesis has been
observed. The rapidity with which cell biosynthetic activity changes following stress
relaxation provides direct evidence for a direct linkage between cell geometry and
biosynthetic function (Mochitate et a!. 1991).
There is also evidence that cells grown in collagen lattices retain more
differentiated physiological functions than cells grown in monolayer (Reid and
Rojkind, 1979). Nusgens et a!. (1984) demonstrated that fibroblasts cultured within
a lattice arrangement synthesised protein, in particular collagen, at a reduced level,
approaching that of in vivo fibroblasts within normal skin, when compared to
fibroblasts in monolayer. This observation was further substantiated by in situ
hybridization studies demonstrating reduced amounts of collagen mRNA in
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fibroblasts embedded in collagen lattices compared with monolayers (Mauch et a!.
1988). Exogenous epidermal growth factor (EGF) is known to accelerate wound
repair, stimulating the accumulation of mesenchyinal cells and collagen synthesis
(Buckley et a!. 1985; Laato et al. 1986); however, when this growth factor is applied
to planar cultures of fibroblasts, collagen synthesis is inhibited. Interestingly, collagen
synthesis is upregulated following the addition of EGF to fibroblasts grown in a 3d
collagen lattice. This would appear to indicate the retention of in vivo function and
growth factor responsiveness by collagen lattice cultured fibroblasts (Colige et a!.
1988). Greve et a!. (1990), studying proteoglycan fonnation, similarly demonstrated
that the synthesis of small dermatan sulphate proteoglycan II by human skin
fibroblasts in a type 1 collagen lattice was down regulated when compared with that
of monolayer culture; the synthesis of other proteoglycans, such as large chondroitin
sulphate, dermatan sulphate and heparan sulphate, was unaffected by 3d culture.
The synthesis of other, non-proteinaceous, extracellular components, for example
glycosaminoglycans, appears to be unaffected by culture within 3d collagen lattices
(Preistley, 1991). Coulomb et a!. (1983) demonstrated that fibroblasts within lattices
express a perinuclear peroxidase activity and exhibit permeability properties typical
of cells in vivo rather than cells grown as monolayer cultures.
The apparent retention of the differentiated state, associated with culture on,
or in, collagen lattices, has been demonstrated for cell types other than fibroblasts.
Tateyama et a!. (1990) studying the cell morphology and growth characteristics of
normal canine mammaiy epitheliál cells demonstrated that under planar culture
conditions a monolayer of flattened polygonal cells was produced; however, when
cultured within collagen lattices they grew into duct like structures of normal
mammary tissues. Shabana et a!. (1991) studying the culture of human oral epithelial
cells, from hard palate/gingiva/alveolar mucosa found that a collagen based
environment facilitated stratification and differentiation into basal cuboidal,
polyhedral spinous cells and elongated superficial cells. Thus the collagenous
environment not only encourages the retention of differentiated physiological
functions, but, it also encourages further differentiation.
From the literature cited above, it would appear that the FPCL model
facilitates the in vitro study of cells in a physiological environment, which appears to
induce cellular phenotypes and functions more representative of the in vivo situation,
than the more common monolayer in vitro culture techniques.
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5.4.4. The mechanism of FPCL contraction
Collagen lattice contraction does not occur in the absence of cells or in the presence
of cell conditioned media alone, the phenomenon requires that cells be trapped
within a polymerising collagen lattice. As such, it is clear that the force for lattice
contraction is generated by cells, rather than by some effect of self-aggregation of the
collagen fibrils (Bell eta!. 1979; Bellows eta!. 1981; Ehrlich et a!. 1989). However, the
local secretion of "factors" by fibroblasts, present within a collagen lattice, has been
suggested to complement this cell mediated physical reorganisation (Grinnell and
Lamke, 1984).
For ease of description the process of FPCL contraction will be divided up
into three phases: (1) attachment.
(2) contraction.
(3) stabiisation.
5.4.4.1. The Attachment Phase
After initial plating, lattice polymerisation and lattice detachment, there is a variable
interval, prior to active contraction, during which minimal contraction occurs. This
interval, termed the lag period by Nishyama et al. (1988), is thought to reflect the
time taken for fibroblasts to attach and elongate along collagen fibrils. The way in
which fibroblasts adhere to collagen fibrils, within a 3d collagen lattice, is the matter
of some disagreement. It is widely accepted that fibroblasts bind to collagen fibrils
to facilitate contraction, but whether it is a direct attachment or an indirect
attachment, mediated by the adhesive glycoprotein fibronectin (Fn), is the centre of
some debate.
Cellular adhesion to the extracellular matrix is brought about primarily by cell
surface receptors called integrins, though non-integrin mediated adhesion has been
reported (Klein et a!. 1991; Schiro et a!. 1991). The integrins are a family of at least
20 different transmembrane glycoproteins that interact with multiple matrix ligands
in a divalent cation-dependent fashion. Integnns are heterodimers made up of an
alpha (a) subunit non-covalently associated with a beta (J3) subunit. Both a and f3
subunits have extracellular, transmembrane and cytoplasmic domains. The
extracellular domains of both a and 1 subunits are thought to combine to form a
ligand (matrix) binding head (Hynes, 1992). This binding head is connected by the
a and f3 transmembrane domains to the two cytoplasmic domains which are thought
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to interact with cytoskeletal proteins and perhaps with other cytoskeletal components
(Burridge et a!. 1988; Duband et at. 1986; Horwitz et a!. 1986; Otey et a!. 1990).
There are presently 8 known /3 subunits (/31.48) and 14 a subunits (a'...a8 and a", a',
aM,
 aC, and a'). Although 8 j3 subunits and 14 a subunits could in theory
associate to give more than 100 integrin heterodimers, the actual diversity appears
to be much more restricted with only 20 integrin heterodimers known to date (Hynes,
1992). Individual integrins can often bind to more than one matrix ligand, for
example the integrin a3/3 1 has been shown to bind fibronectin, laminin and collagen.
Equally, individual ligands are, more often than not, recognised by more than one
integrin, for example fibronectin is recognised by the integrins a 3/3 1 , a4/3 1 , a5/3 1 , a"/31,
a"/35, a"/36, a"/33 and a'11'/33. Considerable progress has been made in defining the
integrin recognition sites on extracellular matrix ligands. The first binding site to be
defined was the tripeptide sequence Arg-Gly-Asp (RGD) which is present in
fibronectin, vitronectin and a variety of other adhesive proteins. This tripeptide
sequence is recognised by several integrins (a 5/3 1 , a"/33, a"/3,, a"135, a"/36 and a"f33),
but not by most of the other integrins. Other integrins recognise different amino acid
sequences: a2f3 1 binds Asp-Gly-Glu-Ala (DGEA) in type I collagen, a 4/3, binds Glu-
Ile-Leu-Asp-Val (EILDV) in fibronectin, and a C132 binds Gly-Pro-Arg-Pro (GPRP)
in fibrinogen. Other binding sites, for other known integrins, have yet to be defined
(Hynes, 1992).
Evidence to support the view that fibronectin is involved in cell attachment
to collagen fibrils prior to lattice cotitraction is limited. The majority of workers, with
the exception of Gillery et a!. (1986) have demonstrated that the absence of serum
fibronectin (sFN), achieved by using precipitating antibodies or serum-free defined
media in the preparation of collagen lattices, has no effect on the contraction of
fibroblast populated collagen lattices (Grinnell and Lamke, 1984; Guidry and
Grinnell, 1985; Guidry and Grinnell, 1987; Schafer et a!. 1989; Gullberg et a!. 1990a;
Golubkov et a!. 1990; Woodley et a!. 1991). Asaga et a!. (1991), similarly
demonstrated that removal of sFN from serum, prior to the mixing and casting of
FPCLs, had no effect on the rate of lattice contraction. They did, however,
demonstrate that the application of an antibody to cellular fibronectin (cFN), which
is produced by and deposited on fibroblasts within the lattice, clearly suppressed
lattice contraction. They also demonstrated that in the presence of the anti-cfn
antibody, fibroblasts were unable to elongate and spread, but rather remained
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rounded up, thus demonstrating a functional difference between sFN and cFN and
clearly implicating cFN in mediating fibroblast-collagen attachment and the
subsequent contraction of collagen lattices. The work of Asaga et a!. (1991)
contradicts a similar experiment carried out by Schafer Ct a!. (1989) which similarly
employed antibodies against cFN and found no effect on lattice contraction. These
contradictory observations may be explained by the observation that Asaga et a!.
(1991) employed anti-cFN antibodies at lmg/ml, whereas Schafer et a!. (1989) used
similar antibodies at a concentration of 2OOig/ml.
The proposal that cFN is required to facilitate the binding of fibroblasts to
collagen fibres within 3d matrices may find some support in the observation that the
application of certain retinoids, known to stimulate the synthesis of fibronectin (King,
1987) has been shown to facilitate more rapid fibroblast mediated lattice contraction
(Adams and Preistley, 1988). Further, established and transformed fibroblasts, which
secrete little cFN (Olden and Yamada, 1977; Rowe et a!. 1978), are less able to
contract collagen lattices than corresponding cells in primary culture, which secrete
significantly more cFN (Steinberg et a!. 1980; Buttle and Ehrlich, 1983; Kono et a!.
1990b). However, cellular transformation has also been shown to affect integrin
expression, including members of the /3 family (Plantefaber and Hynes, 1989), which
may be an alternative explanation for the reduced ability of transformed cells to
contract collagen lattices.
Others have reported that fibroblasts interact directly with collagen fibres
rather than using fibronectin as an intermediary. It has been proposed that the
addition of synthetic peptides containing the ROD sequence would inhibit lattice
contraction if mediated via Fn, by actively competing with one or more of the Fn
RGD sequence receptor integrins (i.e. a513 1, a/33, a"f3 1, a"35, aV136 and a"133) on the
fibroblast. As lattice contraction has been shown to be unaffected by the addition of
such synthetic peptides (Grinnell et a!. 1989; Gullberg et a!. 1990a; Golubkov et a!.
1990), it has been suggested that Fn does not mediate cellular attachment to
collagen. This argument assumes that fibroblasts can only bind to fibronectin by
integrin recognition of the ROD sequence. It has, however, been reported that
cellular binding to fibronectin can occur via an interaction between the integrin
receptor and the amino acid sequence Glu-Ile-Leu-Asp-Val (EILDV) (Hynes,
1992) i.e. non-RGD dependent adhesion via fibronectin which would not be blocked
by the use of synthetic ROD peptides. It would nonetheless appear unlikely that a4$1
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is involved in the attachment of fibroblasts to collagen fibrils, via fibronectin, as it has
been reported that fibroblasts: (1) are unable to recognise the EILDV sequence of
fibronectin using the a4/31
 integrin (Dufour et a!. 1988), (2) express only low levels
of the subunit (Mould et a!. 1990), and (3) expression of a413 1 is down-regulated
during lattice contraction (Klein et a!. 1991), data which would suggest a lack of
involvement of a413 1 in the contraction process. Further, it has been suggested that
cr413 1 expression is normally associated with the transient collagen adhesion that
occurs during cell migration, rather than with the more stable collagen adhesion
associated with lattice contraction (Chan et a!. 1992).
It has been demonstrated, using function blocking antibodies and immuno-
fluorescence microscopy, that lattice contraction depends upon the expression of one
or more members of the /3 integrin family (Gullberg et a!. 1990a; Schiro et a!. 1991;
Klein et a!. 1991; Mochitate et a!. 1991). This, taken together with the fact that the
addition of synthetic RGD peptides has no effect on contraction (Grinnell et a!. 1989;
Gullberg et a!. 1990a), suggests that fibroblast attachment to collagen (type 1), within
a lattice, is mediated either directly, or indirectly, by non-RGD-dependent/3 1
 integrin
matrix receptors, as distinct from the RGD-dependent fibronectin integrin receptors
described above. The observation that fibroblast-mediated lattice contraction was
RGD independent was confirmed more recently by Schiro et a!. (1991) who
demonstrated that antibodies which block the classic RGD dependent fibronectin
integrin receptor (a5131) had no effect on lattice contraction.
To discover which integrin of the j3 integrin family was responsible for the
adhesion of fibroblasts to collagen lattice fibrils, Schiro et a!. (1991) monitored the
ability of fibroblasts to contract collagen lattices in the presence of function blocking
antibodies to various /3 integrins. They found that anti-integrin a2J3 1 was almost as
effective at blocking contraction as a pan-specific anti-/3 1
 monoclonal antibody. Thus
suggesting a major role for 2/3 in fibroblast-mediated lattice contraction. The fact
that anti-a2/3 1
 was not as effective as pan-specific anti-13 1, which prevents contraction,
appears to suggest that another integrin of the /3 family may be interacting with a2131
to facilitate lattice contraction. Schiro et a!. (1991) was unable to demonstrate any
inhibition of contraction following fibroblast incubation with antibodies directed
against either aJ31 or a5/31
 alone, or, any addition inhibition when incubated together
with anti-a2 3 1 . The effect of blocking a1131, which may share the same collagen
binding sequence (DGEA) as a 2/3 1 (Gullberg et a!. 1990b), was not attempted due to
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the lack of availability of an anti-a 1f3 1 monoclonal antibody. It would appear that no
attempt was made to block a4th, the non-RGD dependent fibronectin integrin
receptor, which, as a member of the I3 integrin family would be blocked by the pan-
specific anti-13 1 monoclonal antibody. However, as mentioned earlier, it would appear
unlikely that the a4/3 1 integrin is involved with fibroblast-fibronectin adhesion (Dufour
et a!. 1988; Mould et a!. 1990; Klein et a!. 1991; Chan et a!. 1992).
Klein a a!. (1991) also examined the effect of adding various combinations of
integrin function blocking antibodies and demonstrated, in agreement with Schiro et
a!. (1991), that function blocking anti-a 2 in conjunction with anti-$ 1 most efficiently
inhibited fibroblast-mediated lattice contraction. Furthermore, Klein et a!. (1991)
studied the transcription and synthesis of members of the f3 family and found that
a2f3 1 but not &/3 or a3f3 1, is selectively upregulated when fibroblasts are seeded into
collagen lattices. Time course experiments revealed that high synthetic levels of a2j31
parallel the lattice contraction process and return to "baseline" levels after active
contraction has subsided. Klein a a!. (1991), like Schiro et a!. (1991), reported the
lack of availability of a function blocking antibody to a1!)1, but relying on observations
regarding the synthesis and expression of the a 1 subunit during contraction suggested
that the likelihood of a major role for a 1 in lattice contraction, was remote.
In contrast to the bulk of the literature, which suggests that fibroblasts adhere
to collagen fibrils by recognition of the DGEA sequence (Asp-Gly-Glu-Ala) by the
a2!) 1 integrin, Grinnell et a!. (1989) reported that lattice contraction could be
inhibited by the introduction of synthetic peptides containing the RGE (Gly-Arg-Gly-
Glu-Ser-Pro) sequence. The integrin receptor which recognises the RGE sequence
has not, as yet, been identified.
From the evidence available, it would appear that the majority of integrin-
mediated attachment, and consequently lattice contraction, results from the
interaction of fibroblasts directly with collagen molecules via integrin a2131 recognising
the DGEA sequence (Asp-Gly-Glu-Ala). RGD dependent adhesion, whether direct
or mediated via fibronectin, would appear not to be involved in the attachment of
fibroblasts to collagen fibrils in 3d lattices. There is, as yet, no evidence to suggest
that fibroblasts within 3d lattices are able to interact indirectly with collagen, via
cellular fibronectin, using the RGD-independent integrin a 4/3 1 . However, cellular
fibronectin may be involved in non-integrin mediated fibroblast-collagen interaction
thus, perhaps, explaining the observations of Asaga et a!. (1991).
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The attachment of fibroblasts to collagen lattices is associated with a change
in shape from the spherical (post-trypsinization) form to the elongate/stellate lattice
attached form (Nishyama et a!, 1988). In addition to this initial change in shape,
fibrobiasts within FPCL have been observed to form long cellular extensions which
spread along and wrap around individual collagen fibrils (Bellows eta!, 1981; Grinnell
and Lamke, 1984). The ability of eukaiyotic cells to adopt a variety of shapes and to
cariy out coordinated and directed movements depends on the cytoskeleton, a
complex network of protein filaments that extends through the cytoplasm. The
cytoskeleton is made up of three principle types of protein filaments: actin filaments
(microfilaments), microtubules and intermediate filaments. Each type of filament is
formed from a different protein monomer and can be built into a variety of
structures according to its associated proteins. Some associated proteins link
filaments to one another or to other cell components, such as the plasma membrane.
Others control where and when microfilaments or microtubules are assembled in the
cell by regulating the rate and extent of their polymerisation. Yet other associated
proteins interact with filaments to produce movement, for example muscle
contraction (microfilaments) and the beating of flagella (microtubules) (Alberts et a!.
1989).
The role of the different cytoskeletal components in fibroblast activities
associated with the lag phase of collagen lattice contraction has been examined using
cyto-skeleton affecting drugs. Tomasek and Hay (1984) reported that either
cytocholasin D or nocodazole, which affect microfilaments and microtubules
respectively, inhibited the normal elongation of fibroblast within collagen lattices
when applied at doses of more than 1 pg/mi, thereby, it was suggested, demonstrating
that both microfilaments and microtubules are required for processes of fibroblast
elongation and spreading. It has also been reported that low doses of cytocholasins
(less than 2 pg/mi cyto-cholasin B or 0.25 pg/mi cytocholasin D) applied to 3T3
fibroblasts in monolayer, allow elongation, whereas high doses cause cells to round
up (Atlas and Lin, 1978). Nishyama et a!. (1988) noted that when low doses of
cytocholasin D (0.03 - 0.1 pg/ml) were applied to collagen lattice fibroblasts a
reduction in the lag phase and more rapid fibroblast elongation was observed. It was
suggested that this low dose of cytocholasin D in some way helped cytoskeleton
dynamics by its influence on actin (Nishyama et a!. 1988). Low doses (less than 0.03
pg/mI) of nocodazole or colcemid, both microtubule affecting agents, had no effect
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on the lag phase. Such results led Nishyama et a!. (1988) to suggest that the
elongation and spreading of fibroblasts, and consequently lattice contraction, were
primarily actin-dependent events.
The processes of cell attachment and spreading appear to be essential to
lattice contraction. Cells that have an impaired spreading capacity, either because of
cytoskeletal defects, such as of actin in transformed cell lines (Steinberg et a!. 1980),
or, due to the absence of serum within the culture medium (Guidry and Grinnell,
1985), have a decreased ability to contract collagen lattices. Interestingly, cells
trapped within collagen lattices supplemented with certain factors, for example the
growth factor PDGF, have an enhanced ability to spread along collagen fibres, which
has been shown to shorten the lag phase and quicken the onset of rapid contraction
(Clark et a!. 1988). Coincident with cell spreading, collagen fibrils superficial to the
area of attachment become more dense and aligned in the plane of cell spreading
(Grinnell and Lamke, 1984). This is thought to represent the onset of lattice
remodelling which is associated with lattice contraction.
The length of the lag phase, during which no discernable contraction occurs,
has been shown to be dependent upon cell density and serum concentration, but
independent of collagen concentration over the range 0.3 - 1.5 mg/mI. Increasing the
cell density or serum concentration (up to a maximum of 10%), with all other lattice
variables fixed, leads to a progressive reduction in the length of this phase (Nishyama
eta!. 1988).
5.4.4.2. The contraction phase
It is widely accepted that the contraction of FPCL is a cell-mediated event (Bell et
a!. 1979; Bellows et al. 1981; Ehrlich et a!. 1989). Precisely how fibroblasts seeded
within collagen lattices generate the force necessary for contraction is the centre of
some disagreement. As FPCL contraction is widely used as a model of wound
contraction (Ehrlich and Rajaratnam, 1990), this disagreement closely parallels, and
sustains, the debate (p48) as to the way in which fibroblasts mediate wound
contraction and scar contracture (Ehrlich 1988a; Ehrlich 1988b). Like wound
contraction, two main theories have been proposed to explain the mechanism behind
fibroblast-mediated collagen lattice contraction: the myofibroblast theory and the
fibroblast theory. These two theories have been discussed previously (p48), and will
only be described in brief here.
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The myofibroblast theory
The myofibroblast theory of lattice contraction proposes that collagen lattices
contract as a result of a coordinated multi-cellular contraction of myofibroblasts (see
p49). According to this theory, myofibroblasts, cells morphologically similar to both
fibroblasts and smooth muscle cells (Majno et a!. 1971), which contain microfilament
bundles and display many cell:cell and cell:matrix contacts, shorten as a multi-cellular
unit, leading to a closer approximation of attached collagen fibrils. This theory was
initially proposed to explain wound contraction (Gabbiani et a!. 1971) it has since
been accepted, by some workers, as a mechanism by which to explain contraction of
fibroblast-populated collagen lattices in vitro (Dodd et a!. 1982; Tomasek et a!. 1989).
The fibroblast theory
The fibroblast theory (Stopak and Harris, 1982; Ehrlich, 1988a; Ehrlich and
Rajaratnam, 1990) is primarily associated with cell traction. This theory proposes
that fibroblasts neither shorten in length, nor do they act in a multi-cellular manner
(as proposed by the myofibroblast theory), but that a composite force, made up of
traction forces of many individual fibroblasts, is responsible for lattice contraction.
Such traction forces are shearing forces tangential to the cell surface generated
during cell elongation and spreading (Stopak and Harris, 1982). This traction force
theory is based on the observation that as individual fibroblasts plated onto an elastic
surface elongate and spread they cause that surface to wrinkle (Harris et al. 1981).
This wrinkling is thought to represent a "gathering effect" of the fibroblast on the
elastic surface. Fibroblasts within collagen lattices have also been observed to gather
together collagen fibrils as they elongate and spread thus leading to compaction of
the lattice (Bell et a!. 1979).
Evidence given in support of the myofibroblast theoiy of lattice contraction
invariably comes from FPCL studies carried out on fibroblast seeded lattices that
remain attached to the plastic culture dish in which the lattice was polymerised. Such
lattices are termed "attached lattices". No decrease in their surface area occurs due
to the restriction imposed by petri dish attachment, though a limited reduction in
lattice depth and thereby volume has been reported (Guidry and Grinnell, 1985).
Fibroblasts within these restricted attached lattices have been observed to assume
certain myofibroblastic characteristics including microfilament bundles and
fibronexus-like structures (Farsi and Aubin, 1984; Unemori and Werb, 1986;
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Mochitate et a!. 1991; Tomasek et a!. 1992). If these lattices are "rimmed" some time
after polymerisation and the development of these myofibroblastic cells, they undergo
a rapid and symmetrical contraction (Dodd et a!. 1982; Unemori and Werb, 1986;
Mochitate et a!. 1991; Tomasek et a!. 1992). Rapid contraction occurs within the first
10 minutes after release of the lattice from the substratum, with greater than 70%
of this contraction occurring within the first 2 minutes (Tomasek et a!. 1992). Rapid
contraction results in a shortening of the elongate fibroblasts and a compaction of
stress fibres with their subsequent disappearance from the cell (Dodd et a!. 1982;
Unemori and Werb, 1986; Mochitate et a!. 1991; Tomasek et a!. 1992). It has been
suggested that this rapid lattice contraction, termed "recoil", results from the active
contraction of these myofibroblastic cells, rather than from the release of cyto-tractile
deformation of the matrix, as disruption of the actin cytoskeleton of the cell with
cytocholasin D, just prior to release, inhibits this rapid contraction (Dodd et a!. 1982;
Tomasek et a!. 1992). However, it is possible that this dissolution of the actin
cytoskeleton may weaken integrin-mediated cell:matrix attachment and thereby
release attached, deformed, matrix from the cell surface.
The majority of evidence in support of the fibroblast theo,y of collagen lattice
contraction comes from studies using lattices that had been rimmed soon after
polymerisation. These rimmed lattices float beneath the surface of exuded culture
medium, and are termed free floating collagen lattices. The surface area, and volume,
of such floating lattices diminishes with time (Bell et a!, 1979). During the contraction
of such free-floating lattices cells the majority of fibroblasts do not display the
characteristic microfilament bundles (stress fibres), which are associated with the
myofibroblastic phenotype (Bellows et a!. 1982; Ehrlich, 1988a; Tomasek et a!. 1992).
Once active contraction has ceased, fibroblasts expressing myofibroblastic
characteristics become more prevalent (Bellows et al. 1982; Ehrlich, 1988a), thus
suggesting that the myofibroblast form is a consequence either the contraction
process itself, or the inhibition of further contraction, rather than the cause.
Actively contracting free floating lattices are known to contain more
myofibroblastic cells in the lattice periphery than in more central areas (Bellows et
a!. 1982; Stopak and Harris, 1982; Ehrlich, 1988a). Cells in the myofibroblast-rich
periphery show many intercellular contacts, whereas, the cells of the fibroblast-rich
interior show few if any intercellular contacts (Ehrlich 1988a). When the contraction
of myofibroblast-rich portions of free floating lattices is compared with that of
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fibroblast-rich areas, contraction is more rapid in the latter (Ehrlich, 1988a, Ehrlich
and Rajaratnam, 1990), thus supporting the role of fibroblastic cells, acting
individually, rather than myofibroblastic cells, acting as an intercommunicating group,
in free floating lattice contraction. The myofibroblast theory suggests that lattice
contraction is brought about by microfilament bundle contraction (Skalli and
Gabbiani, 1988). It has been reported that when fibroblasts within collagen lattices
are penneabilised with glycerol and their microfilaments induced to contract with
ATP, neither cellular contraction, nor a stimulation in lattice contraction, is observed
(Ehrlich and Rajaratnam, 1990), thus questioning the ability of cellular contraction
to generate sufficient tension within the lattice matrix to facilitate contraction.
It is generally accepted that fibroblasts displaying certain myofibroblastic
characteristics are present within both attached and free floating collagen lattices;
their role, however, is in question. The appearance of such cells in lattices that are
contraction-restricted, either by petri dish attachment or as a result of maximal lattice
compaction, suggests that they may develop as a consequence of mechanical
hindrance of contraction.
5.4.4.3. Stabilisation
It has been demonstrated that the removal of cells, by either trypsinization or
detergent (Guidry and Grinnell, 1986), or the disruption of the cytoskeleton using
cytocholasin D (Guidry and Grinnell, 1985) results in only a partial re-expansion of
contracted collagen lattices. This partial re-expansion following the 'removal' of the
cellular component of the lattice, suggests that cells are partially responsible for
holding collagen fibnis of contracted lattices in position. The amount of re-expansion
observed, when cells are removed, has been shown to be approximately equal to the
amount of contraction that occurred during the 1 to 2 hours prior to removal of cells
(Guidry and Grinnell, 1986). Thus suggesting that modifications in collagen fibril
arrangement, brought about by cellular activity within the lattice, are, initially
stabiised by mechanical activity of cells. This cellular stabiisation would appear to
be superseded by collagen fibril stabiisation that is independent of the continued
presence of cells, termed chemical stabilisation. As the amount of re-expansion is
equivalent to 1 to 2 hours of contraction it would appear that period of time required
for reorganised collagen fibrils to be chemically stabilised independent of cells is 1
to 2 hours.
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Such chemical stabiisation may involve either covalent or non-covalent cross-
linking of collagen fibrils. Comparing the rate of repolymerisation and electrophoretic
mobility of resolubilised collagen from contracted lattices and control collagen,
Guidry and Grinnell (1985) failed to reveal any permanent structural changes in
collagen fibrils that could be attributed to the formation of covalent cross-links.
Chemical stabilisation of collagen fibrils would thus appear to result from non-
covalent cross-linking of juxtaposed collagen fibrils. It is possible that this non-
covalent chemical stabiisation involves the cross-linking of collagen fibrils by
extracellular matrix components secreted by cells (such as proteoglycans and
glycoproteins). To investigate this possibility Guidry and Grinnell (1986), incubated
contracted collagen lattices with trypsin/EDTA, chondroitinase or hyaluronidase, after
the removal of cells using detergent. None of these treatments caused any further
expansion of lattices beyond that observed with detergent alone, thus suggesting that
cell-secreted products were not necessaiy for stabiisation of rearranged collagen
fibrils and that chemical collagen fibril stabiisation results from the formation of
direct interfibrilar noncovalent bonds between adjacent fibrils. This conclusion was
supported by the observation that collagen fibrils could be reorganised and stabiised
by the application of a non-cellular force to collagen lattices, i.e. centrifugation, in
the absence of cells or cell products (Guidry and Grinnell 1986).
Collagen lattices reorganised (compacted) by centrifugation (693 x g), like
those contracted by cells, demonstrate two mechanisms of stabiisation. When cell-
free lattices are centrifuged compaction occurs. When centrifugation is stopped a
partial expansion is observed. If lattice centrifugation is carried on for progressively
longer periods, then stopped, a re-expansion, equivalent to the last 5 to 10 minutes
of centrifugal (693 x g) 'contraction', occurs (Guidry and Grinnell, 1986). The
discrepancy between the time taken for stable interfibrillar links to form in
centrifuged lattices when compared with those in lattices contracted by fibroblasts is
not surprising, as under the experimental conditions employed, centrifuged lattices
were 50% 'contracted' in 20 minutes, while fibroblasts contracted lattices to 50%
within 4 to 5 hours. Thus, initially, the centrifugal force, equivalent to the
mechanical force of the cells, is required to hold the lattice fibrils together; but, with
time, interfibrillar bonds develop which stabilise the compacted form, at which point
lattices no longer re-expand when centrifugation is stopped.
In summary, during the contraction of collagen lattices by fibroblasts, collagen
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fibrils, which have been rearranged by cellular activity, are stabiised in place by two
different mechanisms. At first, fibrils are mechanically held in position by cells.
Subsequently, the fibrils are stabilised by non-covalent chemical interactions that are
independent of cells.
5.4.5. The effect of varying cell number and collagen concentration on fibroblast
populated collagen lattice contraction.
Introduction. As the rate of lattice contraction has been reported to be directly
proportional to cell number and inversely proportional to collagen concentration
(Bell et a!. 1979; Buttle and Ehrlich, 1983; Nishyama et a!. 1988; Ehrlich 1988b), it
was considered important to determine the most appropriate cell and collagen
concentration for subsequent experimental work using this model. The most
appropriate cell and collagen concentrations are those that allow contraction to
proceed at a rate that is neither so fast nor so slow as to make photographic
assessment of contraction difficult. Also very rapid contraction may preclude the
manifestation of stimulatory activities; whereas, very slow contraction may preclude
the manifestation of inhibitory activities. Other criteria for the most appropriate cell
and collagen concentration include: (1) the most economical use of a limited number
of p6 human dermal fibrobiasts, (2) the most economical use of Vitrogen 100 bovine
type I collagen, and (3) ease of lattice preparation.
Method. The standard protocol for the human dermal fibroblast collagen lattice
contraction assay was employed (Appendix 10, p344) with some modifications.
Briefly, lattices were prepared at collagen concentrations of either 1.2 mg/mI or 1.6
mg/mi, with p6 human dermal fibrobiast concentrations of either 1, 2 or 3 x iO cells
per ml, by combining the components, listed below, in various formulations. For
formulations see Appendix 16 (p352). Three lattices were prepared for each
cell/collagen concentration formulation. Eighteen lattices were prepared in all.
Lattice components:
1. Neutralised collagen (Appendix 10, p344) at 2.4 mg/mI.
2. Ham's FlO medium concentrate (x5)(Appendix 2D, p336).
3. Ham's FlO medium concentrate (x3)(Appendix 2D, p336).
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4. p6 fibroblasts in fibroblast growth medium at concentrations of: 4, 6, 8, 12 and 18
x iO cells/mi prepared according to (Appendix 6, p340).
Lattices mixtures were prepared (Appendix 16, p352), dispensed into 35 mm petri
dishes, polymerised at 37°C, released (rimmed) and 1 ml of fibroblast growth medium
(Appendix 2B, p335) added to each lattice. The lattices were then returned to the
37°C incubator in a humidified box. All eighteen lattices were photographed
(Appendix hA, p345) at 16, 21.4 and 37.8 hours after initial plating and the film
developed according to Appendix 11B (p346). The area of each lattice, in mm 2, was
then measured by computer-assisted planimetry (Appendix 12, p 347). Median area
was calculated for each lattice formulation at each time point (table 5.3) and
displayed graphically with minimum and maximum lattices areas (figures 5.8 a/b and
5.9 a/b/c).
Results. From figures 5.8a and 5.8b, showing lattice area (mm 2) versus time, the
following points are apparent:
1. For a given collagen concentration, lattices prepared at a cell density of 3 x i05
cells/mi contract more rapidly than similar lattices prepared at a cell density of 2 x
iO cells/mi which in turn contract more rapidly than similar lattices seeded at a
density of 1 x i0 cells/mi.
2. Lattices prepared with collagen at 1.2 mg/mi are more sensitive to variation in cell
density than lattices prepared with collagen at 1.6 mg/mi, e.g. By 16 hours, lattices
with a collagen concentration of 1.2 mg/mi seeded at 1, 2 and 3 x iO cells/mi,
contracted to 85, 63, and 40% of their original area respectively; whereas, those
lattices with collagen at 1.6 mg/mi seeded at 1, 2 and 3 x iO cells/mi contracted to
89, 83, and 73% of their original area.
From figures 5.9 a/b/c, showing lattice area (mm2) versus time, the following points
are apparent:
1. For a given cell density, lattices prepared at a collagen concentration of 1.2 mg/mi
contract more rapidly than similar lattices prepared at a concentration of 1.6 mg/mi.
2. The slowest contraction observed was that of lattices prepared with collagen at 1.6
mg/mi and fibroblasts at a concentration of 1 x iO cells/mi, which contracted to
approximately 60% of their original size by 37.8 hours, whereas, the most rapid
contraction observed was that of lattices prepared with collagen at 1.2 mg/mI and
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fibroblasts at a concentration of 3 x iO cells/mi, which contracted to approximately
15% of their original size.
Statistical analysis was not carried as statistical significance is inappropriate with such
a low number of replicate lattices.
Discussion. The results are consistent with literature reports that increasing the cell
density or decreasing the collagen concentration within collagen lattices increases the
rate of lattice contraction (Bell et a!. 1979; Buttle and Ehrlich, 1983; Nishyama et a!.
1988; Ehrlich 1988b). Additionally, it was observed that decreasing collagen
concentration amplifies the effect of changing cell number on the rate of contraction
(collagen lattices prepared with 1.6 mg/ml of collagen are much less sensitive to
increasing cell number than lattices prepared with collagen 1.2 mg/ml).
The formulation of 1.2 mglml collagen and 1 x iO p6 human dermal fibroblasts per
ml was chosen as the most appropriate cell and collagen combination for subsequent
work. This combination is neither too rapid as to prevent photographic assessment
or preclude the manifestation of added contraction stimulators, nor is it too slow as
to preclude the manifestation of added contraction inhibitors. Of all six lattice
formulations examined the 1.2 mg/ml collagen and 1 x i0 p6 fibroblast formulation
uses the least Vitrogen 100 (bovine type I collagen) at 2.4 mg per lattice and the
fewest fibroblasts at 2 x io cells per lattice.
Conclusions. This study confirmed the ability of cell number and collagen
concentration to affect fibroblast populated collagen lattice contraction. It also
indicated that at lower collagen concentrations lattice contraction is highly sensitive
to cell density. This latter point prompted the generation of a standard protocol for
the production of human dermal fibroblast-populated collagen lattices (Appendix 10,
p 344), which was used to investigate both the direct effect, and indirect effects (via
platelets and macrophages) of therapeutic ultrasound on fibroblast mediated
contraction in vitro. According to this protocol all the collagen lattices are prepared
from a single stock of lattice mixture, which is polymerised for a fixed period of time
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The effect of varying collagen concentration at three cell densities on the rate
of collagen lattice contraction (data range is indicated by bars).








to groups and subsequently treated according to that allocation. Thus at the
beginning of a given study, all lattices are the same (i.e. contain the same cell and
collagen concentrations), and as such, would contract at the same rate without
intervention (i.e. application of ultrasound, macrophage supernatant or platelet
releasate). Consequently any change in the rate of lattice contraction observed
following a given intervention, be it an increase or decrease, must be a result of that
intervention. Lattices prepared at a collagen concentration of 1.2 mg/mi and a cell
density of 1 x iO cells/mi were found to be most suitable for further studies.
5.4.6. Examination of the effect of fetal calf serum on the contraction of human
dermal fibroblast-populated collagen lattices.
Introduction. Fibroblast populated collagen lattice contraction is enhanced by
increasing the serum concentration within the lattice (Steinberg et a!, 1980;
Montesano and Orci, 1988 Nishyama et a!. 1988). The serum components responsible
for stimulating contraction are the centre of some debate. However several
polypeptide growth factors, known to be present in serum, have been shown to
stimulate fibrobiast mediated collagen lattice contraction in vitro. Such contraction
stimulating growth factors include basic Fibroblast Growth Factor, bFGF, (Finesmith
et a!. 1990), transforming growth factor-/3, TGF-/3, (Montesano and Orci, 1988;
Finesmith et a!. 1990) and platelet-derived growth factor, PDGF, (Clark et a!. 1989).
The rate of lattice contraction in response to feeding standard collagen fibroblast
populated collagen lattices with various concentrations of fetal calf serum (FCS) was
examined. This study was performed (1) to confirm that elevating serum
concentration increases p6 human dermal fibroblast populated collagen lattice
contraction. (2) to examine the sensitivity of the assay to contraction stimulating
substances or treatments.
Method. The standard protocol for the Human Dermal Fibroblast Collagen Lattice
Contraction Assay (Appendix 10, p344) was employed - with some modifications.
Briefly, 15 standard lattices, containing collagen at 1.2 mg/mI and p6 human dermal
fibroblasts at a density of 1 x i0 cells/mI, were prepared according to steps 1 through
6 of Appendix 10 (p344). After polymerisation and detachment from the petri dish
182
sides, the 15 lattices were divided into 5 groups of 3. Ham's FlO growth media
containing 0, 10, 20, 30 and 40 % FCS and supplemented with 2% penicillin!
streptomycin were prepared. The lattices in each group were fed with a 1 ml aliquot
of one of the growth media described above.
The lattices were then returned to the 37°C incubator in a humidified box. All fifteen
lattices were photographed (Appendix hA, p34.5) at 6.5, 22.5 and 46.5 hours after
initial plating and the film developed according to Appendix 11B (p346). The area
of each lattice, in mm 2, was then measured by computer-assisted planimetry
(Appendix 12, p3F7). Median area was calculated for each of the five groups at each
time point (table 5.4) and displayed graphically with minimum and maximum lattice
areas (figure 5.10).
Results From table 5.4 and figure 5.10 (p185) it is apparent that regardless of the
FCS concentration all lattices contracted rapidly. At the 6.5 hour time point, the
greatest contraction (i.e. 68%) was observed in those lattices fed with 40% FCS. The
smallest contraction observed at this time point (i.e. 52%) was observed in those
lattices fed with 0% FCS. The levels of contraction in response 30, 20 and 10% FCS
were intermediate between these extremes. A similar pattern or contraction was
observed for the 2 remaining time points of 22.5 and 46.5 hours.
Discussion. The effect of increasing FCS levels on the contraction of collagen lattices,
seeded with p6 human dermal fibroblasts, was examined. At all three time points
there was a positive dose dependent relationship between FCS concentration and the
amount of contraction observed. Increasing FCS concentration fed to standard
lattices enhances lattice contraction. Though statistical analysis of this data is
inappropriate due to the small number of replicate lattices, it would appear from
figure 5.10 which displays intra-group errors, that this assay is capable of detecting
the presence, and discerning the relative concentration, of applied pro-contractile
activities.
All lattices within this study contracted significantly faster than expected. If
the rate of contraction of lattices fed with 10% FCS, from this study, is compared
with the rate of supposedly identical lattices, from the previous validation study (i.e
the 1.2 mg/mi collagen & 1 x iO cells/ml lattices, fed with 1 ml of fibroblast growth
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latter. This suggests that even though the preparation of lattices is highly
standardised, significant differences can, and do, occur when lattices are prepared on
different occasions. As a result of this observation, studies which were repeated on
different occasions were only compared on the basis of statistical trends rather by
direct comparison of lattice areas.
Conclusion. The contraction of collagen lattices by p6 human dermal fibroblasts
responds, as previously observed (Steinberg et a!, 1980; Montesano and Orci, 1988
Nishyama et a!. 1988) in a dose dependent fashion to FCS concentration. The
standardised human derinal fibroblast collagen lattice contraction assay (Appendix
10, p344) would appear to be a sensitive technique by which to assay for the presence
of procontractile activities in a qualitative and quantitative manner.
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Chapter 6. Ultrasonic dosimetry
Introduction
This chapter describes the methods used to characterise and standardise the
ultrasonic exposure conditions to which animals and cells were exposed in studies
carried out in completion of this thesis.
In a list of important parameters of irradiation that should be described when
reporting the biological action of ultrasonic beams, Hill (1970) included the
following:
1. The total acoustic energy flux across a region of interest (i.e. total
acoustic power).
2. The spatial distribution of acoustic energy (i.e. the beam profile); this
includes, in particular, the value of spatial peak intensity.
3. The time distribution of acoustic energy (i.e. the pulse shape, or
modulation envelope).
4. Temperature change in a tissue consequent on irradiation.
In accordance with Hill (1970), this section will describe the ultrasonic output, as
described in free field conditions, generated by an Enraf Nonius 434 therapeutic
device, applied to both wound tissues in vivo and cell preparations in vitro. The
dosimetric apparatus used and its application will be described; measurements and
observations made will also be reported.
6.1. Total acoustic power
The most commonly used method used to measure the total acoustic power (also
called total acoustic energy flux), being generated by a therapeutic ultrasound
transducer, is one which relies upon the existence of a fundamental relationship
between total acoustic power in a beam incident on a surface and the radiation force
per unit area experienced by that surface when the beam is reflected by orabsorbed
within it (Rooney and Nyborg, 1972). The force exerted on a surface by any form of
radiation energy, including ultrasound, corresponds to the rate of momentum transfer
from the beam to the surface and, for a perfectly absorbing surface (or one causing
90° reflection of the beam) the radiation force F (newtons) along the beam axis is
related to the power intercepted W (watts) by the relation:
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W = Fl"
Where:	 V is the wave velocity (ms 1)
Substituting into the above equation:
W = 1 watt
V = 1500 ms' (velocity of sound in water)
F= 1
1500
F= 6.7 x iO N
This force is equivalent to the force of gravity acting on a weight of 68.29 mg and as
such can be measured on an appropriately modified balance.
i.e.
Fg =Mg
Where:	 F8 - is the gravitational force on a body (Newtons)
M - is the mass of a body (kg)






M = 6.7 x 10
9.81
M = 6.829 x iO kg
which is:
	 M = 68.29 mg
Thus a total ultrasonic output of 1 watt from a ultrasonic transducer will give a
balance deflection of 68.29 mg. This radiation force is independent of frequency.
1 watt total acoustic output = 68.29 mg
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6.1.1. Force balance
The force balance used in this study (figure 6.1) was custom manufactured by Enraf
Nonius DeIft (Holland). In this balance a hollow aluminium wedge (the target),
which is immersed in a water bath, is coupled to a standard laboratory digital top pan
balance (Sartorius, Germany) by means of a 'U' shaped connecting rod. The
aluminium wedge at the end of the connecting rod is orientated in such a way that
the hypotenuse of the wedge makes an angle of 45° to the vertical (figure 6.2).
The transducer whose beam is to be calibrated is mounted in a vertical orientation
immediately above the wedge. The critical angle for acoustic reflection at a
water/aluminium interface is 14°; the beam incident upon the wedge is thus totally
reflected into a horizontal orientation and terminates in an absorbing structure
consisting of a 'V' shaped rubber wedge.
In routine use it is found necessary to delay measurements for a period of 1
hour after setting up, in order to ensure temperature equilibration of the contents
of the water bath.
Using this fundamental relationship between total acoustic power (watts) and
radiation force (newtons), and knowing the effective radiating area (ERA) of the
transducer under examination (section 6.2.5., p206), the average ultrasonic intensity
generated for a given therapeutic device output can be measured using this balance.
Average ultrasonic intensity, in the sense used above, is more correctly termed the
spatial average intensity (1(a)) and is usually expressed in terms of W/cm 2 (section 2.4,
p84). For example, if a transducer with an ERA of 1 cm2 is set to deliver continuous
wave ultrasound and gives a force balance reading of 68.29 mg the spatial average
intensity (1(e)) generated is 1 W/cm2.
If the same ultrasound generator is then set to give pulsed ultrasound (e.g.
2ms on: 8ms off), without any change in intensity, the force balance because of its
speed of response would then read 13.66 mg. Having pulsed the ultrasonic output,
the terminology used to describe the intensity of the field becomes more complicated
(section 2.4, p84). The average intensity during the pulse (i.e. the "on" time) is
termed the spatial average pulse average intensity (I(sAPA)) whereas, the average
intensity during one pulse repetition period (i.e. the "on" time plus "off' time) is
termed the spatial average temporal average intensity (I(sATA)). For the example





Figure 6.1. Total ultrasonic power is often measured using a force balance. This
balance was custom made by Enraf Nonius Delft (Holland).
Key:
A = Applicator head
R = Absorbent rubber wedge
D = Digital top pan balance
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Figure 6.2. Partially dismantled force balance showing the arrangement of the
applicator head (containing the transducer), the 45° aluminium wedge
(the target) and its connection via a U' shaped connecting rod to the
top pan balance. The water bath was removed for photographic
urposes.
Key:
A = Applicator head
W = 45° Aluminium wedge
U = U' Shaped connecting rod
D = top pan digital balance
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In setting, or resetting, the ultrasonic intensity level prior to, and during,
experimental investigation, the balance reading (in mg) commensurate with the
required 1(SAPA), or 1(SATA), value was calculated taking into account the effective
radiating area (ERA calculation section 6.2.5. p206) of the transducer in use. The
transducer was then positioned on the radiation force balance and the intensity
increased until the calculated balance reading had been achieved.
For example, one experimental regime used in this thesis required pulsed (2ms
on: 8 ms off) 3 MHz ultrasound at an intensity of 0.5 W/cm2 1(SATA) (i.e. 1'A) of 2.5
W/cm2). The ERA of the transducer was 0.5 cm 2. The calculated force balance setting
required to obtain this intensity, for such a transducer in pulse mode (2ms on: 8 ms
off), is 17.07 mg. This is calculated as follows:
The force balance setting for a 1cm2 transducer delivering 0.5 W/cm2 1(SATA)
is 34.15 mg, which is half of that required for a 1cm2 transducer delivering 1 W/cm2
i.e. 68.29 mg. As the ERA of the transducer is 0.5cm 2, rather than 1cm2, the former
figure must be halved again to get the desired force balance setting of 17.07 mg.
Table 6.1 shows the calculated balance settings for both of the ultrasound intensities
used in this thesis.
Table 6.1. Calculated balance settings for Intensities used throughout this thesis.
Required Intensity	 Required Intensity 	 Effective Radiating
	 Balance setting
J RIp)	 j(SATA)	 Area (ERA)
(W/cm2)	 (W/cm2)	 (cm2)	 (mg)
2.5	 0.5	 0.48	 16.39
0.5	 0.1	 0.48	 3.28
6.2. The spatial distribution of acoustic energy
The volume into which energy passes from the transducer is known as the sound
field. In this study, as with many clinical exposures, ultrasound was applied such that
the tissue under treatment was within a few centimetres of the transducer face i.e.
in the near field. As previously explained (section 2.3, p80) ultrasonic intensity within
the near field can vary significantly from position to position. To examine this
heterogeneous spatial distribution of acoustic energy, beam profile measurements
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were carried out using piezoelectric hydrophones. Unlike the piezoelectric material
in applicator head transducers, which convert electrical energy into ultrasonic energy,
piezoelectric hydrophones convert the acoustic energy (pressure) of the sound field
into electrical energy. When properly calibrated, the hydrophone output, measured
in volts, can be precisely converted into pressure amplitude, measured in
atmospheres, bars or mega pascals (MPa) (where 1 atmosphere 1 bar = 0.1 MPa)
experienced within the field.
Hydrophone measurements of ultrasonic fields serve three main purposes:
generation of beam profiles, assessment of peak pressure amplitude and assessment
of effective radiating area.
1. Generation of beam profiles
This gives an overall impression of the distribution of energy within the sound field.
Such profiles also supply information regarding the physical condition of the
transducer element within the applicator. Fractured or poorly mounted transducers
may have areas that are incapable of emitting sound. If the experimentalist, or
clinician, is unaware of such a problem, and is simply using the nominal output of the
generator to set the exposure intensity, the treatment area may be under exposed.
Alternatively, if the intensity is set using a force balance, it is likely that peak
ultrasonic intensities, of a possibly deleterious nature, will be required to compensate
for the damage to the transducer.
2. Assessment of peak pressure amplitude
Once measured, the peak pressure amplitude can be used to calculate the spatial
peak ultrasonic intensity (Ip) within the sound field. The involvement of cavitation,
which is associated with Ip, in the therapeutic use of ultrasound is still open to
question. As explained earlier (section 3.2.1.3. p99) the likelihood of cavitation
occurring is dependent upon many factors. One major factor is thought to be the
pressure change caused by the ultrasound wave (i.e. the variation in acoustic pressure
amplitude). The threshold negative ultrasonic pressure required for the occurrence
of cavitation is thought to be in the region of 0.1 MPa; the more the peak negative
pressure amplitude exceeds this value then the greater the probability of generating
cavitational activity within treated tissues (Williams, 1987). Thus by measuring the
peak negative ultrasonic pressure in a sound field, it is possible to state the likelihood
of the involvement of cavitation for a given observed bioeffect. It must be borne in
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mind, however, that data on the sound field distribution within "loss less" media, such
as water, is taken under effectively "ideal" conditions; and, as such, extrapolation to
the sound field experienced by tissue under treatment, where significant attenuation
is known to occur, is at best tenuous.
3. Assessment of effective radiating area (ERA)
This involves the generation of a beam profile by scanning the hydrophone across the
face of the transducer. As previously mentioned, to set an ultrasonic transducer to
accurately deliver the desired ultrasonic intensity, using a force balance (as described
above), the ERA of the transducer must be known. The ERA is normally calculated
from a pressure amplitude profile obtained by scanning some form of piezoelectric
hydrophone across the applicator face during ultrasonic emission. The United States -
Food and Drug Administration (US-FDA) definition of ERA is: the area consisting
of all points of the effective radiating surface at which the intensity is 5% or more
of the maximum intensity (I max) (Ferguson, 1985). Once the ERA is known, the
force balance can be set and the desired spatial average intensity (1(a)) generated. The
US-FDA do not, however, state the distance in front of the transducer at which such
measurements should be made. The effective radiating area measurements made in
completion of this thesis were undertaken, following the directives of the US-FDA,
at a distance of 0.5 cm from the transducer face. Such a distance was selected as it
approximates to the position of the biological targets used experimentally.
6.2.1. The production of beam profiles
Lateral beam profiles, which are hydrophone scans across the sound field parallel to
the transducer face, were carried out using the apparatus shown in figure 6.3 (drawn
schematically in figure 6.4). The apparatus consists of a perspex tank, lined with an
ultrasound absorbing material (dimpled rubber car matting) to reduce ultrasonic
reverberations, and filled with degassed distilled water. The internal dimensions of
the tank were 52 cm long, 22 cm wide and 25 cm deep. The treatment head (or
applicator) containing the transducer to be examined was immersed in the tank and
clamped firmly in position, directed along the long axis (z) of the tank in a horizontal
fashion. The ultrasound detecting apparatus, a polyvinylidene difluoride (PVDF)
piezo-electric membrane hydrophone (figure 6.5) with a 1.0 mm diameter sensitive
element (Marconi, England), was clamped onto a mobile fixture within the tank. This
fixture provided x, y and z movement throughout the tank. The hydrophone could
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Figure 6.3	 Arrangement of beam profiling apparatus
(Absorbent rubber matting removed for photograph)
Key:
A = Applicator head
D = Degassed distilled water
H = PVDF membrane hydrophone (Marconi, UK)
Po = Linear potentiometer
Pt	 X-Y Plotter
V = Variable gain video amplifier and diode bridge
G = Ultrasound generator
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Figure 6.4 A schematic drawing of the beam profiling apparatus
(Absorbent rubber matting omitted)
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Figure 6.5 The Marconi polyvinylidene difluoride (PVDF) membrane hydrophone
5cm
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also be rotated about its vertical axis. For beam profile work in this thesis the
hydrophone was positioned 0.5 cm in front of the treatment head, such that the
detecting surface of the hydrophone was parallel to the emitting face of the treatment
head.
The following semi-automated technique was used initially to obtain beam
profiles for the calculation of transducer ERA at a nominal intensity, and
subsequently to examine the spatial distribution of ultrasonic energy within the beam
at the two calculated intensity settings used in this thesis (i.e. 0.5 W/cm2 1(SATA) {2.5
W/cm2 and 0.1 W/cm2 1(SATA) {0.5 W/cm2
 I'}). A detector was constructed
using a variable gain video amplifier (NE592) linked to a diode bridge, and the gain
was set so that as the hydrophone was scanned through the sound field, the amplified
output remained within the linear region of the bridge. The result was a rectified
voltage proportional to acoustic pressure which was used to drive axis Y of an X-Y
plotter (JJ Instruments, model PL4). X of the plotter was fed from a linear
potentiometer attached to the mobile hydrophone positioning device, which gave a
fixed voltage for a given hydrophone location within the sound field. The
arrangement was such that a curve of acoustic pressure versus linear displacement,
across the transducer face, was produced immediately on sweeping the hydrophone
through the sound field. All beam profiles were carried out at room temperature (19
- 22°C).
Beam profiles were made of the transducer under both free field and
experimental conditions. Free field beam profiles, carried out in degassed water, in
the absence of any biological tissue exposure apparatus (such as couplants or
exposure chambers), were made at both the experimental ultrasonic intensities used.
Similar profiles were made to show any modification of the sound field by the
biological tissue exposure apparatus used in both in vivo and in vitro studies. Thus
for both of the ultrasonic intensities, 0.5 W/cm2 j(SATA) (2.5 W/cm2 I) and 0.1
W/cm2 1(SATA) (0.5 W/cm2 11'), the following beam profiles were carried out:
1. Free field profile (used to calculate ERA).
2. Field profile with transducer emitting through the wound dressing and ultrasound
transmitting medium Geliperm (in vivo studies).
3. Field profile with transducer emitting through chamber window (in vitro studies).




Figure 6.6	 The spatial distribution of ultrasonic energy within the beam with the
ultrasonic generator set to deliver 0.5 W/cm2 1(SATA) (25 W/cm2 1(sAPA))
05cm
I
Key: RPA = Relative Pressure Amplitude
LD = Linear Displacement across transducer
Black trace = free field conditions
Blue trace = after introduction of in vivo exposimetry apparatus
Red Trace = after introduction of in vitro exposimetry apparatus
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Figure 6.7	 The spatial distribution of ultrasonic energy within the beam with the
ultrasonic generator set to deliver 0.1 W/cm2 1(sAFA) (0.5 W/cm2 I(sAPA))
_.__I__ .	 	





Key: RPA = Relative Pressure Amplitude
LD = Linear Displacement across transducer
Black trace = free field conditions
Blue trace = after introduction of in vivo exposimetry apparatus
Red Trace = after introduction of in vitro exposime try apparatus
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6.2.2. Interpretation of beam profiles
It can be seen from the beam profiles (figures 6.6 and 6.7), where the X axis
represents linear distance across the transducer and the Y axis relative amplitude,
that the applicator head is emitting ultrasound from all points along the diameter of
the element which was scanned. The sound field produced under 'free field'
conditions is characterised by a single pressure peak which approximates to the
centre of the transducer. As the hydrophone scans towards the centre of the
transducer the pressure amplitude increases in an apparently exponential manner.
Such a pressure distribution is characteristic of 3 MHz therapeutic ultrasound
transducer sound field profiles taken in the near field. Further, the beam profiles
taken within the same sound field, following the introduction of either in vivo or in
vitro exposimetry apparatus, appear not to have suffered any significant modification
as a result, although, this, it may be argued, may result from a lack of sensitivity in
the detection system.
Computer controlled hydrophone scanning systems have been developed to
obtain an overall impression of the distribution of acoustic energy within a given
plane perpendicular to the sound beam axis (parallel to the transducer face). They
employ similar apparatus to that described here (for the generation of two
dimensional beam profiles) to carry out sequential beam profiles across the
transducer surface. Each scan through the field is separated by a short distance, as
little as 0.25 mm, from the next. Computer controlled hydrophone measurements,
within each scan, are taken in the order of one every 0.25 mm. This minute
manipulation between, and within, scans is clearly beyond the limits of human
dexterity and is consequently executed by very precise stepper motors; again under
computer control. The three dimensional scans generated in this way are termed
Raster scans. Such a scanning system was used to supply an overall impression of the
sound field generated by the Enraf Nonius transducer used in this thesis (figure 6.8).
Staff at the National Physical Laboratory (Teddmgton, UK) kindly performed this
Raster scan on my behalf using a PVDF point hydrophone with a 0.6mm diameter
sensitive element. From figure 6.8 the axial symmetry of the sound field can be
appreciated. In confirmation of the single scan beam profiles, the Raster scan
illustrates that ultrasound is being generated from all areas of the transducing
surface, with the greatest pressure peak co-axial with the centre of the transducer.
Unlike the single profiles, the Raster scan clearly detected additional pressure peaks
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Figure 6.8	 Raster scan of the sound field generated by the 3 MHz transducer
used in these investigations.
approximateiy í mm
Raster Scan Information:
1. Enraf Nonius generator emitting 3 MHz continuous ultrasound
2. Nominal total power output
3. Nominal spatial average power
4. Scan separation
5. Step size between measurements
6. Area of scan







8. PVDF needle hydrophone used (0.6 mm diameter sensitive element)
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concentric with the axial peak mentioned above (see A, B and C; figure 6.8). This
probably results from the greater spatial resolution associated with the smaller point
hydrophone used to generate the Raster scan (0.6 mm diameter sensitive element)
as compared with the Marconi membrane hydrophone (1.0 mm diameter sensitive
element) used for the single scan beam profiles.
6.23. Spatial Peak Pressure Amplitude (Spatial Peak Intensity (Isp))
Using the apparatus described earlier (p194) for the production of lateral beam plots,
the spatial peak pressure amplitude, for a precalculated force balance setting, was
initially located and measured using the PVDF membrane hydrophone (Marconi,
U.K.). The hydrophone was directly connected to a calibrated Hitachi V-656 F
measuring oscilloscope (figure 6.9) and the on-screen voltage observed while the
hydrophone was swept through the sound field. Once located, the peak screen
voltage was converted into peak pressure amplitude according to the calibrated
sensitivity of the hydrophone for the ultrasonic frequency in use. The hydrophone
used was calibrated by the National Physical Laboratory (NPL) (Teddington, U.K.)
and was found to have a sensitivity of 0.185 M V/Pa at a frequency of 3 MHz. From
this measure of peak pressure amplitude it is possible to calculate the spatial peak
intensity (Isp) of the area of the sound field in which the scan was made. Such
measurements and subsequent calculations were made initially from sound fields
generated under free field conditions (i.e. in the absence of any in vivo or in vitro
exposimetry equipment) at both the ultrasonic intensities studied. Any modification
to the peak pressure, and hence Isp, within the sound field resulting from the
introduction of either in vivo or in vitro exposimetry apparatus was then studied.
Table 6.2 shows the peak voltages observed, and their corresponding spatial peak




Figure 6.9	 Arrangement of beam profiling apparatus for the measurement of
spatial peak intensity (Isp).
(Absorbent rubber matting removed for photograph)
A Applicator head
D = Degassed distilled water
H = PVDF membrane hydrophone (Marconi, UK)
o = Calibrated measuring oscilloscope (Hitachi V-656 F)
Po = Linear potentiometer
G = Ultrasound generator
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6.2.4. Calculation of peak pressure amplitude and spatial peak intensity from
oscilloscope output.
Peak Pressure Amplitude:
As stated above, the NPL-measured sensitivity of the hydrophone at a frequency of
3 MHz is 0.185 1.i.V/Pa. As measurements taken from the oscilloscope screen are in
mV this can be read as 1.85 x 10 mV/Pa. The screen voltage divided by 1.85 x iO
will give the peak pressure in pascals (Pa). This is divided by 1 x 106 to give the more
commonly quoted peak pressure amplitude in MegaPascals (MPa).
Spatial Peak Ultrasonic Intensity:
Peak intensity is related to the peak pressure (measured in bars) according to the
following equation:
'bars (peak) =
P, the pressure in bars, can be calculated from the oscilloscope output voltage
knowing the hydrophone sensitivity. As previously stated the hydrophone sensitivity









I = volts 2 x 973.9469
Spatial peak intensity (Isp), in W cm 2, within the sound field is thus calculated by
multiplying the square of the peak oscilloscope voltage, measured in volts, by
973.9469.
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Table 6.2. Showing peak voltage, pressure amplitude and spatial peak intensity (Isp)
for the spatially and temporally averaged ultrasonic intensities (1T) used in this
thesis.
Calibration	 Average	 Peak	 Calculated peak	 Calculated
arrangement	 Intensity	 scope	 pressure	 spatial peak
(1(SATA))	 voltage	 amplitude	 intensity (Isp)
________	 (W/cm2)	 (mV)	 MPa	 (W/cm2)
	
0.5	 56	 0.30	 3.06
Free Field	
0.1	 28	 0.15	 0.76
	
0.5	 56	 0.30	 3.06
in vivo	
0.1	 27	 0.15	 0.71
	
0.5	 56	 0.30	 3.06
in vitro	
0.1	 26	 0.14	 0.66
6.2.5. Calculation of effective radiating area
As previously stated the US-FDA definition of ERA is "the area consisting of all
points of the effective radiating surface at which the intensity is 5% or more of the
maximum intensity (Imax)" at a given nominal intensity setting. Beam profiles, which
are piots of relative pressure amplitude versus linear displacement across the
transducer face, can be used to measure ERA provided that it is appreciated that:
Amplitude = s/Intensity
and the definition modified accordingly.
According to this relationship the US-FDA value of 5% of I max is equivalent to
22.36% of the maximum amplitude value (A max) i.e.
I max = 1.0 W/cm2





Figure 6.10 Measurement of ERD. A beam profile showing the change in relative
pressure amplitude with linear displacement across the transducer face
The ultrasound generator was set to give a nominal ultrasonic output
of 1.0 W/cm2 1(SATA)





Key: ERD = Effective radiating diameter
A max maximum relative pressure amplitude
207
Thus it is possible to reword the US-FDA definition in terms of relative
amplitude to read 'the area consisting of all points of the effective radiating surface at
which the relative pressure amplitude is 22 36% or more of the maximum relative
pressure amplitude (A max)' for a given nominal intensity setting. Figure 6.10 shows
the free field profile, and measurements thereof, used to calculate the effective
radiating area of the Enraf Nonius 3 MHz transducer used in this thesis. The
nominal intensity setting used to produce this profile was 1.0 W/cm 2 (panel meter
setting) with the generator set to deliver continuous wave ultrasound.
With reference to figure 6.10,
Amax=57
22.36% of A max 12.75
The effective radiating diameter (ERD) of the transducer, consisting of all
points at which the relative pressure amplitude is equal to or greater than 12.75, is
measured directly from this trace and calibrated against the X axis sensitivity of the
plotter. As a linear movement of 1 cm across the face of the transducer is equivalent
to 9.3 cm on the trace. The ERD measured from the trace 7.25 cm is thus equal to
a true linear displacement of 0.776 cm across the transducer face. The effective
radiating radius is thus 0.390 cm and consequently the effective radiating area,
assuming that the transducer is circular and symmetrical, is 0.48 cm2. This correlates
well with the manufacture's information on this transducer assembly, in which they
state the ERA to be 0.5 cm2. The ERA measurement is used to calculate the force
balance setting required to accurately deliver a specified ultrasonic intensity to the
biological target (see section 6.1).
6.3. The time distribution of acoustic enerv
Hill (1970) stated the time distril.,ution of ultrasound, applied to a given biological
target, as a major irradiation parameter which should be reported in communicating
ultrasonic bioeffects. To report properly on the time distribution of pulsed ultrasound
it is necessary to examine two areas of possible variation.
1. The variation associated with the duration of the periods of ultrasonic
emission and non-emission.
2. The variation associated with the distribution of ultrasonic energy within the
pulse envelope.
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6.3.1. Emission and non-emission
Nearly all therapeutic ultrasound generators can emit either a continuous beam of
ultrasound, or chop this beam up into discrete bursts, or pulses, of ultrasound
approximately 2 milliseconds in duration. The 'off, or inactive, time between bursts
can normally be varied. Mark: Space Ratio is a term used, in pulsed ultrasound, to
describe the time distribution of the ultrasonic energy supplied to a given biological
target. It is the ratio of the pulse length (on time) to the gap length (off time), where
time is expressed in milliseconds. The manufacturers of the generator used in this
study, Enraf Nonius, indicate that it is capable of delivering pulsed ultrasound at the
following mark:space ratios:- 2 ms: 8 ms, 2 ms: 18 ms and 2 ms : 38 ms.
As this study is primarily concerned with the biological effects of pulsed ultrasound
at a mark:space ratio of 2ms: 8ms, the other mark: space ratios will be ignored.
The true mark: space ratio, for a given nominal mark: space ratio setting, is
obtained by positioning a hydrophone within the generated sound field and
displaying the output on an oscilloscope (as described earlier for beam profiling and
the measurement of spatial peak pressure amplitude). When set to the correct time
base, the oscilloscope will display the mark and space periods of the generated
ultrasound in milliseconds. The oscilloscope was set such that each major grid line,
dissecting the horizontal axis, corresponded to a time period of 2 ms.
The true mark: space ratio of the pulsed ultrasound emitted, when the
ultrasound generator was set to supply a nominal mark: space ratio of 2ms: 8ms, was
studied at both of the ultrasonic Intensities used in this thesis. Black and white
photographs, of the oscilloscope display, depicting the pulse modulation, were taken
using a Shackman 7000 oscilloscope camera loaded with Polaroid 667 film (figure
6.11). It is apparent from these photographs that the manufacturer's mark: space
ratio information is correct. It is similarly apparent that the mark: space ratio is
unaffected by the ultrasonic intensity being generated.
6.3.2. Variation within the pulse envelope.
The shape of the ultrasonic pulses depends upon the electrical circuitry employed to
modulate a continuous ultrasonic output into a pulsed output. Certain forms of
electrical modulation, for example AC mains modulation, generate pulses in which
the intensity varies throughout the pulse. During the first half of the pulse the
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Figure 6.11 Polaroid oscilloscope photographs showing the temporal distribution
of energy emitted when the ultrasound generator was set to deliver
1(SATA) intensities of 0.5 and 0.1 W/cm2.
Intensity - 0.5 W/cm2
Intensity
 - 0.1 \V'cm2
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intensity gradually rises, reaching a maximum mid way through the pulse; the
intensity then falls off to zero during the latter half of the pulse. This regular rise and
fall in 'in pulse' intensity often fails at high ultrasonic intensities; with the result that
the pulse envelope tends to deform, leading to an even more complicated intensity
distribution within the pulse. This lack of unifonnity of intensity (I') during the
"on "
 period complicates the assessment of the temporal average intensity (J(sATA)) for
a given mark: space ratio. AC mains modulation also tends to suffer from the fact
that as intensity is increased the actual mark:space ratio drifts from the
manufacturer's quoted values (Allen and Battye, 1978).
Ideal pulse modulated outputs have a uniform ultrasonic intensity throughout
the pulse period (rectangular pulse envelope), with mark: space ratios that are
unaffected by the ultrasonic intensity being generated. Such pulse modulation allows
ready assessment of the average intensity (i(sATA)) being applied for a given mark:
space ratio (Allen and Battye, 1978). Such ideal pulse modulation usually results
from some form of precise electronic switching circuit, which is effectively set to
generate ultrasound for a fixed number of wave cycles for a given pulse length. Thus
for 3 MHz ultrasound (3 x 106 cycles per second), at mark: space ratio of 2ms: 8ms,
the switching circuit allows the generator to emit ultrasound for 6000 wave cycles
(pulse on) and then prevents it generating ultrasound for 24,000 cycles (pulse off).
The pulse shape generated by the therapy device used in the completion of
this thesis had an 'ideal' appearance using the criteria of Allen and Battye (1978).
From figure 6.11, it can be seen that the pulse envelope is perfectly rectangular at
the lower ultrasonic intensity of 0.1 W/cm2 1(SATA) used in this thesis, and at the higher
intensity, of 0.5 W/cm2 varies by less than 5%. This slight, and effectively
insignificant, deviation from the 'ideal' perfectly rectangular pulse envelope, at the
higher intensity, may result from an over compensation in power supplied to the
transducer during ultrasonic discharge (Dr J B Pond - personal communication).
6.4. Temperature change n tissue conseiuent on irradiation
All tissues absorb a certain percentage of the ultrasound passing through them, and
this absorbed energy appears as heat which raises the temperature of that tissue. It
is possible to estimate the temperature rise, T (°C) in skin, that may be expected
after an irradiation at spatially and temporally averaged intensity 1(SATA) (W/cm2) after






aa is the absorption coefficient of the skin (approximate)
p is the density of the tissue
cm is the specific heat per unit mass of the tissue
Typical values for the above are p_i g/cm 3, c= 4.2 joules/g. aa is in the region of 0.03
Nepers/cm at a frequency of 1 MHz (Williams, 1983).
Thus the change in temperature (ST) is:
= 2 x 0.03 x 1 x 1
1 x 4.2
which is:	 T=0.0143 °C/second
In this study 3 MHz ultrasound was employed at 1(SATA) of 0.1 and 0.5 W/cm2 . The
expected increases in temperature rely heavily on the absorption coefficient which is
a frequency dependent variable. i.e. aa is in the region of 0.1 Nepers/cm at a
frequency of 3 MHz.
Thus T at an J(SATA) of 0.1 W/cm2 is thus:
= 2 x 0.1 x 0.1 x 1
1 x 4.2
tT=0.0O5 °CJsecond
and zT at an I SATA) of 0.5 W/cm2 is thus:




Bearing in mind that the insonation period used in this thesis was 5 minutes on all
occasions, the expected temperature rises in the absence of any cooling mechanism
(such as blood flow), within the skin (wound tissue) would be of the order of 1.43°C
and 7. 14°C, for I( sATA)s of 0.1 and 0.5 W/cm2 respectively.
The actual temperature rise consequent to 3 MHz insonation at the two
intensities employed in this work was measured under both in vivo and in vitro
exposure conditions. The temperature change during in vivo insonation was measured
using a 1 mm K-type (Chrome Alumel) thermocouple (conforms with BS 4937/4)
inserted under the skin in an otherwise uninjured but anaesthetized animal. The
change in temperature monitored in this way, during 5 minute insonations at
intensities of 0.1 and 0.5 W/cm2 1(SATA) are shown in table 6.3 and graphically depicted
in figure 6.12. The temperature values in table 6.3, which are displayed in figure 6.12,
are average values calculated from triplicate measurements.
The temperature change during in vitro insonation was measured by inserting
the above thermocouple into an exposure chamber via the loading port (Appendix
13, figure 13.1, p 349). Prior to inserting the thermocouple into the chamber, the
latter was filled with a U937 cell suspension (1 x 106 cells per ml of RPM! 1640
culture medium). Once inserted the thermocouple was held in position using Blu-
Tack (Bostik Ltd, UK) which also prevented the cell suspension from leaking out of
the loading port. The change in temperature monitored in this way, during insonation
periods of 5 minutes, at intensities of 0.1 and 0.5 W/cm2 1(SATA) are shown in table 6.4
and graphically depicted in figure 6.13. The temperature values in table 6.4, which
are displayed in figure 6.13, are average values calculated from triplicate
measurements. It is apparent, from the measurements made above, that the observed
temperature increases both in vivo and in vitro are significantly lower than those
predicted by calculation at the beginning of this section.
The in vivo result may be explained by the fact that the calculation to predict
temperature rise does not allow for the loss, or removal, of heat from the tissue. It
thus assumes a linear relationship between the temperature of the tissue and the
amount of ultrasound applied (which is a function of ultrasonic intensity and time).
As can be seen from figure 6.12, showing the change in temperature as a
consequence of insonation in vivo, the temperature rise within the tissue rises quite
rapidly over the first minute or so; the rate of temperature increase then declines
over the remainder of the exposure period. This loss of linearity, is a consequence of
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Table 6.3. The effect of insonation on temperature rise of biological target In vivo.
Intensity 1(SATA)	 Time	 Number of	 Average










0.5	 _________________ __________________ _________________
3	 3	 24.2
5	 3	 25.0
Table 6.4. The effect of insonation on temperature rise of biological target in vitro.
intensity 1(TA)	 Time	 Number of	 Temperature
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the action of cooling mechanisms.
Tissue cooling is effected by the transport of the ultrasonically generated heat
to cooler regions. Part of the transport is accomplished by blood flow, that is, by
perfusion (alternatively called convection), and the remainder is a result of heat
conduction (alternatively called diffusion). In addition to the 'normal' loss of heat by
perfusion, the elevation in tissue temperature, caused by the ultrasound, initiates
physiological reflexes which result in the dilation of blood vessels and thus increased
blood flow. This increased blood flow increases the rate at which heat is carried away
from the area under exposure (Williams, 1983).
It is apparent from table 6.4, and figure 6.13, that the temperature rises
experienced by the biological preparations exposed to ultrasound in vitro are much
smaller than those temperature rises measured in vivo at both intensities studied.
This is explained again in terms of cooling. Under the in vitro conditions used in this
study, it is expected that any heat generated within the exposure chamber would be
rapidly lost by conduction to the metal of the chamber and thence by conduction and
convection to the circulating water within the exposure tank. Further, the absorption
coefficient of the cell suspension would be expected to be far lower than that of skin,
and as such, significantly less energy would be absorbed and hence significantly less
heat generated under in vitro exposure conditions.
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Chapter 7. The effect of pulsed 3MHz therapeutic ultrasound on wound
contraction in the rat
7.1 Introduction
During the healing of a tissue defect, the edges of the wound are progressively
brought together by the retraction of granulation tissue. The phenomenon, called
wound contraction, is of great clinical importance in reducing the size of the wound.
Therapeutic ultrasound has been shown to stimulate various aspects of wound healing
under both clinical (Dyson et a!. 1976; Roche and West, 1984; McDiarmid et a!. 1985;
Callam et a!. 1987) and experimental conditions (Dyson and Pond, 1970; Webster et
a!. 1979; Young and Dyson, 1990a,c; Byl et a!. 1992). Previous experimental studies,
examining the interaction of therapeutic ultrasound with wound repair following
mechanical trauma, have mainly focused on changes in wound cellularity while wound
contraction has received little attention.
The aim of this study was to examine the effect of a clinically applicable
ultrasound treatment regime on the progress, and ultimate extent, of wound
contraction in Wistar rats following full-thickness excision of flank skin.
7.2 Materials and methods
This section describes the materials and methods employed to examine the effect of
therapeutic ultrasound on wound contraction in vivo. Certain techniques have been
covered elsewhere and are referenced accordingly.
7.2.1 Animal husbandry
Adult female Wistar rats (supplied by Tuck and Sons Ltd, London, U.K.) aged
approximately 9 weeks and weighing between 180 and 220 grams were used in this
study. Animals were housed in groups of three, in cages of dimensions 40 x 25 x 20
cm with sawdust bedding (changed twice weekly), in an environment maintained at
an ambient temperature of 23°C with 12-hour light/dark cycles. They were provided
with food (No. 1 maintenance diet, B.P.) and water ad libitum. Prior to
experimentation animals were housed for seven days without disturbance, other than
to refresh their bedding and to replenish their food and water provisions, in an
attempt to accustom them to their new environment. All animal procedures were
carried out under Home Office licence.
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To reduce the likelihood of wound contamination and accidental self
mutilation during the period of post-anaesthetic disorientation, animals were
temporarily housed in recovery cages after anaesthesia. Further it is possible that
returning a semi-conscious rat back into a shared cage, after surgery or treatment,
could be a source of unnecessary stress for the fully conscious rats awaiting similar
treatment. Recovery cages contained clean paper tissue, rather than wood chippings,
to reduce the likelihood of wound contamination. Once the obvious effects of the
anaesthetic had worn off, after approximately five minutes, they were returned to
their original cages.
7.2.2 Creation of a standard wound
Animals were anaesthetized using inhalation of halothane (May & Baker Ltd,
England) and air. One flank of each rat, chosen at random, was shaved and swabbed
with a bactericide (Hibitane). Two concentric squares, of dimensions 2 cm by 2 cm
and 1 cm by 1 cm, were marked onto the shaved skin using a flexible transparent
plastic template (figure 7.1) and an indelible marker pen. The outer square, depicted
by eight dots (one at each corner and one in the centre of each face) was then
permanently tattooed into the skin using a 23 gauge sterile needle and millipore
filtered (0.22 I.Lm) TG 1 drawing ink (Faber-Castell, Nurnberg, Germany). A 1 cm
by 1 cm full thickness excision was then made in this flank, using blunt nosed surgical
scissors, of the tissue limited by the inner square. The excised tissue included the
panniculus carnosus and hypodermis.
7.2.3 Experimental groups
Fifty four Wistar rats were randomly allocated into one of three treatment groups,
namely:	 1. Sham-insonation
2. Insonation with 3 MHz pulsed (2 ms on : 8 ms off) ultrasound at an
intensity of 0.1 W/cm 1(SATA) (i.e. 0.5 W/cm2 I").
3. Insonation with 3 MHz pulsed (2 ms on : 8 ms off) ultrasound at an
intensity of 0.5 W/cm 1(SATA) (i.e. 2.5 W/cm2 I)).
7.2.4 Ultrasound application and photography of wounds
The therapeutic ultrasound source used in this study was a standard Enraf Nonius
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capable of generating either 1 or 3 MHz ultrasound by two separate applicator heads.
Prior to each treatment session the ultrasonic output was checked using a custom
engineered (Enraf Nonius Deift, Holland) sound balance (figure 6.1, p190).
Due to the delicate nature and sensitivity of fresh skin wounds it is necessaiy
to protect them from further damage during treatment. Such damage is associated
with the contact and movement of ultrasound applicator heads during therapy. This
protection must shield the wound without significantly impeding the passage
ultrasound. The wound dressing Geliperm Wet (Geistlich Pharmaceuticals,
Switzerland) fulfils both of these requirements (figure 7.3). Geliperm Wet is a sterile,
transparent polyacrylamide gel manufactured in 0.5 cm thick sheets. As it is 96-97%
water, yet still quite rigid, it offers the required protection against frictional forces
of the moving applicator and is responsible for little, or no, ultrasound beam
impedance (figure 6.6, p 199).
After surgical excision of the 1 x 1 cm of flank skin, the post-surgical cavity
thus formed was flooded with sterile physiological saline and carefully swabbed dry
with sterile gauze to remove any tissue debris and blood. The wound was again filled
with sterile physiological saline and then dressed with 4 x 4 cm square of Geliperm
Wet (Geistlich, Switzerland). The wound cavity was filled with saline to ensure
proper ultrasonic coupling from the applicator head, through the polyacrylamide
dressing, and onto the wound bed. Any bubbles trapped beneath the Geliperm were
released prior to exposure to insonation as ultrasound is reflected at air/water
interfaces and as such, would not reach the wound, thereby confounding dosimetry.
The ultrasound applicator was coupled to the dressing using the ultrasonic couplant
Sonogel (Enraf Nonius Delft, Holland) see figures 7.2 and 7.4.
The applicator head was lowered into contact with the coupling gel. Contact
was maintained throughout treatment by exerting a light pressure on the head.
During treatment the applicator head was kept in continual motion. The practice of
continually moving the ultrasound applicator is common to most clinical ultrasound
treatment regimes, and was adopted to ensure that all areas of the underlying tissue
received a similar, if not identical, ultrasonic exposure. As the ultrasonic fields
generated by the majority of commercially available devices are non-uniform in
nature this continual motion ensures that the applied ultrasound is not concentrated
at any one location within the tissue receiving treatment (Forster and Palanstanga,
1981). It also reduces the likelihood of standing wave formation and subsequent
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Figure 7.2	 Apparatus for exposing rat skin wounds to therapeutic ultrasound
I
-F-	 -
KEY: G - Ultrasound Generator
C - Coupling Gel
P - Polyacrylamide dressing
A - Applicator Head
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Figure 7.3	 An 8 day post-excision rat wound dressed with Geliperm
(note tattoo points around wound)
- ..-.	 ,-
Figure 7.4 The application of ultrasound to a flank skin wound of an anaesthetized
rat. The ultrasound is coupled to the wound via Sonogel, Geliperm and
physiological saline.
223
damage associated with cavitation (Dyson et a!. 1974).
Each animal received a five minute insonation or sham insonation depending
on the treatment group to which the animal belonged. Wounds were filled with
saline, dressed with Geliperm and insonated in this way 24, 48, 72 and 96 hours after
excision and initial insonation, having received a total of 5 insonations/sham
insonations by the end of the treatment programme at 96 hours. While the animals
were still under anaesthetic having just received their second ultrasound/sham
exposure, at 24 hours post-excision, their wounds were photographed using a
standard 35 mm camera (Pentax, Japan), fitted with a macro lens (50 mm) and
loaded with FP4 125 ASA black and white film (Ilford, Cheshire). A plastic identity
plate, carrying information on the animal, the time and date of photograph, and a
centimetre rule (for standardisation) was placed in close proximity to the wound, and
photographed along with the wound. Wounds were photographed in the same
manner following treatment at 48, 72 and 96 hours post-excision. Daily photographs
continued to be taken, after the ultrasound treatment program had ceased, up until
the 11th1 post operative day. The film was processed as described in appendix 11B
(p346). Animals were terminated painlessly on the 1 1" day of study by intraperitoneal
injection of a lethal dose of 20% w/v sodium pentobarbitone (Lethobarb. Duphar Vet
Ltd, UK).
7.2.5 Computerised Image Analysis
Computerised image analysis was used to measure wound area, as depicted by the
eight tattoo points, on each of the photographic negatives. After developing, the
negatives were transferred to a light box and digitised at 1280 by 1024 square pixels.
The negatives were transilluminated on the light box and digitisation was then
performed using a high resolution "charge couple device" CCD camera (Videk
Megaplus, model K00792) fitted with a 55 mm Nikon Nikkor lens. The camera data
was recorded using an IBM PC-AT compatible computer and a Univision UPX 1000
interface and the resulting image displayed using a Univision UDC2600 display
controller. Optimas (Bioscan mc, USA) software was used to capture and analyze the
image of the transilluminated photo-negative.
Each wound image was analyzed with the help of an IBM PC-AT computer
running Optimas software. Computer analysis, using the Optimas package, involved
using the "mouse" to join the tattoo marks of the digitised wound image which had
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been displayed on a large format high resolution monitor. The Optimas package then
calculated the area depicted by the joined tattoo marks and expressed this
information in terms of square pixels. Using the calibration facility within the
Optimas program in conjunction with the centimetre scale, which was photographed
with each wound, wound area was then expressed in terms of square centimetres.
7.2.6 Data Analysis
Wound contraction was expressed in terms of percentage wound area remaining with
time. For a given wound, the wound area measured from the first photograph, taken
at 24 hours after wound excision, was taken to be 100%. The median percentage
wound area remaining and 95% confidence intervals were calculated for each of the
three experimental groups at each time point (tables 7.1, 7.2 and 7.3) and displayed
in the form of a histogram (figure 7.5). The data was analyzed, by non-parametric
statistical analysis, using the Mann Whitney-U test. The rate of contraction observed
in sham-insonated wounds was compared with that observed in both ultrasound-
treated groups at each time point post-wounding (Appendix 18A, p357). Further
analysis (Appendix 18B, p358) was carried out to compare the rate of wound
contraction observed in response to ultrasound treatment at an intensity of 0.1 W/cm2
(I(sATA)) with that observed in response to the higher intensity of 0.5 W/cm2 (i(sATA)).
7.3 Results
Figure 7.5 displays the median 4 wound area remaining data from the three
experimental groups over the 11 day experimental period, 95% confidence intervals
are indicated to aid interpretation.
From figure 7.5, the results in tables 7.1 through 7.3, and statistical analysis
(Appendix 18, p357) the following points are apparent:
1. Irrespective of treatment, the process of wound contraction appears to be'biphasic.
The first phase is characterised by rapid contraction, this subsequently gives way to
the second phase of slower contraction. Differentially exposed wounds appear to
remain in the first, rapid contraction phase, for differing periods of time. Sham-
insonated wounds appear to remain in the rapid contraction phase for the shortest
time, entering the slow contraction phase after day 6 post-wounding. Wounds
exposed to 3 MHz ultrasound at an intensity of 0.5 W/cm2 appear to continue rapid
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contraction a little longer, entering the slow contraction phase after day 7. Ultrasonic
exposure at the lower intensity, of 0.1 W/cm2 1(SATA) results in wounds continuing to
contract rapidly until day 8, entering the slow contraction phase at day 9.
2. Wounds exposed to ultrasound at an intensity of 0.1 W/cm2 (1(sATA)) were smaller,
i.e. had contracted to a greater extent, than sham-insonated wounds at all time
points. Though insonated wounds were physically smaller from day 2 onwards this
observation did not prove statistically significant until 5 days post-wounding (p <
0.002). Insonated wounds were significantly smaller than sham-insonated wounds at
all time points thereafter, i.e. at 6 (p < 0.005), 7 (p < 0.000002), 8 (p < 0.00002),
9 (p <0.00002), 10 (p < 0.0008) and 11 (p <0.02) days post wounding.
3. Wounds exposed to ultrasound at an intensity of 0.5 W/cm2 1(SATA) were smaller,
i.e. had contracted to a greater extent, than sham-insonated wounds at all time
points. This difference proved to be statistically significant at all time points with the
exception of days 4 and 5 post-wounding i.e. at 2 (p < 0.006), 3 (p < 0.006), 6 (p =
0.040), 7 (p < 0.00003), 8 (p < 0.001), 9 (p < 0.0001), 10 (p 0.014) and 11 (p <
0.003) post wounding.
4. Wounds exposed to ultrasound at an intensity of 0.1 WIcm 2 were initially found to
be larger than similar wounds exposed to an intensity of 0.5 W/cm2, i.e at days 2, 3
and 4 post-wounding. This apparent difference did not prove to be statistically
significant. From day 5 until the end of the study, wounds exposed to 0.1 W/cm2 were
found to be smaller than similar wounds exposed to 0.5 W/cm 2; this difference
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The closure of full thickness wounds made in the flank skin of adult Wistar rats was
used as a model of wound contraction. The model facilitated a quantitative and
comparative assessment of the effect of therapeutic ultrasound on the process of
contraction. The contraction of fully excised rat skin wounds treated with 3 MHz
therapeutic ultrasound (at both intensities) was significantly more rapid than that of
similar sham-treated control wounds. At the end of the experimental period
ultrasound-exposed wound were significantly smaller than similar sham-exposed
wounds. These observations suggests that the repair and more specifically the
contraction of mechanical injuries can be accelerated by the application of
therapeutic levels of ultrasound. Though significant differences were observed
between insonated and sham-insonated wounds 2 days after injury, indicating an
immediate effect of insonation, more apparent and statistically significant differences
were observed several days after treatment had ceased. It is thus apparent that
ultrasound exposure soon after injury can induce significant long term changes to the
wound repair process.
It would appear from the results that the lower ultrasonic intensity (i.e. 0.1
W/cm2, I(sATA)) promoted wound contraction to a greater extent than the higher
intensity (i.e. 0.5 W/cm2, I(sATA)). Temperature measurements made in uninjured
dermis during treatment with ultrasound showed that the temperature rise over the
5 minute treatment period was 1°C at an intensity of 0.1 W/cm 2 and 3.3°C at an
intensity of 0.5 W/cm2 (table 6.3, p215). Such observations would appear to suggest
that the mechanisms involved in the stimulation of wound contraction by ultrasound
were not purely thermal.
The stimulation of wound contraction by ultrasound has been previously
reported. Dyson and Smalley (1983), demonstrated that therapeutic intensities (0.1
W/cm2, I(sATA)) of 3 MHz pulsed ultrasound (2ms on, 8ms off) could stimulate the
contraction of cryosurgical lesions made in the flank skin of rats. Freeze injuries are
known to display both minimal inflammation and minimal contraction (Ehrlich, 1988)
when compared with mechanical injuries. This study validates the report of Dyson
and Smalley (1983) and further demonstrates that the stimulation of contraction by
therapeutic ultrasound is not specific to cryosurgical injuries.
It has been suggested that therapeutic ultrasound acts by accelerating the rate
at which wounds progress through the initial inflammatory pha.se of repair (Dyson,
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1990), thereby encouraging a more rapid onset of the subsequent new tissue
formation phase. This view is supported by the work of Young and Dyson (1990a)
who observed that cells characteristic of the granulation tissue formation phase of
repair (i.e fibroblasts and endothelial cells) were recruited more rapidly into
insonated wounds than into similar sham-insonated wounds. The stimulated
recruitment of fibroblasts into insonated wounds may explain the stimulation in
contraction observed in this study, and in cryosurgical lesions by Dyson and Smalley
(1983), as wound contraction is generally accepted to be a fibroblast-mediated
process (Skalli and Gabbiani, 1988).
The recruitment of fibroblasts into cutaneous wounds is thought to involve
both fibroblast migration and proliferation (p3! to 38). It is possible that ultrasound
may stimulate this recruitment by interacting directly with fibroblasts to promote
either their migration, as previously suggested by Mummery (1978), their
proliferation, or both. Further studies later in this thesis address the direct effect of
therapeutic ultrasound on fibroblast proliferation (chapter 8, p134).
During wound repair, fibroblast activities, including migration and
proliferation, are thought to be directed by a variety of stimuli, including various
regulatory peptides often referred to as growth factors (tables 1.2 & 1.3, p35 & 39).
The source of these growth factors changes as the wound proceeds through the repair
process; initially being released during platelet degranulation, they are subsequently
synthesized and secreted by activated macrophages (Clark, 1990). In addition
fibroblasts, endothelial cells and epithelial cells have also been shown to synthesize
and release certain growth factors (Welch et a!. 1990; Guidry et a!. 1990; Nicolas et
a!. 1991). Thus it would appear that there is a continual capacity for the synthesis and
release of growth factors throughout the healing process.
The majority of studies which report enhanced wound healing in response to
therapeutic ultrasound, including this study, report the consequences of treatments
carried out during the first few days after injury, i.e. during the inflammatory phase
of repair (Dyson et a!. 1970; Dyson and Pond, 1970; Webster et a!. 1979; Dyson and
Smalley, 1983; Young and Dyson 1990a,c; Byl et a!. 1992). It is thus possible that
ultrasound may interact with the wound via some component of the inflammatory
phase, possibly modulating growth factor levels, and thereby regulate fibroblast
function indirectly. In vitro studies designed to investigate the capacity of therapeutic
ultrasound to interact with two major cellular components of the inflammatory phase
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(i.e. platelets and macrophages) are described later in this thesis (Chapters 10, pZ53,
and 11, p276). Future in vivo investigations comparing the effect of immediate
treatment with delayed treatment (several days after initial injury) may help to define
the ultrasound responsive target within cutaneous wounds.
It is possible that the early elevation in fibroblasts number in response to
ultrasound, noted by Young and Dyson (1990), is the result of contraction rather
than its cause. The process of wound contraction reduces granulation tissue volume,
and thereby increases cellular density. It is possible that ultrasound may interact
either directly or indirectly (mediated perhaps by platelets or macrophages) with
fibroblasts in a manner that enhances the "contractile" capacity of individual cells,
rather than by increasing the number of contractile cells within the wound. There are
several lines of evidence that point to a direct effect of ultrasound on fibroblast-
mediated wound contraction. Mummery (1978) reported that therapeutic levels of
ultrasound could stimulate fibroblast migration in vitro; this observation may support
a direct stimulation of fibroblast-mediated wound contraction by ultrasound,
according to the cell traction theory of wound contraction (p52). The cell contraction,
or myofibroblast, theory proposes that wound contraction is brought about by a
muscle-like contraction of smooth muscle cell (SMC)-like fibroblasts, termed
myofibroblasts. Smooth muscle contraction is caused by a transient flux of calcium
ions activating actin-myosin sliding systems. As therapeutic levels of ultrasound have
been shown to cause the contraction of guinea pig uterine SMC preparations in vitro
(Talbert et at. 1975), increase the frequency of mouse uterine SMC contraction in
vivo (ter Haar et a!. 1978), and increase the uptake of calcium by fibroblasts in vitro
(Mummery, 1978; Mortimer and Dyson, 1988), it is possible that ultrasound
encourages wound contraction by stimulating myofibroblast contraction. In vitro
studies, carried out using the fibroblast-populated collagen lattice wound contraction
model, were performed to investigate the ability of ultrasound to stimulate fibroblast-
mediated contraction both directly, and indirectly via platelets and macrophages
(Chapters 9 (p244), 10 (p253) and ii (p2'76) of this thesis).
In summary, this investigation demonstrates that clinical levels of therapeutic
ultrasound can promote wound contraction in Wistar rats. If the observations made
in this study can be extrapolated to the clinical situation, these results suggest that
therapeutic ultrasound, applied at sites of tissue loss soon after injury, may encourage
the process of wound contraction thereby reducing the size of the final scar.
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Chapter 8. The direct effect of pulsed 3 MHz therapeutic ultrasound on the
proliferation of human dermal fibroblasts In vitro.
8.1 Introduction.
The application of therapeutic ultrasound has been reported to stimulate the process
of cutaneous repair both clinically and following experimental wounding in various
experimental animals. Chapter 7(p2l8) of this thesis, in which therapeutic ultrasound
was shown to promote wound contraction in rat flank skin wounds, further sustains
such reports. The mechanisms by which therapeutic ultrasound interacts with the
process of wound repair, and more specifically the biological target with which it
interacts to promote wound contraction are unknown. Wound contraction is thought
to be a fibroblast-mediated event, and as such will clearly depend upon fibroblast
density within the wound. In vitro reports suggest that ultrasound is capable of
directly modulating certain fibroblast functions, including collagen synthesis (Harvey
et a!. 1975) and fibroblast migration (Mummeiy, 1978). It is possible that ultrasound
may encourage wound contraction by directly stimulating the proliferation of
fibroblasts, thereby endowing the wound with a greater capacity for contraction.
This investigation tests the hypothesis that ultrasound promotes wound
contraction by stimulating fibroblast proliferation.
8.2 Methods
8.2.1 Insonation of human dermal fibrobiasts - methodology
Primary cultures of human dermal fibroblasts were established and cultured
according to Appendix 3 (p337). Sub-confluent human dermal fibrobiast monolayers,
passage 6, were trypsinized (Appendix 4, p338), washed in fibroblast growth medium
(Appendix 2B, p335) and resuspended in the same, to make a fibroblast stock
suspension that had a cell density of 1 x 106 viable cells/mi (Appendix 6, p34O). 4 ml
volumes of this fibroblast stock suspension were aliquoted into sterile, 15 ml
centrifuge tubes, which were continually mixed on a rocking table and held at room
temperature. The exposure chamber (Appendix 13, figure 13.1, p349) was then
prepared and loaded, according to Appendix 13 (p34.8) with the first aliquot of
fibroblasts. The exposure chamber was located in the exposure tank (figure 8.1, p
235) which was lined with ultrasound absorbent rubber (dimpled car matting) and
























































long 25cm wide and 25cm deep. The sample insonated or sham-insonated was placed
in the exposure tank, as illustrated, for a period of 5 minutes. The ultrasound source
used in this study was a standard Enraf Nonius DeIft 434 Sonopuls machine (Enraf
Nonius Deift, Holland), set to deliver 3 MHz ultrasound (figure 7.2, p222). Prior to
fibroblast suspension exposure, ultrasonic output was calibrated and the generator
set to deliver a fixed ultrasonic intensity - according to chapter 6 (p187).
Aliquots were allocated and exposed according to the following treatment groups:
1. Sham-insonation
2. 3 MHz pulsed (2ms:8ms) ultrasound, Intensity 0.1 W/cm2 (I(sATA))
3. 3 MHz pulsed (2ms:8ms) ultrasound, Intensity 0.5 W/cm2 (I(SITA))
After insonation, or sham-insonation, fibroblast suspensions were unloaded
(Appendix 13, p348) from the exposure chamber into a sterile centrifuge tubes. The
suspensions were continually mixed on a rocking table and held at room temperature
until all insonations and sham-insonations had been completed. Once all insonations
had been carried out the fibroblast suspensions were diluted from 1 x 106 cells per
ml to 2 x iO cells per ml, and kept in suspension on a rocking table. The methylene
blue fibroblast proliferation assay (pl49), a modification of the colorimetric assay
described by Oliver et a! (1989), was used to monitor the proliferation of insonated
or sham-insonated fibroblasts.
8.2.2 Proliferation assay - methodology
The standard protocol for the "methylene blue fibroblast proliferation assay"
(Appendix 8, p342), was employed as follows:
After dilution, to 2 x 1O cells per ml, the three fibroblast suspensions were
plated-out on to 96 well flat-bottomed microtitre plates. On each plate, six replicate
wells received a 1001.il volume, representing 2000 cells, of each fibroblast suspension;
thus filling eighteen wells. With reference to Appendix 9(p343), the sham-insonated,
0.1 W/cm2 insonated and 0.5 W/cm2 insonated fibroblast suspensions were plated into
the 6 central wells of columns 4, 6, and 8 respectively. Those outer wells of columns
4, 6 & 8 (i.e those in rows A and H) that did not receive a fibroblast suspension, and
all wells in columns 3, 5, 7 & 9, were filled with fibroblast growth medium alone. Five
replicate plates were set up in this manner. Plates were sealed and placed in an
236
incubator at 37°C.
Plates were removed from the incubator after 12, 36, 60, 84 and 108 hours. At
each time point the plate sealing tape was removed and the plate "stopped", fixed and
air dried, according to Appendix 8 steps 6 through 9 (p342). Plates stopped at 12, 36,
60 and 84 hours post fibroblast seeding were stored in a dust-free environment until
the 108 hour plate had been stopped, fixed and air dried.
Fibroblast monolayers within the wells were then stained with methylene blue
dye, washed with 0.01 M borate buffer and the dye eluted with acid-alcohol. The
absorbance (A650) of each well, on each plate, was then measured (Appendix 8, steps
10 through 12 p342). For each column of wells, and hence for each treatment group,
the average A650 value of cell-free wells was subtracted from each of the A650 readings
of cell containing wells. The fibroblast number within a given well was then
calculated from this corrected absorbance reading using a standard plot of human
dermal fibroblast number versus A (Appendix 30B, p398). This standard plot was
prepared according to the method described on p152, using the same primary culture
of fibroblasts, at the same passage (i.e. 6), as was used for the fibroblast proliferation
assay described above.
Human dermal fibroblast proliferation in response to sham-insonation or
insonation with pulsed therapeutic ultrasound at intensities of 0.1 or 0.5 WIcm2 1(SATA)
was compared at each of the five time points. The fibroblast proliferation data was
tabulated (table 8.1) displayed graphically (figure 8.2) and analyzed using the non-
parametric Mann Whitney-U test.
8.3 Results:
Figure 8.2 displays the change in median fibroblast number with time, in response to
sham-insonation or insonation with pulsed 3 MHz therapeutic ultrasound at
intensities of 0.1 or 0.5 W/cm2 1(SATA)• 95% confidence intervals are indicated to aid
interpretation. A summary of the statistical analysis for this investigation can be
found in Appendix 19 (p359).
From figure 8.2, and according to statistical analysis, the following points are
apparent:
1. The rate of human dermal fibroblast proliferation in response to sham-insonation
is not significantly different from that in response to insonation with 3 MHz pulsed
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2. The rate of fibroblast proliferation in response to insonation at 0.1 W/cm 2 is not
statistically different from that in response to insonation with 0.5 W/cm2, with the
exception of 84 hours post-insonation. At 84 hours post-seeding significantly more
cells were observed in wells seeded with fibroblasts exposed to 0.1 W/cm 2 than in
similar wells seeded with fibroblasts exposed to 0.5 W/cm2. No such differences were
observed at any other time point.
3. At termination of this study (108 hours) there would appear to be a trend
indicating that exposure to ultrasound at 0.1 W/cm 2 encourage fibroblast proliferation
to a greater extent than 0.5 W/cm2, which, in turn encouraged fibroblast proliferation
to a greater extent than sham exposure. However, this trend did not reach statistical
significance.
8.4 Discussion
Under the experimental conditions employed in this study, it would appear that the
direct application of therapeutic ultrasound to human dermal fibroblasts does not
significantly effect the rate at which they proliferate. On the basis of statistical
significance, this observation suggests that the mechanism by which therapeutic
ultrasound promotes wound contraction in the rat (see chapter 7, p218) is unlikely
to involve direct stimulation of wound fibroblast proliferation. This dbservation does
not rule out the possibility that fibroblast density, within the wound site may increase
in response to the application of therapeutic ultrasound, as has been reported in rat
flank skin wounds, 5 days post wounding (Young and Dyson, 1990a). The recruitment
of fibroblasts into the wound is thought to involve both fibroblast migration and
proliferation; it is possible that ultrasound may interact directly with fibroblasts to
promote their migration, as previously suggested by Mummery (1978), and thereby
increase wound fibroblast numbers and promote contraction.
Alternatively, as the recruitment of fibroblasts is thought to depend on an
array of mitogenic and migratory stimuli (tables 1.2 and 1.3, pages 35 and 39)
generated during the inflammatory phase of repair; it is possible that therapeutic
ultrasound may encourage the influx of fibroblasts into the wound site by modulating
the generation of these mitogenic and migratory agents during inflammation. The
increased elaboration of agents, mitogenic for fibroblasts and endothelial cells, may
explain the enhanced rate of 3H-thymidine incorporation in rabbit ear wounds
exposed to 3 MHz ultrasound (Dyson et a!. 1970). Investigations into the effect of
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therapeutic ultrasound on the elaboration of mitogenic agents by platelets and
macrophages, the principal sources of mitogenic and migratory substances for
fibroblasts in wound repair, can be found in chapters 10 (p253) and 11 (p276).
There are several published reports of the effect of ultrasound on cellular
growth in vitro, however, these studies appear to have been carried out either in
response to safety concerns over possible hazards of exposure (i.e. loss of viability),
or, to study the application of ultrasound to cancer therapy (selective cell killing),
rather than in anticipation of a possibly therapeutic mitogenic effect. Consequently
the ultrasonic parameters used in these studies, specifically ultrasonic intensity, are
generally beyond the therapeutic range, and the experimental endpoints used are
usually cell death or loss of proliferative capacity. There are no published reports
describing the effect of therapeutic ultrasound at the precise parameters used in this
thesis on cellular proliferation in vitro. The limited number of studies that have
employed ultrasound at therapeutic levels have used frequencies of, or about, 1 MHz,
in continuous wave mode. Such studies have been unable to detect a mitogenic effect
in response to therapeutic levels of ultrasound. Rather, they have tended to indicate
that mid intensity ultrasound (up 1 W/cm 2 1(a)) has no effect on cellular growth
(Kaufman et a!. 1977; Ross et a!. 1983; Decat and Leonard, 1984), whereas, at the
upper end of the therapeutic range (approximately 3 W/cm 2 I) ultrasound leads to
a loss of proliferative capacity (Kaufman et a!. 1977; Ciaravino and Miller, 1978;
Kaufman and Miller 1978; Fu et a!. 1980). The loss of cellular proliferative capacity
in response to insonation in vitro has been associated with cavitational damage as
under non-cavitating conditions such losses are not observed (Armour and Cony,
1982; Ciaravino et a!. 1981b; Coaldey et a!. 1971), even at intensities far in excess of
the therapeutic range (Bleaney et a!. 1972). The exposure tank employed in this thesis
was designed to reduce standing wave formation and thereby reduce the likelihood
of transient cavitation. A 450 silicone wedge, placed below the insonation chamber,
was used to both (a) partially absorb, and, (b) partially reflect the ultrasonic beam
into a rubber absorber lining the exposure tank. This, together with the use of a
relatively higher frequency (3MHz) of ultrasound, at which cavitation is less likely
(plO!), may explain why a significant loss in fibroblast proliferative capacity was not
observed in this study.
Studies examining the effect of ultrasound on DNA synthesis by cultured cells
in vitro generally tend to contradict the cellular growth studies. Therapeutic
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ultrasound has been shown to stimulate DNA synthesis, as measured by 3H-thymidine
incorporation, in cultured mouse tibial epiphyses (Elmer and fleisher, 1974),
concanavalin A stimulated lymphocytes (Repacholi et a!. 1979) and mouse L cells
(Kondo and Yoshii, 1985). 3H-thymidine incorporation during DNA repair, following
ultrasound-induced DNA damage, may explain the apparent contradiction in results
between the proliferation studies and the DNA synthesis studies.
This investigation, like many other in vitro studies in the wound healing
literature, makes the assumption that cultures of human dermal fibroblasts from
normal forearm skin can respond to modulatoiy agents in a similar manner to that
of fibroblasts within granulating wounds. In this study fibroblasts were cultured on
plastic in monolayer, a two dimensional arrangement that affords cells a clearly
different environment to the three dimensional arrangement of extracellular matrix
found in vivo (Nusgens et a!. 1984). The fibroblast-populated collagen lattice (p160),
a three dimensional tissue culture system, may provide a more appropriate
environment for the study of fibroblast function in vitro. This model was employed
to investigate the direct and indirect effects (mediated by platelet and macrophages)
of therapeutic ultrasound on the process of fibroblast-mediated collagen lattice
remodelling in chapters 9, 10 and 11. Recently, it has become apparent that
fibroblasts are capable of demonstrating both significant structural and functional
heterogeneity (Sappino et a!. 1990; Regan et a!. 1991; Finesmith et a!. 1990). For
example, Regan et aL (1991) demonstrated that wound-harvested fibroblasts are less
responsive to mitogenic stimuli, but have an increased capacity to synthesize collagen
and have an increased capacity to contract collagen lattices, when compared with
normal dermal fibroblasts. It is thus possible that the lack of effect observed here
may not accurately represent the response of fibroblasts within granulating wounds.
Further studies are necessaiy to investigate the capacity of wound-derived fibroblasts
to respond to therapeutic ultrasound in vitro.
In summary, this investigation demonstrates that therapeutic ultrasound, at the
parameters stated above, is not directly mitogenic for fibroblasts derived from normal
human skin in vitro. This observation suggests that the numerous reports of
ultrasound-stimulated wound healing (Dyson et a!. 1970; Dyson et a!. 1976;; Roche
and West, 1984; McDiarmid et a!. 1985; Young and Dyson, 1990a1c; Byl et a!. 1992),
including stimulated cryosurgical wound contraction (Dyson and Smalley, 1983) and
mechanical wound contraction (reported in Chapter 7), is not due to a direct pro-
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proliferative interaction of ultrasound with fibroblasts. However, care must be
exercised in extrapolating the observations made in this study to other wound healing
ultrasound bioeffects. This study examined the effect of applying a single frequency
of pulsed ultrasound, at just two ultrasonic intensities, to fibroblasts cultured in vitro.
Other studies have reported that ultrasound at clearly different parameters to those
used in this study can modify various aspects of the repair process. It would be
inappropriate to categorically state that all these effects are not a result of a direct
pro-mitogenic ultrasonic effect on fibroblast populations.
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Chapter 9. The direct effect of 3 MHz therapeutic ultrasound on the contraction
of human dermal fibroblast-populated collagen lattices In vitro.
9.1 Introduction.
Ultrasound has been used as a therapeutic agent in physical medicine for over fifty
years (Dyson and Suckling, 1978). A significant literature has developed during that
time, included in this literature are many clinical, laboratory animal and in vitro
model-based reports which suggest that, under appropriate conditions, ultrasound can
stimulate the process of cutaneous repair (chapter 4, plo7). Chapter 7 (p218) of this
thesis, in which therapeutic ultrasound was shown to promote wound contraction in
rat flank skin wounds, further sustains such reports. While various physical
mechanisms by which ultrasound may interact with biological tissues have been
described (p92), the responsive target that mediates the stimulation in cutaneous
repair, and more specifically wound contraction, is as yet unknown.
Wound contraction is widely accepted as a fibroblast-mediated process. The
way in which wound fibroblasts act to bring about wound contraction is, however, the
centre of some debate (Ehrlich, 1988; Gabbiani et a!. 1971). A widely accepted in
vitro model for the process of wound contraction is the fibroblast-populated collagen
lattice (FPCL) (p160). In this model, fibroblasts seeded within a three dimensional
matrix of collagen progressively contract this matrix to a fraction of its original size.
Previous studies investigating the direct effect of therapeutic ultrasound on
fibroblasts in vitro have demonstrated that ultrasound can stimulate fibroblast
migration (Mummery, 1978) and collagen synthesis (Harvey et a!. 1975). The FPCL
model was employed in this study to examine the ability of ultrasound to directly
modulate fibroblast-mediated contraction in vitro, with a view to explaining the
stimulation of wound contraction observed in vivo.
This investigation tests the hypothesis that therapeutic ultrasound promotes
wound contraction by directly stimulating fibroblast-mediated contraction.
9.2 Methods
Eighteen standard fibroblast-populated collagen lattices were prepared according to
steps 1 through 6 of the human dermal fibroblast collagen lattice contraction assay -
standard protocol (Appendix 10, p344). After polymerisation and lattice release, the

























and randomly allocated into 3 experimental groups, each containing 6 lattices.
After polymerization and feeding, FPCLs received a single, 5 minute,
insonation or shani-insonation of therapeutic ultrasound according to figure 9.1
(p245). Petri dishes, containing FPCLs, were floated on the surface of a heated
(37°C) water tank of dimensions 15cm long, 15cm wide and 6cm deep. The
ultrasound transducer, sterilised using 70% alcohol, was slowly lowered into place
above the lattice in such a manner that the suspending medium of the lattice acted
as an ultrasonic couplant. The lattice was then insonated or sham-insonated
according to the experimental group to which it had been allocated. The water tank
was lined with ultrasound absorbent rubber (dimpled car matting) and the petri
dishes slowly moved to prevent standing wave formation and to ensure that all areas
of the lattice were similarly insonated. The therapeutic ultrasound source used in this
study was a standard Enraf Nonius Delft 434 Sonopuls machine (Enraf Nonius Delft,
Holland), set to deliver 3 MHz ultrasound (figure 7.2, p222). Prior to lattice
exposure, ultrasonic output was calibrated and the generator set to deliver a fixed
ultrasonic intensity - according to chapter 6 (p187).
The three groups of lattices were treated as follows:
1. Sham-insonation
2. 3 MHz pulsed (2ms:8ms) ultrasound, Intensity 0.1 W/cm2 (I(sATA))
3. 3 MHz pulsed (2ms:8ms) ultrasound, Intensity 0.5 W/cm2 (ICsATA))
After insonation the lattices were placed in a humidified box and returned to the
incubator. All eighteen lattices were photographed (Appendix 1 1A, p34.5) at 9, 21,
28, 50 and 58 hours after initial plating and the film developed according to
Appendix 11B (p346). The area of each lattice, in mm 2, was then measured by
computer-assisted planimetiy (Appendix 12, p347). Median lattice area, minimum
and maximum lattice area, and 95% confidence intervals were calculated for each
group of lattices (i.e. in response to sham-insonation or insonation with 3 MHz
therapeutic ultrasound at 0.1 or 0.5 W/cm2 i(sATA)) at each time point (table 9.1 p248)
and the data was graphically displayed (figure 9.2, p24 .8). Non-parametric statistical
analyses (Mann Whitney-U tests) were performed to examine the modulation in the
rate of lattice contraction in response to therapeutic ultrasound.
9.3 Results:
Figure 9.1 displays the change in median lattice area (mm 2) with time (hours), in
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response to sham-insonation or insonation with pulsed therapeutic ultrasound at
intensities of 0.1 or 0.5 W/cm2. 95% confidence intervals are indicated to aid
interpretation. A summary of the statistical analysis for this investigation can be
found in Appendix 20 (p360).
From figure 9.2, and according to statistical analysis, the following points are
apparent:
1. The rate of fibroblast-mediated lattice contraction in response to sham-insonation
was not significantly different from that in response to insonation with 3 MHz pulsed
ultrasound at an intensity of 0.1 W/cm2.
2. The rate of fibroblast-mediated lattice contraction in response to sham-insonation
was generally not significantly different to that observed in response to insonation
with 3 MHz pulsed ultrasound at an intensity of 0.5 WIcm 2. At the first time point
recorded, that of 9 hours after lattice polyinerisation, FPCL insonated with an
intensity of 0.5 W/cm2 were.significantly larger i.e. had contracted to a lesser extent
than similar sham insonated FPCL (p = 0.013). After this time no significant
differences were observed.
3. Lattice contraction in response to insonation at an ultrasonic intensity of 0.1
W/cm2 was not statistically different from that observed in response to insonation at
0.5 W/cm2.
9.4 Discussion
It is apparent from the results that a single insonation of pulsed 3 MHz therapeutic
ultrasound has little effect on the rate of fibroblast-mediated collagen lattice
contraction.
At the 9 hour sampling point, an ultrasound intensity-dependent trend in lattice area
would appear to exist. According to this trend, maximal ultrasonic intensity is
paralleled by minimal lattice contraction. At this time point, the first after insonation,
sham-exposed FPCL were smaller (i.e had contracted more rapidly) than similar
FPCL insonated at an intensity of 0.1 W/cm 2; which, in turn were smaller than
lattices exposed to an intensity of 0.5 W/cm2. Statistical significance was only
observed between the sham-insonated lattices and the insonated lattices exposed to
an intensity of 0.5 W/cm 2. This intensity dependent reduction in contraction may
result from ultrasound-associated damage to fibroblasts. It is not clear whether this
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ultrasonic energy absorption by cells in suspension is quickly dissipated into the
suspending medium, and as such, cells in suspension are less likely to be influenced
by temperature rises than cells in vivo (Williams, 1985). However, the FPCL is a
proteinaceous dermis-like matrix seeded with cells, which would be expected to
absorb more energy and consequently generate more heat, than a simple suspension
of cells. Heat dissipation is also probably less efficient due to a sponge-like restriction
in fluid movement. Unlike the majority of in vitro cell insonation systems which both
encourage non-thermal effects and mask thermal effects (Miller, 1985b; Williams,
1985), the dermis-like ultrasound attenuation characteristics of FPCLs makes them
a more appropriate in vitro model for studying ultrasound bioeffects than cell
suspensions. As the trend in lattice contraction inhibition was effectively restricted
to the 9 hour sampling point it would appear that such damage, if damage was
responsible, was of a limited and reversible nature.
This study would appear to suggest that therapeutic ultrasound lacks the
capacity to interact directly with fibroblasts to promote fibroblast-mediated lattice
contraction. As the FPCL is an in vitro system widely accepted as a model of the
process of wound contraction in vivo (Ehrlich and Rajaratnam, 1990), such
observations suggest that therapeutic ultrasound promotes wound contraction by
means other than a direct stimulation of fibroblast activity.
Two theories have been proposed to explain how fibroblasts mediate both
wound contraction in vivo and FPCL contraction in vitro (see chapters 1 (p18) and
5 (p132)). Briefly, the myofibroblast theory proposes that myofibroblasts, cells sharing
phenotypic characteristics of fibroblasts and smooth muscle cells (SMC), undergo a
muscle-like cellular contraction and thereby bring about wound or lattice contraction.
The fibroblast theory proposes that fibroblasts gather extracellular matrix fibrils
together by a cell migration-associated traction-like mechanism and in doing so
facilitate wound or lattice contraction.
It has previously been reported that therapeutic levels of ultrasound can
stimulate smooth muscle contraction both in vitro and in vivo (Talbert et a!. 1975; ter
Haar et a!. 1978) and stimulate calcium uptake by fibroblasts (Mortimer and Dyson,
1988). According to the myofibroblast theory of smooth muscle-like cellular
contraction, in which FPCL contraction is mediated by these SMC-like cells,
therapeutic levels of ultrasound would be expected to promote lattice contraction.
The lack of pro-contractile effects noted here may question the role of myofibroblasts
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in lattice contraction. However, cells with myofibroblastic characteristics are slow to
develop in collagen lattices, and would not have been present in significant numbers
at the time lattices were insonated in this study. Consequently, it is impossible to rule
out a direct ultrasonic effect on myofibroblast contraction as the mechanism
responsible for the stimulated contraction of insonated rat wounds reported in
chapter 7 (p218) and previously by Dyson and Smalley (1983).
Mummery (1978) reported that therapeutic levels of ultrasound could
stimulate fibroblast motility in vitro, with insonated fibroblasts executing fewer
changes in direction than similar non-insonated fibroblasts. According to the traction
theory of contraction, in which FPCL contraction is mediated by a cell migration-
associated traction-like mechanism, contraction may be expected to be more rapid
if cellular migration was more rapid. The lack of a pro-contractile effect noted in this
study may question the traction theory of lattice contraction. However, there are
significant differences in experimental design between the work of Mummery (1978)
and that reported here, including the cell culture environment under which
fibroblasts were studied, which may invalidate any comparison between the two
studies.
The lack of a pro-contractile effect in this study of the direct effect of
ultrasound on fibroblast-mediated contraction does not rule out the possibility that
therapeutic ultrasound acts to promote fibroblast activity in an indirect manner,
possibly by encouraging the synthesis and/or elaboration of pro-contractile substances
from other cell types involved in the wound repair process. As ultrasound exposure
soon after injury, i.e during inflammation, has previously been reported to promote
various aspects of the repair process, it is possible that ultrasound encourages the
release of pro-contractile substances from inflammatory cells. Chapters 10 (p253) and
11 (p2'76) describe studies performed to investigate the ability of therapeutic
ultrasound to encourage the elaboration of pro-contractile activities from platelets
and macrophages, and thereby modulate fibroblast-mediated contraction indirectly.
Fibroblasts have been shown to be capable of significant morphological,
structural and functional heterogeneity (Sappino et a!. 1990; Regan et a!. 1991;
Finesmith et al. 1990). It has been proposed that the wound environment may induce,
or select, specific fibroblast phenotypes that differ in their ability to respond to
exogenous stimuli such as growth factors (Regan et a!. 1991; Finesmith et a!. 1990).
It is possible therefore that the lack of response to therapeutic ultrasound observed
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here results from the use of an inappropriate fibroblast phenotype. The extracellular
matrix (ECM) component of the lattices used in this study is primarily type I
collagen. The ECM experienced by granulation tissue fibroblasts is far more complex.
Initially the ECM is rich in hyaluronic acid, fibronectin and collagen type III, but as
repair proceeds this is gradually replaced by an ECM predominantly composed of
type I collagen and suiphated proteoglycans. Further studies investigating the ability
of therapeutic ultrasound to modulate fibroblast-mediated contraction of FIPCLS,
composed of granulation tissue-derived fibroblasts seeded into a more granulation
tissue-like ECM are necessary to confirm the observations made in this study.
In summary, this investigation demonstrates that therapeutic ultrasound, at the
parameters employed and with a type I collagen matrix, does not promote fibroblast-
mediated collagen lattice contraction in vitro. If this in vitro observation can be
extrapolated to the process of wound contraction in vivo, it would appear that
ultrasound-stimulated wound contraction, reported in chapter 7(p2lS) and by Dyson
and Smalley (1983), is not due to a direct pro-contractile effect on fibroblasts.
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Chapter 10. The effect of therapeutic ultrasound on the release from platelets of
substances capable of modulating fibroblast activity in vitro.
10.1 Introduction
The inflammatory phase that occurs in response to tissue injury is essential to healing
(Clark, 1990). Platelets respond directly to vascular insult by adhesion and activation
of the blood coagulation system. Activated platelets also release a multitude of
biologically active substances, some of which are thought to encourage the onset of
later phases of repair. These active substances include various peptide growth factors
which are thought to initiate cell migration, proliferation and matrix synthesis within
the wound site (p3246).
Therapeutic ultrasound has been shown to enhance several aspects of wound
repair, in both the clinical and experimental arenas (chapter 4). However, its
mechanism and site of action are not fully understood. As treatment with ultrasound
has been shown to be particularly effective when applied during the inflammatory
phase of repair, it has been suggested that ultrasound interacts with some
component(s) of this phase.
The aim of this study was to examine the effect of therapeutic levels of pulsed
ultrasound on the release from platelets of substances capable of modulating the
proliferative and contractile capacity of human dermal fibroblasts in vitro.
The materials and methods employed in the exposure of platelets to
ultrasound and the subsequent generation of platelet releasates is described first. An
investigation into the effect of these ultrasonically generated platelet-releasates on
fibroblast proliferation in vitro is then described, followed by a further investigation
into the effect of similarly generated platelet releasates on fibroblast-mediated
collagen lattice contraction.
10.2 Insonation of human platelets - methodology
A human platelet stock suspension containing 1 x iO platelets per ml of platelet
washing buffer (PWB) (Appendix 1C, p334) was prepared according to Appendix 7,
(p341) and held on ice. (Note. One 450 ml transfusion bag full of freshly donated
blood is sufficient to prepare 20 ml of platelet stock solution). 4 ml volumes of this
platelet stock suspension were aliquoted into sterile, chilled, universal bottles, and
held on ice. The exposure chamber (Appendix 13, figure 13.1, p349) was then
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prepared and loaded, according to Appendix 13 (p 348) with the first aliquot. The
exposure chamber was located in the exposure tank (figure 10.1, p255) which was
lined with ultrasound-absorbent rubber (dimpled car matting) and filled with
circulating degassed distilled water at 4°C. The exposure tank was 40cm long, 25cm
wide and 25cm deep. The sample was insonated or sham-insonated for a period of
5 minutes. One aliquot, in each series, was neither insonated nor sham-insonated, but
treated with 1 unit of sterile thrombin (Diagnostic Reagents Ltd, UK) per ml of
platelet stock suspension at a temperature of 20°C for 5 minutes.
The therapeutic ultrasound source used in this study was a standard Enraf
Nonius Delft 434 Sonopuls machine (Enraf Nonius DeIft, Holland), set to deliver 3
MHz ultrasound (figure 7.2, p222). Prior to platelet exposure, ultrasonic output was
calibrated and the generator set to deliver a fixed ultrasonic intensity as described in
chapter 6 (p187).
Aliquots were allocated to the following treatment groups:
1. Sham-insonation
2. 3 MHz pulsed (2ms:8ms) ultrasound, Intensity 0.1 W/cm2 (i(sATA))
3. 3 MHz pulsed (2ms:8ms) ultrasound, Intensity 0.5 W/cm2 (I(sATA))
4. Thrombin - 1 unit per ml - incubated for 5 minutes
After insonation, shain-insonation, or thrombin exposure, platelet suspensions
were unloaded from the exposure chamber into sterile centrifuge tubes. The platelet
suspensions were then centrifuged at 950 x g to remove spent and remaining intact
platelets, and platelet debris. The resulting supernatant was termed the platelet
releasate for that treatment group. The releasates were then aliquoted into sterile
cryo-tubes and stored at -70°C until requiied for bioassay assessment by either the
methylene blue fibroblast proliferation assay (p 149) or the human dermal fibroblast-
populated collagen lattice contraction assay (p160).
Throughout the preparation of the platelet releasates, as described above, care
was taken to minimise platelet perturbation associated with handling. Such care
included the storage of platelet aliquots on ice throughout the procedure (with the





















10.3 The effect of ultrasound on the release from platelets of substances capable
of modulating fibroblast proliferation in vitro
10.3.1 Introduction
The methylene blue fibroblast proliferation assay (pl49), a modification of the
colorimetric assay described by Oliver et a! (1989), was use to investigate the effect
of ultrasonically generated human platelet releasates on the proliferation of human
dermal fibroblasts in vitro.
10.3.2 Method
The standard protocol for the "methylene blue fibroblast proliferation assay"
(Appendix 8, p342), was employed with the following modifications.
Sub-confluent human dermal fibroblast monolayers, passage 6, were
trypsinised (Appendix 4, p338), washed in fibroblast growth medium (Appendix 2B,
p335) and resuspended in the same, to a final concentration of 2 x iO viable cells/mi
(Appendix 6, p340). 100 ILl volumes of this suspension, each containing 2000 cells,
were aliquoted into 30 wells (i.e. filling all wells in columns 2, 3, 4, 5, and 6, with the
exception of those wells in rows A and H) of a 96 well flat-bottomed microtitre plate
(Appendix 9, p 343). 10 of the remaining wells (i.e. all wells in columns 2, 3, 4, 5, and
6 that did not receive the cell suspension) were filled with fibroblast growth medium
alone. Four replicate plates were set up in this manner. The plates were sealed and
placed in a 37°C incubator for 12 hours to allow for cell attachment.
After 12 hours, all 4 plates were removed from the incubator and the plate
sealing tape removed. One of the four plates, subsequently termed the 12 hour plate,
was "stopped" according to Appendix 8 steps 6 through 9 (p 342), and stored in a
dust- free environment. On each of the three remaining plates, one of each of the 5
columns of wells was then designated to receive one of the four releasates or the
vehicle, platelet washing buffer (PWB) (Appendix 1C, p334), alone. All 8 wells of a
given column, including cell-free wells, received lOOp.l of a given releasate (or PWB).
After thawing, platelet releasates were first stenlised with a 0.22 m millipore filter
and then diluted 1 in 10 with sterile phosphate buffered saline (Appendix 1A, p334)
prior to use.
Once all wells had received either 100 p.1 of one of the four platelet releasates
or PWB alone, the plates were resealed and returned to a 37°C incubator. Individual
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plates were subsequently "stopped" at 60, 108 and 156 hours post initial seeding with
fibroblasts, according to Appendix 8 steps 6 through 9 (p342). Plates stopped at 60
and 108 hours post fibroblast seeding were stored, with the 12 hour plate, in a dust
free environment until the 156 hour plate had been stopped and air dried.
Fibroblast monolayers within the wells were then stained with methylene blue
dye, washed with 0.01 M borate buffer and the dye eluted with acid-alcohol. The
absorbance (A650) of each well, on each plate, was then measured (Appendix 8, steps
10 through 12 p3'42). For each column of wells, and hence for each releasate under
test, the average A value of cell-free wells was subtracted from each of the A650
readings of cell-containing wells. The fibroblast number within a given well was then
calculated from this corrected absorbance reading using a standard plot of human
dermal fibroblast number versus A (Appendix 30B, p398). This standard plot was
prepared according to the method described on page 152, using the same primary
culture of fibroblasts at the same passage (p6) as was used for the fibroblast
proliferation assay described above.
Human dermal fibroblast proliferation in response to the application of each
of the four platelet releasates (and platelet washing buffer - the vehicle) was
compared at each of the four time points. The fibroblast proliferation data was
tabulated (see tables 10.1 through 10.5), displayed graphically (figure 10.2) and
analyzed using the non-parametric Mann Whitney-U test.
10.3.3 Results:
Figure 10.1 displays the change in median fibroblast number with time, in response
to each of the four platelet releasates and PWB. 95% confidence intervals are
indicated to aid interpretation. A summary of the statistical analysis for this
investigation can be found in Appendix 21 (p36!).
From figure 10.1, and according to statistical analysis, the following points are
apparent.
1. Fibroblast proliferation measured over 156 hours is most rapid in the presence
of the thrombin releasate (T-R) and slowest in the presence of the vehicle PWB at
all time points after the addition of releasates (i.e. after 12 hours). After 60, 108 and
156 hours there are significantly more fibroblasts (p < 0.005) within T-R treated
wells than in similar vehicle (PWB) treated wells.
2. The application of the sham-exposed platelet releasate (S-R) leads to more rapid
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fibroblast proliferation than that observed in the presence of the vehicle, PWB, alone,
with significantly more fibroblasts in S-R wells at 60 hours (p = 0.0 12), 108 hours (p
< 0.005) and 156 hours (p < 0.005) post initial seeding.
3. Insonation of platelets with 3 MHz ultrasound at an intensity, 1(SATA), of 0.1 WIcm2
leads to the generation of a platelet releasate (0.1-R) with a greater stimulatory
activity for the proliferation of fibroblasts than that of the platelet releasate
generated by sham-insonation (S-R), with significantly more fibroblasts in 0. 1-R wells
at 108 (p < 0.005) and 156 hours (p = 0.036) post initial seeding. At the 60 hour
time point, fibroblast number was not significantly different in those wells that
received 0.1-R compared with those wells that received the sham-insonated platelet
releasate, S-R.
4. Fibroblast proliferation is more rapid in the presence of the releasate (0.5-R)
generated by the exposure of platelets to 3 MHz ultrasound at an intensity, j(SATA)
of 0.5 W/cm2 than in the presence of the sham-insonated platelet releasate, with
significantly more fibroblasts in ultrasound-treated platelet releasate wells at 108 (p
= 0.036) and 156 (p < 0.005) hours post initial seeding. In parallel with the
comparison of the 0.1 W/cm 2 releasate with the sham-insonated releasate, fibroblast
number was not significantly different in those wells that received 0.5-R compared
with those wells that received S-R at 60 hours post seeding.
5. Though small differences are apparent from the data, there appear to be no
significant differences in the rate of fibroblast proliferation observed in response to
application of the 0.1 W/cm 2 ultrasound releasate compared with that observed in
response to the application of the 0.5 W/cm2 ultrasound releasate, at any time point.
6. Fibroblast proliferation was significantly more rapid in response to the thrombin
platelet releasate than in response to the 0.1 W/cm 2 ultrasound platelet releasate,
with significantly more fibroblasts present in the T-R wells at all time points (p <
0.005).
7. Fibroblast proliferation was more rapid in response to the thrombin platelet
releasate than in response to the 0.5 W/cm2 ultrasound platelet releasate, with
significantly more fibroblasts present in T-R wells at the 108 (p < 0.030) and 156 (p
<0.020) hour time points. Though there were more fibroblasts in thrombin releasate
wells than in 0.5 W/cm2 releasate wells at the 60 hour time point, this difference did
not reach statistical significance (p = 0.065).
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Table 10.1 The effect of platelet washing buffer on the proliferation of p6 human












































Table 10.2 The effect of thrombin platelet releasate, prepared by incubating a
standard platelet suspension with thrombin at a concentration of 1.0































































































































Table 10.3 The effect of the sham-insonated platelet releasate, prepared by sham-
insonating a standard platelet suspension, on the proliferation of p6
human dermal fibroblasts in vitro.
Table 10.4 The effect of the 0.1 W/cm2 insonated platelet releasate, prepared by
insonating a standard platelet suspension with 3 MHz pulsed ultrasound
at an intensity J(SATA) of 0.1 W/cm2, on the proliferation of p6 human











































Table 10.5 The effect of the 0.5 W/cm2 insonated platelet releasate, prepared by
insonating a standard platelet suspension with 3 MHz pulsed ultrasound
at an intensity 1(SATA) of 0.5 W/cm 2, on the proliferation of p6 human
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From the results described above it would appear that therapeutic ultrasound, at the
parameters used here, is capable of indirectly stimulating fibroblast proliferation in
vitro by first interacting with platelets.
The fibroblast performs many essential functions during cutaneous repair.
Early in the repair process fibroblasts elaborate a provisional matrix rich in
fibronectin and hyaluronic acid, and supplemented with collagen types III and 1;
which provides a substrate on which macrophages (Ciano et a!. 1986), new blood
vessels (Madri and Pratt, 1988) and fibroblasts themselves (McCarthy et a!. 1988) can
migrate into the wound. Fibroblasts generate the forces necessary to facilitate the
process of wound contraction (Ehrlich, 1988; Gabbiani et a!. 1971), and are
responsible for the process of matrix remodelling. During remodelling, the
provisional fibroblast-generated matrix is gradually replaced, primarily by the activity
of fibroblasts, by a mechanically superior matrix primarily composed of bundles of
type I collagen (Clark, 1990).
The accumulation of fibroblasts into the wound site is thought to entail both
fibroblast migration and proliferation. Fibroblast proliferation is thought to be under
the control of a variety of stimuli including various peptide growth factors (table 1.3,
p39). Many of these growth factors are present in the a-granules of platelets
(Knighton et a!. 1990) and are thought to be deposited within wounds following
platelet degranulation. The platelet-derived growth factors reported to be mitogenic
for fibroblasts include platelet-derived growth factor [PDGF] (Ross et a!. 1986),
transforming growth factor-beta [TGF-13J (Moses et a!. 1985) which may not be
directly mitogenic (Loef et a!. 1986), transforming growth factor-alpha [TGF-a]
(Delarco and Todaro, 1978), basic fibroblast growth factor [bFGF] (Raines and Ross,
1989), and platelet-derived endothelial cell growth factor [PD-ECGF] (Pierce et a!.
1991; Miyazono and Heldin, 1989).
As platelet adhesion, degranulation and the concomitant elaboration of a-
granule components are some of the earliest events in response to injury, and
treatment with ultrasound soon after injury is conducive to a stimulation in repair
(Dyson et a!. 1970; Dyson and Pond, 1970; Webster et a!. 1979; Dyson and Smalley,
1983; Young and Dyson 1990a,c; Byl et a!. 1992) it is possible that platelets are one
the responsive biological targets for ultrasound within the wound site.
An increase in the level of platelet-derived fibroblast mitogens following
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treatment with ultrasound may explain several literature reports on ultrasound
bioeffects, including the observations that: fibroblasts are recruited more rapidly into
insonated rat skin wounds than into similar sham-insonated wounds (Young and
Dyson 1990a); insonated rabbit ear wounds demonstrate a greater level of 3H-
thymidine labelling than sham-insonated wounds (Dyson et a!. 1970); insonated
cryosurgical rat skin lesions contract more rapidly than similar sham insonated lesions
(Dyson and Smalley, 1983); the temporal scheme of matrix deposition advances more
rapidly in insonated murine granulomata than in non-insonated granulomata
(Pospisilova et a!. 1971; Pospisilova and Rottova, 1977), and the collagen content of
rat skin wounds 7 days after injury is greater in insonated than sham-insonated
wounds (Webster et a!. 1979).
In summary, this investigation demonstrates that clinical levels of therapeutic
ultrasound promote the release of substances from platelets that are mitogenic for
fibroblasts. If the observations made in this in vitro study can be extrapolated to the
process of cutaneous repair in vivo, it is possible that the stimulation in wound
contraction following treatment with ultrasound (reported in chapter 7), may be due
to an increase in fibroblast recruitment into the wound site mediated by an elevated
release of platelet-derived fibroblast mitogens.
10.4 The effect of ultrasound on the release from platelets of substances capable
of modulatin2 fibroblast-mediated colla2en lattice contraction.
10.4.1 Introduction
The contraction of human dermal fibroblast populated collagen lattices, a widely
accepted model of the process of wound contraction in vitro (Ehrlich and
Rajaratnam, 1990), in response to the application of the different platelet releasates
produced as described above (section 10.2, p253) was investigated.
10.4.2 Method
Thirty standard fibroblast populated collagen lattices were prepared according to
steps 1 through 6 of the "human dermal fibroblast collagen lattice contraction assay -
standard protocol (Appendix 10, p344). After polymerisation and lattice release, the
30 lattices were randomly allocated into 5 groups, each containing 6 lattices. All 6
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lattices of each group received a 1 ml aliquot of one of the 4 different platelet
releasates or PWB (Appendix 1C, p344), diluted 1:9 with sterile PBS (Appendix 1A,
p 344). Once all 30 lattices had been "fed" in this manner they were placed in a
humidified box and returned to the 37°C incubator. All thirty lattices were
photographed (Appendix hA, p34 .5) at 4.00, 13.50, 26.00, 42.00 and 51.25 hours after
initial plating and the film developed according to Appendix 11B (p34.6). The area
of each lattice, in mm 2, was then measured by computer-assisted planimetry
(Appendix 12, p347).
Median lattice area, minimum and maximum lattice area, and 95% confidence
intervals were calculated for each group of lattices (i.e. in response to each platelet
releasate or PWB) at each time point (tables 10.6 through 10.10 p 267-269) and the
data was graphically displayed (figure 10.3, p270). Non-parametric statistical analysis
was performed to examine the modulation in the rate of lattice contraction in
response to different platelet releasates. Initially, a Kruskal Wallis test which was
used to compare all 5 groups, at each time point, was carried out as an indicator for
further statistical analysis. According to the Kruskall Wallace analysis, further two
sample analyses were carried out between specific treatment groups using the Mann
Whitney-U test.
10.43 Results
Figure 10.3 (p270) displays the change in lattice area (mm 2) with time (hours) in the
form of a bar chart. For each time point there is a cluster of 5 bars, one for each
platelet releasate and PWB. The maximum height of each bar represents the median
area of the 6 lattices within the group. 95% confidence intervals are displayed (1) to
show the distribution of points within each data group, and (2) to indicate the
significance of apparent differences in median lattice areas between exposure groups.
A summary of the statistical analyses carried out on this data can be found in
(Appendix 22, p 365 - 368). Initial statistical analysis, using the Kruskal Wallace test,
indicated that significant differences were present between the 5 experimental groups
under study, at all time points (Appendix 22, table 1, p 365), thus indicating the
requirement for further analysis between groups using the Mann Whitney-U test.
From figure 10.3 and according to statistical analysis the following points are
apparent:
1. Fibroblast-mediated collagen lattice contraction occurs in response to the
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application of all releasates and PWB. Those lattice that received the thrombin
releasate (T-R) demonstrated the most rapid contraction; whereas those that received
the vehicle (PWB) only, demonstrated the slowest contraction. Non-parametric
analysis indicated that contraction was significantly more rapid in response to T-R
than PWB, leading to significantly smaller lattices (p < 0.05) at all time points
(Appendix 22, table 2, p365).
2. The rates of contraction of lattices in response to the two insonated platelet
releasates (i.e. platelets insonated at ultrasonic intensities, 1(SATA), of 0.1 W/cm 2 and
0.5 WIcm2) and the sham-insonated platelet releasate, were found to be intermediate
between those in response to T-R and PWB. An visible, though not always
statistically significant, trend is apparent at all time points, whereby T-R results in the
most rapid contraction, followed by the less rapid 0.1 W/cm2 releasate, then the 0.5
W/cm2 releasate, the sham releasate and finally the vehicle (PWB) alone.
3. When the rate of contraction in response to the sham-exposed platelet releasate
(S-R) is compared to that of PWB, it would appear from figure 10.3 that the S-R
leads to greater lattice contraction that PWB. This difference proved to be
statistically significant at several time points, i.e. 4.00 hours (p < 0.008), 13.50 hours
(p < 0.005) and 26.00 hours (p < 0.020), but not at 42.00 hours (p < 0.093) and
51.25 (p < 0.298) hours post plating (Appendix 22, table 3, p366).
4. Insonation of platelets with 3 MHz ultrasound at an intensity, 1(SATA), of 0.1 W/cm2
leads to the generation of a platelet releasate (0. 1-R) with a greater stimulatory
activity for fibroblast-mediated lattice contraction than that of S-R, the platelet
releasate generated by sham-insonation, resulting in significantly smaller lattices in
response to the 0.1-R than SR, at 4.00 (p < 0.005), 13.50 (p = 0.031), 26.00 (p <
0.008), 42.00 (p <0.008) and 51.25 (p < 0.008) hours after initial plating (Appendix
22, table 4, p 366).
5. Fibroblast-mediated contraction in response to the platelet releasate 0.5-R,
generated by insonation of platelets with 3 MHz ultrasound at an intensity, 1(SATA),
of 0.5 W/cm2, is initially more rapid than that in response to the shain-insonated
releasate (SR), resulting in significantly more contraction in response to 0.5-R than
S-R by 4.00 hours (p < 0.020). The data in tables 10.8 and 10.10, represented in
figure 10.3, indicates that the median lattice area values of 0.5-R are
lower than S-R at all time points. However, after the 4.00 hour time point, these
differences proved not to be statistically significant, with the exception of 42.00
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Table 10.6 The effect of platelet washing buffer on the contraction of human
dermal fibroblast-populated collagen lattices in vitro.
Time post-plating (hours)
4.00	 13.50 j_26.00J_42.00J_51.25
Number of replicate	 6	 6	 6	 6	 6
lattices
Median lattice area	 759.6	 587.2	 375.8	 301.4	 236.7(mm2)	 ______ ______ ______ _______ ______
Minimum	 734.5	 570.6	 368.1	 287.7	 216.5
and maximum	 to	 to	 to	 to	 to
(mm2)	 776.8	 599.1	 397.1	 330.5	 246.8
95%	 741.7	 575.1	 367.7	 287.1	 220.0
confidence interval 	 to	 to	 to	 to	 to
(mm 2)	 774.3	 595.5	 390.4	 322.7	 246.4
Table 10.7 The effect of adding the thrombin platelet releasate, prepared by
incubating a standard platelet suspension with thrombin at a
concentration of 1.0 units per ml, on the contraction of human dermal
fibroblast-populated collagen lattices in vitro.
Time post-plating (hours)
4.00	 13.50	 26.00	 42.00	 51.25
Number of replicate	 6	 6	 6	 6	 6
lattices
Median lattice area 	 617.3	 499.9	 288.3	 220.6	 177.6(mm2)	 ______ ______ ______ _______ ______
Minimum	 600.8	 483.1	 277.7	 210.1	 167.2
and maximum	 to	 to	 to	 to	 to
(mm2)	 646.2	 553.8	 338.5	 246.3	 207.6
95%	 604.6	 479.0	 274.5	 209.2	 165.5
confidence interval	 to	 to	 to	 to	 to
(mm 2 )	 637.3	 537.2	 328.0	 236.7	 197.1
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Table 10.8 The effect of adding the sham-insonated platelet releasate, prepared
by sham-insonating a standard platelet suspension, on the contraction
of human dermal fibroblast-populated collagen lattices in vitro.
Time post-plating (hours)
4.00	 13.50	 26.00	 42.00	 52.25
Number of replicate	 6	 6	 6	 6	 6
lattices
Median lattice area	 707.5	 559.2	 355.4	 282.3	 223.7(mm 2)	 ______ ______ ______ ______ ______
Minimum	 676.3	 535.7	 323.4	 269.3	 203.9
	
and maximum	 to	 to	 to	 to	 to
(mm 2)	 741.8	 570.4	 372.2	 314.9	 236.8
95%	 681.2	 539.5	 331.2	 270.3	 211.2
	
confidence interval 	 to	 to	 to	 to	 to
(mm 2)	 735.0	 571.1	 371.2	 305.2	 233.7
Table 10.9 The effect of adding the 0.1 W/cm 2 insonated platelet releasate,
prepared by insonating a standard platelet suspension with 3 MHz
pulsed (2ms:8ms) ultrasound at an intensity 1(SATA) of 0.1 W/cm2, on the
contraction of human dermal fibroblast-populated collagen lattices in
vitro.
Time post-plating (hours)
4.00	 13.50	 26.00	 42.00	 51.25
Number of replicate	 6	 6	 6	 6	 6
lattices
Median lattice area 	 639.8	 524.0	 308.0	 238.5	 197.6(mm2)	 ______ ______ ______ ______ ______
Minimum	 607.5	 509.0	 288.5	 215.7	 182.6
and maximum	 to	 to	 to	 to	 to
(mm2)	 667.9	 547.9	 336.6	 272.3	 210.2
95%	 618.9	 508.7	 293.7	 221.8	 187.7
confidence interval	 to	 to	 to	 to	 to
(mm2)	 659.1	 542.0	 324.3	 260.5	 206.9
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Table 10.10 The effect of adding the 0.5 W/cm2
 insonated platelet releasate,
prepared by insonating a standard platelet suspension with 3 MHz
pulsed (2ms:8ms) ultrasound at an intensity 1(SATA) of 0.5 W/cm 2, on the
contraction of human dermal fibroblast-populated collagen lattices in
vitro.
Time post-plating (hours)
4.00 J_13.50 J_26.00J_42.00	 51.25
Number of replicate 	 6	 6	 6	 6	 6
lattices
Median lattice area
	 668.8	 537.1	 331.4	 243.9	 209.6(mm2)	 ______ ______ ______ ______ ______
Minimum	 648.0	 504.0	 304.2	 220.9	 192.2
	
and maximum	 to	 to	 to	 to	 to
(mm2)	 696.3	 554.1	 381.3	 283.1	 233.9
95%	 652.9	 508.0	 307.9	 226.0	 196.4
	
confidence interval	 to	 to	 to	 to	 to
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hours post plating (p < 0.020) (Appendix 22, table 5, p 367).
6. From the data in tables 10.9 (p268) and 10.10 (p269), and figure 10.3 (p270), the
rate of fibroblast-mediated contraction in response to the 0. 1-R is more rapid than
that observed in response to the 0.5-R. At all time points studied, median lattice area
values are consistently smaller in those lattices given 0.1-R than those given 0.5-R.
However, with the exception of the 4.00 hour time point (p < 0.020), this response
trend does not attain statistical significance (Appendix 22, table 8, p368).
7. From a comparison of the median data (tables 10.7 and 10.9, and figure 10.3) the
rate of fibroblast-mediated contraction following the application of the thrombin
releasate (T-R), to standard lattices is more rapid than the response to the 0. 1-R.
Non-parametric analysis was, however, unable to detect any statistically significant
difference at any time point post-plating (Appendix 22, table 6, p 367).
8. When lattice contraction in response to the addition of the thrombin releasate (T-
R) was compared with that in response to the addition of the ultrasonically generated
0.5-R platelet releasate, it became apparent that contraction in response to the T-R
is more rapid than that in response to the 0.5-R. This observation is substantiated by
statistical analysis at 4.00 (p < 0.005), 42.00 (p < 0.045) and 51.25 (p < 0.020) hours
post plating. Statistical analysis failed to demonstrate any significance in this trend
at 13.5 and 26.00 hours post plating (Appendix 22, table 7, p 368).
10.4.4 DiscussIon
From the results described above it would appear that therapeutic ultrasound, at the
parameters used in this thesis, is capable of indirectly stimulating fibroblast-mediated
collagen lattice contraction in vitro by first interacting with platelets.
FPCLS supplemented with the releasate from insonated platelets exposed to
an intensity of 0.1 W/cm 2 contracted more rapidly than lattices supplemented with
the releasate from 0.5 W/cm2 insonated platelets, which in turn contracted more
rapidly than those given the sham-insonated platelet releasate. While statistically
significant differences were consistently observed between the 0.1 W/cm 2 and the
sham releasate, few significant differences in pro-contractile activity were found
between the 0.5 W/cm2 and either the sham or the 0.1 W/cm2 releasate. The
thrombin platelet releasate, which was employed as a positive control for maximal
platelet degranulation (see general discussion, section 10.5, p 273), was found to
display the largest pro-contractile activity at all time points. The negative vehicle
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control (i.e. PWB) was found to display the smallest pro-contractile activity at all
time points. The observation that the sham-insonated releasate exhibited more pro-
contractile activity than the vehicle control suggests that platelet degranulation had
occurred within the former. Such degranulation may have been spontaneous or
handling-induced.
As platelet a-granules are known to be stores of preformed growth factors,
many of which have been shown to promote FPCL contraction, and supernatants of
insonated platelets similarly promote FPCL contraction, it would appear that
ultrasound acts to liberate these factors from a-granule storage. Platelet-derived
factors previously reported to promote FPCL contraction in vitro include: TGF-13
(Montesano and Orci, 1988; Finesmith et a!. 1990); PDGF (Anderson et a!. 1990;
Clark et a!. 1989) and bFGF (Finesmith et a!. 1990). However, it has been suggested
that TGF-f3 acts indirectly to promote lattice contraction by first inducing PDGF
synthesis by fibroblasts, which then acts in an autocrine fashion to promote fibroblast-
mediated contraction (Clark et a!. 1989). Interestingly, basic fibroblast growth factor
(bFGF) has been shown to promote contraction at low doses (0.1-1.0 ng/ml), but,
inhibit contraction at high doses (>lOng/ml) (Finesmith eta!. 1990). It is thought that
certain growth factors, including IL- 1/3 and TGF-/3, promote lattice contraction by
upregulating integrin expression on the surface of cells within the lattice (Heino and
Massague, 1989; Milam et a!. 1991).
While the growth factors described above are known to be mitogenic to
fibroblasts in planar culture, similar mitogenic effects are not observed in free-
floating collagen lattices (Nakagawa et a!. 1989; Nishiyama et a!. 1990; Rhudy and
McPherson, 1988). One possible exception to this statement is PDGF which has been
reported to be mitogenic to fibroblasts in fully contracted collagen lattices (Nishiyama
et a!. 1991), but without mitogenic effect during the contraction process (Clark et a!.
1989). It has been suggested that human fibroblasts do not proliferate in FPCL (Paul
Ehrlich - personal communication), however, the majority of evidence suggests that
proliferation does occur albeit at a severely retarded rate (Rhudy and McPherson,
1988; Nishyama et a!. 1989). It would appear from the literature that fibroblasts
proliferate very poorly within collagen lattices and further that they are refractive to
the mitogenic effects of growth factors. Consequently, the observations made in this
study, whereby different platelet releasates differentially influence FPCL contraction,
indicate that the different releasates are affecting lattice contraction by influencing
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the ability of individual fibroblasts to contract the lattice, rather than influencing the
number of fibroblasts within the lattice.
Ultrasound may indirectly enhance the capacity of individual fibroblasts to
contract their extracellular matrix by first promoting the degranulation of platelets
at the wound site. As it has previously been reported that therapeutic levels of
ultrasound are unable to initiate the processes of platelet aggregation and
degranulation during insonation of undamaged vasculature in vivo (Williams et a!.
1981; Chater and Williams, 1982), it is possible that ultrasound may act in such a
manner as to promote additional platelet degranulation once initiated by injury.
The elaboration of supplementary pro-contractile activity from platelets within
cutaneous wounds as a consequence of exposure to therapeutic ultrasound may
explain the observation that therapeutic ultrasound applied soon after injury
promotes the process of contraction in both cryosurgical (Dyson and Smalley, 1983)
and mechanical wounds (chapter 7 of this thesis, p218).
In summary, this investigation demonstrates that therapeutic ultrasound, at the
parameters employed, promotes the release of substances from platelets that
encourage the process of fibroblast-mediated collagen lattice contraction in vitro. If
the observations made in this in vitro study can be extended to the process of
cutaneous repair in vivo, it is possible that therapeutic ultrasound promotes wound
contraction by encouraging the release of pro-contractile substances from platelets.
10.5 General discussion of the effects of platelet releasates
This section includes discussion points common to both the effect of platelet
releasates on fibroblast proliferation and fibroblast-mediated lattice contraction.
1. Positive control
During this study, a thrombin releasate was used as a positive control for maximal
platelet degranulation against which the effect of ultrasound-mediated degranulation
could be measured. Platelets were treated with thrombin at a concentration of 1
unit/mi, a concentration that has previously been reported to cause maximal a-
granule release (Assoian and Sporn, 1986). Of the various methods available to
degranulate platelets thrombin was chosen as it has been identified as a physiological
agonist for platelet degranulation at wound sites (Hoimsen et a!. 1981).
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2 Mechanism of ultrasonic degranulation
Several studies examining the effect of ultrasound on platelet activity have been
previously reported. Such studies were carried out due to concern over the hazards
of inadvertently causing a haemostatic reaction during the clinical use of this
modality, rather than in anticipation of a beneficial therapeutic interaction. Several
in vitro studies have reported that ultrasound can promote platelet degranulation and
aggregation. Williams eta!. (1976a) was unable to demonstrate platelet damage using
1 MHz ultrasound at intensities as low as 0.065 W/cm 2 (1(a)), but they reported that
such an insonation could speed the clotting process of recalcified anticoagulated
whole blood, an effect later attributed to limited damage of a small sub-population
of platelets, rather than ultrasound-stimulated physiological degranulation, (Williams
et a!. 1976b). Further evidence to support ultrasound-induced platelet damage came
from the work of Williams et a!. (1978), who reported platelet degranulation
following insonation even when the physiological platelet release mechanism had
been chemically inhibited. As heat is rapidly dissipated from cells insonated in vitro,
and in view of the observation that the magnitude of ultrasonic effects on platelets
decreases with increasing ultrasonic frequency (Chater and Williams, 1977) cavitation
has been implicated in platelet damage. While ultrasound has been shown to
encourage platelet degranulation in vitro, the majority of evidence suggests that
therapeutic levels of ultrasound cannot similarly damage platelets in vivo in the
absence of previous injury even at ultrasonic intensities far in excess of the
therapeutic range (Williams et a!. 1981; Chater and Williams, 1982). In vivo studies
to date have studied the effects of ultrasound on undamaged blood vessels. It is
possible that the application of ultrasound to sites of damaged vessels may encourage
additional platelet activity, possibly encouraging the repair process by promoting the
release of growth factors and other stimulatory agents, rather than acting as an
initiator of platelet adhesion and degranulation. However, as cavitation has yet to be
conclusively demonstrated during exposure to therapeutic ultrasound in vivo
(Watmough et a!. 1991), it is possible that ultrasound-induced platelet degranulation
is an event that is restricted to in vitro studies.
3. Platelet-derived wound healing formula
It has been reported that a platelet releasate preparation, termed platelet-derived
wound healing formula (PDWHF), generated by incubating platelets with thrombin,
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encourages the repair of chronic cutaneous wounds (Knighton et a!. 1986; Knighton
et a!. 1990). Other studies have demonstrated that PDWHF is chemotactic to rabbit
wound endothelial cells (Fiegel et a!. 1990) and can promote neovascularisation in
the rabbit cornea angiogenesis assay in vivo (Knighton et a!. 1982). As therapeutic
ultrasound has been shown to (1) degranulate platelets in vitro, generating platelet
releasates with mitogenic and pro-contractile activities on a par with a thrombin
releasate, (2) has previously been shown to promote the repair of chronic wounds
including venous ulcers (Dyson et a!. 1976; Callam et a!. 1987) and pressure sores
(McDiarmid et a!. 1985), and, (3) has been reported to promote angiogenesis in the
rat flank skin wounds (Young and Dyson, 1990c), it is tempting to link these
observations and propose that one of the biological targets of therapeutic ultrasound
during cutaneous repair is the platelet.
4. Ultrasonic intensity
It is apparent from the results described above that the use of the higher ultrasonic
intensity of 0.5 W/cm2 (I(sATA)) had no additional effect on the release of pro-
proliferative substances from platelets above that observed at an intensity of 0.1
W/cm2, an observation that parallels the effect of ultrasonic intensity on wound
contraction in vivo (chapter 7). Such an observation suggests that maximal platelet
degranulation is achieved at the lower intensity. The observation that the thrombin
releasate tended to promote proliferation and fibroblast-mediated lattice contraction
to a greater level than insonated platelet releasates, may be a consequence of the
activity of thrombin itself, as thrombin has been shown to be mitogenic for some
fibroblast cell lines in vitro (Glenn and Cunningham, 1979; Seuwen and Pouyssegur,
1991).
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Chapter 11. The effect of therapeutic ultrasound on the release from U937s
(monocyte/macrophage-ilke cells) of substances capable of modulating
fibroblast activity in vitro.
11.1 Introduction
It was initially thought that the primary function of the macrophage was the removal
and degradation of injured tissue debris in anticipation of the repair process.
However, in 1975, Leibovich and Ross demonstrated that the macrophage plays a key
role in the orchestration and execution of both degradative and reparative phases of
repair. They showed that the depletion of both circulating blood monocytes and
tissue macrophages not only severely retarded tissue debridement but also impaired
fibroblast proliferation and subsequent wound fibrosis.
Upon entering the wound tissue, monocytes undergo a rapid metamorphosis
to macrophages in response to the wound environment (Riches, 1988). Macrophages
not only phagocytose bacteria and scavenge tissue debris, but also generate
chemotactic factors which recruit additional inflammatory cells and release enzymes
which augment tissue degradation (Tsukamoto et a!. 1981). In addition to their role
in tissue debridement, macrophages are thought to release growth and regulatory
factors critical for granulation tissue formation. Early studies by Leibovich and Ross
(1976) reported that peritoneal macrophages cultured in vitro secreted growth factor
activity called macrophage-derived growth factor (MDGF) which stimulated the
proliferation of guinea pig wound fibroblasts. MDGF, secreted by activated
macrophages, has also been shown to stimulate the proliferation of smooth muscle
cells (Greenburg and Hunt 1978; Glenn and Ross, 1981; Martin et a!. 1981), arterial
endothelial cells (Greenburg and Hunt, 1978; Martin et a!. 1981) and mouse
keratinocytes (Ristow, 1986.) It has since been realised that MDGF activity is a
combination of several well characterised growth factors (Raines and Ross, 1989).
The factors macrophages are known to secrete include platelet-derived growth
factor (PDGF) (Shimokado et a!. 1985; Martinet et a!. 1986), basic fibroblast growth
factor (bFGF) (Baird et a!. 1985), transforming growth factor-J3 (TGF-/3) (Assoian et
a!. 1987), insulin-like growth factor-i (IGF-i) (Rom et a!. 1989), tumour necrosis
factor-a (TNF-a) (Kreigler et a!. 1988), the epidermal growth factor-related
transforming growth factor-a (TGF-a) (Madtes et a!. 1988), interleukin-1 (IL-i)
(Postlethwaite et a!. 1983) and fibroblast-activating factor (FAF) (Dohiman et a!.
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1984). Further, macrophages within wounds have been shown to contain mRNA
transcripts for TGF-a TGF-(3, PDGF A-chain and insulin-like growth factor 1 (IGF-
1) (Rappolee et a!. 1988) These and possibly other, as yet uncharacterised, growth
factors are thought to orchestrate the process of wound repair (refer to Chapter 1
for a discussion of growth factor activities within wound repair). Thus macrophages
are able to play a pivotal role in the process of wound repair, elaborating substances
(growth factors) that regulate fibroblast proliferation, migration, matrix synthesis and
degradation, and the process of fibroblast-mediated contraction.
The U937 cell (Chapter 5, p145) is a widely accepted model for monocyte-
macrophages in many areas of biomedical investigation (Mace and Gazzolo, 1991;
Cianciotto et a!. 1990; Dragunsky et a!. 1990; Peck and Bollag, 1991; McDonald and
Atkins, 1990). The U937 is a neoplastic cell of the monocytic lineage, sharing many
morphological, histochemical and functional characteristics of immature monocyte-
macrophages (Sundstrom and Nilsson, 1976; Harris and Ralph 1985; Lyons and
Ashman, 1989). While the immature (uninduced) U937 is monoblastic, it can be
induced to differentiate further along the monocyte-macrophage lineage by exposure
to various inducing agents including phorbol esters (Lyons and Ashman, 1989). This
induced differentiation involves phenotypic changes that resemble those during the
terminal differentiation of normal monocytic cells (Pednnaci et a!. 1990). U937s have
been shown to be capable of synthesizing many of the macrophage-derived growth
factors thought to mediate the process of wound repair, including PDGF (Alitalo et
a!. 1987; Makela et a!. 1987), TGF-/3 (Assoian et a!, 1987; Wager and Assoian, 1990),
FAF (Turck et a!. 1988; Turck et a!. 1989: Demeter et a!. 1991), IGF-1 (Nagoaka et
a!. 1990), IL-i (Palacios et a!. 1982, Barak et a!. 1986) and TNF-a (Sabatini et a!.
1990) (Chapter 5, p146).
Therapeutic ultrasound has been shown to encourage various aspects of
dermal repair (Chapter 4, p107), including wound contraction (Chapter 7, p218), and
has previously been found to be most effective when applied during the inflammatory
phase of repair, a time when macrophages are most numerous, and presumably most
active. The studies described within this chapter were carried out in an attempt to
examine the ability of therapeutic levels of ultrasound to modulate fibroblast activity
indirectly by first interacting with macrophages. Previous in vitro studies within this
thesis (p234 & 244) appear to indicate that fibroblasts are unable to respond directly
to therapeutic ultrasound to bring about the stimulation in wound contraction
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reported in chapter 7 (p218), and previously by Dyson and Smalley (1983).
The aim of this study was to examine the effect of therapeutic levels of pulsed
3 MHz ultrasound on the release from U937s of substances capable of modulating
the proliferative and contractile capacity of human dermal fibroblasts in vitro.
Experimental overview
The macrophage-like cell line, U937, was employed in this study. Both uninduced and
PMA-induced U937 cultures were either: insonated with 3 MHz pulsed therapeutic
ultrasound (at intensities of 0.1 or 0.5 W/cm2, 1(SATA)) sham-insonated or left
uninsonated. After 24 hours, the media "bathing" these U937 cultures (i.e.
conditioned medium) were removed and assayed for their ability to modulate both
fibroblast proliferation and fibroblast-mediated collagen lattice contraction compared
with non-conditioned medium.
After a description of how the various U937 conditioned media were
generated (section 11.3, p279) a study carried out to examine the effect of U937
conditioned media on fibroblast proliferation in vitro is described (section 11.4, p284.).
Section 11.4 initially describes how fibroblast proliferation, in response to the various
U937 conditioned media (from both uninduced and PMA-induced U937s), was
studied (11.4.1. & 11.4.2., p2&I). The results obtained are then described and
discussed. For the sake of clarity, fibroblast proliferation in response to the
application of conditioned media from (1) uninduced U937s and (2) PMA-induced
U937s is described, and discussed, separately. The effect of conditioned media from
uninduced U937s is described in section 11.4.3 (p286) and discussed in section 11.4.4.
(p291). The effect of conditioned media from PMA-induced U937s is described in
section 11.4.5 (p29'7) and discussed in section 11.4.6. (p303).
Section 11.5 initially describes how FPCL contraction, in response to the
various U937 conditioned media (from both uninduced and PMA-induced U937s),
was studied (11.5.1. & 11.5.2, p307). The results obtained are then described and
discussed. Like the proliferation studies described above, FPCL contraction in
response to the application of conditioned media from (1) uninduced U937s and (2)
PMA-induced U937s is described, and discussed, separately. The effect of
conditioned media from uninduced U937s is described in section 11.5.3 (p308) and
discussed in section 11.5.4. (p314). The effect of conditioned media from PMA-
induced U937s is described in section 11.5.5 (p317) and discussed in section 11.5.6.
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(p313). The chapter ends with a general summary of observations and conclusions
(section 11.6, p324).
11.3 Insonation of U937s - generation of U937 conditioned media
U937 cells were cultured at 37°C in 80 cm2 tissue culture flasks (Nunc, Denmark) in
RPMI-1640 medium containing 10% (v/v) heat-inactivated fetal calf serum (FCS),
100 pg/mi streptomycin, 100 units/mi penicillin (macrophage growth medium,
Appendix 2E, p336) according to Turck et al (1989). A U937 suspension was
prepared at a concentration of 1 x 106 viable cells/mi in macrophage growth medium.
This suspension was divided into two aliquots and then centrifuged for 5 minutes at
80 x g. The two cell pellets thus obtained were washed twice with serum-free growth
medium and then resuspended to 1 x 106 viable cells/mi in either: A. Serum-free
macrophage growth medium (Appendix 2G, p337), or, B. Serum-free macrophage
growth medium containing 100 ng/ml of the phorbol ester 43-phorbo1 12-myristate
13-acetate (PMA) (Appendix 2H, p337), thus forming two U937 stock suspensions:
A. Non-PMA exposed U937s
B. PMA exposed U937s
4mi volumes of these two U937 stock suspensions were aliquoted into sterile,
universal bottles, and held at approximately 20°C (room temperature). The exposure
chamber (Appendix 13, figure 13.1, p 349) was then prepared and loaded, according
to Appendix 13 (p348), with the first aliquot. The exposure chamber was located in
the exposure tank (figure 11.1) which was lined with ultrasound absorbent rubber
(dimpled car matting) and filled with circulating degassed distilled water at 37°C. The
exposure tank was 40cm long, 25cm deep and 25cm wide. U937 samples were
insonated with 3 MHz pulsed (2ms:8ms) ultrasound at intensities, 1(SATA), of 0.1
W/cm2
 or 0.5 W/cm2, or sham-insonated, for a period of 5 minutes. One aliquot of
each U937 stock suspension, termed non-insonated was left untreated (i.e. neither
insonated nor sham-insonated).
The therapeutic ultrasound source used in this study was a standard Enraf
Nonious Deift 434 Sonopuls machine (Enraf Nonius Deift, Holland), set to deliver
3 MHz ultrasound (figure 7.2, p222). Prior to U937 exposure, ultrasonic output was
calibrated and the generator set to deliver a fixed ultrasonic intensity - as described
in chapter 6 (p187).
After treatment, U937 suspensions were unloaded from the exposure chamber
279
(or from the universal bottle in the case of the non-insonated aliquot) and decanted
into sterile centrifuge tubes and centrifuged at 80 x g for 5 minutes. Supernatants
were discarded and cell pellets resuspended to 1 x 106 cells per ml in serum-free
growth medium with or without PMA according to which U937 stock suspension the
treated sample originated from. U937 suspensions were then transferred to culture
flasks and returned to a 37°C incubator, where they remained for a period of 24
hours. Cell-free flasks of serum-free macrophage growth medium, supplemented with
PMA or otherwise, were also incubated at 37°C for a period of 24 hours. After 24
hours the post-treatment U937 cultures and cell-free RPMI-1640 media were
removed from the incubator, transferred into centrifuge tubes and centrifuged at 80
x g for 5 minutes. Supernatants were collected, aliquoted into sterile cryotubes and
stored at -20°C until required for bioassay. Conditioned media generation is
summarised on page 283 in the form of a flow diagram. Table 11.1 describes the 10
different RPM!- 1640 conditioned media generated in this way. The ability of these
10 different conditioned media to modulate fibroblast proliferation and fibroblast-
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11.4 The effect of ultrasound on the release from the macrophage-like cell U937 of
substances capable of modulating fibroblast proliferation in vitro.
11.4.1 Introduction
The methylene blue fibroblast proliferation assay (p149), a modification of the
colorimetric assay described by Oliver et a!. (1989), was used to investigate the effect
of conditioned media, from ultrasound-exposed U937s, on human dermal fibroblast
proliferation.
11.4.2 Method
The standard protocol for the Methylene Blue Fibroblast Proliferation Assay
(Appendix 8, p342) was employed with the following modifications:
Briefly, sub-confluent human dermal fibroblast monolayers, passage 6, were
trypsinized (Appendix 4, p338), washed in fibroblast growth medium (Appendix 2B,
p335) and resuspended in the same to a final concentration of 2 x iO viable cells/mi
(Appendix 6, p34.0). 100 p.1 volumes of this cell suspension, containing 2000 cells,
were aliquoted into 60 wells (i.e. filling all wells in columns 2 to 11, with the
exception of those wells in rows A and H) of a 96 well flat-bottomed microtitre plate
(Appendix 9, p343). 20 of the remaining wells (i.e. all wells in columns 2 to 11 that
did not receive the cell suspension) were filled with fibroblast growth medium alone.
Five replicate plates were set up in this manner. All plates were sealed and placed
in a 37°C incubator for a period of 12 hours to allow for cell attachment.
After 12 hours all five plates were removed from the incubator and the plate
sealing tape removed. One of the five plates, subsequently termed the 12 hour plate,
was "stopped" according to Appendix 8 steps 6 through 9 (p342) and stored in a dust-
free environment. On each of the four remaining plates, one of the ten columns of
wells was designated to receive one of the 10 conditioned media (table 11.1, p282).
All eight wells of a given column, including the cell-free wells, received 100 p.1 of a
given conditioned medium. Conditioned media were thawed and sterilised with a 0.22
p.m millipore filter before being applied to fibroblast cultures.
Once all wells had received 100 p.1 of one of the conditioned media the plates
were resealed and returned to the 37°C incubator. Individual plates were "stopped"
at 36, 60, 84 and 132 hours after initial fibroblast seeding, according to Appendix 8
steps 6 through 9 (p342). Plates "stopped" at 36, 60 and 84 hours were stored, with
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the 12 hour plate, in a dust-free environment until the 132 hour plate had been
stopped, fixed and air dried.
Fibroblast monolayers within the wells were then stained with methylene blue
dye, washed with 0.01 M borate buffer, and the dye eluted with acid-alcohol. The
absorbance (A650) of each well, on each plate, was then measured (Appendix 8, steps
10 through 12, p342). For each column of wells, and hence for each conditioned
medium under test, the average A value of cell-free wells was subtracted from each
of the A650 readings of cell containing wells. The fibroblast number within a given
well was then calculated from these corrected A values using a standard plot of
human dermal fibroblast number versus A650 (Appendix 30B, p398). This standard
plot was prepared according to the method described on page 152 using the same
primary culture of fibroblasts, at the same passage (p6), as was used for the fibroblast
proliferation assay above.
For each conditioned medium at each time point the median fibroblast
number within the 6 wells was reported. Minimum and maximum fibroblast number
and 95% confidence intervals were reported to indicate data distribution. The data
was tabulated and graphically displayed. Non-parametric statistical analysis was
employed to compare the ability of different conditioned media to differentially effect
fibroblast proliferation. Statistical analysis took the form of Kruskal-Wallis and Mann
Whitney U-tests.
This study contains two experiments:
I. The effect of ultrasound on the release of substances, from non-PMA-
exposed U937s, capable of modulating fibroblast proliferation in vitro.
and II. The effect of ultrasound on the release of substances, from PMA-
exposed U937s, capable of modulating fibroblast proliferation in vitro.
To aid understanding, the results and discussion of these two studies will be dealt
with separately (see pages 286-296 and 297-306 respectively).
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11.4.3 Results:
I. The effect of therapeutic ultrasound on the release from non-PMA exposed U937s
of substances capable of modulating fibroblast proliferation in vitro.
Figure 11.2 displays the change in median fibroblast number with time in response
to the application of the five non-PMA exposed conditioned media. 95% confidence
intervals are displayed to indicate data distribution. A summary of the statistical
analysis performed on this data can be found in Appendix 23, (p369). Figure 11.2,
the data tables 11.2 through 11. 6 (pages 288 to 289), and statistical analysis of that
data, demonstrate the following.
1. The effect of non-conditioned medium (N-CM) versus conditioned medium from
non-insonated U937s (N-IM).
The conditioning of RPMI-1640 by U937s reduces its ability to support fibroblast
proliferation. On the basis of the median data (tables 11.2 & 11.3) there are fewer
fibroblasts in wells that received N-IM than received N-CM, at all time points
studied. This observation proved statistically significant at the 60 and 132 hour time
points (p <0.050), with a clear trend towards significance at the 84 hour time point
(p = 0.064).
2. The effect of conditioned medium from non-insonated U937s (N-IM) versus
conditioned medium from sham-inonated U937s (S-IM).
Fibroblast proliferation in response to conditioned medium from sham-insonated
U937s was not significantly different from that in response to conditioned medium
from non-insonated U937s.
3. Conditioned medium from sham-insonated U937s (S-IM) versus conditioned
medium from U937s insonated at an intensity. J(SATA) of 0.1 W/cm 2 (0.1-IM).
Fibroblast proliferation was more rapid in fibroblast cultures that received
conditioned medium from U937s insonated with ultrasound at 0.1 W/cmZ,ITA), than
similar fibroblast cultures that received conditioned medium from sham-insonated
U937s. Significantly more fibroblasts were present at 84 (p = 0.030) and 132 ( p =
0.012) hours post-plating in wells to which 0.1-IM was added than in wells in receipt
of S-IM.
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4. Conditioned medium from sham-insonated U937s (S-IM) versus conditioned
medium from U937s insonated at an intensity. 1(SATA) of 0.5 W/cm2 (0.5-IM).
The application of conditioned medium from U937s insonated with 3 MHz
therapeutic ultrasound, at an intensity of 0.5 W/cm2, to fibroblasts in culture led to
more rapid proliferation than was observed following the application of sham-
insonated U937 conditioned medium. Significantly more fibroblasts were found in
wells that received 0.5-IM at 84 (p < 0.0 13) and 132 (p = 0.008) than were found
in wells in receipt of S-IM.
5. The effect of conditioned medium from U937s insonated at intensities of 0.1
W/cm2 versus 0.5 W/cm2.
The rate of fibroblast proliferation observed in response to the application of RPMI-
1640 media conditioned by macrophages insonated with therapeutic ultrasound at an
intensity of 0.1 W/cm2 was not significantly different from that observed in response
to conditioned media of U937s similarly insonated at an intensity of 0.5 W/cm2.
6. The effect of conditioned media from ultrasonically insonated U937s (both
intensities) versus non-conditioned medium.
Fibroblast proliferation observed in response to conditioned medium from U937s
exposed to therapeutic ultrasound, at intensities of 0.1 and 0.5 W/cm2, was not
significantly different to that observed n response to the application of non-
conditioned RPMI- 1640 medium. No statistically significant differences were
observed at any time point.
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12
Number of replicate	 6
wells
Median cell number	 1.933
per well (cells x 10')
Minimum	 1.851
and maximum	 to





(cells a 10')	 2.153
Table 11.2	 The effect of non-conditioned RPMI-1640 on the proliferation of human
dermal fibroblasts in vitro.
12
Number of replicate 	 6
wells
Median cell number 	 1.933
per well (cells a 10')
Minimum	 1.524
and maximum	 to





(cells a 10')	 2.374



























Table 113	 The effect of conditioning RPMI-1640 with non-insonated U937s on the
proliferation of human dermal fibroblasts in vitro.



























Table 11.4	 The effect of conditioning RPMI-1640 with sham-insonated U937s on the
proliferation of human dermal fibroblasts in vitro.
lime post plating (hours)
	
12	 36	 60	 84	 132
Number of replicate	 6	 6	 6	 6	 6
wells
Median cell number	 1.933	 1.727	 1.779	 1.929	 2.351
perwell (cells a 10')
	 ___________ ____________ ____________ ____________ ____________
Minimum	 1.797	 1.181	 1.561	 1.547	 2.106
and maximum	 to	 to	 to	 to	 to
(cells a 10')	 2 288	 2 544	 2.270	 2.310	 2.760
95%	 1.810	 1.274	 1.535	 1.634	 2.149
confidence interval	 to	 to	 to	 to	 to
(cells a 10')
	
2.202	 2.234	 2.168	 2.260	 2.626
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Table 11.5
	 The effect of conditioning RPMI-1640 with insonated U937s, exposed to
pulsed 3 MHz ultrasound (2ms on : 8ms of!) at an intensity of 0.1 W/cm2,
1(SATA), on the proliferation of human dernial fibroblasts in vitro.
12
Number of replicate	 6
wells
Median cell number	 1.961
per well (cells x 10')
Minimum	 1.79 7
and maximum	 to
(cells x 10')	 2.233
95%	 1.827
confidence interval	 to
(cells x 10')	 2.149
























Table 11.6 The effect of conditioning RPMI-1640 with insonated U937s, exposed to
pulsed 3 MHz ultrasound (2ms on : Sms off) at an intensity of 03 W/cm2,
j(SATA), on the proliferation of human dermal fibroblasts in vitro.







Number of replicate	 6	 6	 6	 6	 6
wells
Median cell number 	 2.015	 1.645	 2.051	 2.392	 2.842
perwell (cells x 10')	 ___________ ____________ ____________ ____________ ___________
Minimum	 1.797	 1.345	 1.724	 2.201	 2.706
and maximum	 to	 to	 to	 to	 to
(cells I 10')	 2.124	 1.945	 2.215	 2.528	 3.905
95%	 1.879	 1.423	 1.805	 2.273	 2.572
confidence interval	 to	 to	 to	 to	 to
(cells x 10')







































































Conditioned RPMI-1640 medium obtained after removal of non-insonated and sham-
insonated U937s reduces the level of fibroblast proliferation when compared with
non-conditioned RPMI-1640 medium. Insonation of U937s with 3 MHz therapeutic
ultrasound at intensities of 0.1 or 0.5 W/cm2 leads to the generation of U937
conditioned media that supports fibroblast proliferation at a level not dissimilar to
that of RPMI-1640 medium prior to U937 conditioning.
Hypothetical explanations of these observations include the following;
1. During medium conditioning U937s deplete some component of RPMI-
1640 medium essential for fibroblast proliferation. Insonation of U937s
with therapeutic ultrasound prevents this depletion.
2. During medium conditioning U937s release an inhibitor of fibroblast
proliferation. Insonation of U937s with therapeutic ultrasound prevents
the elaboration of this inhibitor.
3. During medium conditioning U937s release an inhibitor for fibroblast
proliferation. Insonation of U937s with ultrasound leads to the
simultaneous elaboration of a substance that stimulates fibroblast
proliferation.
Alternative 1.
The culture of U937s in RPMI-1640 medium leads to the depletion of some
component(s) of that medium that is/are necessary for fibroblast proliferation. As (a)
fibroblast proliferation is not significantly different in response to conditioned
medium from non-insonated U937s compared with sham-insonated U937s, sham-
insonation would appear not to effect this depletion, and (b) fibroblast proliferation
is similar in wells that received ultrasonically-insonated U937 conditioned media and
wells that received non-conditioned media, it is possible that ultrasound in some way
prevents U937s from depleting RPMI- 1640 of components necessary for fibroblast
proliferation. The most effective way of ultrasound preventing U937s from depleting
medium would be if it caused functional disruption, or death, of some of the U937s.
Alternative 2.
When U937s are cultured in RPMI-1640 medium they elaborate an inhibitor of
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fibroblast proliferation. The elaboration of this fibroblast proliferation inhibitor by
t.J937s is unaffected by sham-insonation, but significantly impaired by exposure to
therapeutic ultrasound. By impairing, or completely preventing, the synthesis and/or
elaboration of this inhibitor, ultrasound acts to promote fibroblast proliferation. This
loss of inhibitory activity in conditioned medium of ultrasonically exposed U937s may
be due either to a subtle change in the U937 function or, more dramatically, due to
a complete loss of cell function, i.e. cell death.
Alternative 1 versus alternative 2
An experiment (Appendix 27, p385) was devised to investigate whether U937s (a)
actively deplete RPMI-1640 of some component essential for fibroblast proliferation
or (b) release a fibroblast proliferation inhibitor. The experiment examined fibroblast
proliferation in response to progressive dilutions of U937 conditioned medium and
unconditioned medium. If U937 conditioned RPMI-1640 medium was in some way
deficient in a given component, compared with unconditioned RPMI-1640 medium,
further dilution of this conditioned medium (with phosphate buffered saline, PBS)
would enhance this deficiency; thus further reducing fibroblast proliferation. If,
however, U937 conditioned RPMI- 1640 medium contained an inhibitor for fibroblast
proliferation, the same dilution of this medium would have the opposite effect and
stimulate fibroblast proliferation. Fibroblast proliferation was found to be (1) more
rapid following the application of diluted U937 conditioned medium, and (2)
progressively less rapid following the application of progressively more dilute
unconditioned medium. As such, under the tissue culture conditions used in this
thesis, the macrophage-like cell line (U937) has been shown to release an inhibitor
of fibroblast proliferation.
Alternative 3
The release of a fibroblast inhibitor having been proven, a further alternative exists
to explain the experimental observations made above. When U937s are cultured in
RPMI-1640 they release an inhibitor, a process unaffected by sham insonation.
Ultrasonic insonation modulates the function of U937 encouraging them to produce
a counteractive fibroblast proliferation promoting "factor", in addition to the
fibroblast proliferation inhibitor. The production of functionally equal quantities of
fibroblast proliferation stimulator and fibroblast proliferation inhibitor would be
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necessary to explain the experimental results obtained. This third alternative is
thought to be unlikely because (a) the simuTtaneous synthesis and release of directly
counteractive substances, by the same cell, would appear physiologically
uneconomical, unless they have other physiological effects, and (b) the generation of
functionally balancing levels of directly counteractive substances would appear
unlikely. Additionally, no reliable reports have been found within the literature to
suggest that undifferentiated (uninduced) U937s are capable of elaborating factors
mitogenic for fibroblasts.
As previously mentioned, exposure to therapeutic ultrasound appears to
reduce, if not completely annul, the production of a fibroblast proliferation inhibitor
by U937s. In order to investigate the mechanism by which ultrasound may prevent
inhibitor production by U937s, a study was performed to investigate the effect of
therapeutic ultrasound on U937 viability. U937 cultures were either sham-insonated,
insonated with 3 MHz therapeutic ultrasound at intensities of 0.1 or 0.5 W/cm2, or
left untreated. Cell counts were performed 1 and 24 hours after treatment and cell
viability measured (Appendix 28, p390). By comparing the number of viable U937s
remaining after 1 and 24 hours in the four uninduced treatment groups it is apparent
that ultrasound exposed U937 cultures contain significantly fewer viable cells than
similar sham or non-insonated U937 cultures. This observation that ultrasound in
some way depletes the number of viable U937s may partially explain the loss of
inhibitory action in ultrasound-exposed U937 conditioned medium. The observation
that a 50% fall in viable cell number is paralleled by a complete loss in fibroblast
proliferation inhibitor activity, suggests that exposure to ultrasound in vitro may in
some way selectively deplete U937s actively engaged in inhibitor production.
Although there are no literature reports regarding the release of specific
fibroblast proliferation inhibitors by U937 cells, they have been shown to produce a
lymphoid specific cytostatic factor (Wilkins and Warrington, 1984). However, other
macrophage-derived substances are known be less specific in their anti-proliferative
effects. Such macrophage-derived anti-proliferative substances include: (a)
interleukin-1/prostaglandins, (b) thymidine., (c) hydrogen peroxide, (d) arginase, and
(e) TGF-/3.
(a). Interleukin-1/Prostaglandins. The inhibition of human fibroblast
proliferation in response to human peripheral blood monocyte conditioned medium
has been reported previously. For example, Korn et a!. (1980) observed that
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monocytes elaborated a factor that concomitantly inhibited proliferation and induced
prostaglandin synthesis in fibroblast cultures. They showed, using indomethacin and
exogenous prostaglandin, that the suppression of proliferation was due, in a large
part, to the stimulation of prostaglandin synthesis by fibroblasts. The monocyte-
derived factor responsible for stimulating prostaglandin synthesis by fibroblasts has
since been identified as interleukin-1 (IL-I) (Sisson and Dinarello, 1989). Several
research groups have demonstrated that U937s lack the capacity to produce IL-i
(Krane and Amento, 1983; Wakasugi et a!. 1984; Knudsen et a!. 1986; Demczuk et a!.
1988) or prostaglandins (Schenkein, 1986; Roux-Lombard, 1986; Koehler et a!. 1990)
prior to exposure to a differentiating agent such as PMA. In disagreement with the
majority of the literature, Palacios et a!. 1982 and Barak et a!. (1986), reported that
U937s constitutively secreted IL-i.
(b). Thymidlne. Thymidine is secreted by activated macrophages in culture and
has been shown to contribute to the anti-proliferative nature of macrophage
conditioned media (Stadecker et a!. 1977). The thymidine within macrophage culture
supernatants is thought to inhibit DNA synthesis by inhibiting the conversion of
cytosine to deoxycytosine, thus causing a deficiency in one of the precursors of DNA
(Stadecker et a!. 1977). It is not known whether U937s, like activated macrophages,
secrete thymidine into their culture medium.
(c). Hydrogen peroxide. Co-culture of activated macrophages and splenic
lymphocytes leads to proliferation suppression in the latter; when catalase is added
to this co-culture normal proliferation is reinitiated. This implicates hydrogen
peroxide in this macrophage-associated suppression, as the only known physiological
function of catalase is the reduction of hydrogen peroxide (Metzger et a!. 1980).
Hydrogen peroxide is an inducible characteristic of phorbol ester differentiated
U937s, but it is not constitutively elaborated by U937 cultures (Harris et a!. 1985)
which suggests that it may not be involved in the inhibition of fibroblast proliferation
noted here.
(d). Arginase. It has been demonstrated that activated macrophages produce
arginase, an enzyme which thought to inhibit proliferation by depleting culture
medium of the amino acid arginine (Currie, 1978). It is not known whether U937s,
like activated macrophages, produce and secrete arginase into their culture medium.
(e). TGF-/3. Transforming growth factor-$ (TGF-f3), while initially reported as
a mitogen for rodent fibroblasts grown in soft agar (Moses et a!. 1981; Roberts et a!.
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1981), was subsequently shown to inhibit anchorage dependent growth in rat kidney
fibroblasts (Roberts et a!. 1985) and bovine aortic smooth muscle cells (Assoian and
Sporn, 1986). TGF-/3 has since been shown to be a potent, but reversible, inhibitor
of the proliferation of many cell types in vitro, including epithelial cells, endothelial
cells, most lymphoid cells and many myeloid cells (Graycar et a!. 1989; Bascom et al.
1989). In addition to these in vitro observations, in vivo studies have reported that
TGF-/3 inhibits the proliferation of epithelial cells, endothelial cells and fibroblasts
in chorioallantoic membrane studies (Yang and Moses, 1990), and mammary
epithelial cell proliferation in rodents (Siberstein and Daniel, 1987). It has been
suggested that TGF-J3 is unlikely to be directly mitogenic to any cell type (Moses et
a!. 1991), and that mitogenic activities attributed to TGF-13 are probably due to the
induction of autocrine stimulation by endogenous growth factors such as PDGF (Loef
et a!. 1986). TGF-13 is thought suppress proliferation by suppressing the transcription
of a proto-oncogene, c-myc, which has been shown to be necessary for proliferation
in a number of cells (Bascom et a!. 1989). The U937 cell has been shown to express
TGF-f3 mRNA and upregulate this expression in response to PMA induction
(Assoian et a!. 1987; Wager and Assoian, 1990). Whether this mRNA expression is
paralleled by active secretion of TGF-/3 into culture is as yet unknown.
The identity of the U937-derived inhibitory factor for fibroblast proliferation
observed in these studies is unknown. From literature reports it would appear there
are several candidates for this inhibitory activity (see above). The majority, if not all,
of these inhibitors are characteristically produced by differentiated, and usually
activated, macrophages. The uninduced U937 is an immature promonocytic cell that
is apparently unable to generate most of these inhibitors. Further work is necessary
to characterise the inhibitor produced by uninduced U937s. In view of the
observations of (1) Barak et a!. (1986), who demonstrated that uninduced U937s
constitutively produced IL-i, and, (2) Assoian et a!. (1987) and Wager and Assolan
(1990) who reported TGF-13 mRNA expression in uninduced U937s, future work
should include studies of the synthesis of IL-i by uninduced U937s, the synthesis of
E-series prostaglandins by fibroblasts in response to U937 conditioned media, and,
the capacity of uninduced U937s to elaborate TGF-/3.
Interestingly, it has previously been reported that therapeutic ultrasound, at
the parameters used in this thesis, stimulates uninduced U937s to synthesize and
release factors mitogenic to fibroblasts (Young and Dyson, 1990b). Such observations
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appear to contradict the observations made in this study. On examination of the
experimental protocol used by Young and Dyson (1990b) it is apparent that they did
not employ an unconditioned medium control but restricted their comparisons to a
medium conditioned by sham-insonated cells. They were thus unaware of either the
presence of an inhibitory activity within their sham-insonated control, or the relief
of this inhibition with exposure to ultrasound. They thus reported that U937
insonation appeared to lead to the generation of a pro-proliferative conditioned
medium rather than a less inhibitive one.
In summary, it would appear that U937s, under the tissue culture conditions
used in this work, produce an inhibitory factor for fibroblast proliferation - further
studies are necessary to characterise this inhibitor of fibroblast proliferation.
Therapeutic ultrasound exposure appears to reduce the level of this inhibitor in U937
culture supernatants. The observation that the reduction in inhibitory activity
following ultrasound treatment is paralleled by a loss in viable cell number, suggests
that ultrasound acts to reduce inhibitory activity by damaging inhibitor producing




II. The effect of therapeutic ultrasound on the release from PMA-exposed U937s of
substances capable of modulating fibroblast proliferation in vitro
Figure 11.3 displays the change in median fibroblast number with time in response
to the application of the four different conditioned media from PMA-exposed U937s
and unconditioned RPMI-1640 supplemented with PMA. 95% confidence intervals
are displayed to indicate the distribution of points about median values. A summary
of the statistical analysis performed on this data can be found in Appendix 24,
(p373). Figure 11.3, the data tables 11.7 through 11.11 (pages 300 to 301), and
statistical analysis of that data, demonstrate the following.
1. The effect of non-conditioned medium containing PMA (PMA N-CM) versus
conditioned medium from PMA-exposed non-insonated U937s (PMA N-tM).
U937 conditioning of RPMI-1640 medium (supplemented with PMA) reduces its
ability to support fibroblast proliferation. From the median fibroblast number data
(tables 11.7 & 11.8) there are fewer fibroblasts in wells that received PMA N-IM
than received PMA N-CM, at all time points after the 60 hour time point, an
observation which proved statistically significant at the 60 (p < 0.0 16), 84 (p <0.045)
and 132 (p < 0.005) hour time points.
2. The effect of conditioned medium from PMA-exposed non-Insonated U937s (PMA
N-IM) versus conditioned medium from PMA-exposed sham-insonated U937s (PMA
S-tM).
Fibroblast proliferation in response to conditioned medium from PMA-exposed
sham-insonated U937s was not significantly different from that of conditioned
medium from PMA-exposed non-insonated U937s at any time point, with the
exception of 60 hours post plating. At 60 hours fibroblast number was found to be
significantly lower in those wells in receipt of PMA S-IM compared with those in
receipt of PMA N-IM (p = 0.030).
3. The effect of conditioned medium from PMA-exposed sham-insonated U937s
(PMA S-tM) versus conditioned medium from PMA-exposed U937s insonated with
3 MHz therapeutic ultrasound at an intensity, fSATA), of 0.1 W/cm2 (PMA 0.1-tM).
Fibroblast proliferation was more rapid in fibroblast cultures that received
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conditioned medium from PMA-exposed U937s insonated with ultrasound at 0.1
W/cm2, 1(SATA) than similar fibroblast cultures that received conditioned medium from
PMA-exposed sham-insonated U937s. Significantly more fibroblasts were present at
60 (p = 0.008), 84 (p = 0.03 1) and 132 (p < 0.005) hours post plating in wells in
receipt of PMA 0.1-IM than in similar wells in receipt of PMA S-IM.
4. The effect of conditioned medium from PMA-exposed sham-Insonated U937s
(PMA S-IM) versus conditioned medium from PMA-exposed U937s Insonated with
3 MHz therapeutic ultrasound at an intensity, J(SATA), of 0.5 W/cm2 (PMA 0.5-IM).
The application of conditioned medium from PMA-exposed U937s insonated with
3 MHz therapeutic ultrasound, at an intensity of 0.5 W/cm 2, to fibroblasts in culture
led to more rapid proliferation than was observed following the application of
conditioned medium from sham-insonated PMA-exposed U937s. Significantly more
fibroblasts were found in wells that received PMA 0.5-IM, at the 36 ( p = 0.045), 60
(p = 0.030) and 132 (p < 0.005) hour time points, than were found in wells in
receipt of PMA S-IM. No significant difference in fibroblast proliferation was
observed in response to these conditioned media at 84 hours post initial fibroblast
plating.
5. The effect of conditioned medium from PMA-exposed U937s insonated at
Intensities of 0.1 W/cm2 versus 0.5 W/cm2
 (PMA 0.1-IM & PMA 0.5-IM).
The rate of fibroblast proliferation observed in response to the application of RPM!-
1640 media conditioned by PMA-exposed macrophages insonated with therapeutic
ultrasound at an intensity of 0.1 W/cm 2
 was not significantly different from that
observed in response to conditioned media of PMA-exposed U937s similarly
insonated at an intensity of 0.5 W/cm2.
6. The effect of conditioned media from PMA-exposed U937s insonated with
therapeutic ultrasound at an intensity J(SATA) of 0.1 W/cm2 (PMA 0.1-IM) versus non-
conditioned medium containing PMA (PMA NC-M).
Fibroblast proliferation observed in response to conditioned medium from PMA-
exposed U937s insonated with therapeutic ultrasound, at an intensity of 0.1 W/cm2,
was not significantly different to that observed in response to the application of non-
conditioned RPMI-1640 medium until 132 hours post plating. At this time point
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significantly more fibroblasts were observed in those wells that received PMA 0. 1-IM
than received PMA NC-M (p = 0.013).
7. The effect of conditioned media from PMA-exposed U937s insonated with
therapeutic ultrasound at an Intensity of 0.5 W/cm 2 (PMA 0.5-IM) versus non-
conditioned medium containing PMA (PMA N-CM).
Proliferation in response to these two media was not significantly different when
examined at the 36 and 84 hour time points. At 60 hours post initial fibroblast plating
there were significantly fewer fibroblasts (p <0.013) in wells given PMA 0.5-IM than
in similar wells in receipt of the non-conditioned medium (PMA N-CM). However,
at the final time point of 132 hours there were significantly more fibroblasts in those
wells in receipt of ultrasonically-exposed U937 conditioned medium than in similar
wells given non-conditioned medium (p <0.005).
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Table 11.7
	 The effect of non-conditioned RPMI-1640 (containing PMA) on the
proliferation of human dermal tibroblasts in vitro.
12
Number of replicate	 6
wells
Median cell number 	 2.124
per well (cells x 10')
Minimum	 1.85 1
and maximum	 to





(cells x 10')	 2.316


























	 The effect of conditioning RPMI-1640 (containing PMA) with non-insonated
U937s on the proliferation of human dermal fibroblasts in vitro.




36	 60[	 84	 132
Number of replicate	 6	 6	 6	 6	 6
wells
Median cell number 	 2,206	 1.972	 1.833	 1.983	 1.997
perwell (cells x 10')	 ____________ _____________ ____________ _____________ ____________
Minimum	 1.906	 1.563	 1.670	 1.765	 1.288
and maximum	 to	 to	 to	 to	 to
(cells x 10')
	
2.451	 2.272	 2.106	 2.529	 2.106
95%	 1.929	 1.677	 1.666	 1.788	 1.560
confidence interval	 to	 to	 to	 to	 to
(cells x 10')
	
2371	 2.176	 2.055	 2.361	 2.216
Table 11.9
	 The effect ofconditioning RPMI-1640 (containing PMA) with sham.insonated
U937s on the proliferation of human dermal fibroblasts in vitro.
Time post plating (hours)
	
12	 36	 60	 132
Number of replicate	 6	 6	 6	 6	 6
wells
Median cell number 	 2.151	 2.108	 1.615	 2.256	 1.778
perwell (cells x ia')	 ___________ ___________ ____________ ____________ ___________
Minimum	 2.015	 1.563	 1.306	 1.765	 1.561
and maximum	 to	 to	 to	 to	 to
(cells a 10')	 2.397	 2.926	 1 833	 2.801	 1.888
95%	 2.021	 1.586	 1.494	 1.875	 1.604
confidence interval	 to	 to	 to	 to	 to
(cells a 10')
	




















Table 11.10	 The effect of conditioning RPMI-1640 (containing PMA) with insonated
U937s exposed to pulsed 3 MHz ultrasound (2ms on : Sms off) at an
intensity of 0.1 W/cm2, 1(MTA), on the proliferation of human dermal
fibroblasts in vitro.
12
Number of replicate	 6
wells
Median cell number	 2.124
per well (cells x 10')
Minimum	 1.906
and maximum	 to




confidence interval 	 to
(cells x 10')	 2.327












Table 11.11	 The effect of conditioning RPMI-1640 (containing PMA) with insonated
U937s exposed to pulsed 3 MHz ultrasound (2ms on : Sms off) at an












Time post plating (hours)
	
60	 J	 84
6	 6	 6	 6
	
2.124	 1.427	 1.861	 2.692
	
1.961	 1.236	 1.724	 2.256
to	 to	 to	 to
	
2.288	 2.217	 2.051	 3.128
	
1.967	 1.174	 1.726	 2.302
to	 to	 to	 to
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11.4.6 Discussion
To examine whether the lack of mitogenic agent release, reported in section 11.4.3,
was due to the lack of U937 maturity, U937s were induced to differentiate using the
phorbol ester 413-phorbol 12-myristate 13 acetate, according to the method of Turk
et a!. (1989).
Conditioned RPML-1640 medium obtained from non-insonated and sham-
insonated PMA-exposed U937s reduces the level of fibroblast proliferation when
compared with non-conditioned RPM!- 1640 medium supplemented with PMA, an
observation which can be explained on the basis of inhibitor generation by U937s
(see Appendix 27, p385). Insonation of PMA-exposed U937s with 3 MHz therapeutic
ultrasound at intensities of 0.1 or 0.5 W/cm2
 leads to the generation of U937
conditioned media that encourage fibroblast proliferation when compared to PMA-
supplemented RPMI-1640 medium prior to U937 conditioning, thus suggesting that
PMA-exposed U937s elaborate a substance which stimulates fibroblast proliferation
after insonation with therapeutic ultrasound.
Hypothetical explanations of such observations include the following:
1. U937s may produce a fibroblast proliferation inhibitor (p292). The amount of
which is reduced by exposure to ultrasound (section 11.4.4, p29l) possibly
because of damage to a subpopulation of U937s. PMA may modify a further
sub-population so that they (a) are less responsive to the damaging effects
of ultrasound, and (b) produce fibroblast proliferation promoters.
2. Ultrasound may predispose U937s to the effects of PMA. After insonation a
previously resistant subpopulation of U937s become able to respond to PMA,
which facilitates U937 maturation and the concomitant production of
fibroblast proliferation promoters.
Alternative 1.
According to this hypothesis, in response to PMA pre-conditioning a fraction of
U937s adopt novel characteristics that set them apart from the remainder of the
culture. These U937s with novel characteristics, hereinafter termed modified U937s,
are (a) no longer responsive to the damaging effects of ultrasound, and are (b) now
able to produce substances capable of promoting fibroblast proliferation. Cells that
retain the original U937 characteristics continue to elaborate the fibroblast inhibitor
and are easily damaged by ultrasound. Conditioned medium from non-insonated or
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sham-insonated PMA-exposed U937s is conditioned by both modified and original
U937s. The inhibitory activity of the original (unmodified) U937s appears to
outweigh the stimulatory activity of modified U937s, as demonstrated by the
inhibitory action of conditioned media from non-insonated and sham-insonated
PMA-exposed U937s on fibroblast proliferation. Insonation of a mixture population
of modified and original U937s, with therapeutic ultrasound selectively depletes the
latter, i.e. the ultrasound sensitive subpopulation. Fibroblast inhibitor production can
be stopped by damaging U937s that produce the inhibitor, while the elaboration of
the fibroblast proliferation promoter remains unaffected since this is from the
modified, ultrasound resistant subpopulation. This would be expected to result in an
elevation in proliferation in fibroblast cultures in receipt of conditioned medium from
insonated PMA-exposed U937s. The observation that exposure of PMA-exposed
U937s to ultrasound leads to a loss in the number of viable cells remaining in culture
(Appendix 28, p390) supports the idea of selective damage of a sub-population of
cells.
Alternative 1 is in agreement with the literature on U937 activity. U937s,
which share many characteristics with promonocytes, have been shown to mature into
macrophage-like cells following treatment with phorbol esters including PMA. These
PMA-matured U937s have been shown to produce various factors mitogenic for
fibroblasts (see Chapter 5, pl46), including fibroblast activating factor (FAF) (Turck
et a!. 1988; Turck et a!. 1989; Demeter et a!. 1991), platelet-derived growth factor
(PDGF) (Alitalo et a!. 1987; Makla et a!. 1987), transforming growth factor-beta
(TGF-/3) (Assoian et a!, 1987; Wager and Assoian, 1990), tumour necrosis factor-
alpha (TNF-a) (Sabatini et a!. 1990), interleukin-1 (IL-i) (Palacios et a!. 1982,
Wakasugi et a!. 1984) and insulin-like growth factor-i (IGF-i) (Nagoaka et al. 1990).
Additionally, several researchers have observed a distribution in U937 responsiveness
to PMA within apparently homogenous cultures; some U937s undergo morphological
and functional changes reminiscent of macrophage differentiation, while other U937s
within the same culture appear unresponsive (Elsas et a!. 1990; Hatton et a!. 1983).
Those responsive to PMA stop proliferating and tend to become adherent. These
observations (1) support the idea that PMA may have acted by giving a selective
advantage to a subpopulation of U937s within this study, and (2) point to a possible
mechanism by which ultrasound may selectively deplete cells unresponsive to PMA
i.e. ultrasound may preferentially damage actively dividing non-adherent cells.
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Alternative 2
U937s were cultured in PMA supplemented RPMI-1640 medium both prior to, and
after, exposure to ultrasound. According to this hypothesis, it is possible that
ultrasound predisposes previously resistant U937s to the influence of PMA. i.e. some
U937s may require insonation before they can mature into cells with the
characteristics of macrophages in response to PMA. It is suggested that such mature
U937s either produce less, or no longer produce any, fibroblast inhibitor, but rather
produce a substance that encourages fibroblast proliferation. Sham-insonated and
non-insonated U937s are not similarly predisposed and consequently cannot respond
as readily to PMA; they thus continue to produce the fibroblast inhibitor
characteristic of U937s not exposed to PMA. This hypothesis suggests that some
U937s cannot respond directly to PMA, as the work of Elsas er al. (1990) and Hattori
et a!. (1983) suggests. However, the majority, if not all, of the pertinent U937
literature report that PMA is capable of acting directly on U937s to facilitate U937
maturation and growth factor production (Harris and Ralph, 1985; Turck et a!. 1988;
Alitalo et a!. 1987; Makela et a!. 1987; Assoian et a!, 1987; Wager and Assoian, 1990;
Sabatini et a!. 1990; Nagoaka et a!. 1990).
In summary, it would appear that conditioned medium from PMA-exposed
U937s, like that of non-PMA exposed U937s, contains an inhibitor of fibroblast
proliferation. Exposure of PMA-exposed U937s to therapeutic ultrasound results in
the production of a conditioned medium that promotes fibroblast proliferation above
that of non-conditioned PMA-supplemented medium. This gain in pro-proliferative
activity is paralleled by a loss in viable U937s (Appendix 28, p390). This would
appear to suggest that ultrasound selectively depletes inhibitor generating cells within
the culture and in doing so enriches the culture with PMA-responsive, mitogen
producing U937s.
Conditioned media from Induced and non-induced U937s
The majority of the literature indicates that PMA-induced U937s produce factors that
promote, rather than inhibit, fibroblast proliferation (Palacios et a!, 1982; Sabatini es
a!. 1990; Assoian et a!. 1987; Wager and Assoian, 1990; Makela et a!. 1987 Turck et
a!. 1988; Turck et a!. 1989; Demeter et a!. 1991; Nagoaka et a!. 1990). In this study
conditioned media from non-insonated U937s, both uninduced and PMA-induced,
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appears to contain a substance, or substances, that significantly inhibit fibroblast
proliferation. The methods used to induce differentiation in U937s in this study were
taken from the experimental methods of Turck et a!. (1988), Turck et a!. (1989) and
Demeter Ct a!. (1991) who reported the production of fibroblast proliferation
promoters by U937s. One possible explanation for this disparity in results may
involve genetic drift of the U937 line used here. It is known that monocytic cell lines
can drift from their original characteristics, especially if repeatedly passaged (Lyons
and Ashman, 1989). Further work using a fresh source of U937s, and involving a
comparison of functional activities with the U937s presently in use, may help to
explain the disparity described above.
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11.5 The effect of ultrasound on the production b y the macrophage-like cell line
U937 of substances capable of modulating fibroblast-mediated colla gen lattice
(FPCL) contraction In vitro.
11.5.1 Introduction
The contraction of human dermal fibroblast-populated collagen lattices, a widely
accepted model of the process of wound contraction in vitro (Ehrlich and
Rajaratnam, 1990), was used to investigate the effect of conditioned media, from
ultrasound-exposed U937s produced as described above (section 11.3, p297), on
human dermal fibroblast-mediated collagen lattice contraction.
11.5.2 Method
Sixty standard fibroblast populated collagen lattices were prepared according to steps
1 through 6 of the Human dermal fibroblast collagen lattice contraction assay -
Standard protocol (Appendix 10, p344). After polymensation and lattice release, the
60 lattices were randomly allocated into 10 groups, each containing 6 lattices. All 6
lattices of each group received a 1 ml aliquot of one of the 10 different conditioned
media (table 11.1, p282). Once all 60 lattices had been "fed" in this manner they were
placed in a humidified box and returned to the 37°C incubator. All sixty lattices were
photographed (Appendix hA, p345) at 4.75, 21.25, 30.75, 45.75, 54.25 and 69.25
hours after initial plating and the film developed according to Appendix 11B (p346).
The area of each lattice, in mm 2, was then measured by computer-assisted planimetry
(Appendix 12, p347).
Median lattice area, minimum and maximum lattice area, and 95% confidence
intervals were calculated for each group of lattices (i.e. in response to each
conditioned medium) at each time point. The data was tabulated (tables 11.12
through 11.16) and displayed graphically (figure 11.4). Non-parametric statistical
analysis was performed to examine the modulation in the rate of lattice contraction
in response to different conditioned media. Kruskall Wallace tests were used to
compare all groups, at each time point, as an indicator of any need for further
statistical analysis. The Mann Whitney U-test was then applied between specific
treatment groups where appropriate.
This study contains two studies:
I. An investigation of the effect of ultrasound on the production by non-PMA-
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exposed U937s of substances capable of modulating fibroblast-mediated
collagen lattice contraction in vitro.
jj4 II. An investigation of the effect of ultrasound on the production by PMA-
exposed U937s of substances capable of modulating fibroblast-mediated
collagen lattice contraction in vitro.
In the interests of clarity the results and discussion of these two studies will be
described separately (pages 308-316 and 3 17-323 respectively).
11.53 Results:
I. The effect of ultrasound on the production by non-PMA exposed U937s of
substances capable of modulating FPCL contraction in vitro.
Figure 11.4 displays the change in median lattice area (mm 2) with time, in response
to the application of the five non-PMA exposed conditioned media. 95% confidence
intervals are displayed to indicate data distribution. A summary of the statistical
analysis performed on this data can be found in Appendix 25, (p379). Figure 11.4,
the data tables 11.12 through 11.16 (p311 to 312), and statistical analysis of that data,
demonstrate the following.
1. Non-conditioned medium containing PMA (N-CM) versus conditioned medium
from PMA-exposed non-insonated U937s (N-IM).
RPMI-1640 medium conditioned by non-insonated U937s stimulates fibroblast-
mediated collagen lattice contraction. Fibroblast-populated collagen lattices (FPCL)
that received N-IM were significantly smaller (i.e. had contracted faster) than those
in receipt of N-CM at all time points studied (p <0.005).
2. Conditioned medium from non-insonated U937s (N-IM) versus conditioned
medium from sham-insonated U937s (S-IM).
FPCLs in receipt of conditioned RPMI- 1640 medium conditioned by sham-insonated
U937s (S-IM) contracted more slowly than those in receipt of conditioned medium
from non-insonated U937s (N-IM). Based on the median lattice area data (tables
11.13 & 11.14, p311), FPCLS that received S-IM were always larger than those in
receipt of N-IM at all time points studied. This observation reached statistical
significance at 30.75 (p = 0.013), 54.25 (p < 0.020) and 69.25 (p = 0.045) hours post
lattice polymerisation.
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3. Conditioned medium from sham-insonated U937s (S-IM) versus conditioned
medium from U937s insonated with 3 MHz therapeutic ultrasound at an intensity.
1(SATA) of 0.1 W/cm 2 (0.1-IM).
Contraction appeared slower in FPCLs that received conditioned medium from
U937s insonated with ultrasound at 0.1 W/cm2, 1(SATA), than in similar FPCLS that
received conditioned medium from sham-insonated U937s. This observation was,
however, not substantiated by statistical analysis. Lattices in receipt of 0. 1-IM were
found to be statistically larger (i.e. had contracted more slowly) only at 30.37 hours
post lattice polymerisation (p = 0.013).
4. Conditioned medium from sham-insonated U937s (S-IM) versus conditioned
medium from U937s insonated with 3 MHz therapeutic ultrasound at an intensity.
1(SATA) of 0.5 W/cm 2 (0.5-IM).
Lattice contraction was observed to proceed more slowly in FPCLS that received
conditioned medium from U937s insonated with ultrasound at 0.5 W/cm2, 1(SATA), than
in similar FPCLs that received conditioned medium from sham-insonated U937s. This
observation was substantiated by statistical analysis. Lattices in receipt of 0.5-IM were
found to be statistically larger at 4.75 (p = 0.020), 54.25 (p = 0.045) and 69.25 (p <
0.005) hours post lattice polymerisation than those receiving S-IM.
5. Conditioned medium from U937s insonated with therapeutic ultrasound at
intensities of 0.1 W/cm 2 (O.1-IM) versus 0.5 W/cm2 (O.5-IM).
The rate of FPCL contraction observed in response to the application of RPMI- 1640
medium conditioned by U937s insonated with therapeutic ultrasound at an intensity
of 0.5 W/cm2 was slower than that observed in response to conditioned RPMI-1640
medium from U937s insonated at an intensity of 0.1 W/cm 2. FPCL in receipt of 0.5-
IM were found by non-parametric statistics to be significantly larger than those in
receipt of 0.1-IM at 4.75 (p = 0.020), 21.25 (p = 0.03 1), 45.75 (p = 0.03 1) and 69.25
(p < 0.005) hours post lattice polymerisation.
6. Conditioned medium from U937s insonated at an intensity. 1(SATA) of 0.1 W!cm2
(0.1-IM) versus non-conditioned medium (N-CM).
The rate of FPCL contraction observed in response to conditioned medium from
U937s insonated with therapeutic ultrasound, at an intensity of 0.1 W/cm 2, was more
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rapid than that observed in response to the application of non-conditioned RPMI-
1640 medium at all time points studied. FPCL supplemented with 0.1-IM were
significantly smaller, and thus had contracted quicker, than FPCL supplemented with
N-CM at all time points studied: 4.75 (p = 0.31), 21.25 (p < 0.008), 30.75 (p <
0.008), 45.75 (p < 0.005), 54.25 (p < 0.005), 69.25 (p <0.005).
7. Conditioned media from U937s insonated with therapeutic ultrasound at an
intensity. 1(SATA), of 0.5 W!cm2 (0.5-IM) versus non-conditioned medium (N-CM).
Contraction was observed to proceed more rapidly in FPCLS that received
conditioned medium from U937s insonated at 0.5 W/cm2, than in similar FPCLS that
received non-conditioned medium. This observation was substantiated by statistical
analysis. FPCLS given 0.5-IM were found to be statistically smaller than those given
N-CM at 21.25 (p = 0.031), 30.75 (p < 0.008), 45.75 (p < 0.013) and 69.25 (p <

























































	 The effect of non-conditioned RPMI-1640 on the contraction of human
dermal fibroblast populated collagen lattices in vitro.
Table 11.13
	 The effect of conditioning R.PMI-1640 with non-insonated U937s on the contraction
of human dermal fibroblast populated collagen lattices in vitro.
Time post plating (hours)
4.75	 21.25	 30.75	 J	 45.75	 54.25	 69.25
Number of replicate 	 6	 6	 6	 6	 6	 6
lattices
Median lattice area	 554.8	 319.1	 267.0	 205.0	 174.0	 162.4
(mm2)	 _______ ________ ________ ________ ________ ________
Minimum	 514.0	 315.1	 254.9	 188.7	 168.7	 156.8
and Maximum	 to	 to	 to	 to	 to	 to
(mm2)	 580.3	 327.1	 274.6	 209.1	 181.6	 164.9
95%	 529.6	 315.7	 256.8	 192.3	 169.6	 158.2
Confidence interval	 to	 to	 to	 to	 to	 to
(mm2)	 575.7	 325.7	 273.8	 210.5	 179.7	 165.2
Table 11.14
	 The effect of conditioning RPMI-1640 with sham insonated U937s on the contraction
of human dermal libroblast populated collagen lattices in vitro.
Tlaie po.t plating (hour.)
4.75	 21.25	 30.75	 (	 45.75	 J	 54.25	 69.25
Number of replicate 	 6	 6	 6	 6	 6	 6
lattices
Median lattice area
	 568.7	 336.2	 279.8	 206.3	 180.9	 167.2(mm2 )	 _______ ________ _______ ________ ________ ________
Minimum	 491.9	 314.3	 272.6	 201.7	 179.1	 162.2
and Maximum	 to	 to	 to	 to	 to	 to(mm2)	 608.6	 3486	 2849	 217.2	 212.3	 173.5
95%	 511.0	 321.5	 274.0	 201.6	 185.1	 163.0
Confidence interval	 to	 to	 to	 to	 to	 to
(mm2)	 602.4	 346.5	 284.7	 215.4	 207.7	 172.3
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Table 11.15 The effect of conditioning RPM! with insonated U937s, exposed to pulsed 3 MHz
ultrasound (2mg on : 8ms of!) at an intensity of 0.1 W cm', 1tUTA), on the contraction
of human dermal fibroblast populated collagen lattices in vitro.





Number of replicate	 6	 6	 6	 6	 6	 6
lattices
Median lattice area
	 566.1	 336.3	 267.9	 210.7	 186.2	 172.1
(mm2)	 ________ ________ ________ ________ _________ ________
Minimum	 547.2	 330.1	 263.4	 206.1	 179.5	 166.5
and Maximum	 to	 to	 to	 to	 to	 to
(mm2)	 598.4	 342.7	 2734	 215.6	 188.8	 178.2
95%	 552.1	 331.3	 264.7	 206.9	 181.1	 168.1
Confidence interval
	
to	 to	 to	 to	 to	 to
(mm2)	 587.8	 340.7	 271.4	 214.6	 189.1	 176.1
Table 11.16
	 The effect of conditioning RPM! with insonated U937s, exposed to pulsed 3 MHz
ultrasound (2ms on 8ms off) at an intensity of 0.5 W/cm',	 on the contraction
of human dermal fibroblast populated collagen lattices in vitro.




Number of replicate	 6	 6	 6	 6	 6	 6
lattices
Median lattice area	 618.3	 346.3	 268.4	 216.2	 196.7	 187.5(mm2)	 ________ ________ ________ ________ ________ ________
Minimum	 573.6	 336.4	 264.0	 212.4	 179.2	 178.9
and Maximum	 to	 to	 to	 to	 to	 to
(mm2)	 638.2	 356.9	 274.1	 227.1	 212.3	 192.7
95%	 587.1	 338.6	 265.1	 212.2	 185.1	 181.4
Confidence interval	 to	 to	 to	 to	 to	 to
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11.5.4 Discussion
The culture of U937s in RPMI-1640 medium leads to the generation of a conditioned
medium that promotes the contraction of human fibroblast populated collagen
lattices. FPCLs fed with U937 conditioned medium contracted more rapidly than
similar FPCLs fed with unconditioned RPMI-1640 medium. Generally, when
conditioned medium from sham-insonated U937s was applied to FPCLs, contraction
was observed to proceed more rapidly than in those lattices supplemented with
unconditioned medium; but, more slowly than in those lattices supplemented with
conditioned medium from non-insonated U937s. FPCLS supplemented with
conditioned medium from ultrasonically exposed U937s (at intensities of both 0.1 and
0.5 W/cm2) tended to contract more slowly than similar lattices in receipt of sham-
insonated U937 conditioned medium, and more rapidly than those lattices given non-
conditioned RPMI-1640 medium.
As with the studies examining the effect of U937 conditioned media on fibroblast
proliferation, several explanations exist to account for these observations, including
the following:
1. U937s produce a substance, or substances, that act(s) to promote
fibroblast-mediated collagen lattice contraction. Insonation, and to a certain
degree sham-insonation, of U937s acts to reduce the production of such a
substance(s).
2. Prior to insonation U937s produce a substance, or substances, that act(s)
to promote fibroblast-mediated collagen lattice contraction. Insonation, and
to a certain degree sham-insonation, with therapeutic ultrasound leads to the
simultaneous production of an antagonistic substance(s) that inhibits
fibroblast-mediated collagen lattice contraction.
Studies carried out to determine U937 viable cell density before and after
exposure to therapeutic ultrasound (Appendix 28, p390) support the first of these
alternatives. Such studies have demonstrated that U937 viable cell density falls after
insonation in vitro. The concomitant loss of pro-contractile activity within U937
conditioned medium and fall in viable cell density of U937s conditioning that
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medium, in response to ultrasonic exposure, suggests a causal relationship between
the two, i.e. ultrasound depletes U937 cultures of pro-contractile activity-generating
cells.
Such studies, while supporting the first alternative, also throws doubt on the
second. Assuming that the generation of pro- and anti-contractile activities are active
processes, the generation of an anti-contractile activity would depend on the
retention of cell viability. The observation that a fall in cell viability apparently
parallels an upregulation in the production of this anti-contractile activity, appears
to confound this alternative. Such observations cannot preclude the concomitant
elaboration of both stimulatory and inhibitory activities by ultrasound exposed U937s,
as even after insonation, approximately 50% of the U937 culture remained viable
(Appendix 28, p390). It is theoretically possible that ultrasound may act as an inducer
of U937s, perhaps in a similar fashion to that of phorbol esters. Under such
circumstances, exposure of U937s to therapeutic ultrasound may lead to the
upregulation of factors such as IL-i which have been shown to inhibit fibroblast-
mediated collagen lattice contraction (Gillery et a!. 1989). That FPCLs supplemented
with insonated U937 conditioned medium contract less rapidly than similar FPCLs
supplemented with non-insonated U937 conditioned medium is clear. However, it is
not known whether insonation of U937s leads to a loss of pro-contractile activity, or
a gain in anti-contractile activity, or a modulation of both pro- and anti-contractile
activities.
The identity of this U937-derived pro-contractile activity is unknown.
However, several substances, many of which are growth factors known to be
produced by macrophages, have been shown to promote fibroblast-mediated collagen
lattice contraction in vitro and are thought to involved with the process of wound
contraction in vivo. Macrophage-derived factors which have been reported to
stimulate fibroblast-mediated collagen lattice contraction include: FAF (Turck et a!.
1989); TGF-/3 (Montesano and Orci, 1988; Finesmith et a!. 1990); the AB and BB,
but not the AA, isoforms of PDGF (Clark et a!. 1989); aFGF (Turck et a!. 1989);
bFGF (Finesmith et a!. 1990) and TGF-a (Finesmith et a!. 1990). That one of these
factors is involved in U937 conditioned medium stimulation of contraction can be
questioned on the basis that (1) the uninduced U937 is not thought to produce
biologically significant levels of any of these growth factors (see Chapter 5, p147),
and (2) while many of these growth factors have been observed to stimulate
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fibroblast proliferation in vitro (McGrath, 1990), U937 conditioned medium inhibits
fibroblast proliferation (p291). One factor that has been shown to both stimulate
fibroblast-mediated FPCL contraction (Montesano and Orci, 1988; Finesmith et a!.
1990) and inhibit subconfluent monolayer proliferation of fibroblasts (Roberts et a!.
1985) is TGF-f3. Future work is planned to investigate the composition of U937
conditioned medium, specifically with respect to the presence of TGF-J3.
In summary, it would appear that U937s, under the tissue culture conditions
used in this work, produce a stimulatory factor for fibroblast-mediated FPCL
contraction, further studies are necessary to characterise this stimulator. Therapeutic
ultrasound exposure appears to reduce the level of this stimulator in U937 culture
supernatants. The observation that the reduction in stimulatory activity following
ultrasound treatment is paralled by a loss in viable cell number, suggests that




H. The effect of ultrasound on the production by PMA-exposed U937s of substances
capable of modulating FPCL contraction in vitro.
Figure 11.5 displays the change in median lattice area (mm 2) with time, in response
to the application of the four different conditioned media from PMA-exposed U937s
and unconditioned RPMI-1640 supplemented with PMA. 95% confidence intervals
are displayed to indicate the distribution of points about median values. A summary
of the statistical analysis performed on this data can be found in Appendix 26,
(p381). Figure 11.5, the data tables 11.17 through 11.21 (p320 to 321), and statistical
analysis of that data, demonstrate the following.
1. Non-conditioned medium containing PMA (PMA N-CM) versus conditioned
medium from PMA-exposed non-insonated U937s (PMA N-IM).
U937 conditioning of RPMI-1640 medium (supplemented with PMA) increases its
ability to support fibroblast-mediated collagen lattice contraction. FPCL that received
PMA N-IM were significantly smaller (i.e had contracted more rapidly) than those
in receipt of PMA N-CM at all time points studied (p < 0.005), with the exception
of at 4.75 hours at which no significant difference was observed.
2. Conditioned medium from PMA-exposed non-insonated U937s (PMA N-IM)
versus conditioned medium from PMA-exposed sham-insonated U937s (PMA S-IM).
Sham insonation of PMA-exposed U937s leads to the generation of a conditioned
medium (PMA S.IM) that promotes FPCL contraction compared with conditioned
medium (PMA N-IM) from non-insonated PMA-exposed U937s. FPCL in receipt of
PMA S-IM demonstrated more rapid contraction at all time points studied (p <
0.005).
3. Conditioned medium from PMA-exposed sham-insonated U937s (PMA S-IM)
versus conditioned medium from PMA-exposed U937s insonated with 3 MHz
therapeutic ultrasound at an intensity. J(SATA) of 0.1 W!cm 2 (PMA O.1-IM).
Fibroblast-mediated lattice contraction was slower in those lattices in receipt of
conditioned medium from PMA-exposed U937s insonated with 0.1 W/cm 2 (PMA 0.1-
IM) than in those lattices that were given conditioned medium from similarly exposed
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U937s that were sham-insonated. FPCL in receipt of PMA 0.1-IM were consistently
significantly larger than those in receipt of PMA S-IM at all time points studied (P
< 0.005), with the exception of at the first time point of 4.75 hours.
4. Conditioned medium from PMA-exposed sham-insonated U937s (PMA S-IM)
versus conditioned medium from PMA-exposed U937s insonated with 3 MHz
therapeutic ultrasound at an intensity. 1(SATA) of 0.5 W/cm2 (PMA 0.5-tM).
FPCL supplemented with conditioned medium from PMA-exposed U937s insonated
with 3 MHz therapeutic ultrasound at an intensity of 0.5 W/cm2 contracted more
slowly than similar FPCL supplemented with conditioned medium from PMA-
exposed sham-insonated U937s. Those lattices given PMA 0.5-tM were found to be
significantly larger than similar lattices given PMA S-tM at all time points studied
(4.75 hrs, p <0.008; 21.25 hrs, p < 0.005; 30.75 hrs, p <0.005; 45.75 hrs, p = 0.031;
54.25 hrs, p = 0.03 1; 69.25 hrs, p < 0.005).
5. Conditioned medium from PMA-exposed. U937s insonated at intensities of 0.1
W/cm 2
 (PMA 0.1-tM) versus 0.5 W/cm 2
 (PMA 0.5-tM).
The rate of FPCL contraction observed in response to the application of RPM!- 1640
medium conditioned by PMA-exposed U937s insonated with therapeutic ultrasound
at an intensity of 0.5 W/cm 2 was similar to that observed in response to conditioned
RPM!- 1640 medium from PMA-exposed U937s similarly insonated at an intensity of
0.1 W/cm 2. FPCL in receipt of PMA 0.5-tM were found to have contracted at rates
statistically indistinguishable from those in receipt of PMA 0.1-tM for the majority
of the study. However, at the first time point, 4.75 hours, PMA 0.5-tM lattices were
statistically larger (i.e had demonstrated less contraction) than PMA 0.1-tM lattices
(p < 0.005); while at a later time point, 54.25 hours, PMA 0.5-IM lattices were
statistically smaller (i.e had demonstrated more contraction) than PMA 0.1-tM
lattices (p < 0.005).
6. Conditioned medium from PMA-exposed U937s insonated with therapeutic
ultrasound at an intensity. 1(sATA) of 0.1 W!cm 2 (PMA 0.1-tM) versus non-conditioned
medium containing PMA (PMA N-CM).
The rate of FPCL contraction observed in response to conditioned medium from
PMA- exposed U937s insonated with therapeutic ultrasound, at an intensity of 0.1
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W/cm2, was more rapid than that observed in response to the application of non-
conditioned RPM!- 1640 medium, supplemented with PMA, at all time points studied.
FPCL supplemented with PMA 0.1-IM were significantly smaller than, and thus had
contracted quicker, than FPCL supplemented with PMA N-CM at all time points
studied (p < 0.005).
7. Conditioned media from PMA-exposed U937s insonated with therapeutic
ultrasound at an intensity. 1(SATA) of 0.5 W/cm2
 (PMA 0.5-tM) versus non-conditioned
medium containing PMA (PMA N-CM).
Lattice contraction in response to conditioned medium from PMA-exposed U937s
insonated with therapeutic ultrasound, at an intensity of 0.1 W/cm 2, was more rapid
than that observed in response to the application of non-conditioned RPMI-1640
medium, supplemented with PMA, at all time points studied. FPCL supplemented
with PMA 0. 1-tM were significantly smaller, and thus had contracted quicker, than
FPCL supplemented with PMA N-CM at all time points studied (p < 0.005).
11.5.6 Discussion
The culture of U937s in RPM!- 1640 medium containing PMA leads to the generation
of conditioned medium that promotes the contraction of human dermal fibroblast
populated collagen lattices. FPCLs fed with PMA-exposed U937 conditioned medium
contracted more rapidly than similar FPCLs fed with unconditioned RPMI-1640
medium supplemented with PMA. Sham-insonation of PMA-exposed U937s leads to
the generation of a conditioned medium that stimulates FPCL contraction more than
the conditioned medium generated by non-insonated PMA-exposed U937s. FPCLs
supplemented with conditioned medium obtained from insonated PMA-exposed
U937s (exposed to both 0.1 and 0.5 Wfcm 2) contracted more slowly than similar
lattices in receipt of conditioned medium from sham-insonated PMA-exposed U937s,
but more rapidly than lattices given non-conditioned medium supplemented with
PMA.
The majority of observations regarding the effect of PMA-exposed U937
conditioned media on FPCL contraction follow the general scheme observed for non-
PMA-exposed U937 conditioned media on FPCL contraction. During conditioning
of RPMI-1640, be it by uninduced or PMA-induced U937s, an activity is acquired
that promotes FPCL contraction; ultrasonic exposure leads to the generation of
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Table 11.17	 The effect of non-conditioned RPMI-1640, containing PMA, on the contraction of
human dermal fibroblast populated collagen lattices (FPCL) in vitro.
Time post plating (hours)
21.25	 30.75	 45.75	 54.25	 69.25
Number of replicate	 6	 6	 6	 6	 6	 6
lattices
Median lattice area 	 677.7	 425.4	 331.4	 253.5	 240.8	 211.6
(mm2)	 ________ ________ ________ _________ ________ ________
Minimum	 615.5	 389.0	 304.9	 244.9	 235.5	 207.1
and Maximum	 to	 to	 to	 to	 tO	 to
(mm2)	 749.5	 519.8	 396.4	 281.2	 246.3	 216.7
95%	 631.0	 382.1	 300.5	 243.4	 237.1	 208.3
Confidence interval 	 to	 to	 to	 to	 to	 to
(mm2)	 727.5	 483.8	 377.7	 272.6	 244.5	 215.3
Table 11.18
	
The effect of conditioned RPMI.1640 (conditioned with non-insonated, PMA exposed,
U937s) on the contraction of human dermal FPCL in vitro.






Number of replicate	 6	 6	 6	 6	 6	 6
lattices
Median lattice area	 621.3	 356.4	 293.2	 221.1	 200.4	 178.9
(mm2)	 ________ ________ ________ ________ _________ ________
Minimum	 601.3	 341.6	 279.6	 203.5	 197.1	 169.9
and Maximum	 to	 to	 to	 to	 to	 to
(mm2)	 668.0	 379.5	 303.3	 242.8	 204.6	 184.8
95%	 601.1	 344.7	 282.1	 208.7	 197.9	 171.5
Confidence interval	 to	 to	 to	 to	 to	 to
(mm2)	 655.6	 . 372.4	 302.3	 235.1	 203.2	 185.4
Table 11.19
	 The effect of conditioned RPMI-1640 (conditioned with sham-insonated, PMA-
exposed, U937s) on the contraction of human dermal FPCL in vitro.






Number of replicate	 6	 6	 6	 6	 6	 6
lattices
Median lattice area
	 552.3	 303.7	 233.8	 188.0	 173.1	 163.1
(mm2)	 ________ ________ ________ ________ ________ ________
Minimum	 505.7	 285.5	 221.8	 179.9	 168.3	 158.2
and Maximum	 to	 to	 to	 to	 to	 to
(mm2)	 598.3	 333.5	 250.1	 196.7	 182.9	 169.3
95%	 520.4	 288.4	 224.2	 180.5	 168.7	 159.5
Confidence interval 	 to	 to	 to	 to	 to	 to
(mm2)	 584.1	 327.5	 245.8	 195.5	 180.1	 167.6
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Table 11.20	 The effect of conditioned RPMI-1640 (conditioned with PMA-exposed U937s
insonated with pulsed 3 MHz ultrasound {2ms on : Sms off} at an intensity of 0.1
W/cm2, 1(sATA)) on the contraction of human dennal FPCL in vitro.
Time post plating (hours)
4 75	 j	 21.25	 30.75	 45.75	 j	 54.25	 j	 69.25
Number of replicate	 6	 6	 6	 6	 6	 6
lattices
Median lattice area 	 562.4	 348.3	 291.1	 217.4	 202.1	 178.1
(mm2 )	 ________ _________ _________ ________ _________ ________
Minimum	 542.0	 341.4	 280.0	 195.5	 193.2	 173.2
and Maximum	 to	 to	 to	 to	 to	 to
(mm2 )	 591.4	 357.1	 303.6	 226.8	 210.6	 187.1
95%	 545.4	 342.4	 282.5	 202.4	 194.1	 173.7
Confidence interval 	 to	 to	 to	 to	 to	 to
(mm2 )	 587.4	 355.7	 300.5	 226.5	 209.7	 184.6
Table 11.21	 The effect of conditioned RPMI-1640 (conditioned with PMA-exposed U937s
insonated with pulsed 3 Mhz ultrasound {2ms on : Sms off} at an intensity of 03
W/cm2, 1T) on the contraction of human dermal FPCL in vitro.
Time post plating (hours)
	
4.75	 21.25	 30.75	 45.75	
f	
54.25	 (	 69.25
Number of replicate	 6	 6	 6	 6	 6	 6
lattices
Median lattice area 	 604.2	 340.5	 275.6	 212.6	 182.4	 175.5
(mm2)	 ________ _________ _________ ________ _________ ________
Minimum	 593.5	 334.9	 254.8	 181.2	 178.5	 159.2
and Maximum	 to	 to	 to	 to	 to	 to
(mm2)	 633.5	 378.1	 304.0	 226.4	 189.4	 184.5
95%	 593 2
	
340.5	 258.1	 193.2	 178.8	 163.7
Confidence interval 	 to	 to	 to	 to2	 to	 to









































































conditioned media that have a reduced capacity to encourage FPCL contraction.
Two theoretical explanations to explain these observations have been previously
described. Briefly, ultrasound could cause the loss of this contraction promoting
activity by either (1) depleting U937 cultures of those cells elaborating this activity,
or, (2) encouraging the production of a substance(s) with anti-contractile activities,
or (3) modulating the production of both pro- and anti-contractile activities (for a
discussion of these two theoretical explanations refer to page 314).
The FPCL contraction data from PMA-exposed U937s does differ from that
of non-induced U937s in one respect. Using non-PMA-exposed U937s, FPCL
contraction was more rapid in response to medium from non-insonated cells than
that in response to medium from sham-insonated cells. However, using PMA-exposed
U937s, FPCL contraction in response to medium from sham-insonated cells displayed
significantly more pro-contractile activity than medium from non-insonated cells. As
PMA treatment was the only manner in which the two sham-insonated cell
populations differed, this effect can be assumed to be a direct effect of PMA
exposure. One possible explanation for this observation may be that PMA exposure
primes the U937 into a state that is responsive to mechanical disturbance. The
physical processes of pipetting the PMA-primed U937 culture into and out of the
exposure chamber may in some way encourage the elaboration of pro-contractile
activities by these primed cells. Future work to test this hypothesis should include
PMA induction of U937s which should be followed by variable levels of agitation
(repeated aspiration). The pro-contractile capacity of conditioned medium from
differentially agitated cultures should then be assessed using the fibroblast-populated
collagen lattice contraction assay.
In summary, it is apparent that PMA-exposed U937s, cultured as described
above, produce a stimulatory factor for fibroblast-mediated collagen lattice
contraction; further studies are necessary to characterise this stimulator. Therapeutic
ultrasound exposure appears to reduce the level of this stimulator in U937 culture
supernatants. The observation that the reduction in stimulatory activity following
ultrasound treatment is paralled by a loss in viable cell number, suggests that
ultrasound acts to reduce stiniulatory activity by damaging the cells actively
generating this stimulator. PMA exposure would appear to have little effect on the
generation of pro-contractile substances by U937s.
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11.6 General summary
 of chapter 11.
The effect of therapeutic ultrasound on the release from macrophage-like U937 cells
of substances capable of stimulating fibroblast proliferation and fibroblast-mediated
collagen lattice contraction in vitro was examined. Therapeutic ultrasound was applied
to both differentiation-induced and uninduced U937 suspensions. It was found that
both types of U937s, cultured without ultrasonic intervention, produced conditioned
media which demonstrated inhibitory activity for fibroblast proliferation and
stimulatory activity for fibroblast-mediated collagen lattice contraction.
The conditioned medium taken from ultrasound-treated uninduced U937s was
found not to inhibit fibroblast proliferation like similar non-insonated and sham-
insonated culture supernatants, but was similar in effect to the application of
unconditioned U937 medium. When applied to fibroblast-populated collagen lattices
ultrasound-treated uninduced U937 conditioned medium encouraged lattice
contraction when compared with unconditioned medium, but delayed contraction
when compared with conditioned media from non-insonated or sham-insonated
U937s. Ultrasound treatment of uninduced U937 cultures leads to the loss of both
fibroblast growth inhibition activity and lattice contraction stimulation activity. As the
losses in both these activities were paralleled by a reduction in viable U937 cells after
insonation, ultrasound-associated damage may be responsible for these effects.
When differentiation-induced U937 cultures were treated with ultrasound the
conditioned medium so generated was found promote fibroblast proliferation above
that observed in response to non-conditioned U937 growth medium. When applied
to fibroblast-populated collagen lattices, ultrasound-treated differentiation-induced
U937 conditioned media modulated lattice contraction in a similar fashion to
ultrasound-treated uninduced U937 conditioned media, i.e. encouraged lattice
contraction when compared with unconditioned medium, but delayed contraction
when compared with conditioned media from non-insonated or sham-insonated
U937s. This gain in mitogenic activity and loss in stimulatory activity for lattice
contraction, in response to treatment with ultrasound, was paralleled by a reduction
in U937 viable cell density. It is suggested that ultrasound acts to selectively deplete
U937 cultures of PMA-unresponsive cells, which elaborate an inhibitory activity for
fibroblast growth and a stimulator)' activity for lattice contraction, and in doing so
positively selects for PMA-responsive cells, which elaborate a fibroblast growth
promoting agent(s).
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Chapter 12. Summary of experimental findings
1. p6 human dermal fibroblasts
Human dermal fibroblasts were cultured from a small elliptical skin biopsy, taken
from the forearm of a 35 year old healthy male volunteer, by the primary explant
technique. By passage 2, cell cultures were morphologically homogenous, being
multipolar in disperse culture and forming whorls of bipolar cells at near-confluency
both characteristic of fibroblasts in culture. Passage 6 cultures, which retained the
morphological characteristics of passage 2 cultures, were further characterised by
immunohistochemistry. They were found to be vimentin positive, Factor VIII and
cytokeratin LE1 and LP34 negative. These morphological and immunohistochemical
observations confirm p6 human dermal fibroblast cultures to be of the fibroblastic
lineage.
2. Sensitivity of the methylene blue fibroblast proliferation assay
The proliferation of p6 human dermal fibroblasts cultured under different
concentrations of fetal calf serum (FCS) was studied. Fibroblast proliferation was
found to increase as FCS concentration increased, thus indicating that the p6 human
dermal fibroblasts were capable of responding, in a dose dependent fashion, to
known mitogenic substances. The data also indicated that the methylene blue assay
was capable of measuring that response. The observation that the assay could detect
a statistically significant difference in proliferation between 1.0% FCS and 0.5% FCS
suggests that this technique is a highly sensitive one; it also suggests that the assay
may be able to detect even smaller differences in FCS concentration. These
observations supported the use of the methylene blue proliferation assay to monitor
changes in fibroblast proliferation.
3. FPCL formulation and its effect on lattice contraction
The rate of lattice contraction has previously been reported to be dependent on
lattice formulation, being directly proportional to fibroblast number and inversely
proportional to collagen concentration. A study was performed (1) to examine the
effect of varying fibroblast density and collagen concentration on the rate of lattice
contraction, and (2) to determine the most appropriate fibroblast number and
collagen concentration for subsequent experimental work with this model. Lattice
contraction was found to be more rapid with increasing cell density and decreasing
collagen concentration. The data also indicated that lattices prepared at low collagen
concentrations are more sensitive to changes in cell density than lattices prepared at
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higher collagen concentrations. The lattice formulation of 1.2 mg/mI collagen and 1
x i0 cells/ml was found to be the most appropriate choice for further studies on
FPCL contraction. Lattices formulated in this way represent the most economic use
of both collagen and cells and yet contract at a rate that does not preclude the
manifestation of stimulatory or inhibitory activities.
4. Sensitivity of the fibroblast-populated collagen lattice contraction assay
Fibroblast-populated collagen lattice contraction has previously been reported to be
more rapid with increasing serum concentration. A pilot study was performed (1) to
confirm this report, and (2) examine the sensitivity of the FPCL contraction assay to
pro-contractile substances. FPCL contraction was found to increase in a dose-
dependent fashion with increasing fetal calf serum (FCS) concentration. Though the
number of replicate lattices at each FCS concentration made statistical analysis
inappropriate, the data indicated that the FPCL contraction assay was a sensitive
technique capable of detecting pro-contractile activity.
5. Temperature changes consequent on exposure to therapeutic ultrasound
The temperature rise consequent to 3 MHz insonation at the two intensities
employed in this thesis was measured under both in vivo and in vitro exposure
conditions. Under in vivo exposure conditions a 5 minute insonation at an intensity
of 0.1 W/cm2, 1(SATA), led to a mean temperature rise of 1.0°C, whereas a similar
insonation at an intensity of 0.5 W/cm2, 1(SATA), led to a mean temperature rise of
3.3°C. Under in vitro exposure conditions a 5 minute insonation at an intensity of 0.1
W/cm2, 1(SATA) led to a mean temperature rise of 0.2°C, whereas a similar insonation
at an intensity of 0.5 W/cm2, 1(SATA) led to a mean temperature rise of 0.5°C.
6. The effect of pulsed 3 MHz therapeutic ultrasound on wound contraction in
the rat.
The closure of full thickness wounds made in the flank skin of adult Wistar rats was
used as a model of wound contraction. The model facilitated a quantitative
assessment of the effect of therapeutic ultrasound on the process of contraction. The
contraction of fully-excised rat skin wounds treated with 3 MHz therapeutic
ultrasound (at both intensities) was significantly more rapid than that of similar
sham-treated control wounds. At the end of the experimental period ultrasound-
exposed wounds were significantly smaller than similar sham-exposed wounds.
Wounds insonated at an intensity of 0.1 W/cm2 (I(sATA)) displayed a tendency to
contract more rapidly, and were ultimately smaller, than similar wounds insonated
326
at an intensity of 0.5 W/cm2 (I(sATA)).
7. The direct effect of pulsed 3 MHz therapeutic ultrasound on the proliferation
of human dermal fibroblasts in vitro.
The methylene blue proliferation assay was employed to investigate the direct effect
of therapeutic ultrasound on the proliferation of p6 human dermal fibroblasts in vitro.
Under the experimental conditions employed in this study, the direct application of
therapeutic ultrasound did not significantly effect the rate of fibroblast proliferation.
8. The direct effect of pulsed 3 MHz therapeutic ultrasound on the contraction
of human dermal fibroblast-populated collagen lattices in vitro.
The fibroblast-populated collagen lattice contraction assay, a widely accepted in vitro
model for the process of wound contraction, was employed to investigate the direct
effect of therapeutic ultrasound on fibroblast-mediated contraction. Under the
experimental conditions employed in this study, the direct application of 3 MHz
pulsed therapeutic ultrasound to fibroblast-populated collagen lattices did not
significantly effect lattice contraction.
9. The effect of pulsed 3 MHz therapeutic ultrasound on the release from
platelets of substances capable of modulating fibroblast activity in vitro.
To investigate the effect of therapeutic ultrasound on platelet degranulation,
suspensions of human platelets were either sham-insonated, insonated with 3 MHz
pulsed therapeutic ultrasound (at intensities, 1(SATA) of either 0.1 or 0.5 W/cm 2) or
treated with thrombin (physiological release). The platelet releasates, generated by
centrifugation of platelet suspensions after exposure, were then studied for their
ability to modulate fibroblast proliferation and fibroblast-mediated collagen lattice
contraction. Releasates generated from platelet suspensions exposed to therapeutic
ultrasound were found to promote both fibroblast proliferation and fibroblast-
mediated collagen contraction when compared with similar releasates generated from
sham-insonated platelet suspensions. Fibroblast proliferation in response to the
releasate generated by insonating platelets at an intensity of 0.1 W/cm 2 did not differ
from that generated by insonating platelets at 0.5 WIcm 2. Lattice contraction was
more rapid in response to the 0.1 W/cm 2 releasate than in response to the 0.5 W/cm2
releasate. Platelet releasates generated by exposing platelet suspensions to thrombin
were generally found to promote fibroblast proliferation and fibroblast-mediated
collagen lattice contraction when compared with releasates generated from insonated
platelet suspensions.
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10. The effect of pulsed 3 MHz therapeutic ultrasound on the release from U937s
(monocyte/macrophage-like cells) of substances capable of modulating
fibroblast activity in vitro.
The effect of 3 MHz therapeutic ultrasound (at intensities of 0.1 and 0.5 W/cm2
I(sATA)) on the release from U937s of substances capable of modulating fibroblast
proliferation and fibroblast-mediated collagen contraction in vitro was examined.
Studies were carried out on both differentiation-induced and uninduced U937
suspensions. Both types of U937s, cultured without ultrasonic intervention, produced
conditioned media which demonstrated inhibitory activity for fibroblast proliferation
and stimulatory activity for fibroblast-mediated collagen lattice contraction.
Ultrasound treatment of uninduced U937 cultures led to the generation of
conditioned media that displayed a loss of both fibroblast proliferation inhibition
activity and lattice contraction stimulation activity relative to non-insonated U937
conditioned medium, losses which were paralleled by a reduction in U937 viability.
Fibroblast proliferation in response to conditioned medium taken from uninduced
U937s insonated at an intensity of 0.1 W/cm2 did not differ from that in response to
conditioned medium taken from uninduced U937s insonated at an intensity of 0.5
W/cm2. Lattice contraction was more rapid in response to conditioned medium from
uninduced U937s insonated at an intensity of 0.1 W/cm 2 than that in response to
conditioned medium from uninduced U937s insonated at an intensity of 0.5 W/cm2.
Ultrasound treatment of differentiation-induced U937 cultures led to the
generation of conditioned media that promoted fibroblast proliferation and exhibited
a loss of lattice contraction stimulation activity. The gain in pro-proliferative activity
and loss of pro-contractile activity was paralleled by a loss in U937 viability. The
conditioned media generated by differentiation-induced U937s insonated at an
intensity of 0.1 W/cm2 was similar, with regard to its effects on both fibroblast
proliferation and FPCL contraction, to that generated by differentiation-induced
U937s insonated at an intensity of 0.5 W/cm2.
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Chapter 13. Conclusions
This thesis describes studies carried out to examine the effect of therapeutic levels
of ultrasound on certain aspects of mammalian cutaneous repair. From these studies
it is possible to draw the following conclusions:
1. Ultrasound at therapeutic levels, when applied soon after injury, can interact
with and promote the process of mammalian wound contraction at sites of tissue loss
(Chapter 7, p218), suggesting that treatment with therapeutic ultrasound soon after
injury is clinically advisable.
2. In vitro results suggest that this promotion in wound contraction is unlikely to
be due to a direct stimulation of fibroblast proliferation (Chapter 8, p234) or
fibroblast-mediated contraction (Chapter 9, p244).
3. Since therapeutic ultrasound, at levels used to stimulate wound contraction in
the rat, has been shown to encourage the release of pro-proliferative and pro-
contractile substances from platelets in vitro (Chapter 10, p253) it is suggested that
therapeutic ultrasound may promote the process of cutaneous repair by elevating the
release of platelet-derived pro-proliferative and pro-contractile substances within the
wound site. As several platelet-derived substances are known to be attractants for
both monocytes and fibroblasts, it is possible that ultrasound may act to promote
wound repair, and more specifically wound contraction, by encouraging the release
of these cellular attractants.
4. The conditioned medium of differentiation-induced U937 cells (which are
morphologically, histochemically and functionally more macrophage-like than
uninduced U937s) while displaying reduced levels of pro-contractile activity, acquire
an activity which is mitogenic for fibroblasts when treated with therapeutic ultrasound
in vitro (Chapter 11. p276). If similar behaviour occurs in activated macrophages at
the wound site, this could lead to an increase in fibroblast number, which may, in
part, explain the ability of therapeutic ultrasound to stimulate fibroblast-mediated
wound contraction.
5. Therapeutic ultrasound at an intensity of 0.1 W/cm2 (I(sATA)) was found to
promote the process of wound contraction to a greater extent than when applied at
an intensity of at 0.5 W/cm2 (I SATA)) (Chapter 7, p218). Temperature measurements
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made in uninjured dermis during treatment with ultrasound showed that the
temperature rise over the 5 minute treatment period was 1°C at an intensity of 0.1
W/cm2 and 3.3°C at an intensity of 0.5 WIcm2 (table 6.3, p215). Such observations
would appear to suggest that the mechanisms involved in the stimulation of wound
contraction by ultrasound were not purely thermal. These observations question the
benefit of using high intensity ultrasound and support the use of low intensity
therapeutic ultrasound in clinical practice.
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Chapter 14. Future work
In completion of this thesis various lines of future work have revealed themselves.
Possible avenues of future work include:
1. Similar investigations to those performed on healthy young Wistar rats, on rats
which are known to be impaired with respect to their capacity to repair. Studies may
include investigations into the effect of ultrasound on genetically obese diabetic mice,
strain C57BLJK&J-db/db, or on elderly rats, both known to displayed impaired healing
(Sprugel et a!. 1990; Broadley et al. 1990).
2. Fibroblasts have been shown to be capable of significant morphological,
structural and functional heterogeneity. Additionally, it has been proposed that the
wound environment may induce, or select, specific fibroblast phenotypes that differ
in their ability to respond to exogenous stimuli such as growth factors. The
observation that therapeutic ultrasound cannot directly modulate fibroblast
proliferation or fibroblast-mediated lattice contraction may result from the use of an
inappropriate fibroblast phenotype. Further studies to test this possibility may include
comparative studies into the effect of therapeutic ultrasound on fibroblasts derived
from normal skin and wound tissue.
3. The extracellular matrix (ECM) component of the lattices used in this thesis
is primarily type I collagen. The ECM experienced by granulation tissue fibroblasts
is far more complex. Initially the ECM is rich in hyaluronic acid, fibronectin and
collagen type III, but as repair proceeds this is gradually replaced by an ECM
predominantly composed of type I collagen and suiphated proteoglycans. Further
studies investigating the ability of therapeutic ultrasound to modulate fibroblast-
mediated contraction may include the use of lattices formulated in a more
granulation tissue-like fashion.
4. The mechanisms of fibroblast-mediated collagen lattice contraction are not
clear. It is known that culture medium must contain serum for contraction to occur.
This requirement for serum has complicated studies utilising various biological
mediators. A serum-free model for cell-mediated contraction of collagen lattices is
necessary to define the role of serum components in lattice contraction. Anderson
el a!. (1990) described a serum-free FPCL contraction assay using human foreskin
fibroblasts and studied the effects of various agents including growth factors. It may
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be more appropriate to employ such a model in further investigations into detecting
ultrasound-induced release of substances from both platelets and macrophages
capable of modulating fibroblast-mediated contraction.
5. It has been demonstrated that therapeutic ultrasound, at the parameters
employed in this thesis, can promote the release of substances from platelets that
stimulate fibroblast proliferation and fibroblast-mediated collagen lattice contraction.
Platelet a-granules are known to contain various growth factors, many of which have
been shown to promote either fibroblast proliferation or fibroblast-mediated lattice
contraction, or both. In order to investigate which platelet-derived substance(s) is/are
primarily responsible for stimulating fibroblast proliferation or fibroblast-mediated
lattice contraction, future studies may involve the use of neutralising (or
precipitating) antibodies to selectively deplete platelet releasates of one or more a-
granule components.
6. It has been demonstrated that the application of a mu rifle antibody MA 710F
to PMA-treated U937s further encourages differentiation of U937s into cells with the
morphological appearance of macrophages. Therapeutic ultrasound applied to
wounds would interact with both monocytes (blood borne) and macrophages
(extravascular), the latter being thought to orchestrate repair. Further studies on
MA 719F treated, PMA-exposed U937s may prove beneficial in understanding the
effect of therapeutic ultrasound on wound repair (Koyama et a!- see U937 search
89/90 in FW folder).
7. U937s are monoblastic cells that must be induced to differentiate in order to
develop some properties peculiar to mature monocytes (Koren et a!. 1979), such as
antibody-dependent cell-mediated cytotoxicity, phagocytosis and expression of the
My4-defmed antigen (Hermann et a!. 1985). Even after induction, U937s have been
shown not to express various antigenic markers (such as 63D3, M42, Mo2, LeuM3
and U1HM1) known to be expressed by peripheral blood monocytes (Zeigler-
Heitbrock et a!. 1988). Another cell line, Mono Mac 6, has been established from the
peripheral blood of a patient with monoblastic leukemia. This cell line has the
morphological appearance of monocytes (under both light and electron microscopy)
and constitutively expresses certain phenotypic and functional features of mature
monocytes. Including the expression of significant levels of various peripheral blood
monocyte markers and the ability to phagocytose antibody-coated erythrocytes
(Zeigler-Heitbrock et a!. 1988). Such observations suggest that Mono Mac 6 is a more
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appropriate in vitro model of mature monocytes. Future studies are planned to
compare the effect of therapeutic ultrasound on PMA-induced U937s and the Mono
Mac 6 cell line. Conditioned media from these two cell lines will be assayed for its
ability to promote fibroblast proliferation, FPCL contraction and, additionally,
fibroblast migration.
8. One theoretical explanation for the loss of fibroblast growth inhibitory activity
in conditioned medium after U937 insonation, is that ultrasound damages U937s
which leads to less U937-derived inhibitor being released into the medium they
condition, and consequently more proliferation when that conditioned medium is
applied to fibroblasts in culture. Future work to test this theory may include studying
the effect of cellular damage on the release of fibroblast proliferation inhibitors by
U937s.
9. Sham-insonated differentiation-induced U937s tend to produce more pro-
contractile activity than non-insonated differentiation-induced cells. It is possible that
the physical process of pipetting the PMA-induced U937s into and out of the
exposure chamber in some way encourages the release of pro-contractile activities
from these cells. Future work may include a study into the effect of variable levels









Appendix IA. Phosphate Buffered Saline (PBS) pH 73
Prepared by dissolving 1 PBS tablet (Oxoid, Unipath Ltd, Basingstoke, UK) in 100









To sterilise, autoclave or filter with 0.22 p.m filter.
Appendix lB. 0.01 M Borate Buffer pH 8.6
Prepared according to the method of Clark and Lub, (1917).
Solution A:	 0.1 M boric acid in 0.1 M potassium chloride
= 6.2 g H2B04 + 7.46 g KC1 per litre
Solution B:	 0.1 N sodium hydroxide
= 4.0 g NaOH per litre
Add 12 ml of B to 50 ml of A and make up to 100 ml with distilled water to give 0.1
M borate buffer. Dilute this by the addition of a further 900 ml of distilled water to
make 0.01 M borate buffer.
Appendix 1C. Platelet Washing Buffer (PWB)
Prepared according to the method of Knighton et al. (1986).
Components to make 250 ml PWB:




Ciystallised Bovine Albumin (BDH)
Method:
1. Dissolve the above components in 100 ml distilled water.
2. Add more distilled water to final volume of 250 ml.
3. Check pH, which should be 7.4, correct if necessaly.
4. Steriise by passing through a 0.22 p.m millipore filter.
5. Store at 20°C, and use within 5 days of preparation.
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Appendix 1D. 4% Paraformaldehyde (fixative)
To prepare 2.5 litres of stock:
1. Dissolve 100 g paraformaldehyde (Solmedia, Essex, UK) in 2 litres of stirring
distilled water at 60-70°C adding a maximum of 4 drops/I of 10 M NaOH in a fume
cupboard.
2. When cool, filter if necessary (Whatman 113).
3. Add PBS salts (Oxoid, UK) 1 tablet per 100 ml and make up to 2.5 1.
APPENDIX 2
Culture Media
Appendix 2A. Primary Culture Wash
Components to make 100 ml wash:
Ham's FlO (Gibco BRL, Scotland)
Gentamycin (Gibco BRL, Scotland)
Penicillin/Streptomycin (Gibco BRL, Scotland)
Appendix 2B. Fibroblast Growth Medium
Components to make 100 ml medium:
Ham's FlO (Gibco BRL, Scotland)
Fetal calf serum (Gibco BRL, Scotland)
Penicillin/streptomycin (Gibco BRL, Scotland)
Appendix 2C. Fibroblast Freeze Medium
Components to make 100 ml medium:
Ham's FlO (Gibco BRL, Scotland)
Fetal calf serum (Gibco BRL, Scotland)
Penicillin/streptomycin (Gibco BRL, Scotland)











Notes applying to AppendA 2A, 2B and 2C:
Penicillin/St reptomycin is supplied as a solution containing 5000 units/mi and 5000
j.g/mi respectively. Gentamycin is supplied as a solution containing 10 mglmL The final
concentrations of antibiotics within the medium are: gentamycin 100 pg/mi penicillin 100





Appendix 2D. Concentrated Fibroblast Growth Medium.
Growth Medium x 3
Components to make 100 ml concentrated medium:
7.5% Sodium bicarbonate (Flow Laboratories, Scotland)
1 M HEPES Buffer solution (Gibco BRL, Scotland)
Penicillin/Streptomycin (Gibco BRL, Scotland)
Fetal Calf Serum (Gibco BRL, Scotland)
Ham's FlO (x3) (Gibco BRL, Scotland)
Growth Medium x 5
Components to make 100 ml concentrated medium:
7.5% Sodium bicarbonate (Flow Labs, Scotland)
1 M HEPES buffer solution (Gibco BRL, Scotland)
Penicillin/Streptomycin (Gibco BRL, Scotland)
Fetal Calf Serum (Gibco BRL, Scotland)











Note: 1. Ham's FlO x3 & x5 is prepared by diluting Ham's FlO (xlO) medium
concentrate with sterile distilled water.
2. Ham's FlO (xlO) concentrate is supplied sodium bicarbonate free, hence the
requirement for supplementation with 7.5% sodium bicarbonate.
3. The final concentrations of antibiotics within the medium are: penicillin 150
units/mi and streptomycin 150 .LgfmI.
Appendix 2E. Macrophage Growth Medium
Components to make 100 ml medium:
RPM! 1640 (Gibco BRL, Scotland)
Heat-inactivated fetal calf serum (Gibco BRL, Scotland)
Penicillin/streptomycin (Gibco BRL, Scotland)
Appendix 2F. Macrophage Freeze Medium
Components to make 100 ml medium:
RPM! 1640 (Gibco BRL, Scotland)
Heat-inactivated fetal calf serum (Gibco BRL, Scotland)
Penicillin/streptomycin (Gibco BRL, Scotland)






Appendix 2G. Serum-free macrophage growth medium
Components to make 100 ml medium:
RPMJ 1640 (Gibco BRL, Scotland)	 98.0 ml
Penicillin/streptomycin (Gibco BRL, Scotland)
	 2.0 ml
Appendix 2H. PMA supplemented serum-free macrophage growth medium
Components to make 100 ml medium:
PMA/acetone (100 .g/mJ)	 0.1 ml
Serum-free macrophage growth medium (Appendix 2G)
	 99.9 ml
Notes applying to appendfr 2E & 2F:
1. Fetal calf serum employed has complement activity removed by heat-inactivation.
2 The final concentrations of Penicillin/Streptomycin are as Appendir 24.
APPENDIX 3
Protocol for the Explant Technique for the Primary Culture of Human Biopsy
Material - Adult Human Forearm Fibroblast Primary Culture.
1. Obtain biopsies under sterile operating conditions, and place then directly into
a sterile universal containing primary culture wash (Appendix 2A). Hold in
wash for 1 hour at 37°C.
2. Wash the biopsy material with sterile PBS (Appendix 1A) and transfer to a
sterile petri dish.
3. Using 2 sterile scalpel blades, chop the tissue into pieces of less than 0.1 mm3.
Transfer these pieces of tissue to the "normal culture surface", (i.e. the upper
surface) of an inverted 50 cm3
 tissue culture flask using a sterile Pasteur
pipette.
4. Aliquot 1 ml of fibroblast growth medium (Appendix 2B) into the base of the
inverted flask and place the flask, still in its inverted orientation, in a 37°C
incubator for 24 hours. During incubation this fibroblast growth medium
provides a humid environment for the pieces of tissue thus preventing
desiccation.
5. After 24 hours gently turn the flask the correct way round, such that the
pieces of tissue are now bathed in fibroblast growth medium. Carefully add
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an additional 1 ml of growth medium to the flask. The pieces of tissue should
attach to the culture surface during this initial incubation, and should not
move when this additional growth medium is added.
6. Examine the pieces of tissue for cellular outgrowth, on a regular basis, using
an inverted microscope. Outgrowth normally starts to become visible from day
5 onwards.
7. As soon as outgrowth is established renew the growth medium. Renew growth
medium every 2 to 3 days.
8. When the outgrowth appears near-confluent use short trypsinisation
(Appendix 4) to remove the fibroblasts without removing the generally
more adherent keratinocytes. Fibroblast cultures are maintained by feeding
on a twice weekly basis, and are passaged upon near confluency with a
subcultivation ratio of 1:3. 	 Protocol adapted from Freshney (1987)
APPENDIX 4
Fibroblast Trypsinisation Protocol
1. Discard used culture medium into waste receptacle, and rinse near-confluent
fibroblast monolayer with sterile PBS (Appendix 1A).
2. Add sufficient Trypsin-EDTA (Gibco BRL, UK) to cover the base of the flask
(3 ml to a 260 ml flask; 1 ml to a 50 ml flask).
3. Return flask to 37°C incubator for 10 minutes (5 minutes for short
trypsinisation).
4. Remove flask from incubator and examme under inverted microscope for
detachment of cells. If detachment is not complete either swirl trypsin over the
monolayer until the majority of cells go into suspension or incubate for a
further 5 minutes.
5. Decant fibroblast/trypsin suspension into a sterile centrifuge tube and add an
equivalent volume of fibroblast growth medium (Appendix 2B). Serum
containing growth medium not only dilutes the trypsin but also actively
reduces further proteolytic attack of cells by supplying an alternative substrate
for the enzyme.
6. Centrifuge for 5 minutes at 80 x g to form a cell pellet and supernatant.




Cell storage and recovery
Appendix 5A. Freezing-down of cells (adapted from that of Freshney, 1987)
1. Perform standardised trypsinisation (Appendix 4) and resuspend in fibroblast
freeze medium (Appendix 2C) at an approximate concentration of 5 x 106
fibroblasts per ml.
2. Dispense 1.0 ml aliquots of this cell suspension into each 1.8 ml cryo-ampule
(Nunc, Inter Med, Denmark), place in polystyrene box and transport
immediately to -70°C freezer. Hold at -70°C for between 2 and 3 hours. This
pennits the cell suspension to freeze at the recommended rate of 1°C per
minute (Leibo and Mazur, 1971; Harris and Griffiths, 1977).
3. After -70°C cooling and holding, quickly transfer to liquid nitrogen (-196°C)
for storage.
Appendix SB. Recovering cells from cryo-store (adapted from that of Freshney, 1987)
1.	 Remove cryo-ampule from nitrogen store and place immediately in 37°C
water.
2. Once thawed, swab the ampule with 70% alcohol and open. Pour the contents
of the ampule into a 15 ml sterile centrifuge tube and slowly add 5 ml of
fibroblast growth medium. Medium should be added slowly to reduce the
likelihood of osmotic damage as the DMSO within the freeze medium
(Appendix 2C), is diluted.
3. Centrifuge the suspension for 3 minutes at 80 g, discard the supernatant,
gently resuspend the pellet in 5 ml of fresh growth medium and decant into
a 50 ml tissue culture flask.
4. Place in 37°C incubator. Feed with fibroblast growth medium (Appendix 2B)
on a twice weekly basis.
Note: The techniques for cry-storage and recovery for the pro-monocyte cell line U937
are essentially those described above. However, as anchorage independent cells they do
not require tiypsinisation, and are routinely cultured in macrophage growth medium
(Appendix 2E). The basic techniques described above were employed substituting
macrophage freeze medium (Appendix 2F) for fibroblast freeze medium and macrophage




Percentage viability and the concentration of viable cells per ml.
1. Tiypsinise cells according to Appendix 4 and resuspend in 2 ml of fibroblast
growth medium per 260 ml flask trypsinised. Ensure that the pellet is
thoroughly resuspended such that cells are in single cell suspension.
2. Remove a 300 pi sample of this suspension and place in a 15 ml centrifuge
tube, and add 300 p.1 of 0.4% trypan blue solution (Sigma T-8154) and mix
thoroughly.
3. Dispense approximately 20 p.1 of this mixture into the cell counting chamber
of a correctly assembled modified Neubaur haemocytometer.
4. Place the haemocytometer on the stage of a light microscope and focus on the
chamber grid. The Improved Neubaur haemocytometer slide is basically a 3
x 3 arrangement of 9, 1.0 mm2, large squares. These large squares are divided
up into 25 small squares each of which is further divided up into 16 smaller
squares.
5. Count the number of cells within each of the 9 large squares, noting for each
large square counted:
(a) the total number of clear and blue cells (i.e viable and non-viable cells)
(b) the number of blue cells (non-viable).
Then calculate:
(I).	 The average number of non-viable cells/large square, defined as B.
(ii). The average number of both viable and non-viable/large square, defined
here as T.
A. Percentage viability:
% viability = I - (BIT) x 100
B. The concentration of viable cells per ml:
(i). Calculate the average number of viable cells per large square, defined
asN.
N=T-B
(ii). Calculate the volume, V, of cell suspension over one large square.
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Knowing the area of a large square to be 1 mm 2 and the depth to be
0.1mm;
V = 1 x 1 x 0.1 mm3
= 0.1 mm3
= 0.0001 cm3
= 1 x iO ml
(iii). Calculate C, the concentration of cells per ml in suspension under
study.
C=N/V
= N x iO cells per ml
APPENDIX 7
The preparation of the platelet stock suspension
1. Perform venepuncture and fill a 450 ml blood transfusion bag containing
anticoagulant (Travenol), with freshly donated human blood. During
collection place the transfusion bag on ice.
2. Aliquot the contents of the transfusion bag into 50 ml sterile centrifuge tubes
and hold on ice. Complete the following steps (3 to 8) within 1 hour.
3. Centrifuge aliquots at 150 x g for 15 minutes at 4°C to form a platelet rich
plasma supernatant (PRP). The erythrocytes and leucocytes form the pellet.
4. Aspirate off the PRP taking care not to disturb the underlying cell pellet and
perform a platelet count, using a Coulter counter, on the PRP.
5. Centrifuge the PRP at 1500 x g for 20 minutes at 4°C to form a platelet pellet
and a platelet poor plasma (PPP) supernatant. Perform a platelet count on the
PPP using a coulter counter.
6. Using the PRP and PPP platelets counts, and taking into consideration the
total volume of PRP, calculate the number of platelets in the pellet.
7. Resu spend the platelet pellet in platelet washing buffer (Appendix 1C) to give
a concentration of 1 x iO platelets per ml - thus making the platelet stock
suspension. The platelet stock suspension is held on ice.
* The transfusion bag (Travenol) is a 450 ml blood transfusion bag containing 63 ml
citrate phosphate dextrose adenine formula 1 (CPD-adenine 1). Each 100 ml of
CPD-adenine 1 contained sodium citrate 2.63 g, anhydrous glucose 2.90 g, citric acid
monohydrate 327.00 mg, phosphate 251.00 mg and adenine 27.50 mg.
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APPENDIX 8
Methylene Blue Fibroblast Proliferation Assay - Standard Protocol
1. Trypsinise sub-confluent monolayers of passage 6 (p6) human dermal
fibroblasts and generate cell pellets according to the Fibroblasts Tiypsinisation
Protocol (Appendix 4).
2. Resuspend cell pellet in Ham's FlO medium, supplemented with 10% fetal calf
serum and 2% penicillin/streptomycin, to make a cell suspension of 2 x 10
viable cells/ml (Appendix 6).
3. Aliquot 100 p.l volumes of this cell suspension (i.e. 2000 cells) into each well
in rows B through G (Appendix 9) of a sterile 96-well flat bottomed cell
culture microtitre plate (Linbro, Flow Laboratories, Scotland).
4. Plate out 100 p.1 aliquots of Ham's FlO, supplemented with 10% fetal calf
serum and 2% penicillin/streptomycin, into each well in rows A and H of the
same plate. These wells are medium blank wells as discussed earlier (p152).
Note. The number of plates prepared in this way depends upon the number of intended
time points at which proliferation is going to be studied.
5. Once all wells of each plate have received their 100p.l aliquot of the cell
suspension or growth medium alone, seal the plates with plate sealing tape
(Titertek, Flow Laboratories, Scotland) and place in a 37°C incubator.
6. At predetermined times remove plates from the incubator, remove the plate
sealing tape, and discard the medium within the wells by inverting the plate
over a sink.
7. Carefully wash each plate by immersing in 5 changes of PBS (pH 7.6) and
gently tap on tissue paper to remove excess PBS.
8. Aliquot 100 1il of methanol (AnalaR, BDH) into each well and allow to fix for
10 minutes. After fixation discard the methanol by inverting the plate over an
alcohol waste tank, place the plate upside down and allow to air dry.
9. Once dry, plates are stored in a dust free environment until the plate of the
final time point, of a given investigation, has been fixed and dried. All plates
from a given study are then stained, as a batch, with methylene blue.
10. 100 p.1 of 1% methylene blue in 0.01 M borate buffer (Appendix 1B) is
added to each well, of each plate in the study, and left to stain for 30 minutes.
Excess stain is then discarded and the plates washed by carefully immersing
342
Row
in 5 changes of 0.01 M borate buffer and then tapped onto tissue paper to
remove excess buffer. Plates are then placed upside down to air dry.
11. Once dry, lOOp.l of acid-alcohol (50% 0.1 M HC1 : 50% absolute ethyl-alcohol)
is then added to each well to elute the methylene blue.
12. The absorbance (A 650 nm) of each well is then measured using a microplate
photometer (Anthos Labtech Instrument type 10 500, Austria), after ensuring
the eluted dye is thoroughly mixed with the elution solvent. This is
accomplished by programming the photometer to shake the plate for 60
seconds prior to taking A650 readings.
APPENDIX 9
96-well microtitre plate.
The diagram below shows the well vectors of the 96 well flat bottomed tissue culture




Human Dermal Fibroblast Collagen Lattice Contraction Assay- Standard Protocol
This protocol uses Vitrogen 100 purified, pepsin solubilised bovine dermal collagen
(Celtrix Laboratories, Palo Alto, California, USA)
1. Prepare a cell suspension containing 4 x i05 viable (p6) human dermal
fibroblasts per ml of fibroblast growth medium (Appendix 6) by following the
trypsinisation protocol (Appendix 4).
2. Prepare concentrated fibroblast growth medium (Appendix 2D).
3. Prepare neutratised collagen solution as follows:
Materials:
(i) Vitrogen 100 Collagen, chilled to a temperature of 4 - 6°C.
(ii) Sterile PBS (Appendix 1A) at 10 times normal concentration.
(iii) 0.1 M HC1.
(iv) 0.1 M NaOH.





Mix 8 ml of chilled Vitrogen with 1 ml of PBS (lOX). Add 1 ml
of 0.1 M NaOH and mix thoroughly.
Check pH and adjust if necessary to pH 7.2 ± 0.2 by the
addition of a few drops of 0.1 M HCI or 0.1 M NaOH.
One neutralised the collagen solution can be stored at 4°C for
several hours prior to use.
Note. Vitrogen 100 is supplied at 3.0 mg/mI in 0.012 N HC4 once neutralised the
collagen concentration falls to 24 mg/mI.
4. Thoroughly mix the neutralised collagen with the concentrated growth medium
and then add the cell suspension, followed by further thorough mixing, in the
following proportions to produce the lattice mixture.
(i) Neutralised collagen	 3.0 ml
(ii) Concentrated fibroblast growth medium 1.5 ml
(iii) Fibroblast suspension (4 x iO cells/ml) 1.5 ml
Note. Once combined in this way the concentrations of collagen and fibroblasts are 1.2
mg/mi and 1 x io cells/mi respectively. Upon mixing 3 ml of neutralised collagen with
1.5 ml of concentrated growth medium the medium component of the lattice mixture
returns to that of normal fibroblast growth medium (Appendix 2B).
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5. Carefully dispense the lattice mixture, in 2 ml aliquots, into 35 mm diameter
bacteriological petri dishes (Falcon, Becton Dickinson, UK); ensuring that
there are no bubbles. Place the lattice mixture containing petri dishes in a
37°C humidified incubator and leave undisturbed to polymerise for 1 hour.
6. After 1 hour remove the polymerised lattices from the incubator and release
them from their attachment to the sides of the petri dish by "rimming". This
is performed by first tilting the petri dish, then gently tapping around the
circumference of the inclined dish as it is rotated.
7. Add either 1 ml of fibroblast growth medium, of 1 ml of the substance under
test to the petri dish. The lattices should then float freely within the petri
dish.
8. Place lattices in a sealed humidified box and place in a 37°C incubator.
9. Examine lattices at 30 minute intervals for the onset of lattice contraction.
10. Photograph lattices at regular time points (Appendix 11) and develop
films according to Appendix 12.






Clear plastic ruler with milinnetre graduations
Pentax ME super single lens reflex camera loaded with FP4 black and white
film (Ilford, Cheshire, UK) and fitted with macro lens
Camera gantry
Method:
1. Load camera and attach to camera gantry. The gantry arrangement is such
that it: (I) provides rigid support for the camera, thus reducing camera
shake, and (ii) holds the camera at a fixed distance from lattice, thus
ensuring a fixed photographic magnification of the lattice.
2. For each film, prepare an acetate sheet of the experimental information. This
should include the time and date at which the photographs were taken and
indicate of the investigation being monitored. This acetate should be the first
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photograph taken.
3. Carefully remove the fibroblast populated lattices from the incubator and
place them on the light box in preparation for photography. Remove the lids
of the petri dishes to reduce distortion of the final photographic image.
Prepare an acetate strip name tag for each lattice and label appropriately.
Place these name tags in close proximity to the petri dish within the
photographic field of view. Similarly, locate a clear plastic rule within the
photographic field of view, then photograph the whole assembly. The image
of the ruler is used as a standard during subsequent planimetric quantitation
of lattice areas. As petri dish lids are removed for photography all
photographs are taken within the sterile confines of a laminar flow cabinet.
4. Films are developed according to the procedure described in appendix 12.
APPENDIX 11B
Black and white film (Ilford FP4) processing.
Requirements:
Hand held developing tank
ID11 developer (Ilford, Cheshire, UK) at 20°C
Hypam-Rapid-fix fixative (ilford, Cheshire, UK) at 20°C




Under dark room conditions:
1. Open film cartridge, detach film from cartridge spindle and cut off film
tongue.
2. Wind film onto developing spool and place the loaded spool in the light-proof
developing tank.
3. Pour sufficient ID11 developer (20°C) into the developing tank to cover the
loaded spool. Start timer.
4. Develop film for a total of 6.5 minutes, with 20 seconds agitation per minute.
5. Discard developer and wash in running 20°C tap water for 30 seconds.
6. Discard tap water and add sufficient Hypam-Rapid-Fix fixative to cover loaded
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spool. Start timer.
7. Fix film for a total of 5 minutes, with 30 seconds of agitation at the beginning
and end of this period.
8. Discard fixative and wash in running tap water for 30 minutes.
9. Rinse with distilled water and hang weighted film to dry in drying cabinet.
APPENDIX 12
Computer-assisted planimetry
1. Lattices are photographed using standard black and white photography
(Appendix 11), and the films developed according to Appendix 12.
2. After developing, transfer the photographic negatives to a light box and
digitise at 1280 by 1024 square pixels. The negatives are transilluminated on
the light box and digitisation is then performed using a high resolution "charge
couple device" CCD camera (Videk Megaplus, model K00792) fitted with a
55 mm Nikon Nikkor lens. The camera data is recorded using an IBM PC-AT
compatible computer and the Univision UPX 1000 interface and the resulting
image displayed using a Univision UDC2600 display controller. Optimas
(Bioscan mc, USA) software is used to capture and analyze the image of the
transilluminated photo-negative.
3. With the aid of an IBM PC-AT computer running Optimas software analyze
each image of each black and white lattice negative. Using the "mouse" draw
round the perimeter of each of the digitised lattice images, which are
displayed on a large format high resolution monitor. The lattice images
displayed on this large format high resolution monitor are magnified by a
factor of 10 (a 3.5 cm diameter petri dish measuring 35 cm on the monitor).
Once the perimeter of the lattice has been defined the Optimas software
package calculates lattice area and expresses this information in terms of
square pixels. Using the calibration facility within the Optimas program in
conjunction with the scale on the millimetre rule, photographed with each




The cell exposure chamber
1. Loosen the 6 end plate retaining nuts and disassemble the exposure chamber
(figure 13.1).
2. Thoroughly wash all components in 5% aqueous solution of RBS 25 detergent
(Solmedia, Essex, UK) at a temperature of 50°C and rinse well with distilled
water. Dry components in a 60°C oven.
3. Assemble components loosely, place in an autoclave bag and autoclave at 100
kPa at a temperature of 120°C for 20 minutes.
4. Once the chamber assembly is sterile, ultrasound-transparent cling film
windows are then fitted. Stretch cling film over a wooden embroidery frame,
sterilise the cling film by rinsing with 70% ethanol, and leave to dry in a
laminar flow cabinet.
5. On one side of chamber, loosen end plate retaining nuts, and remove the end
plate assembly. Lay stretched cling film sheet over centre plate such that the
side washed with 70% ethanol is innermost. Replace end plate and end plate
retaining nuts. Firmly tighten all three nuts, thus trapping and sealing the cling
film in position against the rubber "0" ring of the centre plate. Repeat
procedure for other side of chamber.
6. After constructing the cling film windows at each end of the chamber, remove
the loading port bolt and load 2 ml of sterile PBS with a sterile glass pasteur
pipette. Replace the loading port bolt and swirl the PBS over all inner
surfaces of the chamber; this practice wets the inner surfaces of the chamber
and thus reduces the likelihood of bubble formation within the chamber
during loading of cell suspensions. After wetting, remove PBS with a sterile
glass pippete.
7
	 The chamber is now ready to be loaded with a given cell suspension.
8 Loading is accomplished using a sterile long shaft pasteur pipette. After
filling the pipette with the cell suspension, the tip of the pipette is gently
inserted into the loading port and lowered until it touches the inner wall of
the chamber. The contents are then slowly dispensed into the chamber
ensuring that bubble formation is avoided. The loading port bolt is then









Appendix 13 - continued
9. After treatment the chamber is first rinsed in 70 	 alcohol to sterilise, the
loading port bolt removed and the cell suspension extracted.
10. Before the chamber is used again it is rinsed with three changes of sterile
PBS.
	KEY: CP	 -	 Centre plate
	
EB	 -	 End plate retaining bolt
	
EP	 -	 End plate
	
LB	 -	 Loading port bolt
	
LP	 -	 Loading port
Figure 13.1 The cell exposure chamber
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APPENDIX 14
Lattice formulations used in the study of the effect of cell number and collagen
concentration on fibroblast populated collagen lattice contraction (p 176).
L	 Lattices with 1.2 m/ml collaen & I x 1O fibroblasts per ml.
3 ml neutralised collagen (Appendix 10)
1.5 ml Ham' FlO (x3) (Appendix 2D)
1.5 ml of 4 x iO cells/mi fibroblast suspension (Appendix 6)
2.	 Lattices with 1.2 m-/ml colla2-en & 2 x 1& fibroblasts per ml
3 ml neutralised collagen
1.5 ml Ham' FlO (x3)
1.5 ml of 8 x iO cells/mi fibroblast suspension
3.	 Lattices with 1.2 m2-/mI collaRen & 3 x 1O fibroblasts per ml
3 ml neutralised collagen
1.5 ml Ham' FlO (x3)
1.5 ml of 12 x iO cells/mi fibroblast suspension
4.	 Lattices with 1.6 m-/ml colla-en & 1 x 1O fibroblasts per ml
4 ml neutralised collagen
1.0 ml Ham' FlO (x5) (Appendix 2D)
1.0 ml of 6 x iO cells/mi fibroblast suspension
5.	 Lattices with 1.6 m2/,nl collaRen & 2 x 1 fibroblasts per ml
4 ml neutralised collagen
1.0 ml Ham' FlO (x5)
1.0 ml of 12 x iO cells/mi fibroblast suspension
6.	 Lattices with 1.6 m'/ml colla2-en & 3 x 10N fibroblasts per ml
4 ml neutralised collagen
1.0 ml Ham' FlO (x5)
1.0 ml of 18 x iO cells/mi fibroblast suspension
























































































Indirect immunofluorescence method used to characterise p6 human dermal
fibroblasts
1. Prepare sterile coverslips:
a. Immerse coverslips in 70% alcohol and flame to sterilise.
b. Place coverslips in the bottom of 60 mm petri dishes.
2. Plate Out p6 human dermal fibroblasts, p31 SVK14 transformed keratinocytes and p7
bovine aortic endothelial cells onto coverslips in different petri dishes.
a. Trypsinize cell monolayers (Appendix 4).
b. Resuspend cells to a concentration of 1 x 106 cells per ml.
c. Place 2 ml of cell suspension into each 60 mm petri dish.
d. Place seeded petri dishes in a 37°C humidified incubator until cells are confluent.
3. Once confluent monolayers are achieved fix the coverslips.
a. Wash coverslips twice in PBS (Appendix 1A).
b. Fix cells with 4% paraformaldehyde (Appendix 1D).
c. Wash twice more in PBS.
4. Label with antibody.
a. Permeabilize cells with 0.1% v/v triton X-100 detergent diluted in PBS for 15
minutes.
b. Wash twice in PBS to remove detergent.
c. Apply appropriately diluted primary antibody to coverslip (sufficient to completely
cover the coverslip).
d. Incubate for 1 hour at room temperature in a humidified box.
e. Tap off the antibody onto absorbent paper, wash the coverslip 3 times in PBS and
tap off excess PBS.
f. Apply appropriately diluted secondary antibody to coverslip, return to the
humidified box and incubate for 1 hour.
g. Repeat step e.
h. Wash in distilled water.
i. Mount the coverslip onto a microscope slide with the water based anti-quenching
mountant Citifluor.
j. Seal the coverslip to the microscope slide with nail varnish.
k. View under Olympus BH2 fluorescence microscope fitted with appropriate
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Summary of non-parametric statistical analysis (Mann Whitney-U test). A comparison
of "percentage wound area remaining" data. Both experimental groups, insonated
with intensities of 0.1 or 0.5 W/cm 2 (3 MHz ultrasound), are compared with the
sham-insonated control group at each time point. The statistical significance and p
value is stated for each comparison.
Experimental Insonation	 Sham Insonation	 Probability (p value)
0.1 W/cm2	Not Significant	 0.304
Day 2
0.5 W/cm2	Significant	 5.853 x 1O
0.1 W/cm2	Not Significant	 0.275
Day3
0.5 W/cm2	Significant	 5.634 x 10
0.1 W/cm2	Not Significant	 0.5 93
Day 4
0.5 W/cm2	Not Significant	 0.094
0.1 W/cm2	Significant	 1.326 x iO
Day 5
0.5 W/cm2	Not Significant	 0.144
0.1 W/cm2	Significant	 4.875 x iO
Day 6
0.5 W/cm2	Significant	 0.040
0.1 W/cm2	Significant	 1.196 x 10
Day7
0.5 W/cm2	Sigmficant	 2.225 x iO
0.1 W/cm2	Significant	 2.035 x i0
Day 8
0.5 W/cm2	Significant	 9.457 x iO
0.1 W/cm2	Significant	 1.655 x iO
Day9
0.5 W cm2	Significant	 6.276 x iO
0.1 W/cm-	 Sigmficant	 7.68 x 10
DaylO
0.5 W cm2	Significant	 0.0 14
0.1 Wfcm2	Significant	 0.011
Day!!	 .


































Table 1. The effect of therapeutic ultrasound on fibroblast proliferation in vitro.
Summary of non-parametric statistical analysis (Mann Whitney-U test). Both
experimental groups, insonated with intensities of 0.1 or 0.5 W/cm2 (3 MHz pulsed
[2:8J ultrasound), are compared with the sham-insonated control group at each time
point. The statistical significance and p value are stated for each comparison.
	
Experimental Insonation 	 Sham Insonation	 Probability (p value)
	
0.1 W/cm2 	Not significant	 0.808
12 hours
	
0.5 W/cm2 	Not significant	 0.935
	
0.1 W/cm2 	Not significant	 0.575
36 hours	
0.5 W/cm2	 Not significant	 0.145
	
0.1 Wfcm2 	Not significant	 0.687
60 hours	
0.5 W/cm2 	Not significant	 0.470
	
0.1 W/cm2 	Not significant	 0.467
84 hours	
0.5 W/cm 2	Not sigmficant	 0.375
	
0.1 Wfcm2 	Not significant	 0.093
108 hours	
0.5 W/cm2 	Not significant	 0.521
Table 2. The effect of therapeutic ultrasound on fibroblast proliferation in vitro.
Summary of non-parametric statistical analysis (Mann Whitney-U test). Human
fibroblast proliferation in response to insonation with 3 MHz therapeutic ultrasound
at an intensity of 0.1 W/cm 2 compared with 0.5 W/cm2. The statistical difference and
p value are stated for each comparison (i.e at each time point).
Time (hours)	 12	 36	 60	 84	 108
Statistically different	 No	 No	 No	 Yes	 No
Probability (p value)	 0.746	 0.334	 0.26 1	 0.008	 0.470
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APPENDIX 20
Table 1. The effect of therapeutic ultrasound on the contraction of fibroblast-
populated collagen lattices in vitro. Summary of non-parametric statistical analysis
(Mann Whitney-U test). Both experimental groups, insonated with intensities of 0.1
or 0.5 W/cm2 (3 MHz pulsed [2:8] ultrasound), are compared with the sham-
insonated control group at each time point. The statistical significance and p value
are stated for each comparison.
Experimental Insonation	 Sham Insonation	 Probability (p value)
0.1 W/cm2 	Not significant	 0.230
9 hours
0.5 W/cm2 	Significant	 0.0 13
0.1 Wfcm2 	Not significant	 0.471
21 hours	
0.5 W/cm2	 Not sigmficant	 0.936
0.1 W/cm2 	Not significant	 0.810
28 hours	
0.5 W/cm2 	Not significant	 0.8 10
0.1 W/cm2 	Not significant	 0.575
50 hours	
0.5 W/cm2 	Not significant	 0.093
0.1 W/cm2 	Not significant	 0.936
58 hours	
0.5 WIcm2	 Not significant	 0.47 1
Table 2. The effect of therapeutic ultrasound on the contraction of fibroblast-
populated collagen lattices in vitro. Summary of non-parametric statistical analysis
(Mann Whitney-U test). FPCL contraction in response to insonation with 3 MHz
therapeutic ultrasound at an intensity of 0.1 W/cm 2 is compared with 0.5 W/cm2. The
statistical difference and p value are stated for each comparison (i.e at each time
point).
Time (hours)	 9	 21	 28	 50	 58
Statistically different 	 No	 No	 No	 No	 No
Probability (p value)


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































The effect of progressive dilutions of both U937 conditioned medium and unconditioned
RPMI-1640 on fibroblast proliferation in vitro.
Introduction
When U937 conditioned RPMI-1640 medium is applied to fibroblasts in culture tIbroblast
proliferation is inhibited. Unconditioned RPMI-1640 does not similarly suppress fibroblast
proliferation. Inhibition may be brought about by a number of mechanisms, including (1) the
depletion of a nutrient component of RPMI-1640 by U937s, which is essential for fibroblast
proliferation, and (2) the elaboration by U937s of a "factory
 that inhibits fibroblast
proliferation. In order to explain the inhibitoiy nature of U937 conditioned medium on
fibroblast growth, serial dilutions of both conditioned and unconditioned macrophage
medium (RPMI-1640) were applied to fibroblast cultures. If U937 conditioned medium is in
some way deficient, compared with unconditioned RPMI-1640 medium, further dilution of
this conditioned medium would further enhance this deficiency, thus further reducing
fibroblast growth. If, however, U937 conditioned medium contained an inhibitor for fibroblast
growth, dilution of this medium would have the opposite effect and stimulate fibroblast
growth.
The methylene blue fibroblast proliferation assay (p149), a modification of the
colorimetric assay described by Oliver et a!. (1989), was used to investigate the effect of
adding various dilutions of both U937 conditioned and unconditioned RPMI-1640 on human
dermal fibroblast proliferation.
Method
The standard protocol for the Methylene Blue Fibroblast Proliferation Assay (Appendix 8)
was employed with the following additions/modifications.
Briefly, sub-confluent human dermal fibroblast monolayers, passage 6, were
trypsinised (Appendix 4), washed in fibroblast growth medium (Appendix 2B) and
resuspended in the same to a final concentration of 2 x iO viable cells ml (Appendix 6). 100
iil volumes of this cell suspension, containing 2000 cells, were aliquoted into 72 wells (i e.
filling all wells in columns 1 to 12, with the exception of those wells in rows A and H) of a
96 well flat-bottomed microtitre plate (Appendix 9). The 24 remaining wells (i.e. all wells in
columns 1 to 12 that did not receive the cell suspension) were filled with fibroblast growth
medium alone. The plate was sealed and placed in a 37°C incubator for a period of 12 hours
to allow for cell attachment. U937 conditioned medium (RPMI-1640 "conditioned" media
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number 2, table 11.1, p282) was removed from -20°C storage, thawed and sterilised with a
0.22 i.im millipore filter. After sterilisation the conditioned medium was serially diluted to 80,
60, 40 and 20% of its original concentration using sterile PBS. Unconditioned RPMI-1640
was similarly diluted using PBS.
After 12 hours the plate was removed from the incubator and the plate sealing tape
removed. One of the twelve columns of wells was designated to receive one of the five U937
conditioned RPMI-1640 dilutions (100%, 80%, 60%, 40% or 20%) or one of the five
unconditioned RPMI-1640 dilutions. The two remaining columns were designated to receive
the diluent, PBS, alone. All eight wells of a given column, including the cell free wells,
received 100 l of a given RPMI-1640 dilution or PBS. Once all wells had received 100 .il
of media, or PBS, the plate was resealed and returned to the 37°C incubator. 108 hours after
initial seeding with fibroblasts the plate was stopped according to Appendix 8 steps 6 through
9).
Fibroblast monolayers within the wells were then stained with methylene blue dye,
washed with 0.01 M borate buffer, and the dye eluted with acid-alcohol. The absorbance
(A) of each well was then measured (Appendix 8, steps 10 through 12). For each column
of wells, and hence for each medium dilution under test, the average A 650 value of cell-free
wells was subtracted from each of the A650 readings of cell containing wells. The fibroblast
number within a given well was then calculated from these corrected A650 values using a
standard plot of human dermal fibroblast number versus A (Appendix 29B). This standard
plot was prepared according to the method described in chapter 5 (p152) using the same
primary culture of fibroblasts, at the same passage (p6), as was used for the fibroblast
proliferation assay above.
For each medium dilution and PBS the median fibroblast number within the 6 wells
(or 12 wells in the case of PBS) was reported. Minimum and maximum fibroblast number
and 95% confidence intervals were reported to indicate data distribution (table 27.1).
Results and discussion:
Figure 27.1 displays the variation in median fibroblast number in response to the application
of the five U937 conditioned medium dilutions, the five unconditioned medium dilutions and
PBS. 95% confidence intervals are displayed to indicate data distribution.
From figure 27.1, the data table 27.1, the following points are apparent.
1. The application of progressive serial dilutions of normal unconditioned serum-free RPM!-
1640 to fibroblast cultures results in a progressive reduction in fibroblast proliferation. By 108
hours there are more fibroblasts within wells supplemented with 100% unconditioned RPM!-
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medium; the latter, in turn contain more fibroblasts than those wells supplemented
with 60% unconditioned medium. This trend is continued with progressive dilution,
with the fewest fibroblasts found in wells supplemented with the diluent, PBS alone.
2. The application of progressive serial dilutions of U937 conditioned medium to
fibroblast cultures does not result in a progressive reduction in fibroblast
proliferation. By 108 hours there are fewer fibroblasts within wells supplemented with
100% unconditioned than in similar wells supplemented with 80% unconditioned
medium. Serial dilution of U937 conditioned medium from 80% to 20% appears to
follow a trend similar to that of unconditioned medium, in that progressive dilutions
of U937 conditioned medium appear to result in progressively fewer fibroblasts
within wells.
The progressive reduction in fibroblast growth in response to the application
of progressively more dilute unconditioned RPM!- 1640 to fibroblast cultures indicates
that fibroblasts can respond to growth medium deficiencies. Thus, if nutrient
depletion was primarily involved in the U937 conditioned medium inhibition of
fibroblast growth, further depletion of U937 conditioned medium, by dilution, should
result in further fibroblast growth inhibition. However, the observation that fibroblast
proliferation was found to be more rapid in response to 80% U937 conditioned
medium than 100% U937 conditioned medium suggests that U937 conditioned
medium contains some form of inhibitor for fibroblast growth. With subsequent
progressive dilutions of conditioned medium fibroblast growth was inhibited, it is
therefore suggested that this reduction in fibroblast growth, which parallels medium
dilution, may be associated with nutrient depletion.
In summary, under the tissue culture conditions used in this thesis, the macrophage-
like cell line (U937) has been shown to elaborate an inhibitor of fibroblast growth.
(A discussion relating to the possible identity of this fibroblast growth inhibitor can
be found on page 293).
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APPENDIX 28
The effect of therapeutic ultrasound on U937 viability
Under the culture conditions employed in this thesis U937s (both uninduced and
PMA-induced) appear to elaborate an inhibitor of fibroblast growth. Exposure of
U937s to therapeutic ultrasound appears to reduce, if not completely annul, the
production of a fibroblast growth inhibitor by U937s (chapter 11, p276). In order to
investigate the mechanism by which therapeutic ultrasound may prevent inhibitor
production by U937s, a study was performed to investigate the effect of therapeutic
ultrasound on U937 viability. A loss in viability of fibrobiast growth inhibitor-
producing cells would be expected to lead to a reduction in the level of inhibitor
within medium conditioned by those cells.
Insonation of U937s and cell counting
U937 cells were cultured at 37°C in 80 cm 2 tissue culture flasks (Nunc, Denmark) in
RPMI-1640 medium containing 10% (v/v) heat inactivated fetal calf serum (FCS),
100 .g/mI streptomycin, 100 units/mi penicillin (macrophage growth medium,
Appendix 2E, p336) according to Turck et a! (1989). A U937 suspension was
prepared at a concentration of 1 x 106 viable cells/mi in macrophage growth medium.
This suspension was divided into two aliquots and then centrifuged for 5 minutes at
80 x g. The two cell pellets thus obtained were washed twice with serum-free growth
medium and then resuspended to 1 x 106 viable cells/mi in either: A. Serum-free
macrophage growth medium (Appendix 2G, p337), or, B. Serum-free macrophage
growth medium containing 100 ng/ml 4/3-phorbol 12-myristate 13-acetate (PMA)
(Appendix 2H, p337).
Thus forming two U937 stock suspensions:
A. Non-PMA exposed U937s
B. PMA exposed U937s
4ml volumes of these two U937 stock suspensions were aliquoted into sterile,
universal bottles, and held at 20°C (room temperature). The exposure chamber
(Appendix 13, figure 13.1, p3'19) was then prepared and loaded, according to
Appendix 13 (p348), with the first aliquot. The exposure chamber was located in the
exposure tank (figure 11.1, p281) which was lined with ultrasound absorbent rubber
(dimpled car matting) and filled with circulating degassed distilled water at 37°C.
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U937 samples were insonated with 3 MHz pulsed (1:4) ultrasound at intensities,
1(SATA), of 0.1 W/cm2 or 0.5 W/cm2, or sham-insonated, for a period of 5 minutes. One
aliquot of each U937 stock suspension, termed non-insonated, was neither insonated
nor sham-insonated, but, rather left untreated. The therapeutic ultrasound source
used in this study was a standard Enraf Nonius Deift 434 Sonopuls machine (Enraf
Nonius DeIft, Holland), set to deliver 3 MHz ultrasound (figure 7.2, p222). Prior to
U937 exposure, ultrasonic output was calibrated and the generator set to deliver a
fixed ultrasonic intensity - according to chapter 6 (pl87).
After treatment U937 suspensions were unloaded from the exposure chamber
(or from the universal bottle in the case of the non-insonated aliquot) into sterile
centrifuge tubes and centrifuged at 80 x g for 5 minutes. Supernatants were discarded
and cell pellets resuspended in serum-free growth medium with or without PMA
according to which U937 stock suspension the treated sample originated. The volume
of medium used to resuspend the different cell pellets depended upon the cell
suspension volume previously centrifuged. U937 suspensions were then transferred
to culture flasks and returned to a 37°C incubator.
One hour post-exposure the U937 cultures were removed from the incubator,
gently mixed to homogeneity, samples removed and viable cell counts performed on
these samples using a haemocytometer. Cell counts were performed according to
Appendix 6 (p340) employing trypan blue to assess cell viability. Counts were
performed in triplicate. After sampling the different U937 cultures were returned to
a 37°C incubator. Viable cell counts were similarly performed twenty four hours after
exposure. Average viable cell counts were tabulated (table 28.1).
Results: Non-PMA-exposed U937s
1. By studying the number of viable cells present after 1 hour the following points are
apparent:
(a) There was a loss in viable cell number, relative to the initial seeding
density of 0.97 x 106 cells/mI, in all treatment groups.
(b) Sham-insonated U937 cultures appeared to experience a slightly
greater loss in viable cell number than similar non-insonated cultures.
(c) Ultrasound-exposed U937 cultures experienced a significantly greater loss
in viable cell number than similar non-insonated or sham-insonated U937
cultures.
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2. By studying the number of viable cells present after 24 hours the following points
are apparent:
(a) There were further losses in viable cell number, above that observed at
1 hour, in all treatment groups.
(b) Non-insonated U937 cultures experienced the smallest "further loss" in
viability (viability fell by 12.5%). The remaining U937 cultures experienced
more extensive further losses in viability, with viability falls of 24.1% for the
sham-, 26.1% for the 0.1 W/cm2, and 26.0% for the 0.5 W/cm2-insonated
cultures
Results: PMA-exposed U937s
1. By studying the number of viable cells present after 1 hour the following points are
apparent:
(a) As with the non-PMA-exposed U937 cultures, there was a loss in viable
cell number, relative to the initial seeding density of 0.97 x 106 cells/mI, in all
treatment groups.
(b) Sham-insonated U937 cultures appeared to experience a similar loss in
viable cell number to non-insonated cultures.
(c) In a similar fashion to non-PMA-exposed cultures, ultrasound-treated
PMA-exposed U937 cultures experienced a significantly greater loss in viable
cell number than similar non-insonated or sham-insonated U937 cultures.
2. By studying the number of viable cells present after 24 hours the following points
are apparent:
(a) As with the non-PMA-exposed U937 cultures, there were further losses
in viable cell number, above that observed at 1 hour, in all treatment groups.
(b) The extent of this further loss in viability was dependent upon treatment.
In parallel with the results observed in non-PMA-exposed U937s, non-
insonated PMA-exposed U937 cultures experienced the smallest further loss
in viability (viability fell by 20.7%). The remaining U937 cultures experienced
more extensive further losses in viability, with viability falls of 29.0% for the
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U937s exposed to therapeutic ultrasound experience a significant loss in cell viability.
It is apparent that ultrasound-exposed U937 cultures, both non-PMA-exposed and
PMA-exposed, contain significantly fewer viable cells than similar sham or non-
insonated U937 cultures when studied 1 hour after exposure. This observation
suggests ultrasound-mediated cell killing. This killing occurs during ultrasound
exposure, or soon thereafter. It is also apparent that in addition to this exposure-
associated cell killing a further population of cells are irreversibly damaged, to such
an extent that cell death occurs some time after exposure. The results indicate PMA-
exposed U937s are less resistant to the damaging effects of ultrasound. It is possible
that PMA-exposure prior and during ultrasonic exposure predisposes U937 cultures,
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